Postoperative on-line monitoring with intraperitoneal microdialysis (IPM) detects early visceral ischemia and correlates to the current intraperitoneal cytokine response by Jansson, K et al.
S1
Available online http://ccforum.com/supplements/7/S2
Critical Care Volume 7 Suppl 2, 2003
23rd International Symposium on Intensive Care and Emergency
Medicine
Brussels, Belgium, 18–21 March 2003
Published online: 3 March 2003
This article is online at http://ccforum.com/supplements/7/S2
© 2003 BioMed Central Ltd (Print ISSN 1364-8535; Online ISSN 1466-609X)
P1 Endocrine dysfunction in the immediate period following traumatic brain injury
I Dimopoulou, S Tsagarakis, G Assithianakis, M Christoforaki, M Theodorakopoulou, A Kouyialis, S Korfias, N Thalassinos, 
C Roussos
Department of Critical Care Medicine and Department of Endocrinology, Evangelismos Hospital, Athens, Greece
Critical Care 2003, 7(Suppl 2):P001 (DOI 10.1186/cc1890)
Studies on head injury-induced pituitary dysfunction are limited in
number and conflicting results have been reported. To further clarify
this issue, 29 consecutive patients (24 males), with severe (n=21)
or moderate (n=8) head trauma, having a mean age of
37±17 years were investigated in the immediate post-trauma
period. All patients required mechanical ventilatory support for
8–55 days and were enrolled in the study within a few days before
ICU discharge. Basal hormonal assessment included measurement
of cortisol, corticotropin, free thyroxine (fT4), thyrotropin (TSH),
testosterone (T) in men, estradiol (E2) in women, prolactin (PRL),
and growth hormone (GH). Cortisol and GH levels were measured
also after stimulation with 100µg human corticotropin releasing
hormone (hCRH) and 100µg growth hormone releasing hormone
(GHRH), respectively. Cortisol hyporesponsiveness was consid-
ered when peak cortisol concentration was less than 20µg/dl fol-
lowing hCRH. TSH deficiency was diagnosed when a subnormal
serum fT4 level was associated with a normal or low TSH. Hypogo-
nadism was considered when T (males) or E2 (women) were below
the local reference ranges, in the presence of normal PRL levels.
Severe or partial GH deficiencies were defined as a peak GH
below 3µg/l or between 3 and 5µg/l, respectively, after stimulation
with GHRH. Twenty-one subnormal responses were found in 15 of
the 29 patients (52%) tested; seven (24%) had hypogonadism,
seven (24%) had cortisol hyporesponsiveness, five (17%) had
hypothyroidism, and two patients (7%) had partial GH deficiency.
These preliminary results suggest that a certain degree of hypo-
pituitarism occurs in more than 50% of patients with moderate or
severe head injury in the immediate post-trauma period, with cortisol
hyporesponsiveness and hypogonadism being most common. Further
studies are required to elucidate the pathogenesis of these abnor-
malities and to investigate whether they affect long-term morbidity.
P2 Cortisol reserve in head trauma victims: evaluation with the low-dose (1µ µg) corticotropin (ACTH) stimulation test
I Dimopoulou, A Kouyialis, S Tsagarakis, M Theodorakopoulou, G Assithianakis, M Christoforaki, N Thalassinos, C Roussos
Department of Critical Care Medicine and Department of Endocrinology, Evangelismos Hospital, Athens, Greece
Critical Care 2003, 7(Suppl 2):P002 (DOI 10.1186/cc1891)
To investigate cortisol reserve in head trauma, 35 consecutive
patients (30 men) with a mean age of 36±16 years were studied
5–60 days after physical injury. Patients were enrolled in the study
within a few days before ICU discharge. First, a morning blood
sample was obtained to measure baseline cortisol, and ACTH
plasma levels. Subsequently, 1µg synthetic ACTH was injected
intravenously and, 30 min later, a second blood sample was drawn
to determine stimulated plasma cortisol. Patients having stimulated
cortisol levels below 18µg/dl were defined as nonresponders to
the low-dose stimulation test (LDST). Mean (±SD) values for
ACTH, baseline, and stimulated cortisol concentrations were
49±27pg/ml, 19.7±5.5µg/dl and 23.6±6.7µg/dl, respectively.
Six of the 35 patients (17%) failed the LDST. Nonresponders were
similar to responders with regard to age, gender, and severity of
head injury. However, nonresponders more frequently required
vasopressors (6/6 vs 14/29, P=0.02) and for a longer time inter-
val (median, 293 hours vs 24 hours, P=0.01) to maintain haemo-
dynamic stability compared with responders to the LDST.
In conclusion, adrenal cortisol secretion following dynamic stimula-
tion is deficient in a subset of head injury patients; this condition is
associated with vasopressor dependency.
P3 Steroid hormone synthesis is impaired in patients with severe sepsis
M Angstwurm, A Rashidi Kia, J Schopohl, R Gaertner
Medical Intensive Care Unit, Medizinische Klinik, Ziemssenstraße 1, 80336 Munich, Germany
Critical Care 2003, 7(Suppl 2):P003 (DOI 10.1186/cc1892)
In patients with severe illness, adrenal insufficiency is often sus-
pected and treatment with hydrocortisone has been shown to
decrease mortality. However, the pathophysiology of an adrenal
failure is only partially understood.
We analyzed the synthesis of different steroid hormones within
the adrenal in severely ill patients in a prospective study using
the established high dose stimulation test with synthetic
cosyntropin.S2
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Using commercially available essays, the steroid hormones proges-
terone, cortisole, testosterone, dehydroepiandrostenedione (DHEAS)
and 17β-estradiol were determined before, and 30 and 60 min
after stimulation with cosyntropin. Patients were characterized by
scoring systems (APACHE II, SAPS II, MOD score). The underly-
ing admission diagnosis grouped patients in septic, cardiogenic
shock or control.
Sixty-five patients (22 in cardiogenic and 43 in septic shock, five
and nine women, mean age 58 years, APACHE score of 20) were
compared with 34 control patients (17 cancer patients, 10 healthy,
four pulmonary emphysema and three other).
At baseline, septic and cardiogenic patients showed similar cortisol
levels (21 and 21µg/dl), higher than control (15µg/dl,  P<0.05).
Progesterone was increased fourfold (P<0.001) in septic
(1.2ng/ml) and cardiogenic shock (1.1ng/ml) compared with
control (0.3ng/ml). Men with sepsis had the highest β-estradiol
levels. Baseline cortisol levels were only slightly higher in intensive
care patients compared with control. There were no clear correla-
tions between steroid hormones and scoring systems or laboratory
signs of infections like CRP, PCT, leukocyte or platelet counts.
After stimulation with cosyntropin, testosterone, 17β-estradiol and
DHEAS remained constant, whereas progesterone increased
(P<0.001) in all groups of patients without significant difference
between groups. In control or cardiogenic patients cosyntropin
stimulation leads to significantly increasing values of cortisol
(P=2.15×10 –12 and  P=0.04); in patients with sepsis the
increase of cortisol (P>0.1) was blunted, however. This decrease
in cortisol stimulation was independent of the use of sedatives or
mechanical ventilation. In cardiogenic patients the increase in corti-
sol levels after stimulation was similar to control patients (7µg/dl)
and was not influenced by increasing dosage of catecholamines; in
septic patients the cortisol increase was significantly lower
(P<0.01) with high catecholamines (2µg/dl) than with low cate-
cholamines (7µg/dl).
At baseline, patients at the intensive care unit had higher proges-
terone levels than normal. Septic patients showed diminished
response to cosyntropin stimulation regarding cortisol levels
despite a normal increase of progesterone. This points to an
impairment of cortisol synthesis.
P4 Determination of functional states during sepsis-induced activation of the hypothalamic–pituitary–adrenal (HPA) axis
using measurement of ACTH, cortisol, dehydroepiandrosterone-sulfate (DHEAS) and dehydroepiandrosterone (DHEA)
C Marx1,2, M Wendt1, SPetros3, L Engelmann1, M Weise2, G Höffken1
1Internal Medicine I/2Medical ICU, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307 Dresden; 3Medical ICU, University of
Leipzig, Germany
Critical Care 2003, 7(Suppl 2):P004 (DOI 10.1186/cc1893)
Introduction Activation of the HPA axis occurs in order to control
potentially deleterious effects of systemic inflammation during
sepsis. Practically, it is difficult to determine different states of HPA
activation since a differing dynamics and individual risk have to be
considered.
Methods Recently, we examined levels of cortisol, DHEAS, DHEA
as well as ACTH in 30 patients with severe sepsis (15 survivors,
15 nonsurvivors) and correlated the time course during early and
late sepsis to the clinical course and inflammatory markers [1].
Here, we demonstrate and describe different states of HPA activa-
tion in characteristic surviving (n=3) and nonsurviving (n=3) septic
patients of this study by use of hormone and inflammatory profiles.
Results Four functional states of HPA response with prognostic
relevance could be differentiated. I) Activation: infection, systemic
inflammation and activation of the HPA axis; high cytokine levels
lead to release of ACTH and cortisol. II) Immunogenic stimulation:
high cytokine levels maintain cortisol release whereas ACTH is
suppressed by high glucocorticoid levels. III) Suppression of
inflammation or exhaustion and hyperinflammation, respectively:
suppression of inflammation by glucocorticoids or development of
relative adrenal insufficiency by adrenal exhaustion resulting in rela-
tive hyperinflammation. IV) Recovery or insufficiency, respectively:
normalisation of cytokine levels and regeneration of the adrenal
driven by normalisation of ACTH. Reconstitution of physiologic
ACTH-driven regulation or relative adrenal insufficiency with poor
prognosis, respectively.
Discussion The HPA axis reflects the individual prognostic risk of
the patient. The clinical course rarely enables the detection of all
time-dependent states of HPA response. For individual diagnostic
benefit of hormone measurements in septic patients, rapid avail-
ability of hormone levels is necessary.
Reference
1. Marx C, et al.: Adrenocortical hormones in survivors and non-
survivors of severe sepsis: diverse time course of dehy-
droepiandrosterone, dehydroepiandrosterone-sulfate, and
cortisol. Crit Care Med 2003, in press.
P5 Does transient hyperglycaemia affect cerebral energy metabolism in patients with severe brain trauma?
C-H Nordström, P Diaz-Parejo, N Ståhl, W Xu, P Reinstrup, U Ungerstedt
Department of Clinical Neuroscience, Lund University Hospital, S-22185 Lund, Sweden
Critical Care 2003, 7(Suppl 2):P005 (DOI 10.1186/cc1894)
Objective To study whether transient hyperglycaemia adversely
affects cerebral energy metabolism in patients with severe trau-
matic brain lesions.
Design Prospective, nonrandomised study.
Interventions All patients were treated according to neurosurgical
intensive care routine including monitoring of intracranial pressure.
One microdialysis catheter was inserted via a burr hole frontally to
that used for the intraventricular catheter (‘better’ position). In
patients with focal lesions one or more catheters were inserted intoS3
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the cerebral cortex surrounding an evacuated focal contusion or
underlying an evacuated haematoma (‘worse’ position). The perfu-
sion rate was 0.3µl/min and samples were taken every 30 or
60 min. The levels of glucose, pyruvate, lactate, glutamate, and
glycerol were analysed and displayed bedside.
Measurements and main results In 108 patients, 18 episodes of
moderate (12–15mmol/l) and six episodes of pronounced
(>15mmol/l) hyperglycaemia occurred. Moderate hyperglycaemia
did not change intracerebral levels of lactate, pyruvate, glutamate,
glycerol or lactate/pyruvate ratio. During pronounced hypergly-
caemia lactate concentration increased. A pronounced cerebral
lactic acidosis and a moderate increase in interstitial glycerol con-
centration indicating cell membrane degradation was observed in a
single patient with pronounced, long-lasting hyperglycaemia.
Conclusions Cerebral energy metabolism was affected by tran-
sient hyperglycaemia only at blood glucose concentration above
15mmol/l as shown by a moderate increase in interstitial lactate
level.
P6 Hyperglycemia at admission to ICU is independently associated with increased serum levels of IL-6 and reduced ex vivo
TNF-alpha production
HE Wasmuth1, F Lammert1, J Graf2, EA Purucker1, A Koch1, C Gartung1, D Kunz3, AM Gressner3, S Matern1
1Department of Medicine III and 2Department of Medicine I, and 3Institute of Clinical Chemistry and Pathobiochemistry, University Hospital
Aachen, Aachen University, Pauwelsstraße 30, 52074 Aachen, Germany
Critical Care 2003, 7(Suppl 2):P006 (DOI 10.1186/cc1895)
Background Hyperglycemia has been shown to be an independent
risk factor of mortality in patients with stroke and myocardial infarc-
tion. Furthermore, strict control of hyperglycemia reduces mortality
and rates of infectious complications in surgical ICU patients. The
aim of the present study was to investigate immunological changes
in medical patients in relation to blood glucose at admission to ICU.
Patients and methods Overall, 189 consecutive medical ICU
patients were enrolled. At admission, blood glucose and serum
levels of IL-6, IL-8, IL-10, and TNF-alpha were measured. Further-
more, monocyte HLA-DR expression and ex vivo TNF-alpha pro-
duction in whole blood after stimulation with LPS were determined.
In all patients, SAPS II score was calculated for day of admission
to ICU. Hyperglycemia was defined as a venous blood glucose
>126mg/dl in fasting and >200mg/dl in nonfasting individuals.
Frequencies in contingency tables were calculated with Fisher’s
exact test. Logistic regression was used with hyperglycemia as the
dependent variable and immune parameters, SAPS II score, and
history of diabetes as covariates.
Results Overall mortality within the study period was 20.1%. Patients
with hyperglycemia had an increased risk of mortality in the ICU com-
pared with patients with normoglycemia at admission (29.3% vs
15.2%; OR=2.3, P=0.03). Sepsis according to Bone criteria was
equally distributed between groups (14.3% vs 10.7%; P>0.05). At
logistic regression analysis, higher serum levels of IL-6, a reduced
ex vivo production of TNF-alpha, and a history of diabetes were inde-
pendently associated with hyperglycemia at admission to ICU
(P=0.007, P<0.001, P=0.002, respectively), while IL-8, IL-10, TNF-
alpha, monocyte HLA-DR expression and the SAPS II score were not
associated with increased blood glucose levels (all P>0.05).
Conclusions Independent of SAPS II score and underlying
disease, hyperglycemia at admission to ICU is associated with
immunological changes that are frequently observed in critically ill
patients (‘immunoparalysis’). Particularly, a reduced ex vivo produc-
tion of TNF-alpha might contribute to the increased risk for infec-
tious complications and death in patients with acute and chronic
hyperglycemia.
P7 Influence of insulin clearance to glucose tolerance in acutely ill severe patients: analysis with glucose clamp method by
means of artificial pancreas
M Hoshino1, Y Haraguchi2, M Sakai1, I Mizushima1, Y Morita1, M Kobayashi1
1Department of Intensive and Critical Care Medicine, Tokyo Police Hospital, Fujimi 2-10-41, Chiyoda-ku, 102-8161 Tokyo, Japan; 
2Tokyo Disaster Medical Center, Tokyo, Japan
Critical Care 2003, 7(Suppl 2):P007 (DOI 10.1186/cc1896)
Purpose Acutely ill patients often have glucose intolerance (GI),
which is one of the factors preventing appropriate nutritional
support. However, mechanisms of GI are not clearly understood.
Among the factors that influence GI, insulin sensitivity (IS) and
insulin clearance (IC) are considered to be the important factors,
because insulin is one of the most important factors which control
glucose metabolism and insulin therapy is usually performed for
patients with GI. We investigated glucose tolerance in terms of IS
and IC in acutely ill severe patients by the glucose clamp method
(GC) by means of a bedside-type artificial pancreas (STG-22:
NIKKISO Corporation, Tokyo, Japan).
Method Thirty-one patients (27 patients had sepsis) in whom
blood glucose levels were controlled by means of the artificial pan-
creas were investigated. First measurement of GC was performed
in acute condition or within 3 days after admission for all the
patients, and second measurement was done 1 week after the first
measurement for 13 patients. GC was performed with clamped
blood glucose level of 80mg/dl and Insulin Infusion Rate (IIR) of
1.12 and 3.36mU/kg per min. I1/I3 and M1/M3 indicate the blood
insulin level (µU/ml) and glucose disposal rate: M value (mg/kg per
min), when IIR is 1.12/3.36mU/kg per min, respectively (normal
value of M1: 5–10mg/kg per min). M1/I1: (M1/I1×1000) was cal-
culated as the parameter of IS (normal value of M1/I1: more than
50mg/l per kg per min perµU). IC was calculated from the follow-
ing formula: IC=(3.36–1.12)×1000/(I3–I1) (normal value of IC:
10–15ml/kg per min). Glucose tolerance was analyzed in terms of
M1, IS (M1/I1), and IC.
Results 1) The proportion of the patients who had M1 levels less
than 5mg/kg per min (GI), IS (M1/I1) less than 50mg/l per kg per
min per µU (insulin resistance), and IC more than 15ml/kg per min
(increased IC) were 66% (29/44), 27% (12/44), and 61%
(27/44), respectively. 2) Among the patients with GI (n=29), only
38% (11/29) of the patients had insulin resistance. Sixty-two
percent (18/29) of the patients with GI had normal IS, and 83% ofS4
Critical Care    March 2003 Vol 7 Suppl 2 23rd International Symposium on Intensive Care and Emergency Medicine
them (15/18) had increased IC (mean±SD of IC, I1:
22±3.8ml/kg per min, 38.3±9.5µU/ml,  n=15). 3) Among the
patients with normal glucose tolerance (n=15), 93% (14/15) of
them had normal IS. However, one patient had both insulin resis-
tance (M1/I1=43.5mg/l per kg per min perµU) and decreased IC
(IC=3.9ml/kg per min, I1=131µU/ml).
Interpretation and conclusions 1) IC was the important factor
that influenced the glucose tolerance in acutely ill severe patients,
although the mechanisms of the change of IC was unclear. 2) Suffi-
cient insulin administration was considered to be necessary from
the aspect of metabolic and nutritional control for those patients
with increased IC.
P8 Bone turnover in prolonged critical illness: effect of vitamin D
P Vanhove, D Van Roosbroeck, P Wouters, L De Pourcq, R Bouillon, G Van den Berghe
Department of Intensive Care & LEGENDO, Leuven University Hospital, Herestraat 49, 3000 Leuven, Belgium
Critical Care 2003, 7(Suppl 2):P008 (DOI 10.1186/cc1897)
Introduction In prolonged critical illness, substantially increased
bone resorption and osteoblast dysfunction have been reported in
the face of low 25-hydroxy vitamin D [25(OH)D] concentrations.
The current prospective, randomized, controlled study investigates
the impact of increased daily vitamin D supplement during intensive
care on the time course of bone turnover and its major regulators
such as cytokines and calciotropic hormones.
Methods Critically ill patients, assumed to require >10 days of
intensive care, were compared with healthy matched controls and
randomly allocated to a daily vitamin D supplement of either
±200IU (low dose) or ±500IU (high dose). Of the 33 patients
included, 22 remained in ICU for >10 days and were analyzed.
Urine from 24 hour collections and blood was sampled daily for
characterization of vitamin D status, bone turnover and inflammation.
Results The 12 patients who received the high dose vitamin D and
10 patients who received the low dose were comparable at base-
line. At intensive care admission, serum concentrations of
25(OH)D, 1,25(OH)2D, DBP, ionized calcium, osteocalcin, IL-1
and sIL-6-R were lower than in controls; PTH and bone-specific
alkaline phosphatase levels were normal; serum carboxy and amino
terminal of propeptide type-I collagen, serum and urinary collagen
cross-links (βCTX, PYD and DPD) as well as IL-6, TNF-α and OPG
were several fold elevated. sRANKL was undetectable.
The high dose increased circulating 25(OH)D (P<0.05) but
normal levels were not reached and low 1,25(OH)2D levels not
altered. High dose vitamin D slightly increased osteocalcin and
decreased carboxy terminal propeptide type-I collagen (P<0.05).
Bone-specific alkaline phosphatase and collagen cross-links
markedly increased with time in both groups (P<0.01). Elevated
CRP and IL-6 decreased significantly with time and more so in the
high dose group (P<0.05). TNF-α and IL-1 remained unaltered.
Except for a mirroring of βCTX rise by a decrease in OPG, circulat-
ing cytokines were unrelated to the progressively aggravating bone
resorption.
Conclusions Prolonged critically ill patients were vitamin D defi-
cient. Increasing vitamin D supplement to the currently recom-
mended dose did not normalize circulating 25(OH)D or
1,25(OH)2D. Furthermore, severe bone hyperresorption was asso-
ciated with osteoblast dysfunction and aggravated with time in
intensive care, independent of vitamin D supplementation.
P9 Assessment of energy expenditure and CO2 production with different enteral feeds
Z Rusavy, M Zourek, Z Jankovec, D Cechurova, S Lacigova
Department of Medicine I, University Hospital, Plzen Alej Svobody 80, Plzen 300 00, Czech Republic
Critical Care 2003, 7(Suppl 2):P009 (DOI 10.1186/cc1898)
The aim of the study is to consider to which extent the production
of CO2 (VCO2) and the resting energy expenditure (REE) are influ-
enced by overfeeding and to which extent by the composition of
enteral nutrition.
Five male and four female patients with Crohn’s disease in remis-
sion were enrolled. REE and VCO2 were measured using the
method of indirect calorimetry. The measurements were performed
under hospitalization in the morning after 10 hours fasting in four
modifications: I. high sugar (60%) in dose 1.2×REE; II. high sugar
(60%) and high-energy supply (2.4×REE); III. high fat (60%) in
dose 1.2×REE; IV. high fat (60%), high energy (2.4×REE).
Between measurements there was a time interval of 7–10 days,
when patients were only on home enteral nutrition.
Results did not differ depending on the different composition of
nutrition in the case of adequate energy supply I. (REE=
1438±264.1kcal/24 hours, VCO2= 179.1±31.6ml/min)× III. (REE=
1431±342.7, VCO2= 190±54.2), likewise upon overfeeding II.
(REE=1674±389.6, VCO2= 218±52.0)×IV. (REE= 1661±378.7,
VCO2= 202±42.3). In the high-sugar (60%) diet the overfeeding
increased REE (P<0.05) and VCO2 (P<0.01) (I.×II.). In the high-
lipid (60%) diet the overfeeding increased REE (P<0.01) but not
VCO2 (III.×IV.)
Conclusion Excessive energy supply results in higher VCO2 and in
higher REE in comparison with adequate food intake. However, the
nutrition with high content of fat does not lead upon overfeeding to
significant increase of CO2 production. The composition of the
nutrition with appropriate energy amount does not significantly
influence VCO2 and the REE.S5
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P10 The metabolic effect of induced mild hypothermia in critically ill patients
M Bitzani, G Vassiliadou, C Iasonidou, S Tsaggalof, T Kontakiotis, D Riggos
ICU, ‘G. PAPANIKOLAOU’ Hospital, Thessaloniki, Greece
Critical Care 2003, 7(Suppl 2):P010 (DOI 10.1186/cc1899)
Introduction The aim of our study was to evaluate the metabolic
effect of induced mild hypothermia in critically ill patients and to
assess if rewarming reverses these effects.
Methods During a 2 year period, 12 consecutive critically ill patients
under continuous veno-venous hemofiltration (CVVH), due to acute
renal failure, were studied prospectively. All patients were mechani-
cally ventilated, nine of them were sedated but none was paralyzed.
Core temperature (T) was continuously monitored through a
nasopharyngeal sensor, while resting energy expenditure (REE), VO2
and VCO2 were evaluated by means of indirect calorimetry. Baseline
measurements were recorded before the onset of CVVH. Serial
measurements were performed each time T was decreased by 1°C.
After the interruption of CVVH, measurements were also repeated
serially with the increase of core temperature of 1°C.
Results Decrease of temperature from 37°C to 35°C has no sta-
tistically significant influence on metabolic demands. During the
reduction of temperature from 38°C to 35°C a statistically signifi-
cant decrease in REE (2593±228kcal vs 2095±618kcal,
P=0.041), as well as in VCO2 (P=0.051) was observed. A differ-
ence at the limits of significance was also observed in REE from
38°C to 36°C (2593±228kcal vs 2292±434 kcal, P=0.056).
Rewarming was followed by a gradual reverse of these effects.
Statistics were calculated with SPSS version 10, using nonparametric
tests. Correlation between T, REE, VO2 and VCO2 was tested by Pear-
son’s correlation coefficient. Comparison between REE, VO2 and VCO2
at different temperatures was performed using Student’s paired t test.
Conclusion Mild hypothermia does not affect the metabolic rate in
critically ill patients. Cooling in the febrile critically ill patient is fol-
lowed by a significant decrease in energy expenditure. This may
prove beneficial, minimizing the potential for tissue hypoxia, in situ-
ations of limited oxygen delivery.
References
1. Faenza S: Hypothermia: an adverse effect or a missing
partner? Intensive Care Med 1997, 23:1015-1017.
2. Frank SM, et al.: Adrenergic respiratory and cardiovascular effects
of core cooling in humans. Am J Physiol 1997, 272:557-562.
3. Sessler DI: Deliberate mild hypothermia. J Neurosurg Anesthe-
siol 1995, 7:38-46.
4. Prakash O, et al.: Cardiorespiratory and metabolic effects of
profound hypothermia. Crit Care Med 1978, 6:340-346.
P11 Changes in lymphocyte subpopulations during enrichment of early enteral nutrition with lactic acid bacterium after major
abdominal surgery
S Lüdemann1, O Ahlers1, A Möller1, D Keh1, I Kürer1, N Rayes2, P Neuhaus, H Gerlach3
1Department of Anesthesiology and Intensive Care, and 2Department of Surgery, Charité-Virchow-Klinikum, 13344 Berlin, Germany;
3Department of Anesthesiology, Vivantes-Klinikum Neuköln, 12313 Berlin, Germany
Critical Care 2003, 7(Suppl 2):P011 (DOI 10.1186/cc1900)
Background/aims Major abdominal surgery causes changes in
lymphocyte subpopulations and impairs the immune response.
Early enteral nutrition (EEN) enriched with probiotic bacteria may
reduce this phenomenon and may improve the clinical course of
this patients. The aim of this randomised, double-blind trial was to
investigate changes of lymphocyte subpopulations of patients
receiving EEN either enriched with lactic acid bacterium (LAB) or
placebo before and after major abdominal surgery.
Patients and methods Thirty-three patients undergoing either
pylorus-preserving pancreaticoduode-nectomy or Whipple’s opera-
tion were enrolled. EEN enriched with either LAB (n=17) or
placebo (n=16) was supplied for a period of 5 days beginning on
the day before surgery. Blood samples were taken before surgery
as well as postperatively on day 1, 4 and 8. Flow cytometry analysis
was performed immediately.
Results Numbers of total lymphocytes as well as T-helper (T4)-,
T-suppressor (T8)- and natural-killer-lymphocytes decreased signif-
icantly in both groups. No significant differences in this parameters
could be found between the groups. However, the T4/T8 ratio
showed a higher increase from day 1 until day 8 in the verum-
group. Simultaneously, mean expression of CD45RA on T4 cells
was significantly lower in the verum-group while mean expression
of CD45RO on T8 cells was significantly higher in this group.
Summary/conclusion Enrichment of EEN with LAB seems to
have no significant influence on the well known postoperative
decrease of total lymphocytes and natural-killer cells. In contrast,
LAB supply seems to improve the T4/T8 ratio by mobilisation of
mature T4 and T8 cells. Further investigations are necessary to
evaluate the underlying mechanisms and clinical consequences.
P12 Enrichment of early enteral nutrition with lactic acid bacterium influences the innate immune system after major
abdominal surgery
A Möller1, O Ahlers1, S Lüdemann1, I Kürer1, N Rayes2, D Keh1, P Neuhaus3, H Gerlach3
1Department of Anesthesiology and Intensive Care, and 2Department of Surgery, Charité-Virchow-Klinikum, 13344 Berlin, Germany;
3Department of Anesthesiology, Vivantes-Klinikum Neuköln, 12313 Berlin, Germany
Critical Care 2003, 7(Suppl 2):P012 (DOI 10.1186/cc1901)
Background/aims There is strong evidence that early enteral
nutrition (EEN) enriched with probiotic bacteria may improve the
clinical course of patients undergoing major abdominal surgery.
Reduced bacterial translocation in the gut and resulting changes in
innate immune response may be responsible for this phenomenon.
The aim of this randomised, double-blind trial was to investigateS6
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changes of innate immunity of patients receiving EEN either
enriched with lactic acid bacterium (LAB) or placebo before and
after major abdominal surgery.
Patients and methods Thirty-three patients undergoing either
pylorus-preserving pancreaticoduode-nectomy or Whipple’s opera-
tion were enrolled. EEN enriched with either LAB (n=17) or
placebo (n=16) was supplied for a period of 5 days beginning on
the day before surgery. Blood samples were taken before surgery
as well as postperatively on day 1, 4 and 8. Flow cytometry analysis
was performed immediately.
Results Number of neutrophil granulocytes (PMNs), monocytes
and total leukocytes increased significantly in both groups during
the observation period. CD62L-positive PMNs decreased while
CD62L-positive monocytes increased in both groups with signifi-
cantly lower values in the verum-group. HLA-DR-positive mono-
cytes decreased in both groups until day 1 but showed a
significantly lower increase until day 8 in patients receiving LAB.
Number of PMNs, monocytes, total leukocytes and CD62L-positive
PMNs showed no significant differences between both groups.
Summary/conclusion Numbers of PMNs, monocytes and total
leukocytes as well as CD62L-positive PMNs showed well known
changes after major surgery regardless of enrichement of EEN with
LAB. In contrast, LAB supply seems to impair the expression of
HLA-DR and CD62L on monocytes. Further investigations are nec-
essary to evaluate the underlying mechanisms.
P13 High correlation between increased negative calorie balance and morbidity in critically ill patients
D Dvir, L Gibstein, E Grozovski, I Alterman, M Shapiro, J Cohen, P Singer
General Intensive Care Department, Rabin Medical Center, Beilinson Campus, petah Tikva 49100, Israel; Sackler School of Medicine, 
Tel Aviv University, Israel
Critical Care 2003, 7(Suppl 2):P013 (DOI 10.1186/cc1902)
Accurate energy balance is difficult to assess since prescribed
energy intake is not always actual energy intake administered, intra-
venous dextrose given as part of a fluid program is not always taken
into account and resting energy expenditure (REE) is not usually mea-
sured on a daily basis. We used a bedside computerized information
system to measure daily and cumulative energy balance in critically ill
ventilated patients to assess its impact on patient outcome.
Methods and patients Twenty-five ventilated patients (mean age
54.7±18.4 years, 19 males, six females) were prospectively fol-
lowed during their ICU stay. Energy balance (REE) was measured
daily using both indirect calorimetry (Deltatrac II, Datex-Ohmeda,
Finland) and a bedside computerized information system (iMDsoft,
Israel) which was able to collect data from all sources (enteral, par-
enteral nutrition and and IV fluids containing calories). Daily and
total energy balance were calculated on a continuous basis. Mor-
bidity (acquired organ dysfunction, pressure sores, need for
surgery) and mortality were noted.
Results Mean body mass index was 26.9±5.0kg/m2 and mean
APACHE II was 22.7±7.2. The bedside information system
revealed a mean IV calorie intake of 154kcal/day and reaching
370kcal/day in some patients. Mean cumulative balance for an
overall ICU stay of 395 days was –4261kcal (range
172 to –17,274kcal). Six of 25 patients had a negative calorie
balance >–10,000kcal. A strong correlation (r=–0.75) was found
between negative energy balance and complication rate, but not
with length of ventilation, length of ICU stay or length of hospitaliza-
tion. Six patients died (three had a negative energy balance
>–10,000kcal).
Conclusion We conclude that a bedside information system pro-
vides online and accurate information regarding energy balance in
critically ill patients and may allow for the early detection and pre-
vention of severe negative energy balance, which is correlated with
the occurrence of significant complications (organ dysfunction and
pressure sores).
P14 Use of anabolic steroid therapy in critically ill ICU patients
J Pikul1, MD Sharpe2
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Critical illness leads to a loss of lean body mass (LBM) and is
associated with impaired immune function and wound healing,
increased infection, and poorer outcomes [1,2]. Aggressive nutri-
tional support can decrease net catabolic losses by only ~50%,
therefore other methods need to be examined. We initiated ana-
bolic steroid therapy (AS) (nandrolone intramuscular injection,
once weekly × three doses) on 10 critically ill patients. Criteria for
AS: moderate to severe malnutrition, ICU stay >14 days, tolerating
enteral feeds, and exhibiting poor response to nutritional support.
Feeds were 130–150% of measured energy expenditure and
protein at 2.0–2.5g/kg per day. Response was monitored by nitro-
gen balance and LBM.
Eight of 10 patients exhibited a good response to AS, with attain-
ment of positive nitrogen balance and improvement in skeletal and
visceral protein levels. AS may be useful as adjunctive therapy for
malnourished, critically ill patients for protein repletion.
Table 1
2 weeks prior to AS After 3 doses
Pre- N balance LBM  Pre- N balance LBM 
Patient ALB (g/day) (kg) ALB (g/day) (kg)
1. F 0.09 +2.3 22.3 0.09 +3.2 22.8
2. F 0.08 –3.4 18.4 0.21 +4.8 19.2
3. M 0.11 –5.8 36.3 0.32 +7.2 38.1
4. M <0.07 –6.7 27.2 0.19 +1.8 27.9
5. M 0.18 –14.2 39.4 0.28 +6.9 40.8
6. F 0.07 –5.2 12.8 0.16* +5.3* 15.3*
7. M 0.14 –6.8 N/A 0.35 +3.8 N/A
8. M <0.07 –10.2 29.1 0.16 +5.4 29.9
9. M 0.15 –17.6 20.5 0.14 –10.0 22.1
10. M 0.10 –19.6 26.8 0.14 +4.6 25.8
*Data collected 6 weeks post steroid.S7
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P15 Hypercapnia attenuates the endotoxin-induced tissue metabolic acidosis in esophageal mucosa
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Objective To assess the effects of hypercapnia on the tissue meta-
bolic response to Escherichia coli endotoxemia in rabbits.
Design Prospective, controlled experimental study.
Setting University laboratory.
Subjects Thirty-six rabbits of both sexes, anesthetized with pento-
barbital and ventilated mechanically (normoventilation).
Interventions Animals were assigned to one of four groups:
a) endotoxemic control group (n=9), receiving intravenous
Escherichia coli endotoxin (20mg/kg bolus) via a peripheral vein;
b) hypercapnia control group (n=9), receiving exogenous carbon
dioxide to achieve mild hypercapnia 60–90mmHg; c) hypercapnia
treated group (n=9), treated identically to endotoxemic controls,
and additionally receiving exogenous carbon dioxide to achieve
mild hypercapnia 60–90mmHg; d) control group (n=9), receiving
neither endotoxin nor carbon dioxide.
Measurements We compared hemodynamics, blood gases, WBC,
rectal temperature and tonometric findings in esophageal mucosa
obtained in each group. Endotoxin injection decreased mean arterial
pressure from 79±9 to 54±17.5mmHg, decreased bicarbonate
level from 21.6±3 to 17.6±4mmHg, decreased WBC from 7.9±2
to 1.9±0.7G/l, increased rectal temperature from 37.7±1 to
39.9±1.5ºC, and caused a marked, continuous decrease in regional
pH (pHi) from 7.40±0.08 to 7.12±0.11 at the end of the experi-
ment. Hypercapnia alone had a minimal effect on the parameters and
findings. Both hypercapnia and endotoxemia had no significant effect
on regional CO2 (PrCO2) compared with controls, indicating lack of
significant mucosal blood flow abnormalities throughout the experi-
ment. In the hypercapnia treated group we observed an initial
decrease in regional pH (pHi) from 7.42±0.13 to 7.13±0.08, but
the value of this parameter remained stable (7.07±0.05 at the end
of the experiment) and the statistical difference compared with
hypercapnia controls was nonsignificant (P>0.05).
Conclusions 1. Endotoxin injection caused marked tissue acidosis
without disturbing esophageal mucosal blood flow, which indicates
a metabolic character of acidosis and underlines the significance
of intracellular abnormalities during endotoxemia. 2. We hypothe-
size that hypercapnia attenuates the endotoxin-induced tissue
metabolic acidosis and may exert a cytoprotective effect.
P16 Blood gases: a dreadful combination of metabolic, respiratory and lactic acidosis
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Introduction Arterial blood gases (ABGs) are the immediate,
easiest, most reliable and cost effective bedside method of assess-
ing an unstable patient. It portrays an array of functional reserves
from the lungs to the kidneys and the blood cells in between. It
also hints at the causes of hypoxia and hypercarbia. We applied
the Henderson Hasselbalch Equation (PCO2=HCO3×1.5+8) to
interpret the blood gas and used it effectively to prognosticate the
patient’s outcome.
Methods All patients with acidosis on blood gas were included. In
addition, PCO2 was calculated independently using the Hender-
son Hasselbalch Equation. Patients are divided into three groups
as shown in Table 1. Prototype ABGs of each group as shown in
Table 2.
Explanation Group 1. Patients in blood gas group 1 did not have
any problem, responded very well to the treatment and were stable.
The PCO2 matches with the HCO3 according to the Henderson
Hasselbalch Equation. In dehydrated patients, sodabicarb was
given to replace the loss of carbonates.
Group 2. These patients came to the ICU deteriorated with
multiorgan involvement, in an unstable condition needing mechani-
cal support beside all medical strategies. The outcome was not
that good in this group.
Group 3. Very poor outcome from this group. Patients did not
survive after this combination of metabolic, respiratory and lactic
acidosis occurred. This was much in evidence in a patient who had
multiorgan failure and septic shock. The PCO2 in this group was
always on the higher side then the calculated value as is in evi-
dence in sample number 3.
Conclusion 1. The Henderson Hasselbalch Equation is very useful
in the interpretation of blood gases and guides us about the sever-
ity of illness and prognosis of the patient.
2. If soda-bicarbonate has to be used, the equation can be used to
guide us of its effect on the patient.
3. The combination of metabolic, lactic and respiratory acidosis is a
dreadful combination usually culminating in death. Commonly
patients had multiorgan dysfunction and irreversible shock.S8
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4. It is imperative that we adopt an aggressive approach early on in
treatment of metabolic and lactic acidosis combination and should
not allow patients to go in to Group 3.
5. To begin with, patients presenting in group 3 were more
severely ill and warranted an aggressive approach irrespective of
the blood gas.
Table 1
Group Features Calculated PCO2 Typical case scenario Treatment Mortality
(%)
1 Metabolic acidosis without lactic  Matches with blood gas Infections, dehydration Antibiotics, fluids 5
acidosis (n=200)
2 Metabolic acidosis with lactic  Matches with blood gas Sepsis, cardiogenic  Ventilator, inotropes 20
acidosis (n=151) shock
3 Metabolic acidosis with lactic  Higher than blood gas  Septic shock, MOF Ventilator, iInotropes 99
acidosis (n=119) by +4–5
Table 2
Group pH PCO2 PO2 HCO3 TCO2 BE SO2 Interpretation
1 7.25 25 120 11.2 12.2 –5 98.1 Dehydration, pulmonary edema, infection
2 7.27 29.1 135.6 13.6 14.5 –11.4 98.4 MODS, septic shock
3 6.96 59.4 142.3 13.4 15.2 –20.1 97.1 MODS, septic shock
P17 Lactic versus nonlactic metabolic acidosis: outcomes in critically ill patients
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Introduction Critical care physicians associate lactic acidosis (LA)
with higher morbidity and mortality. Other forms of metabolic aci-
dosis are generally regarded as less dangerous and any associa-
tion with adverse outcomes in critically ill patients is poorly
understood. We sought to compare differences in mortality and
length of stay (LOS) between LA and other forms of metabolic
acidoses.
Methods In this observational pilot study, we reviewed records of
9799 patients admitted to the ICUs at our institution between
1 January 2001 and 30 June 2002. This cohort of patients had an
inpatient mortality of 14%, a hospital LOS of 12 days and an ICU
LOS of 5.8 days. We selected cases on the following criteria:
1) clinicians caring for each patient suspected the presence of LA;
2) arterial blood gas (ABG) and lactate were measured; 3) Na+, K+,
Cl–, and CO2
– were drawn within 4 hours of the referenced ABG,
Ca, Mg, Phos within 24 hours, and albumin any time during the
hospitalization. When multiple data sets were available, the set
with the highest lactate was used. We classified patients into four
groups: A) no metabolic acidosis, standard base excess (SBE)
≥–2; B) lactic acidosis, lactate accounted for >50% of SBE;
C) strong ion gap (SIG) acidosis, SIG accounted for >50% of
SBE (and not LA); D) hyperchloremic acidosis, absence of A, B,
or C.
Results We identified 862 patients (8.9% of ICU admissions). Of
these, 546 patients (63.3%) had a metabolic acidosis. LA
occurred in 43% of acidemic patients and was associated with a
57% mortality. Table 1 presents the unadjusted relative mortality
and LOS. Other forms of acidosis were collectively associated with
a 37% mortality. There was no difference in ICU or hospital LOS
between all groups.
Table 1
All cases SBE<–2 Lactic acidosis SIG acidosis Hyperchloremic
n 546 237 205 104
% of acidosis 100 43 38 19
ICU LOS days (survivors) 18.02 19.38 21.41 14.42
LOS days (survivors) 31.2 33.2 33.6 29.3
Mortality (%) 46 57 40 30S9
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Conclusions In patients suspected of having LA, LA was more
commonly associated with hospital mortality than non-LA.
However, all forms of metabolic acidosis, even hyperchloremic,
appear to be associated with high mortality and increased ICU and
hospital LOS.
P18 Relationship between platelet counts, C-reactive protein and plasma fibrinolytic capacity in critically ill patients
K Zouaoui Boudjeltia1, M Piagnerelli1, E Carlier2, S Jamart2, Ph Cauchie1, M Vanhaeverbeek1
1Experimental Medicine Laboratory, ULB 222 Unit, and 2Department of Intensive Care, A. Vésale Hospital, 6110 Montigny-le-Tilleul, Belgium
Critical Care 2003, 7(Suppl 2):P018 (DOI 10.1186/cc1907)
Background Multiple Organ Failure (MOF) complicating the
sepsis remains the first cause of death in the ICU. A recent study
showed that vascular endothelial damage was the primary cause of
MOF in patients with thrombopenia and that humoral mediators
played a major role in the development of this process [1]. Other
parameters like C-protein reactive were also probably important via
a direct effect on endothelial cells and increasing the secretion of
IL-6. In this study, we aimed to evaluate the relation between the
platelet counts (PC), the C-reactive protein and plasma fibrinolytic
capacity (as a marker of endothelium dysfunction) in ICU patients.
Methods We studied blood samples of ICU patients with (n=11)
and without (n=21) sepsis at the first day of admission. Fibrinolytic
capacity was evaluated by the Euglobulin Clot Lysis Time (ECLT)
determined by a new method [2]. We also collected biological
data and the SAPS II score for each patients. The correlations
were depicted by Spearman’s test.
Results The ECLT was significantly correlated with CRP (R=0.64;
P<0.001) and PC (R=–0.4;  P=0.02). The two-way ANOVA
showed that the sepsis status increased significantly the ECLT
(P=0.023) and that platelets under 208,500 cells/µl (median of the
histogram of PC was used as the cut-off) also increased the ECLT
(P=0.023). However, there was no interaction (P=0.184).
Conclusion Platelets can protect the endothelium against several
forms of oxidative injuries [3]. With this study we showed that the
decrease of the platelets count could favor the endothelium dys-
function and impaired fibrinolytic capacity, and this independently
of sepsis. In addition, C-reactive protein is not only an inflammatory
marker, but it might be involved in the endothelium damage.
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P19 Drotregocin alfa (activated) inhibits degradation of cytokine-mRNA in an endothelial model of inflammation
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Background The activated protein C (APC) pathway has been
suggested to be a common link between coagulation and inflam-
mation. APC may function to restore hemostasis via modulation of
cytokine expression. We investigated the effect of Drotrecogin alfa
(activated) (recombinant human activated protein C [rhAPC]) on
the expression of monocyte chemoattractant protein-1 (MCP-1),
interleukin-6 (IL-6) and IL-8 in human umbilical vein endothelial
cells (HUVEC) in the presence and absence of tumor necrosis
factor-alpha (TNF-alpha). MCP-1, IL-6 and IL-8 are mediators of
inflammation and their gene expression is controlled by the activa-
tion of the transcription factor nuclear factor-kappa B (NF-κB).
Results rhAPC (2.5–20µg/ml) upregulated the amount of MCP-1-
mRNA and IL-8-mRNA and caused a time-dependent and dose-
dependent increase in MCP-1-, IL-6- and IL-8-protein production
(P<0.001 for rhAPC 5µg/ml at 4–24 hours) in HUVEC. Experi-
ments were conducted to evaluate the effect of rhAPC on mRNA
degradation and mRNA stability independently of its possible
effects on gene transcription. After stimulation of mRNA transcrip-
tion by TNF-alpha (0.1–1ng/ml) for 3 hours, HUVEC were treated
with actinomycin D (1µg/ml), preventing new synthesis of tran-
script, in the presence or absence of rhAPC. HUVEC receiving
rhAPC contained more MCP-1-mRNA and IL-8-mRNA after 1 hour
and up to 8 hours than controls, suggesting an inhibitory effect of
rhAPC on mRNA degradation. Electrophoretic mobility shift assays
(EMSA) revealed that APC attenuated NF-κB activity implying that
NF-κB may not be involved in the upregulatory effect of rhAPC on
MCP-1, IL-6 and IL-8 production.
Table 1
Sepsis (n=11) Nonsepsis (n=21) P value
CRP (mg%) 25 (17–30) 6.9 (2.1–11.6) <0.001
WBC (x103cells/µl) 10.5 (7.7–12.9) 9.8 (8–12) 0.69
Fibrinogen (mg%) 662 (597–686) 455 (333–542) <0.001
SAPS 48 (39–56) 23 (15–35) 0.003
Platelets (x103cells/µl) 186 (123–227) 229 (179–296) 0.17
ECLT (min) 987 (845–1375) 599 (477–950) 0.01
Data presented as median (25–75%).S10
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Conclusions The ability of APC to upregulate the production of
MCP-1, IL-6 and IL-8, most likely by increasing the stability of
MCP-1-mRNA rather than by transcriptional activation via NF-κB,
identifies a novel post-transcriptional pathway, by which APC may
control the local inflammatory reaction, thereby modulating the
extent of endothelial injury.
P20 Gene array transcript profiling of human endothelial cells identifies pathways regulated by Drotrecogin alfa (activated)
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Background Although the role of Drotrecogin alfa (activated)
(recombinant human activated protein C [rhAPC]) in modulating
microvascular coagulation through the inhibition of thrombin gener-
ation has been well studied in experimental and clinical settings of
severe sepsis, little is known about its direct anti-inflammatory
effects on vascular endothelial cells. To better understand the mol-
ecular mechanisms of action of rhAPC on endothelial cell function
during sepsis we used gene array transcript profiling of messenger
RNA (mRNA) from primary cultured human umbilical vein endothe-
lial cells (HUVEC) exposed to Drotregocin alfa (activated) in the
presence of the central proinflammatory mediator tumor-necrosis
factor-alpha (TNF-alpha).
Methods and results The effect of rhAPC on TNF-alpha-activated
HUVEC was assessed using Affymetrix microarrays. Briefly, mRNA
from treated cells was isolated and converted to double-stranded
copy (c)DNA, which was then used to generate biotinylated cRNA.
Biotinylated cRNA was hybridized to Affymetrix oligonucleotide
arrays, containing approximately 33,000 human genes. Data analy-
sis was performed using GeneChip 3.1 software. We found that
rhAPC reproducibly upregulated TNF-alpha-induced gene expres-
sion of the following genes: monocyte chemoattractant protein-1
(MCP-1), platelet-derived growth factor-alpha-chain (PDGF-A),
interleukin-6 (IL-6), transforming growth factor-beta receptor II,
insulin-like growth factor-binding protein (IGF-BP) and interleukin-8
(IL-8). rhAPC downregulated the following genes induced by
TNF-alpha stimulation: the secreted apoptosis related protein-1
(SARP-1), basic fibroblast growth factor (bFGF), lymphotoxin-β, the
adhesion molecules vascular cell adhesion molecule-1 (VCAM-1)
and intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2).
Results for IL-6, IL-8 and MCP-1 were confirmed by protein mea-
surements in cell culture supernatants by ELISA as well as by a col-
orimetric assay for mRNA quantitation (Quantikine assay).
Conclusions The ability of rhAPC to modulate gene expression of
a cluster of proinflammatory genes, genes responsible for cell
adhesion and leukocyte trafficking as well as genes involved in
endothelial apoptosis, provides insight into the molecular mecha-
nisms contributing to the efficacy of rhAPC in systemic inflamma-
tion and sepsis.
P21 Treatment of adults with sepsis-induced coagulopathy and purpura fulminans with a plasma-derived protein C
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Disseminated intravascular coagulation (DIC) is a severe complica-
tion of sepsis, especially when associated with skin or organ necro-
sis appearing as purpura fulminans. Several reports described
beneficial effects of protein C replacement in preterm neonates,
infants, and adults with purpura fulminans. We treated seven adult
patients (six female, one male), median age 35 years (range
19–48 years), with DIC and purpura fulminans with a plasma-
derived human protein C concentrate (Ceprotin®; Baxter, Vienna,
Austria). Three patients had meningococcal, three had pneumococ-
cal, and one had pseudomonas and cytomegaly-virus infections. At
admission, all patients had signs of skin necrosis, severe infection
and acute illness. Coagulation assays suggested DIC in five
patients (median [range]): platelet count 19 (17–23) G/l, fibrinogen
60 (44–103)mg/dl, antithrombin activity 0.47 (0.25–0.76)U/ml,
normotest 32 (14–39)%, APTT 88 (42–160)s, D-dimer
66 (3.3–140)ng/ml; the remaining two patients were treated
because of typical skin necrosis and meningococcemia alone. Initial
protein C activity was reduced to 0.35 (0.2–0.5)U/ml. Five patients
had neurologic alterations, five renal failure, three respiratory failure,
one a large intrahepatic necrosis. In five patients Ceprotin® was
given as a level-adjusted continuous infusion (starting with 10U/kg
per hour) after an initial bolus of 100U/kg, two patients were
treated with bolus infusions (100U/kg every 8 hours). Additionally,
heparin infusions (seven patients), fresh-frozen plasma (five
patients), antithrombin concentrates (three patients), fibrinogen
concentrates (two patients), low-dose rtPA (two patients), platelet
and erythrocyte transfusions, antibiotics, and hydrocortisone (four
patients) were given. Protein C activity increased to 1.34–2.0U/ml
in all patients, coagulation abnormalities resolved within 1–6 days. A
total of 8000–77,000U Ceprotin® were given during 1–7 days.
One patient died the same day from multiorgan failure, one died
14 days after the end of Ceprotin® infusion from candida sepsis. All
other patients survived, three needed amputations of toes, two had
no sequels. Our data suggest that Ceprotin® can be a useful
hemostatic support in the treatment of adults with severe, life-threat-
ening purpura fulminans, which would have a high mortality with
conventional therapy alone. Controlled studies are needed to estab-
lish the value of this drug in the treatment of sepsis.S11
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P22 Treating medical and surgical patients with activated protein C: a preliminary comparison
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Sepsis is a significant cause of morbidity and mortality in the criti-
cally ill patient. Drotrecogin alfa (activated) (APC) has been shown
to significantly decrease mortality in patients with severe sepsis,
although surgical patients constituted the minority in the initial mul-
ticenter trial. In our initial experience with APC, we sought to deter-
mine whether surgical intensive care unit (ICU) patients have the
same rate of bleeding complications as medical ICU patients. We
hypothesized that surgical patients are more apt to bleed following
APC administration, but have higher survival rates than medical
patients.
Methods We performed a retrospective analysis of all medical and
surgical patients in a single academic medical center who received
APC for the treatment of sepsis between January 2002 and
November 2002. Primary outcome variables included incidence of
clinically significant bleeding, defined as blood loss requiring trans-
fusion of at least 4 units of packed red cells (PRBC) during APC
treatment, and 28-day mortality. Secondary outcomes included
ICU length of stay (ILOS), hospital length of stay (LOS), comple-
tion of treatment course, and units of blood products transfused.
Demographic data such as sex, age, severity of illness at the time
of APC administration (APACHE II score), and primary site of infec-
tion at the time of sepsis diagnosis were obtained. Coagulation
parameters were compared at three time points: within 24 hours of
APC administration, during APC infusion, and within 24 hours of
stopping APC. Hospital mortality following APC treatment was
compared with baseline mortality for historically similar patients in
our ICU matched 2:1 by age within 12 years, APACHE II score
within 10 points and same site of infection.
Results A total of 29 patients were treated with APC, 59% in the
surgical ICU. Demographics and severity of illness were similar
(Table 1). Prior to APC infusion, surgical patients were more coag-
ulopathic and anemic, and had already received on average four
times as many PRBC units than medical patients. Surgical patients
also received more PRBC after APC infusion was started. All
bleeding events occurred in surgical patients at surgical sites and
two of the bleeds occurred in patients who received therapeutic
heparin infusions as well as APC. However, no difference was
demonstrated in the number of patients who completed APC
therapy, LOS or mortality. For all patients, the mean partial throm-
boplastin time during APC infusion was higher than has been pre-
viously reported (99.4 medical vs 94.3 surgical, P=0.7408), and
there was an 84% increase in the mean PTT (52.4±4.9 before vs
96.4±7.5 during, P<0.0001), as well as a 32% decrease in the
mean platelet count during the APC administration (189.9±24 vs
130.0±16, P=0.008), both of which normalized in the 24 hour
period following cessation of APC. Mean maximum INR during
APC infusion was 1.9±0.2; after treatment, there was a 21%
decrease to 1.5±0.1 (P=0.0025). In the case–control analysis,
APC recipients had a similar age (61±3.1 vs 60±1.9, P=0.83)
and APACHE II score (31±1.4 vs 29±0.9, P=0.37), but signifi-
cantly lower mortality than matched controls (35% vs 66%,
P=0.0119).
Conclusions In this preliminary comparison of the open-label use
of activated protein C in patients with severe sepsis, we witnessed
a 30% reduction in overall hospital mortality compared with histori-
cal controls, and a substantial, but reversible, coagulopathy during
APC infusion. Although the severity of illness and degree of
coagulopathy were similar between medical and surgical patients,
the only clinically significant bleeding complications were observed
in the surgical cohort. This may be due to the unique features of
surgical sepsis, with increased incidence of tissue barrier violation
and blood loss anemia, or perhaps a reflection of the burden of
blood product transfusion and greater tendency towards coagu-
lopathy than thrombosis. Further studies should endeavor to define
risk factors for bleeding among surgical patients and to determine
whether interventions such as repletion of other coagulation
factors, intermittent infusion of APC, or restriction of other antico-
agulant therapies may be beneficial.
Table 1
Medical Surgical P
n 12 (41%) 17 (59%) –
Age 60.2 ± 5.3 61.3 ± 3.8 0.86
Sex = female 5 (42%) 8 (47%) 0.77
APACHE II score 31.1 ± 0.7 31.0 ± 1.9 0.97
PTT before APC 39.6 ± 2.7 61.5 ± 7.5 0.03
HCT before APC 30.7 ± 1.8 26.1 ± 1.4 0.0561
# PRBC units transfused 0.58 ± 0.3 2.5 ± 0.7 0.03
Bleeding (≥ 4 U) 0 (0%) 5 (29%) 0.0588
Completed APC course 6 (50%) 10 (59%) 0.64
Hospital LOS 23.4 ± 7.7 41.3 ± 7.9 0.13
28-day mortality 4 (33%) 3 (18%) 0.40
P23 Quality of life in ICU survivors with severe sepsis who received activated protein C
WT Cook, JM Eddleston, D Conway, J Streets
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Appropriate treatment of severe sepsis with activated protein C
(rhAPC) has been associated with an absolute reduction in mortal-
ity of 6.1% [1]. The aim of this study was to followup patients who
received rhAPC and to evaluate their quality of life postdischarge
from the intensive care unit (ICU).
Method Twenty-three patients in our unit were recruited into the
ENHANCE study and received rhAPC. The 28 and 90 day mortal-
ity was calculated and quality of life was assessed at 90 days using
the Short Form-36 (SF-36) [2]. Psychological distress and depres-
sion was measured at the same time using the Hospital Anxiety
and Depression score (HAD) [3].S12
Critical Care    March 2003 Vol 7 Suppl 2 23rd International Symposium on Intensive Care and Emergency Medicine
Results Twenty-three subjects had at least three or more acute
organ dysfunction associated with severe sepsis, with a range of
APACHE II scores of 8–33. The median length of stay in ICU for
survivors was 16.4 days, and hospital stay post-ICU was 19.5
days. The 28 and 90 day all-cause mortality was 21.7% (five
patients) and 26.1% (six patients), respectively. Eight of the
17 survivors completed the SF-36 (Table 1) and HAD forms. HAD
scores indicated heightened anxiety in two patients and none were
clinically depressed.
Conclusion Mortality is similar to that already published [1].
Encouraging, the quality of life for these patients is comparable at
90 days with a general ICU population. A limitation is the number
of patients.
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Table 1
SF-36 scores for patients who received rhAPC, published figures for a general ICU population [4] and those of the UK population [2]
Physical  Role Lim  Role Lim  Social  Mental  Energy  Health 
function physical emotion function health vitality Pain perception
rhAPC 69.4 46.9 54.3 91.8 76.0 61.9 84.9 72.3
General ICU [4] 58.9 46.1 56.4 70.9 68.9 44.2 77.6 57.6
UK population [2] 92.5 91.4 85.6 91.3 75.4 64 86.3 78.8
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Background Recombinant human activated protein C (rhAPC) has
been shown to significantly reduce mortality in severe sepsis (SS)
patients.
Purpose To identify best clinical practices (BCPs) using several
benchmarks (BMs) related to rhAPC administration as the starting
point.
Methods Five Spanish experts on SS and main investigators
involved in the PROWESS trial were interviewed in order to identify
BCPs for rhAPC administration with regard to the following BMs
also obtained from the same experts: BM1) SS identification; BM2)
clinical or microbiologically documented infection; BM3) standard-
ized criteria for infection focus identification; BM4) SS considered
as the main diagnosis; BM5) length of SS induced organ dysfunc-
tions (OD) <48 hours; BM6) no limitation of life support measures;
BM7) adequate standard therapy; BM8) rhAPC administration.
Interviews were oriented to identify BCPs to succeed in reaching
the BMs when considering rhAPC administration in clinical practice.
Each BCP implied key factors and an objective.
Results The following BCPs were identified for each BM: BM1)
SS patient considered a critically ill patient, consensus criteria for
SS definition, early identification of SS. BM2–BM3) Complete
medical history; radiological and macroscopic examinations, basic
microbiological study, other medical specialties’ involvement. BM4)
SS documented as main reason for patient admission. BM5) Use
of validated score systems, unified required OD degree (SOFA
score >2), undocumented OD does not imply normality; no con-
sideration of chronic ODs. BM6) Evaluation of previous health
status and concomitant medical history, involvement of patient’s
family and other health professionals, no scale score considered as
criterion for rhAPC indication. BM7) Protocol-driven antibiotic
therapy, antibiogram, control of infection focus, sequential order in
shock therapy, early mechanical ventilation. BM8) Lack of rhAPC
contraindications, drug prescribed by a critical care physician
Conclusions The use of BMs related to the clinical use of rhAPC
allows the identification of BCPs for BMs compliance, which my
lead to an optimization of the drug cost-effectiveness
Correction (12 March 2003)
The original published version of the abstract (as shown above) included incorrect data in the first sentence of the Results section. 
The sentence should read as follows:
Results Twenty-three patients had at least one or more acute organ dysfunction associated with severe sepsis, with a range of 
APACHE II scores of 8–33.S13
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A 15-year-old boy presented with fever, confusion, headache and
nausea. On examination, he had purpuric lesions, meningeal irrita-
tion and signs of systemic inflammatory response to sepsis. Cul-
tures were obtained and ceftriaxone was administered. Laboratory
findings were consistent with impending disseminated intravascu-
lar coagulation (DIC) and the patient was given fresh frozen plasma
(FFP), antithrombin III (AT III) and low dose enoxaprin. Hemody-
namics improved with fluid challenge. However, 12 hours later, he
became agitated and developed shock. The patient was intubated
and given high doses of catecholamines. The ECG and the
echocardiogram showed extensive acute anterior wall MI. We
decided to perform thrombolysis with recombinant tissue plasmino-
gen activator (t-PA) given over 4 hours (total dose 1.25mg/kg) [1].
Shortly after thrombolysis, hemodynamics improved and the ECG
normalized. Peak CPK levels were 5200IU/ml. The patient devel-
oped multiple organ failure (MOF) with adult respiratory distress
syndrome and renal failure. Neisseria meningitidis group C was
found in the cerebrospinal fluid. The patient recovered completely
afterwards. The followup echocardiogram showed normal left ven-
tricular function and mild anterior hypokinesis.
FM, or Waterhouse Friderichsen syndrome, is characterized by the
abrupt development of shock, DIC and MOF. Impaired myocardial
contractility is commonly seen in FM and contributing to shock. It is
well established that endotoxin causes myocardial dysfunction [1]
and plays a key role in septic myocardial dysfunction. The exact
mechanisms of endotoxine-induced myocardial dysfunction are
complex and probably involve cytokines such as tumor necrosis
factor-α [2,3] and perhaps also myocardial apoptosis [4]. MI
during FM is exceedingly rare, and to our knowledge only one case
hase been reported in the pediatric literature [5]. Our patient devel-
oped MI, presumably on the basis of DIC, despite aggressive treat-
ment. Although levels of plasminogen activator antigen are
increased in septic shock, its activity is almost completely inhibited
by plasminogen activator inhibitor type 1 (PAI-1). Theoretically,
treatment with t-PA may help reverse the procoagulant state. Zenz
et al. [1] and others [6–8] observed significant clinical improve-
ment after a 4-hour infusion of t-PA in a few pediatric patients with
FM. This is the first report of successful thrombolysis with t-PA in a
patient with FM complicated by MI and shock.
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Background and aims Accumulation of ADMA has been linked to
endothelial dysfunction, and is an important risk factor for cardio-
vascular disease. Its elimination from the body is dependent on
urinary excretion and degradation by the enzyme dimethylarginine
dimethylaminohydrolase. This enzyme is highly expressed in the
liver, and in rat studies a high net hepatic uptake of asymmetrical
dimethylarginine was found. In critically ill patients, we investigated
the relation between indicators of renal and hepatic dysfunction
and plasma ADMA concentration, and tested the association
between ADMA concentration and outcome.
Methods We prospectively collected blood samples from a cross-
section of critically ill patients (n=52) with clinical evidence of dys-
function of more than two organs. We identified correlates of
plasma ADMA concentration with laboratory values, organ failures
score and outcome by univariate and multiple regression analyses.
Results In critically ill patients, plasma ADMA concentration was
independently related to the presence of hepatic failure (b=0.334,
95% CI=0.207–0.461; P<0.001), and to lactic acid (b=0.395,
95% CI=0.230–0.560; P<0.001) and bilirubin (b=0.121, 95%
CI=0.031–0.212; P=0.009) concentration as markers of hepatic
function. Twenty-one (40%) patients deceased during their ICU
stay. In a logistic regression model, plasma ADMA ranked as the
first and strongest predictor for outcome, with a 17-fold (95%
CI=3–100) increased risk for ICU death in patients who were in
the highest quartile for ADMA.
Conclusions In critically ill patients, plasma ADMA concentration
is a strong and independent risk factor for ICU mortality, and
hepatic dysfunction is the most prominent determinant of ADMA
concentration in this population.S14
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Introduction Recent developments [1] have increased the require-
ment for good clinical data on the aetiology, incidence and
outcome from sepsis in the intensive care unit (ICU). Assessment
of sepsis in the Scottish ICU database has previously been limited.
Our aim was to conduct a prospective audit of sepsis, severe
sepsis and septic shock following ICU admission in Scotland using
predetermined sepsis criteria.
Methods Between January 2002 and 31 May 2002, 25 of the
26 adult, general ICUs in Scotland participated in a prospective
audit of sepsis. Daily data were recorded on Ward Watcher soft-
ware (Critical Care Audit Ltd) enabling identification of the first
episode of sepsis: fulfilment of the systemic inflammatory response
syndrome (SIRS) [2] criteria in response to infection. First 24-hour
APACHE II scores are generated routinely in Scottish ICUs;
however, source and type of infection and a sepsis-related organ
failure assessment (SOFA) [3] were also mandatory in patients
identified as septic.
Results In this 5 month study, 46% (n=1618) of ICU admissions
developed sepsis, equating to 0.77 cases per 1000 population,
per annum, in Scotland. Sepsis was present at, or shortly after,
admission (median of 1 day). ICU length of stay (LOS) was double
that of the Scottish ICU population (mean=9.02 days,
median=5.1 days). Of all admissions, 38% (n=1341) had severe
sepsis or septic shock. Two-thirds of this group had more than one
organ failure, of which 290 also had an APACHE II score of 25 or
more. Both mortality and APACHE score rose with the number of
organs failing. In those with severe sepsis or septic shock, the
major source of sepsis (bronchopulmonary=56.5%) and the ICU
mortality (33%) were similar to those of the placebo group in the
PROWESS study [1]. The septic shock group had a significantly
higher ICU mortality than those with severe sepsis (61.5% vs
31.8%, P<0.0001). Mean SOFA (10.9 vs 5.1, P<0.0001) and
APACHE II scores (24.1 vs 20, P<0.0001) were also significantly
higher in this group.
Conclusion Almost one-half of the admissions to Scottish ICUs
have sepsis, which presents on or shortly after admission. Mortality
increases with APACHE score and the number of organs failing.
Septic shock appears to be significantly associated with poor
outcome.
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Introduction Changes in hemodynamics and a variety of mediators
such as cytokines were compared with respect to the number of
dysfunctional organs in MODS cases treated with blood purification.
Subjects and methods This study included 113 cases of MODS
that were treated with endotoxin-absorption therapy (PMX-DHP).
Background factors, respiration, circulatory parameters and inflam-
matory mediators (IL-6, IL-1ra, ELAM-1, PAI-1, MIP-1α and BNP)
were measured before the start of PMX-DHP. Organ dysfunction
was evaluated using the MOF score according to Goris, where
organ dysfunction was judged positive when the score was more
than one point for each organ.
Results The rate of survival for more than 28 days from the start of
blood purification clearly decreased as the number of dysfunctional
organs increased. The APACHE II score, the Septic Severity Score
(SSS), and the SOFA score significantly increased with an
increase in dysfunctional organs, with a significant positive
correlation (P<0.0001) between the scores (r=0.59 between
APACHE II and SOFA, r=0.60 between APACHE II and SSS, and
r=0.76 between SSS and SOFA). In comparison, by prognosis,
the number of dysfunctional organs was 3.1±1.2 in survival cases
and 4.3±1.0 in the nonsurvival cases before the start of blood
purification. The mean IL-6 level was highest in cases with dysfunc-
tion of four organs. The BNP level appeared to increase as the
number of organs with dysfunction increased. In particular, the dif-
ference between the two-organ dysfunction group and the three-
organ dysfunction group was statistically significant (P<0.05).
Conclusion A variety of humoral mediators, including cytokines,
increased as the number of dysfunctional organs increased, while
the level of the increase differed for each mediator. Hemodynamics
and PaO2/FiO2 ratio prior to the start of PMX-DHP appeared to
influence the prognosis. Possible involvement of BNP was sug-
gested in development of sepsis-associated MODS and will be
further studied in the future.S15
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Summary Mediastinitis is still a challenging condition, which can
easily result in lethal sepsis. We previously reported parasternal
anterior mediastinal drainage. In this congress, we will present
another method of mediastinal drainage along the carotid sheath
around the aortic arch approach without thoracotomy (oblique cer-
vical incision, exposed carotid sheath, and bluntly dissected and
inserted drainage tube along the carotid sheath reaching to the
aortic arch). Three patients were treated by this procedure.
Introduction Mediastinitis is still a challenging condition, which
can easily result in severe lethal sepsis. It is important for manage-
ment of mediastinitis to perform an effective and noninvasive
drainage. We reported the ‘parasternal anterior approach’ as a
method of mediastinal drainage for mediastinitis around the supe-
rior caval vein. In this congress we will present another method of
mediastinal drainage for the septic mediastinitis around the aortic
arch by the ‘along carotid-sheath approach’ without thoracotomy.
The aim of this presentation is to clarify the usefulness and safety
of this method.
Patients and surgical procedure Three patients with septic medi-
astinitis were treated by this procedure. We drained the upper
mediastinum from the supraclavicular pouch along the neck
vessels, or the carotid sheath, by blunt dissection. We performed
at first an oblique cervical incision, exposed the carotid sheath, and
bluntly dissected and inserted a drainage tube along the carotid
sheath reaching to the aortic arch. The neck and chest CT
revealed that the drainage tube reached the aortic arch in two
cases. The inflammatory signs of these two patients were improved
after this procedure and repeated neck and chest CT revealed
improvement of mediastinitis. No complications such as vascular
injury related with this procedure was seen. The other case under-
went this procedure when sepsis was already uncontrollable and
died due to uncontrollable sepsis. The report of her autopsy
showed the position of drain in the level of the aortic arch in front
of the esophagus without any vascular injury and mediastinitis
localized within the upper mediastinum.
Conclusion Our method of mediastinal drainage, the ‘along
carotid-sheath approach’, is useful, safe, and a minimal invasive
procedure for septic patients with mediastinitis.
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Tumor necrosis factor-α (TNF-α) plays an important role in the
induction of the pulmonary endothelial cell injury by activating neu-
trophils in sepsis. The resultant pulmonary endothelial cell injury
leads to a decrease in the production of PGI2, which might be an
important etiology for the development of acute respiratory distress
syndrome, a critical complication of sepsis. Endotoxin (ET)-resistant
mechanisms in C3H/HeJ mice involve the mutation of Toll-like recep-
tor-4 (TLR-4) by which ET signals to increase TNF-α production in
monocytes. Thus, it is possible that the pulmonary endothelial cell
injury leading to the impairment of the production of PGI2 could be
attenuated in C3H/HeJ mice, contributing to the ET-resistant mech-
anism. The present study was conducted to examine this possibility.
Plasma levels of 6-keto-PGF1a were significantly higher in
C3H/HeJ mice than those in C3H/HeN mice, the ET-sensitive
strain, 90 min after intravenous injection (IV) of ET. Survival rates on
the 6th day of IV of ET were 100.0% and 0% in C3H/HeJ mice and
C3H/HeN mice, respectively, while it was 50.0% in C3H/HeJ mice
when they were pretreated with indomethacin (IM), which inhibits
PGI2 production. Plasma levels of 6-keto-PGF1a in C3H/HeJ mice
90 min after intra-arterial injection (IA) were significantly lower than
those in C3H/HeJ mice 90 min after IV of ET. Although the survival
rate of C3H/HeJ mice on the 6th day of IV of ET was 81.2%, it was
only 27.7% in these mice on the 6th day of IA of ET. These observa-
tions suggested that the major part of 6-keto-PGF1a in the plasma
of C3H/HeJ mice after IV of ET could be derived from PGI2
released from the lung vasculature, and the PGI2 release might be
critical for the ET-resistance in C3H/HeJ mice. Plasma levels of
6-keto-PGF1a 90 min after IV of ET were significantly higher in
C3H/HeN mice pretreated with ONO-5046, an inhibitor of neu-
trophil elastase, than those in these mice without ONO-5046 pre-
treatment. The survival rate of C3H/HeN mice pretreated with
ONO-5046 on the 6th day of IV of ET was 80.0%, while that of
these mice without ONO-5046 pretreatment was 10.0%.
Taken together, these observations raise a possibility that the acti-
vated neutrophil-induced pulmonary endothelial cell injury could be
attenuated in C3H/HeJ mice, leading to maintaining higher produc-
tion of PGI2 than that in C3H/HeN mice, which could at least partly
explain the ET-resistant mechanism in C3H/HeJ mice.
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Introduction The systemic inflammatory response of the body to
invading microorganisms, termed sepsis, leads to profound activa-
tion of the complement (C) system. The main proinflammatory
properties of the complement system can be attributed to the ana-S16
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Table 1
Best cutoff values, area under the curve (AUC) (mean ± SE), sensitivity and specificity of all variables to differentiate patients with
sepsis from patients with SIRS
C3 (mg/dl) C4 (mg/dl) CRP (mg/dl) Thrombocyte Leukocyte
Best cutoff value 55.0 20.5 14.5 164000 14800
AUC 0.560 ± 0.06 0.544 ± 0.06 0.522 ± 0.05 0.640 ± 0.06 0.507 ± 0.06
Sensitivity 0.61 0.56 0.58 0.66 0.41
Specificity 0.62 0.53 0.50 0.69 0.66
phylatoxins C3a, C4a, C5a. These polypeptides are generated
after proteolytic cleavage of the α-chain of C3, C4 or C5. The
present study was conducted to determine serum complement
3 and 4 levels for differentiation in patients with SIRS and sepsis,
in comparison with C-reactive protein (CRP), thrombocyte and
leukocyte counts.
Method Fifty-eight patients with SIRS and 41 patients with sepsis
were admitted to the study. Blood samples were taken at the first
day of intensive care unit for analysis of C3, C4, CRP, thrombocyte
and leukocyte counts.
Results Thrombocyte count was significantly lower in septic
patients (mean±SE: 179,975±14,932, P=0.005) compared with
SIRS patients (243,165±16,243). The plasma concentrations of
CRP, C3 and C4 level were not different between groups. The
power of parameters to discriminate between septic and SIRS
patients was determined in a receiver operating characteristic analy-
sis. Thrombocyte was the best analysis to differentiate between
both populations with a maximal sensitivity and specificity (Table 1).
Discussion In this study, C3, C4 and CRP had poor sensitivity and
specificity for the differentiation of SIRS and sepsis. Because of
the complex pathophysiology involved, it is likely that not a single
mediator but a panel of different inflammatory mediators will ulti-
mately predict the outcomes of individual patients.
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Background Many researchers are investigating the expression of
inflammatory proteins as contributors to the variable onset and pro-
gression of infection, sepsis, and organ dysfunction. We explored
the relationship between plasma lipopolysaccharide binding
protein (LBP) levels and the development of severe sepsis in com-
munity-acquired pneumonia (CAP).
Hypothesis Plasma LBP levels are higher in CAP patients who
develop severe sepsis.
Methods We are conducting a large multicenter inception cohort
study of patients arriving in the Emergency Department (ED) with
CAP. We conducted a planned interim analysis on the first 385
enrolled patients. Plasma LBP was assayed using a commercially
available immunoassay system (Diagnostic Products Corp., Los
Angeles, CA, USA). Severe sepsis was defined as a Sequential
Organ Failure Assessment Score increase of 2 for any one nonrespi-
ratory organ, or an increase of 1 for any two nonrespiratory organs,
or an absolute score of 3 or 4 for the respiratory component.
Results Plasma LBP levels were available for 379/385 (98.4%)
patients. Of the 379 patients, 26.1% had severe sepsis at initial
presentation; 29.8% were PSI class I or II, 27.2% class III, 33.0%
class IV, and 10.0% class V; 29.6% had chronic lung disease;
50.9% were female; 12.9% were black and 85.0% white; average
age was 65.5±17.2 years. Day 1 serum LBP levels distinguished
between ED presentation of CAP with severe sepsis (n=87) and
without (n=236): 40.4±31.9µg/ml vs 27.9±19.3µg/ml, respec-
tively; P=0.0005 by Wilcoxon. Over the course of hospitalization,
mean LBP levels for each patient correlated with worst diagnosis:
26.8±17.2µg/ml for CAP patients who at any time met criteria for
severe sepsis (n=158), compared with 20.8±13.9µg/ml for
patients who did not (n=221); P<0.0001 by Wilcoxon. Mortality
analysis was not possible in this preliminary interim analysis.
Conclusions In our CAP cohort, patients who developed severe
sepsis had significantly higher plasma LBP levels.
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Background Acute inflammatory diseases such as sepsis are
characterized by activation of leukocytes, which contain MMP-9
(Gelatinase B) in tertiary granules. Matrix metalloproteinases play
an important role in the degradation of extracellular matrix and
basement membranes by destroying the elastic lamina. These main
enzymes of tissue turnover are controlled by their inhibitors such as
TIMP-1 (tissue inhibitor 1 of metalloproteinase). To assess the
importance of clinical outcome of septic patients we measured
TIMP-1, TIMP-2, MMP-2, MMP-3 and MMP-9 in septic patients.
Patients and methods Serum was collected from 37 septic
patients admitted to the ICU with APACHE score 14.5 on day 1
(SD 7.6). Blood was collected from the 37 septic patients and
from 14 healthy controls on day 1. Twelve of the 37 critically ill
patients died within 28 days. We measured MMP-9, MMP-2,
MMP-3, TIMP-2 and TIMP-1 serum levels from all healthy controls,
from the 25 survivors and the 12 nonsurvivors with ELISA
methods. We compared the serum levels of MMP-9, TIMP-2 and
TIMP-1 between the three groups.
Results MMP-9 and TIMP-1 levels (MMP-9 mean ± SD=80±86,
TIMP-1 = 3216±1222) in the severely ill patients were significantly
higher (P<0.001) than in controls (MMP-9 = 6±7, TIMP-1 =
953±184). MMP-2 showed no difference between septic patients
(948±287) and control group (928±165). We noted a signifi-
cantly (P=0.003) increased concentration of TIMP-1 in the nonsur-
vivors (953±184) compared with the survivors (4675±1507).
TIMP-2 was significantly higher (P<0.001) in nonsurvivors than in
the control group. Statistic analysis shows a correlation (Spearman
Rank correlation, r=0.7958) between serum levels of TIMP-1 and
the severity of sepsis and the probability to die, but there was no
correlation shown between the serum levels of MMP-3 and MMP-2.
Conclusion Our results indicate that MMP-9, TIMP-2 and TIMP-1
may serve as sensitive and early markers for cell activation during
the course of sepsis. Furthermore, TIMP-1 may be related to the
prognosis and clinical outcome of septic patients.
P34 Peripheral blood lymphocytes of critically ill patients show signs of late stage apoptosis
SU Weber, J-C Schewe, S Schroeder, A Hoeft, F Stueber
Department of Anaesthesiology and Intensive Care Medicine, University Bonn Medical Center, Germany
Critical Care 2003, 7(Suppl 2):P034 (DOI 10.1186/cc1923)
Among the immunological events, apoptosis plays an important
role in sepsis. Inhibition of apoptosis in mouse models of sepsis
improved survival [1]. Phosphatidyl serin externalisation has been
detected in peripheral blood leukocytes of patients suffering from
sepsis as an early stage of apoptosis [2,3]. It has not been shown
if they undergo complete apoptosis. Therefore, the aim of the
current study was to examine if circulating lymphocytes of septic
patients display DNA degradation as a sign of late apoptosis.
Isolated mononuclear cells of 11 critically ill patients (three with
severe sepsis) were compared with eight healthy controls. Phos-
phatydil serin externalisation was evaluated by annexin V binding.
Necrotic cells were excluded by propidium iodine stain. DNA frag-
mentation was detected by TUNEL staining using flow cytometry.
In critically ill patients annexin binding was increased to
12.1±7.5% compared with a basal population of 3.8±0.9% in
healthy controls (P<0.05). The TUNEL-positive population
increased from 0.5±0.1% to 2.3±1.5% in critically ill patients
(P<0.05).
The study demonstrates that mononuclear cells of critically ill
patients show signs of early apoptosis and to a lesser degree also
signs of DNA fragmentation. This may be explained by rapid clear-
ing of phosphatydil serin expressing cells from the circulation by
phagocytosis.
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Background Polymorphonuclear cell (PMN) activation, adhesion
and transpulmonary emigration to the alveolar space are important
steps in the pathogenesis of the acute respiratory distress syn-
drome (ARDS). β2 agonists accelerate alveolar fluid clearance and
have been suggested as a potential treatment for patients with
ARDS. In addition, these agents have a variety of effects on poly-
morphonuclear cells (PMN). In animal models of sepsis, treatment
with β2 agonists has been shown to reduce pulmonary neutrophil
sequestration and ameliorate the development of lung injury. The
aim of this study was to investigate the effect of the β2 agonist
salbutamol on three aspects of PMN function: PMN activation
(CD 64 expression), chemotaxis, and adhesion molecule expres-
sion (VLA-4).
Methods PMNs from 10 healthy volunteers were separated using
Ficoll-histopaque gradients and incubated with RPMI or salbutamol
(10–4 to 10–10M). PMN chemotaxis to FMLP (10–6) was deter-
mined using the under agarose method. The effects of salbutamolS18
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(10–5M and 10–9M) on unstimulated PMN VLA-4 and CD 64
expression were determined using flow cytometry on whole blood.
Results There was no effect on VLA-4 or CD 64 expression.
However, salbutamol did reduce PMN chemotaxis (see Table 1).
Conclusion Salbutamol reduced PMN chemotaxis but had no
effect on VLA-4 adhesion molecule expression or CD 64 expres-
sion (PMN activation). β2 agonists may have beneficial effects
beyond simply enhancing alveolar fluid clearance in patients with
ARDS.
Table 1
Salbutamol 0 10–9 M1 0 –7 M1 0 –5 M
Chemotaxis (mm) [mean (SD)] 9.3 (1.8) 8.7 (2.3) 8.4 (2.3) 6.7 (1.6)*
VLA-4 (MFI) [median (IQR)] 10 (1.5–16) 9 (2–20) X 11 (5.5–25)
CD 64 (MFI) [median (IQR)] 12 (6–18.5) 13.5 (1.7–20.8) X 10.5 (5.3–26.8)
* P < 0.05 compared with control. IQR, interquartile range.
P36 Lymphopenia, hypoprolactinemia and lymphocyte depletion in pediatric multiple organ failure
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Introduction Lymphopenia is associated with secondary infection,
multiple organ failure (MOF) and death in adults. Lymphocyte
apoptosis has been described in autopsies of adults dying of MOF.
In experimental models, prolactin protects against lymphocyte
apoptosis.
Hypothesis Lymphocyte apoptosis occurs in pediatric patients
with MOF and is associated with prolonged hypoprolactinemia and
lymphopenia.
Methods Blood was collected on days 1, 3, 7, and 14 from
55 critically ill children without MOF and 58 with MOF (organ
failure index ≥2 for ≥3 days.) Lymphopenia was defined as lym-
phocyte count <1000×106/l. Hypoprolactinemia was defined as
<2.5ng/ml in patients >6 months and <20ng/ml in patients
>6 months (chemiluminescent assay; DPC, Los Angeles, CA,
USA). Both were considered prolonged when lasting ≥1 week.
Severe lymphocyte depletion (SLD) was determined by a patholo-
gist’s histologic evaluation of lymph nodes and spleen at autopsy.
Linear and logistic regression models were used to control for
immune suppression, steroid use, and severity of illness (PRISM
score).
Results Lymphocyte counts were lower in children with MOF than
in those without (median [range]: 864 [0–5525], n=58 vs 1787
[0–16,250], n=55; P=0.001, rank sum) even when controlling for
immune suppression and steroid use (P=0.001). Prolonged lym-
phopenia was only seen in children with MOF (17/58 vs 0/55) and
was independently associated with secondary infection (OR=5.5,
95% CI=1.7–17, P=0.004) and death (OR=6.8, 95%
CI=1.3–34,  P=0.02). Sixteen patients died; 11 underwent
autopsy. SLD was seen in 89% of those dying of MOF. Two
patients died without MOF; neither had autopsy evidence of SLD. In
patients with MOF, prolonged hypoprolactinemia (OR=12.2, 95%
CI=2.2–65,  P=0.01) and prolonged (OR=42.2, 95%
CI=3.7–473, P=0.001) were independently associated with SLD.
Conclusions Prolonged lymphopenia and SLD occur in pediatric
MOF. Prolonged lymphopenia predicts death independent of severity
of illness. Unrecognized hypoprolactinemia may contribute to SLD.
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Objective Directed migration is a crucial element of PMN’s
defence capacity against microorganisms in a septic state.
The aim of our study was to look at the course and the significance
of PMN migration capacity in surviving and nonsurviving critically ill
patients.
Method Intensive care patients with the diagnosis of SIRS or
sepsis according to the SCCM/ACCP criteria were enrolled in this
prospective study. The APACHE III score for each patient was cal-
culated within 24 hours of admission.
PMN migration capacity was measured in 30µl fresh whole blood
in a membrane filter assay. Measurements were made daily from
admission until discharge from the ICU or until death.
Numbers and distribution of the PMNs immigrant into the filters
were evaluated in an automated image analyser. The relevant para-
meter was the percentage of PMNs migrating from the blood
samples into the filters upon FMLP stimulation.
In parallel, the PMN blood count, reactive oxygen species produc-
tion, blood levels of C-reactive protein, PMN elastase, procalci-
tonin, neopterin and sL-selectin were determined.S19
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P38 Impaired PMN migratory capacity: a risk marker for impending infections in severe trauma patients
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Results Sixteen patients (10 men/six women), mean age
48.8±16.43 and mean APACHE III score 94.37±23.71, were
investigated. During the major part of the observation time, all
patients had migration values below the critical minimum of 6%.
The nonsurvivers kept this low reactivity until death, while survivors
regained normal PMN migration during the period of clinical recov-
ery. No such discriminative power could be attributed to the other
inflammation parameters.
Conclusion PMN migration was impaired both in sepsis and SIRS.
An improvement of PMN migration capacity signals the restoration
of PMN-based immunity and may be a useful aid in deciding how
long to maintain and when to discontinue antimicrobial therapies in
intensive care patients.
Objective PMNs represent the foremost line of host defence
against bacterial and fungal infections. We investigated the associ-
ation between impaired PMN migratory capacity and subsequent
infections in critically ill trauma patients.
Method Twenty-six patients with different ISSs were included in a
prospective study. PMN migration was measured daily in fresh
whole blood in a membrane filter assay. Migration was evaluated in
an automated image analyser. The relevant parameter was the per-
centage of PMNs migrating from the blood samples into filters upon
FMLP stimulation. Migration values below the critical minimum of
6% on three consecutive days predict high infection risk, as we
have repeatedly found in our numerous studies on this subject.
Results Nine patients developed microbiologically verified infec-
tions. In comparison with the 17 noninfected patients, these
patients showed reduced PMN migratory capacity 1–19 days
before infection occured.
The group with infections developed a significantly lower total
PMN migration (P=0.0018); they more frequently had values
below the critical limit of 6% (P=0.0005) and low values over
longer periods (P=0.0008). When these parameters were com-
bined, infections could be predicted with a specifity/sensivity of
82.3/88.8%. Trauma severity had no influence on PMN migra-
tion. An increase of PMN migration signalled the restoration of
immunity.
Conclusion Trauma patients with impaired PMN migratory capac-
ity are at increased risk for infections. PMN migration tests can
define the risk and may be useful for deciding when to initiate,
maintain and discontinue antimicrobial treatment.
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Lower respiratory tract disease caused by respiratory syncytial
virus (RSV) is characterized by profound airway mucosa inflamma-
tion, both in infants with naturally acquired infection and in experi-
mentally inoculated animal models. Chemokines are central
regulatory molecules in inflammatory, immune and infectious
processes of the lung. Previously we have shown that the deple-
tion of MIP-1α/CCL3 reduces lung inflammation and chemokine
expression in RSV-infected lung tissue. In this study, we demon-
strate that depletion of CCR5 as a receptor for MIP-1α results in
upregulation of chemokines and cytokines in RSV-infected lung
tissue but had no influence on viral clearance or histopathology
compared with the wild type animals. Genetically altered mice with
additional deletion of the MIP-1α/CCL3 gene demonstrated an
upregulation in the chemokine mRNA expression paralleled by
comparable cytokine expression following RSV infection, com-
pared with wild type mice. There was no difference in lung inflam-
mation or viral clearance. Pathology scores were only reduced in
mice depleted for MIP-1α/CCL3. These results provide some evi-
dence that the pattern of chemokine expressed in lung tissue
determines the severity of lung inflammation during RSV infection.
P40 Measurement of endotoxin, IL-6, IL-8 and blood lactate after cardiac surgery: re-evaluation of the systemic inflammatory
response induced by cardiopulmonary bypass
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Introduction Cardiopulmonary bypass (CPB) has been thought to
induce endotoxemia and/or ischemia-reperfusion injury. These
factors are believed to play an important role in the systemic inflam-
matory response following cardiac surgery with CPB. However,
recent surgical advances made coronary artery bypass grafting
(CABG) without CPB possible. In our study, we re-evaluate the rel-
ative contributions of CPB on the production of various mediators
in patients who received cardiac surgery with CPB by comparing
them with patients who received the off-pump coronary artery
bypass grafting (OPCAB) procedure.S20
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Methods With institutional approval and informed consent, we
studied: (1) the changes of endotoxin (ET) and beta-glucan (BG)
during the perioperative period of cardiac operations performed
with CPB (n=15) or without CPB (n=5) by using the kinetic tur-
bidmetric assay (KTA) with ET-specific and BG-specific LAL
reagents that allows separate determinations of ET and BG; and
(2) the changes of interleukin-6 (IL-6), interleukin-8 (IL-8), and
blood lactate during the perioperative period of CABG with CPB
(n=5) or without CPB (n=5). Those were compared within the
group and between the groups by ANOVA and other methods.
Results (1) ET was not detectable at any time-point in any
patients. In patients with CPB, BG rose in a time-dependent
fashion, reaching a maximum (130.2±93.1pg/ml) at 2 hours after
the initiation of CPB, then gradually decreased. No BG elevations
were observed in patients without CPB. (2) IL-6 and IL-8 were ele-
vated on ICU admission in both groups, but no significant differ-
ences were observed between the groups. In patients with CABG
with CPB, blood lactate increased from ICU admission to 12 ICU
hours compared with OPCAB patients, and decreased to the
same level as those in OPCAB patients on 24 ICU hours.
Discussion These results indicate that CPB does not affect the pro-
duction of endotoxin, IL-6 and IL-8. Other factors may contribute to
the rise in blood lactate. Further studies are needed to clarify the rela-
tionship between CPB and the postsurgical inflammatory response.
P41 Enterococcal aggregation substance as target for opsonic antibodies in vitro and in murine sepsis
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Introduction In ICU patients, the mortality of enterococcal sepsis
is high, and treatment is often difficult due to multiple antibiotic
resistance. Aggregation substance (AS) is a surface protein of
E.faecalis, which mediates transfer of (resistance) plasmids and
was also identified as a virulence factor. We investigated whether
AS may serve as target for antibodies in phagocytosis assays and
in a murine sepsis model.
Methods Using the Qiagen pQE vector system, AS was
expressed in E. coli and a histidine-tag served for purification by
Ni-NTA chromatography. After purity was verified by western blot,
AS was used to immunize rabbits. In phagocytosis assays, the
immune rabbit sera (IRS) were compared with pre-immune sera for
their opsonic activity, using human leukocytes, complement, and
mutants of E. faecalis OG1. In order to show the specificity of the
antibodies, the sera were absorbed with mutants of E. faecalis
OG1 constitutively expressing (AS+), or not expressing AS (AS–).
In the sepsis model, aliquots of IRS or normal rabbit sera (NRS)
were used for IV passive immunization of Balb/c mice 24 hours
before bacterial challenge, and 4 hours and 24 hours thereafter.
IV bacterial challenge was performed via tail vein injection of AS+
E. faecalis. The mice were sacrificed 5 days thereafter for examina-
tion of bacterial levels in internal organs.
Results When incubated with IRS, the number of AS+ E. faecalis
recovered at the end of the phagocytosis assay was reduced by
more than 50% compared with incubation with pre-immune sera
(P<0.01), whereas there was no difference against AS– strains.
IRS was still opsonic after absorption with AS– E. faecalis but the
activity was lost after absorption with AS+ mutants. In the mouse
sepsis model, weight loss was significantly less in the IRS group
(mean±SD, 97.9±3.6% of baseline weight) versus the NRS
group (95.3±2.9%, P=0.04). The highest organ load with entero-
cocci were found in the kidneys and the log cfu/g were signifi-
cantly lower in the IRS group (P=0.03).
Conclusion In our mouse sepsis model, antisera against AS signif-
icantly reduced weight loss and also the number of enterococci
recovered from kidneys. The usefulness of AS as a target for anti-
bodies is further confirmed by enhanced killing of AS+ enterococci
by IRS. Our results are encouraging and point to the possibility of
adjunctive immunotherapeutic approaches in enterococcal sepsis.
P42 Identification of diagnostic criteria of septic complications in children with neutropenia
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Introduction Septic complications in neutropenic patients after
chemotherapy lead to high morbidity and mortality in the pediatric
oncology ward. There are no clear criteria of systemic inflammatory
response syndrome (SIRS) and sepsis for neutropenic patients. It
is usual that patients after chemotherapy have altered WBC, and
the majority of them demonstrate tachycardia and mild to moderate
fever (signs of SIRS) without infection. There is no clear differentia-
tion between definitions of febrile neutropenia and sepsis for this
group of patients.
Objective To define additional diagnostic criteria of SIRS in chil-
dren with febrile neutropenia after chemotherapy.
Study design Monocentric, retrospective, case–control (equili-
bration of age, sex, diagnose) study, cases of severe sepsis and
septic shock compared with control patients with febrile
neutropenia.
Methods Ninety-two patients were investigated (48 cases and
44 controls), aged 12±4.5, and included 52 males and
40 females. The majority of patients had lymphoproliferative and
myeloproliferative disorders, acute lymphoblastic leukemia 27%,
acute myeloblastic leukemia 26%, non-Hodgkin lymphoma 13%,
CNS tumors 17%, solid tumors (oseosarcoma, Ewing sarcoma,
neuroblastoma, rhabdomyosarcoma) 14%. All patients had fever
and neutropenia. We compared data of vital signs, levels of
C-reactive protein, fibrinogen, urea and creatinin during 72 hours
before a febrile episode or ICU admission. For the statistical analy-
sis the Mann–Whitney U test was used; P<0.05 was considered
significant.S21
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Results Forty-eight patients (case group) (52%) developed severe
sepsis or septic shock and required ICU admission (27 and 21
patients, respectively); all of these patients had clinical signs of
sepsis, but only 76% had positive blood cultures. The mortality rate
in the case group was 65%. In the control group only eight
patients out of 44 had ICU admission, and in the control group we
observed recovering in 24–32 hours after start of treatment with
antibiotics in all patients. There was no mortality in the control
group. Heart rate higher than 140% to normal, fever higher than 38
more than three times daily, and CRP level higher than 7.5mg/dl
was found in 92% patients of the case group 48 hours before ICU
admissions. In the control group the level of CRP was significantly
lower (2.6±1.1mg/dl), the heart rate was in a range between 110
and 122% to normal, fever higher than 38 was observed one or
two times daily and discontinued in 24–48 hours. There were no
significant difference in levels of fibrinogen, urea, and creatinin in
the two groups as well as the presence of tachypnea, blood pres-
sure and other signs during the period of observation.
Conclusion The presence of high levels of CRP, tachycardia, and
severe fever in children with neutropenia are predictors of transfor-
mation febrile neutropenia to sepsis, severe sepsis and septic
shock. The use of these factors as diagnostic criteria should allow
preventing severe complication in patients after chemotherapy.
P43 The IL-10 –819T polymorphism is associated with increased susceptibility to severe sepsis
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Introduction Severe sepsis is characterized by an aggressive
inflammatory response, and is more common in patients with
genetic polymorphisms that promote greater production of pro-
inflammatory cytokines (e.g. –308A on the TNF gene). Thus, we
hypothesized that the genetic predisposition to lesser anti-inflam-
matory response (–819T on the IL-10 gene) would also increase
the risk of severe sepsis.
Methods As part of a first interim analysis of an ongoing NIH-
sponsored multicenter study of Genetic and Inflammatory Markers
of Sepsis (GenIMS), we analyzed 284 adult patients presenting to
the Emergency Department (ED) with community-acquired pneu-
monia (CAP). We drew blood from patients presenting to EDs in
southwest Pennsylvania with CAP for genotyping and plasma IL-10
levels. We defined severe sepsis as a Sequential Organ Failure
Assessment Score increase of 2 for any one nonrespiratory organ,
or an increase of 1 for any two nonrespiratory organs, or an
absolute score of 3 or 4 for respiratory organs.
Results The cohort had a mean age of 66.9±17.1 years; 49.6%
were female; 87.7% were Caucasian; 30.3% had underlying respi-
ratory disease; and 39.4% developed severe sepsis. Subjects with
either genotype C/T or T/T at IL-10 –819 were associated with a
greater risk of progression to severe sepsis compared with the
common homozygote C/C (odds ratio=1.71, P=0.03). We did
not find a consistent difference in plasma IL-10 levels in subjects
with different genotypes.
Conclusion: In this preliminary analysis of subjects with CAP,
those with the IL-10 –819 C/T or T/T genotypes are more likely to
develop severe sepsis compared with those with the usual
homozygous C/C phenotype.
Acknowledgement Supported by NIH grant R01 GM61992-01.
Table 1
IL-10 –819 polymorphisms
All C/C C/T T/T
n 284 151 114 19
% severe sepsis 39.4 33.8 43.9 57.9
P44 Modulation of NF-κ κB signaling in macrophages under long-term and second-hit stimulation
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Introduction Sepsis often leads to deterioration of organ function,
so-called multiple organ dysfunction syndrome (MODS). Patho-
physiologically, impaired control mechanisms of NF-κB activation
result in a dysbalance between proinflammatory and anti-inflammatory
gene transcription. In regard to hyperinflammation, NF-κB activation is
thought to play a central role [1], while being inalienable for the
inflammation process [2]. Therefore it is conceivable that both
proinflammatory and anti-inflammatory cell functions are mediated by
NF-κB in the same cell system. The aim of this study is to elucidate
the activation kinetics of NF-κB under long-term stimulation (LTS) and
two-time stimulation (TTS), simulating conditions in critical diseases.
Methods Murine macrophages (cell line RAW 264.7) were cul-
tured in standard medium (DMEM+10% FCS) and incubated in
0.1µg/ml, 1.0µg/ml and 10µg/ml lipopolysaccharide (LPS).
After 5, 10, 20, 30, 60 min, and again after 2, 4, 8, 12, 16, and
24 hours, we analyzed the activity of NF-κB in cellular and nuclear
protein extracts using the methods of Electrophoretic Mobility Shift
Assay (EMSA) and western blots (p65, IκBα). After 4 hours pre-
incubation with 0.1µg/ml, 1.0µg/ml and 10µg/ml LPS, we stimu-
lated again a second time with 1µg/ml LPS (TTS). The analysis
mentioned above was done after 5, 10, 20, 30, 60, and 120 min.
Results Cells incubated with high concentrations of LPS
(10µg/ml) showed a biphasic activation pattern of NF-κB after
5–10 min and 12–16 hours. Cells incubated with lower LPS con-
centrations showed no further activation after the early activation
peak. After preincubation with 0.1µg/ml LPS and TTS an unaltered
timely activation of NF-κB with delayed IκBα degradation was
observed.S22
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Conclusion The LPS tolerance [3] often described in the literature
does not exist in macrophages preincubated with low concentra-
tions of LPS. The biphasic activation pattern of the NF-κB signaling
pathway induced by high LPS concentrations occurs possibly
within the scope of an anti-inflammatory regulation mechanisms.
These results clarify the varying activation kinetic of the NF-κB sig-
naling pathway.
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Introduction Previously it has been shown that ischemic precondi-
tioning could increase the tolerance of intestinal tissue to ischemia
[1]. In this study we investigated the effects of pharmacological
preconditioning with adenosine infusion on intestinal
ischemia/reperfusion (I/R) injury and bacterial translocation. We
also evaluated the presence of any additive effects of adenosine
administration when used together with ischemic preconditioning.
Materials and methods Forty-six Sprague–Dawley rats were
used, and rats were randomly divided into five groups: Group I,
sham operated controls: only laparotomy was performed; Group II,
ischemia-reperfusion (I/R): superior mesenteric artery was clamped
for 40 min to induce ischemia in the small bowel that was followed
by 24 hours of reperfusion; Group III, ischemic preconditioning
(IPC): two cycles of 5 min of ischemia–5 min of reperfusion were
performed prior to the I/R schedule given in Group II; Group IV,
pharmacologic preconditioning (Ado): adenosine at a dose of
1000µg/kg was infused from the internal jugular vein prior to the
I/R schedule given in Group II; Group V, adenosine enhanced IPC:
adenosine was infused as in Group IV prior to ischemic precondi-
tioning that was followed by a 40 min ischemia–24 hours reperfu-
sion schedule. Twenty-four hours later, to evaluate whether the I/R
induced intestinal injury and bacterial translocation, blood, liver,
spleen, and mesenteric lymph node (MLN) specimens were
obtained under sterile conditions for microbiological analysis.
Samples of jejunum were removed for histopathological evaluation
by Chiu scoring and determination of apoptotic cell number is
achieved by the staining of M30 monoclonal antibody.
Results In the I/R group, the incidence of bacteria-isolated MLNs,
spleen, and liver was significantly higher than other groups
(P<0.05). IPC, Ado and Ado + IPC prevented I/R-induced bacter-
ial translocation and they significantly reduced the I/R-induced
intestinal injury and intestinal epithelial apoptosis.
Conclusions This is the first study showing that adenosine admin-
istration was as effective as ischemic preconditioning in inducing
ischemic tolerance and in preventing bacterial translocation in the
rat intestine. However, there was no enhancement of IPC with prior
adenosine infusion.
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Objective Despite their widespread use, there are limited data on
the pharmacokinetics and pharmacodynamics of dopamine (DA)
and norepinephrine (NE) in critically ill patients. We have
addressed these issues in a randomised cross-over study in a
group of head-injured patients.
Methods Eight patients with a head injury, requiring DA or NE
infusions to support cerebral perfusion pressure (CPP), were
recruited following informed assent from patients’ next of kin.
Patients received in randomised order either DA or NE to achieve
and maintain a CPP of 70mmHg and then, following a 30 min
period of stable haemodynamics, a CPP of 90mmHg. Data were
then acquired using the second agent. Haemodynamic
measurements were made during each period and a blood sample
was obtained at the end of each study period; plasma was stored
for later analysis of catecholamine levels by high performance
liquid chromatography. Data were analysed with paired t tests and
regression analysis using Statview 4 (SAS), with P<0.05 treated
as significant.
Figure 1S23
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Results Plasma levels of NE and DA were significantly related to
infusion rates (Fig.1), but neither predicted haemodynamic para-
meters. However, there was a significant quadratic relationship
between the infusion rate of DA and CI (r2=0.431), and SVRI
(r2=0.605), with a breakpoint (at which the CI reduced and the
SVRI increased) at a DA plasma level of ~50nM/l (corresponding
to an infusion rate of ~15µg/kg per min).
Conclusions NE and DA have predictable pharmacokinetics;
however, those of DA do not fit a simple first-order kinetic model.
The pharmacodynamic effects of DA and NE show much inter-indi-
vidual variability and unpredictability. DA plasma levels appear to
relate to variations in adrenergic receptor effects with break points
that reflect expectations from infusion rate related pharmacody-
namics.
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Introduction Vasopressin increases blood pressure and
decreases catecholamine requirements in septic shock patients
[1–3]. Few clinically relevant data are available on the effect of
vasopressin on the splanchnic circulation.
Objective To study the effect of continuous infusion of vasopressin
on the splanchnic circulation in septic shock patients.
Design Prospective clinical study.
Setting Intensive care unit in a teaching hospital.
Patients Eleven consecutive patients with documented septic
shock who remained hypotensive despite norepinephrine infusion
at a rate of ≥0.2µg/kg per min.
Interventions Insertion of a gastric tonometry catheter; continuous
infusion of vasopressin 0.04U/min during 4 hours.
Measurements and main results P(g–a)CO2 gap, blood pres-
sure and cardiac index were recorded at baseline and
after 15, 30, 60, 120 and 240 min.
The median P(g–a)CO2 gap increased from 5mmHg at baseline to
19mmHg after 4 hours (P=0.022; Fig.1). Blood pressure
(mean±SD) increased from 61±13mmHg at baseline to
68±9mmHg after 4 hours (P=0.055). No significant changes in
cardiac index were noted (P=0.978). There was a strong correla-
tion between median plasma levels of vasopressin and the median
P(g–a)CO2 gap (r2=0.98) as is shown in Fig.2.
Conclusions In norepinephrine-dependent septic shock patients,
continuous infusion of low-dose vasopressin results in a significant
and dose-dependent increase of the P(g–a)CO2 gap compatible
with gastrointestinal hypoperfusion.
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Figure 1
Median P(g–a)CO2 gap (mmHg) with 25th and 75th percentiles.
Figure 2
Relationship between median plasma levels of vasopressin and median
P(g–a)CO2 gap.S24
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Background and goal of study The use of vasopressin for treat-
ment of hypotension in sepsis might deteriorate splanchnic
regional and microcirculatory blood flow. The aim of this study was
to measure regional blood flow and microcirculatory blood flow
(MBF) continuously and simultaneously in multiple abdominal
organs during administration of Ornithin-8-Vasopressin in peritoni-
tis-induced sepsis.
Materials and methods Pigs (20–25kg, n=32) were anaes-
thetised and ventilated. Cardiac index was measured with ther-
modilution. Blood flow was measured in the superior mesenteric
and hepatic artery as well as in the portal vein using transit time
flowmetry. MBF was measured on the surface of the liver and pan-
creas, using a multichannel Laser Doppler flowmeter. Peritonitis
was induced by instillation of autologous faeces in the peritoneal
cavity. After 240 min of peritonitis, intravenous colloids were given
to transform hypodynamic shock into hyperdynamic septic shock.
After 300 min of peritonitis, 0.06IU/kg per hour of Ornithin-8-Vaso-
pressin was administered continuously as an intravenous infusion.
Four groups of animals were investigated: Group C (n=8) served
as control; Group V (n=8) received only ornithin-vasopressin;
Group S (n=8) was exposed to peritonitis and fluid resuscitation;
Group SV (n=8) received ornithin-vasopressin after peritonitis and
fluid resuscitation.
Results and discussion Baseline measurements were taken at
T=300 min (before ornithin-vasopressin). Results are presented
as percent of baseline. P<0.05 was considered significant.
Mean arterial blood pressure increased during infusion of vaso-
pressin by 25% (P<0.05) in the groups V and SV (P>0.05), while
it remained constant in the other two groups. Cardiac output
decreased by 30% in the groups V and SV (P<0.05) and
remained constant in groups C and V. Blood flow in the superior
mesenteric artery and in the portal vein decreased by 25% in
group V (P<0.05) while there was no change in group C, and by
50% in group SV (P<0.05), which was significantly more com-
pared with a decrease of 25% in group S. Blood flow in the
hepatic artery increased by 120% (P<0.05) in group V and by
50% (P<0.05) in group SV, while there was an increase by 25%
in group C and a 20% decrease in group S. MBF of the liver
decreased gradually in groups S and SV to 15% (P<0.05) below
baseline after 180 min in both groups. MBF of the liver decreased
during infusion of vasopressin in nonseptic animals (Group V) by
30% (P<0.05) while it remained constant in nonseptic controls
(Group C). MBF of the pancreas decreased by 20% (P<0.05) in
groups C and S, while it decreased 35–40% (P<0.05) in
groups S and SV.
Discussion and conclusions 1) During the infusion of ornithin-
vasopressin, blood flow in the superior mesenteric artery and the
portal vein decreased. 2) Increased blood flow in the hepatic artery
during administration of ornithin-vasopressin suggests that the
hepatic arterial buffer response was involved. 3) MBF in the liver
decreased during administration of ornithin-vasopressin in nonsep-
tic animals in contrast to the septic group. 3) Ornithin-vasopressin
appeared to decrease significantly MBF in the pancreas in both
septic and nonseptic animals. 4) In this model, increasing arterial
blood pressure with ornithin-vasopressin did not result in an
increase of microcirculatory blood flow in any of the organs
studied.
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Background and goal of study The use of vasopressin for treat-
ment of hypotension in sepsis might deteriorate splanchnic
regional and microcirculatory blood flow. The aim of this study was
to measure renal artery blood flow and microcirculatory blood flow
(MBF) of the kidney continuously and simultaneously during admin-
istration of Ornithin-8-Vasopressin in peritonitis-induced sepsis.
Materials and methods Pigs (20–25kg, n=32) were anaes-
thetised and ventilated. Cardiac index was measured with ther-
modilution. Blood flow was measured in the renal artery using
transit time flowmetry. MBF was measured on the surface of the
kidney using a multichannel Laser Doppler flowmeter. Peritonitis
was induced by instillation of autologous faeces in the peritoneal
cavity. After 240 min of peritonitis, intravenous colloids were given
to transform hypodynamic shock into hyperdynamic septic shock.
After 300 min of peritonitis, 0.06IU/kg per hour of Ornithin-8-Vaso-
pressin was administered continuously as an intravenous infusion.
Four groups of animals were investigated: Group C (n=8) served
as control; Group V (n=8) received only vasopressin; Group S
(n=8) was exposed to peritonitis and fluid resuscitation; Group SV
(n=8) received vasopressin after peritonitis and fluid resuscitation.
Results and discussion Baseline measurements were taken at
T=300 min (before ornithin-vasopressin). Results are presented as
percent of baseline. P<0.05 was considered significant. Mean
arterial blood pressure increased during infusion of vasopressin by
25% (P<0.05) in groups V and SV (P>0.05), while it remained
constant in the other two groups. Cardiac output decreased by
30% in groups V and SV (P<0.05) and remained constant in
groups C and V. Renal artery blood flow decreased after 60 min of
vasopressin by 15% (P<0.05) in group V and returned to baseline
after 180 min. In group SV, renal blood flow decreased by about
10% (P>0.05) after 30 min and returned to baseline after 90 min.
MBF of the kidney remained constant in groups C and S. In
group V, MBF of the kidney decreased by 25% (P<0.05) after
60 min of ornithin-vasopressin but returned to baseline after
180 min. In group SV, MBF of the kidney decreased by 15%
(P<0.05) and remained decreased. Urine output increased signifi-S25
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cantly in both septic and nonseptic groups receiving ornithin-vaso-
pressin.
Discussion and conclusions 1) In nonseptic animals, blood flow
in the renal artery and microcirculatory blood flow of the renal
cortex decreased only initially and recovered after 180 min during
infusion of vasopressin. This finding suggests the presence of an
autoregulatory mechanism. 2) Although vasopressin decreased
renal artery blood flow to a lesser extent in the septic group, micro-
circulatory blood flow decreased. This finding suggests that
autoregulation at the microcirculatory level of the renal cortex might
be impaired in sepsis. 3) In this model, increased urine output was
not due to increased blood flow but rather the result of pressure
diuresis.
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Introduction The hepatosplanchnic region is quite important in the
physiopathology of shock, trauma, SIRS and sepsis [1]. The intesti-
nal mucosa is one of the first parenchimis that are influenced by
the alterations of the perfusion and/or splanchnic oxygenation [2].
Particularly, a pHi <7.1 for a period greater than 2 hours, defined
as sigmoid ischemia of low degree, is predictive for major compli-
cations and death [3].
Fenoldopam has been demonstrated to improve glomerular perfu-
sion through D1 receptors, which are present also in the mesen-
teric region.
The purpose of our study is to verify whether fenoldopam infusion
during abdominal aortic surgery can prevent gut ischemia.
Materials and methods It is a prospective, controlled, randomized
clinical trial on a preliminary series of 14 patients operated for
abdominal aortic aneurysm. These patients were monitored with a
sigmoid tonometer and with a NiCO system to measure cardiac
index (CI). Patients just after anesthesia induction were randomized,
allocated in two groups: one receiving corlopam at the dosage of
0.05µg/kg per min (Group A) and the other receiving placebo
(Group B). ∆O2, pHi and CO were detected at the following times:
just after the anesthesia inducion (t0), before aortic clamping (t1),
30 min after aortic clamping (t2), and just after the operation (t3). At
these times an arterial sample was taken to detect arterial blood
lactate, tumor necrosis factor alpha (TNF-α), and interleukin-1B,
interleukin-6 and interleukin-8 (IL-1β, IL-6, IL-8). At T1 and T2 a
portal blood sample was taken to detect portal blood lactate,
TNF-α, IL-1β, IL-6, IL-8. At each time point medians of pHi, ∆O2,
systemic and portal lactate, and hemoglobin (Hb) were calculated
for both groups of patients. The trend of pHi was determined with
the Friedman test and Dunn’s post-test. Median comparison was
performed using the two-tailed non-parametric Mann–Whitney test.
The Fischer exact test was used to compare a possible abnormal
distribution of pHi and/or ∆O2 within groups of patients.
Results Phi decreased significantly at T2 in both groups
(P<0.01), but at T3 was significantly higher, compared with T0,
only in Group B (P<0.05).  ∆O2 did not increase significantly
during aortic clamping in Group A, while in Group B at T2 it
increased significantly (P<0.01). CI decreased significantly in
both groups at T2 (P<0.05). Portal lactates were significantly
higher in group B at T1 (P<0.05), but at T2 there was not any sig-
nificant difference. The arterial lactates trend was similar in the two
groups. Any significant difference could be found for cytokines
between the two groups.
Conclusions From these preliminary data it seems that corlopam
can ameliorate gut perfusion, as suggested by the increase of pHi
and ∆O2, even if these data have to be confirmed on a larger number
of patients. After that other work must be done to investigate
whether corlopam infusion can increase the outcome, that is morbid-
ity and mortality, of patients undergoing abdominal aorta aneurysm.
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Sepsis causes increased capillary stopped-flow, loss of capillary
density, maldistribution of blood flow and increased oxygen
extraction from ‘normal’ capillaries [1] in skeletal muscle. Since
nitric oxide overproduction has been associated with refractory
hypotension, capillary stopped-flow and decreased RBC
deformability [2], we hypothesized that NO inhibition would
prevent microvascular dysfunction. In a rat cecal ligation and per-
foration sepsis model, plasma NOx– level (NO chemilumines-
cence) was maintained at baseline by NO inhibition (L-NIL) and
skeletal muscle capillary geometry, hemodynamics and RBC O2
saturation (SO2) were quantified (spectrophotometric functional
imaging). O2 flux, amount of O2 leaving the capillary per unit
surface area, was calculated from capillary dimensions and O2
flow rates. Sepsis increased plasma NOx– (145%), capillary
stopped-flow (140%) and O2 flux (70%) and decreased MAP
(30%) and RBC supply rate (SR) (25%) (P<0.05). NO inhibition
maintained RBC SR and partially maintained MAP (90% of base-
line), but had no effect on capillary stopped-flow or O2 flux. We
conclude that NO-independent capillary ischemia caused func-
tional capillaries to off-load greater amounts of O2 to supply
larger tissue volumes. Capillary SO2<8% indicated microvascu-
lar dysregulation and inefficient matching of local O2 delivery to
local O2 demand. Improving capillary flow may benefit the septic
patient.S26
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Objective In sepsis, generalized tissue edema develops as a rule
due to fluid management under conditions of systemic capillary
leak. Edema formation in a closed and noncompliant anatomic
compartment can lead to increased intracompartmental pressure
and subsequent tissue damage as seen, for example, in post-
ischemic compartment syndrome. We hypothesized that increased
intramuscular tissue pressure caused by muscle swelling in a
closed fascial space can contribute to skeletal muscle damage in
sepsis. The aim of this study was to describe intramuscular pres-
sure changes during massive fluid resuscitation in experimental
porcine sepsis.
Material and methods Seven anesthetised, artificially ventilated
and multicatheterized domestic pigs (body weight 29.7±3.9kg)
were randomly subjected to either live E. coli IV infusion to induce
sepsis (n=4) or to a sham procedure (n=3). Animals were fluid
resuscitated with 20ml/kg per hour Ringer’s lactated solution and
followed for 24 hours after start of the microbial infusion. Hourly
fluid balance and cumulative fluid balance were recorded. Intra-
muscular pressure was measured every hour using an electronic
transducer-tipped catheter system placed into the m. tibialis longus
of the right pelvic extremity. For statistical analysis, ANOVA for
repeated measures, the Dunnett test and the Mann–Whitney U
test were used.
Results In both groups, positive fluid balance was observed. In
septic animals, final cummulative fluid retention was
345±121ml/kg per 24 hours compared with 149±25ml/kg per
24 hours in controls (P<0.00001). Intramuscular pressure
increased from initial values (median 10mmHg, range
6–11mmHg) gradually in both groups during the experiment to 13
(11–20)mmHg in septic and 16 (15–17)mmHg in controls.
Despite lower fluid retention, the intramuscular pressure increased
to significantly higher values in the control group (P<0.01) com-
pared with septic animals. The increase reached statistical signifi-
cance compared with baseline in hour 5 in controls, and in hour 13
in the septic group. In both groups, the intramuscular pressure
never exceeded 20mmHg, which is clearly below the pressure that
is proven to cause skeletal muscle damage in compartment
syndrome.
Conclusions Increased skeletal muscle tissue pressure during
fluid retention following crystaloid infusion was observed in both
septic and control animals. Tissue pressures did not reach levels
proven to promote direct damage to skeletal muscle in any group.
The increase was delayed and significantly lower in septic animals
compared with controls despite higher fluid retention in the septic
group.
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Objective To determine the presence of otherwise undetected
myocardial cell injury in patients with septic shock using daily
eletrocardiographics, and bidimensional echocardiography, serum
troponin I (cTN I) and serum C-reactive protein (when electrocar-
diographic evidence of acute myocardial infarction).
Design Prospective observational study.
Setting Intensive care unit (ICU) of a tertiary institution.
Patients Twenty-eight consecutive patients with sepsis or septic
shock.
Interventions Daily collection of blood for the measurement of
cTN I serum levels. Cineangiography when necessary. Illness
severity assessment and collection of demographic data.
Measurements and main results Twenty-eight patients were
studied for a mean period in the ICU of 17.2 days (range, 3–37
days). All 10 patients who died in the intensive care unit had ele-
vated levels of cTN I, mean 21.9ng/ml (range, 2.9–94.1). Survivors
tended to lower levels of cTN I than nonsurvivors in septic shock,
mean 12.4ng/ml (range 0.5–57.0). All five patients who had
abnormal cineangiography had elevated levels of cTN I, mean
38.4ng/ml (range, 5.4–94.1), while normal cineangiography had
cTN I mean 9.1ng/ml (range, 0.5–27.8). The difference between
serum C-reactive protein and cTN I or mortality failed to reach sta-
tistical significance. No patient had electrocardiographic evidence
of acute myocardial infarction, although, on admission, five patients
had left bundle branch patterns, two patients had right bundle
branch patterns and two had evidence of an atrial fibrillation. Sev-
enteen cardiac catheterizations were done and five were abnormal
correlating to abnormalities of the ecochardiogram. Three patients
used intraaortic baloon pumping in a period of time up to 6 days
(mean 3 days).
Conclusion Myocardial cell injury (cardiac dysfunction) appears to
be common in patients with septic shock but does not correlate
with coronary artery disease. It seems to be an imbalance between
oxygen delivery and consumption.S27
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Introduction The mortality of patients with cardiogenic shock (CS)
following acute myocardial infarction (AMI) remains high, despite
modern reperfusion strategies. The progressive hemodynamic
deterioration in patients with AMI is usually caused by left ventricu-
lar systolic dysfunction as a consequence of necrosis or ischaemia.
The special subset of CS patients comprises patients with
mechanical complications, mainly the severe acute mitral regurgita-
tion (SAMR), ventricular septal and free wall rupture (8%, 6% and
2.7%, respectively, of all CS patients).
Methods Prospective observation of six consecutive patients with
SAMR September 2001–October 2002.
Results See Table 1.
Conclusion Initial aggressive organ support and stabilization fol-
lowed by mitral valve replacement can offer the patients with
SAMR good long-term prognosis.
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Table 1
Patient (9/2001–10/2002) AMI IRA MI to shock Shock/MODS Outcome Valve replacement
50-year-old male Anterior LAD < 1 day +/+ Survived +
57-year-old male Posterior LCx 3 days +/+ Survived +
70-year-old female Inferior LCx 3 weeks +/– Survived +
38-year-old male Lateral LCx Immediately +/+ Died –
60-year-old male Anterior LAD Immediately – Died –
54-year-old female Lateral LCx 3 weeks +/– Survived +
LCx, left circumflex (coronary) artery.
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Introduction Sepsis induces myocardial dysfunction and vascular
hypocontractility. Recent data suggest that phosphorylation of
myocardial contractile proteins decreases myofilament sensitivity
to calcium and may contribute to myocardial depression [1]. Lev-
osimendan (LS), a new calcium sensitizing drug and KATP channel
opener, is used in human heart failure [2].
Aim To evaluate the LS effect on heart function, vascular tone and
renal microcirculation in rabbit without LPS (LPS–) and 36 hours
after LPS administration (LPS+).
Methods n=8 LPS+ and n=4 LPS– rabbits were analyzed. No
animal died following LPS or saline injection, nor during the experi-
ment. Heart rate (HR), systolic (sAP) and diastolic (dAP) arterial
pressure (mmHg), systolic (sAoV), and mean aortic (mAoV) blood
flow velocities (20MHz pulsed Doppler [cm/s]), systolic (sRen)
and diastolic (dRen) renal artery blood flow (transonic Doppler
[ml/min]) and renal cortical (Cort) and medullary (Med) flows (laser
Doppler [tissue perfusion units, TPU]) were measured in anes-
thetized and ventilated rabbits. Heart inotropic quality was esti-
mated by maximal acceleration (γmax [cm/s]) and sAoV. In the
LPS+ group, LPS (600µg/kg) was injected 36 hours before the
experiment. Data were collected in both groups before and at the
end of a fluid loading test (20ml in 5 min), 10 min after, and then
every 15 min during a 4 hour LS infusion (200µg/kg per hour).
Statistical analysis was performed using one-way and two-way
ANOVA.
Results (Mean±SD, all parameters were gaussian.) Myocardial
failure in LPS+ animals was confirmed by fluid loading effect on
γmax and sAoV (+8% vs +14% and +8% vs +20%, respectively,
in LPS+ and LPS–; P<0.05, two-way ANOVA).
Despite its effects on macrocirculation, LS only slightly decreased
Cort in LPS– animals, whereas no effect was observed on Med
(Table 1).
Conclusion  In this model of endotoxin-induced myocardial dys-
function, LS improved cardiac systolic parameters. Hypotension
could be related to LS interaction with KATP channels. The effects
on renal macro and microcirculation need further investigation.S28
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Table 1
Effects of LS
10 min after fluid LS 30 min LS 4 hours
LPS+ LPS– LPS+ LPS– LPS+ LPS–
HR 276 ± 40 319 ± 10 309 ± 36 336 ± 8 318 ± 35*† 328 ± 19
γmax 6898 ± 1955 6576 ± 1372 8177 ± 2151 7821 ± 1541 7812 ± 2069† 7205 ± 1150†
sAoV 91 ± 27 86 ± 9 102 ± 27 101 ± 15 102 ± 27† 97 ± 12†
sAP 99 ± 23 111 ± 8 88 ± 22 93 ± 9 76 ± 15† 88 ± 7†
dAP 61 ± 22 85 ± 6 44 ± 20 66 ± 8 35 ± 16*† 52 ± 5†
sRen 36 ± 10 28 ± 5 51 ± 16 44 ± 10 52 ± 17† 40 ± 7†
dRen 17 ± 7 16 ± 3 17 ± 9 19 ± 2 12 ± 6† 7 ± 6†
* P < 0.05, two-way ANOVA and † P < 0.05, one-way ANOVA.
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Background Levosimendan enhances cardiac contractility and
ventricular diastolic function [1], acting as a calcium sensitiser, and
producing vasodilation via vascular smooth muscle relaxation by
ATP-dependent K+-channel activation. Although hemodynamic
variables are often used to assess patients, less invasive measures
are often preferred. Plasma levels of BNP correlate well with
cardiac wall stress and changes in plasma BNP are associated
with changes in morbidity and outcomes [2]. We investigated
using echocardiographic-determined left ventricular ejection frac-
tion (LVEF) and plasma BNP concentrations as surrogate end-
points to assess the efficacy of levosimendan in decompensated
heart failure patients.
Methods Informed consent was obtained to treat 14 critically ill
patients, five with unstable hemodynamic conditions admitted to
the ICU and nine with left ventricular ejection fraction
(LVEF)<25%; five with ischemic cardiomyopathy and four with
dilated idiopathic cardiomyopathy (all NYHA class IV) were
recruited. Levosimendan was infused as a 10-min bolus of
12µg/kg, followed by 0.1µg/kg per min for 24 hours. The left ven-
tricular ejection fraction was determined echocardiographically by
Simpson’s method, before and after (<1 hour) the infusion. Blood
(4ml) was collected before and immediately after infusion for
plasma BNP measurements (Biosite®, San Diego, CA, USA).
P<0.05 was regarded as significant.
Results See Table 1.
Conclusion In this initial study, we have confirmed the improve-
ment in cardiac function after levosimendan infusion in patients
with decompensated heart failure. We have demonstrated that lev-
osimendan produces significant improvements in cardiac function
as demonstrated by plasma BNP and echocardiographic LVEF
measures. Changes in BNP level were more easily obtained and
prone to less technical error than LVEF by echocardiography,
which requires an experienced operator.
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Table 1
n=14 Pre-infusion Post-infusion % Change P*
LVEF (%) 25 ± 3 31 ± 3 +31 ± 10 0.006
BNP (pg/ml) 859 ± 140 475 ± 111 –35 ± 11% 0.004
Data presented as mean ± SE. * Wilcoxon Rank Sum.S29
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Renal dysfunction is an adverse prognostic sign in patients with
chronic stable heart failure. We used pooled data from the LIDO
(n=203) and RUSSLAN (n=498) trials to explore the influence
of renal function on outcome in severe, unstable heart failure, and
to evaluate the effects of the novel calcium sensitising agent, lev-
osimendan, in those patients with severe heart failure with differ-
ent levels of renal impairment. Patients in the LIDO study with
low-output heart failure received infusions of either levosimendan,
loading dose 24µg/kg over 10 min, followed by a continuous
infusion of 0.1µg/kg per min, or dobutamine, 5µg/kg per min
with no loading dose, for 24 hours. In patients with <30%
increase in cardiac output after 2 hours the infusion rate of both
drugs was doubled for the rest of the treatment period. Patients
in the RUSSLAN study with heart failure following an acute
ischaemic event were given either levosimendan, loading dose
6–24µg/kg over 10 min, then 0.1–0.4µg/kg, or placebo, for
6 hours. Six patients were excluded as baseline serum creatinine
values were unavailable. Patients were classified according to
their baseline renal function by calculating creatinine clearance
(CLcr) values from baseline serum creatinine by the formula of
Cockroft and Gault. The groups were, normal renal function
(CLcr>80ml/min;  n=236); mild impairment (CLcr
50–80ml/min;  n=274); moderate impairment (CLcr
30–49ml/min;  n=151); and severe impairment
(CLcr<30ml/min; n=40). The overall 180-day mortality rate in
the total study population increased significantly in relation to the
severity of renal impairment (overall hazard ratio [HR] for each
incremental increase in renal impairment, 1.5 [1.2, 1.9];
P=0.001). Mortality was 18% for patients with normal renal
function, 23% for mild impairment, 43% for moderate impairment
and 45% for severe impairment. However, the 180-day mortality
rate was significantly lower in patients treated with levosimendan
compared with patients treated with dobutamine or placebo in
LIDO and RUSSLAN, respectively (HR 0.64 [0.47, 0.88];
P=0.006). The HRs for the reduction in mortality within each
class of renal impairment were similar. These results suggest that
levosimendan has a long-term beneficial effect on patient sur-
vival, independent of the degree of observed renal impairment.
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Two pharmacological approaches are established in the treatment
of atrial fibrillation (AF): ‘rhythm control’ — usage of antiarrhythmic
agents, in order to restore and maintain normal sinus rhythm
(NSR); and ‘rate control’ — usage of agents that prolong cardiac
atrioventricular conduction, in order to alleviate clinical symptoms.
A retrospective study was conducted, aiming to determine
outcome of pharmacological treatment of patients with AF in the
emergency room (ER). Discharge Letters of all patients admitted
to the ER and subsequently diagnosed with AF over a 1-year
period were reviewed (May 2001–May 2002). Data on symptoms
duration, drugs administered and outcome of treatment were
analysed.
In a 1-year period, AF was registered in 242 patients, which repre-
sented 4% of total medical emergency admissions (n=6142). In
patients with AF, 64% (n=152) had paroxysmal AF, 12% (n=29)
had persistent AF, and 24% (n=58) had permanent AF. In a group
of patients with paroxysmal AF, pharmacological conversion into
NSR was attempted in 74% of patients (n=113). ‘Rhythm control’
was achieved in 50% (n=56) of patients, ‘rate control’ in 12%
(n=14) and 38% (n=43) of patients required prolonged hospital
treatment. The anti-arrhythmic drug of choice was propafenon, with
conversion attempted in 62% of patients (n=71) and control
achieved in 61% (n=43), and amiodarone, with conversion
attempted in 7% of patients (n=8), and rhythm control achieved in
50% patients (n=4).
In a group of patients with permanent AF (n=58), pharmacological
treatment was attempted in 69% of patients (n=40). ‘Rate control’
was achieved in 50% (n=20) patients, whereas the others
required prolonged hospital treatment. The pharmacological drug
of choice was a combination of verapamil and digoxine, with 81%
success rate.
AF is the most common cardiac arrthymia presented in the emer-
gency room. The ‘rhythm control’ approach still represents the
main target in the treatment of patients with AF presented in the
emergency room, whereas ‘rate control’ is attempted in patients
with persistent and permanent AF. In the study, the drug of choice
for pharmacological conversion of AF into NSR is propafenon, and
for ‘rate control’ the best results are obtained by administering the
combination of verapamil and digoxine.
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Recognising and intervening in the early stages of critical illness,
basic life support and defibrillation are essential for improving
outcome from inhospital cardiac arrest [1,2]. The Resuscitation
Council (UK) (www.resus.org.uk) launched the Immediate Life
Support Course (ILS) in January 2002. This multiprofessional
1-day resuscitation course provides tuition on the knowledge andS30
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skills required by a first responder to manage a patient in cardiac
arrest for the short time before the arrival of a cardiac arrest team.
ILS also introduces healthcare professionals to the role of a
cardiac arrest team member. Recognition and intervention in the
acutely unwell patient prior to cardiac arrest, basic airway skills and
rapid safe defibrillation using either manual or automated external
defibrillators (AEDs) are the prime objectives of the course. The
course includes lectures, skill stations and cardiac arrest scenar-
ios. ILS has standardised much of the life support training that
already takes place in hospitals in the UK.
In the first year, 14,409 candidates attended ILS courses in 122
course centres. The backgrounds of the participants are sum-
marised in Table 1. Participants are continually assessed during the
course and those that demonstrate satisfactory performance are
awarded a certificate valid for 12 months. During the first year the
majority (99%) of participants successfully achieved the course
objectives. The preliminary results presented here show a promising
start for the new ILS course. The challenge now is opening up the
course in more centres while maintaining the quality of teaching.
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Table 1
Professions Pre-hospital  Dental Medical/nursing 
Doctors Nurses allied to medicine staff staff students Other
Number 964 11,179 786 94 192 878 316
% 6.7 77.6 5.5 0.6 1.3 6.1 2.2
P60 Medicine college curriculum and problem based learning: a training program guided with Basic Life Support course
M Canesin1, S Timerman2, C Grion1, L Cardoso1, S Silva1, P Gordan1
1Skills Laboratory/C.C.S., Londrina University Medical School, Parana, Brasil; 2Heart Institute University of São Paulo, School of Medicine,
São Paulo, Brasil
Critical Care 2003, 7(Suppl 2):P060 (DOI 10.1186/cc1949)
Introduction The medical college curriculum at the University of
Londrina uses the PBL (problem based learning) method of teach-
ing. This method is based on adult education and it is focused in
learning to learn and doing to learn. One of the worries of this
teaching method is the development of practical skills and the
practicing of these skills before the application in patient care. The
objective of this paper is to describe the experience of the Basic
Life Support training in the curriculum of a medicine college that
uses the PBL method.
Materials and methods The Basic Life Support training uses a
skills laboratory of the University Hospital. This laboratory has five
skills classrooms equipped with video monitoring, training manikins
with monitoring system, automatic external defibrillator simulator
and other materials for technical support. The Basic Life Support
training is divided in two parts of growing complexity and has the
main objective of training the adult in prehospital cardio respiratory
arrest. In the first year of the medicine college the students are
divided into groups of 20 for the cognitive classes and groups
of 10 for the skills or psychomotor classes of cardiopulmonary
resuscitation (CPR) with one or two rescuers. In the third year of
the college the students are divided in the same way for the
reinforcement of the cognitive and the skills classes, now including
the use of the automatic external defibrillator. The knowledge and
skills performance evaluation is realized in the second year so the
retention is well documented.
Results Since the institution of this method of teaching 240 stu-
dents were trained in Basic Life Support. A first evaluation has
been performed after 1 year of training in the first group of 80 stu-
dents. The percentage of the students that performed right skills in
this first evaluation was 84.9%. The initial results showed excellent
performance of the students in the first evaluation and a good
retention after 1 year of training. The students showed high interest
for the subject with a frequency to the classes superior of 95%.
Conclusion The institution of basic life support guided courses in
the PBL curriculum of the medicine college is very important. The
student that already has trained in CPR in the laboratories starts the
patient care very well prepared and with a padronized view. This rec-
ommendation follows the International and American Heart Associa-
tion recommendation for the padronization of CPR. This new
recommendation says that the training of CPR may be started in the
medical college and then reinforced later with other specific courses.
P61 Seasonal variation in the incidence of inhospital cardiac arrest: analysis of three groups of cardiac arrest
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Introduction Many studies have analysed circadian variation in the
onset of cardiovascular disorders. Only a few studies have exam-
ined the occurrence of cardiac arrest by month of year. To our
knowledge none has studied seasonal variation in the incidence of
three kinds of inhospital cardiac arrest: nontraumatic with pre-
sumed noncardiac etiology cardiac arrest (NTNCA), traumatic
cardiac arrest (TCA), and cardiac arrest (CA).
Methods We performed a retrospective analysis of computerized
records of all patients discharged from our hospital from SeptemberS31
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1998 to September 2002. We examined 101,390 clinical comput-
erized records. One thousand two hundred and ninety-three con-
secutive patients were included with the diagnosis of cardiac arrest
using codes according to the International Classification of
Diseases,  Ninth Revision (ICD-9). We divided (using the ICD-9
codes) all cases found in the three groups: NTNCA, TCA, CA. Data
were aggregated using the medical program Oracle and MS Access
2000 software. With the chi-square test we examined whether
cardiac arrests uniformly occurred during seasons and months.
Results There were 1293 cardiac arrests with 956 NTNCA, 143
TCA, 194 CA. For our analysis we divided the year into four
seasons: winter (December–February), autumn (September–
November), spring (March–May), summer (June–August).
Our data shows a seasonal variation in all cases, with a greater
number of cardiac arrests in winter (26.8%) and fewer in autumn
(24.2%) and summer (24%). This variation is different among three
groups: in the group of NTNCA there are more cases in spring
(26%) and winter (25.8%) and fewer in autumn (23.7%), in the CA
group the cases are more in winter (33.5%) and fewer in spring
(20.6%) and summer (21.2%), and in the TCA there are more in
autumn (25.8%) and fewer in spring (24.5%) and summer
(24.5%). Unluckily the chi-square test did not reject uniformity over
the whole year for all groups examined.
Discussion Our data show a seasonal variation in all cardiac
arrests with a greater number of cases in the cold months. This
trend is similar to that found in other studies. In particular we found
a similar trend in the group of CA and of TCA: more cases in
autumn and winter. The seasonal hormonal variation and stresses
caused by shorter hours of daylight could explain this distribution.
On the contrary the NTNCA group showed a different trend: more
cardiac arrests in spring and winter. We suppose that the NTNCA
cardiac arrests are not linked to the same seasonal hormonal varia-
tion of CA and TCA.
Conclusion There are several limitations to our findings, one of the
major is the use of a database using ICD-9 codes. Moreover our
results were not confirmed by statistic test. Nevertheless we
believe that our findings are reliable, because they were confirmed
by several studies. In any case we suggest further research: large
studies on the link between environmental factors and the NTNCA
cardiac arrests.
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Introduction Defibrilation or cardioversion in critically ill cardiac
patients may be followed by serum cardiac marker elevation.
However, only few studies with limited patient samples assessing
electrical myocardial injury have been published [1,2]. The aim of
our study was to evaluate the response of serum cardiac markers
following elective cardioversion for supraventricular tachyarrhyth-
mias (SVT) and to analyze the impact of type of shock waveform.
Methods Eighty-three patients with various SVTs indicated for
elective cardioversion were randomized to monophasic or biphasic
electrical cardioversion (CV). Serum levels of creatine kinase (CK),
MB fraction of CK (CK-MB), myoglobin (Mg) and troponin I (TnI)
were analyzed before CV and 262±69 min after the procedure.
Results Average age was 66.3±11.2 years, 43 patients under-
went biphasic and 40 monophasic CV. The most frequent type of
arrhythmia was atrial fibrilation (63%). Mean cumulative energy
(CE) was 301±260 J. Delivered CE>150J was associated with
significant elevation of CK and Mg levels after CV (0.96µmol/l and
166µg/l, respectively), while CE<150 was not (P<0.01). Base-
line values of TnI were negative in all patients. No significant
changes in CK-MB and TnI levels after CV were identified. Strong
correlation between increase of CK and Mg levels and CE was
observed. Multivariate logistic regression analysis identified only
cumulative energy >150J as an independent positive predictor for
CK and Mg elevation. Randomization to the biphasic or monopha-
sic waveform group was not associated with significant differences
in serum cardiac marker elevation and with the success rate in
sinus rhythm restoration (88.37% vs 87.18%, respectively;
P=0.8692). However, a trend to lower CE necessary for sinus
rhythm restoration was detected for biphasic wave shock (259 vs
347, P=0.1237).
Conclusion According to our study, elective electrical cardiover-
sion for SVTs is not associated with biochemical signs of myocar-
dial injury. Application of cumulative energy >150J can be
followed by CK and Mg elevation most likely due to skeletal muscle
damage. This pattern is not dependent on the type of the shock
waveform.
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Introduction In recent years there has been an increased interest in
the use of capnometry, the noninvasive continuous measurement of
partial pressure of end-tidal carbon dioxide (petCO2) in expired air.
petCO2 monitoring has been useful in determining the effectiveness
of cardiopulmonary resuscitation. During cardiopulmonary reanima-
tion (CPR) the petCO2 correlates with cardiac output and efficacy of
cardiac compressions and as such has been shown to have prog-
nostic value in CPR. This study was undertaken to compare initial
petCO2 and petCO2 after 1 min during CPR in cardiac arrest due to
asphyxia versus cardiac arrest due to ventricular fibrillation (VF).S32
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Methods This prospective study was conducted at the Center of
Emergency Medicine – Pre-hospital Unit Maribor, Slovenia. The
study included two groups of patients. The first group represented
patients who suffered from heart arrest due to asphyxia. The
causes of asphyxia included foreign body in the airway, aspiration,
suicide with hanging, drowning, edema or tumor of airway and
acute asthma attack. The initial rhythm was either asystole or pulse-
less electrical activity. We compared this group of patients with
those whose cause of heart arrest was AMI or malignant arrhyth-
mias (VF or pulseless VT). petCO2 measurements were made by
infrared side stream capnometer (BCI Capnocheck Model
20600A1; BCI international, Waukesha, WI, USA). petCO2 was
measured for both groups immediately after intubation (first mea-
surement) and then repeatedly every minute. Thus the initial,
average and end petCO2 was detected for both groups. We per-
formed the same procedure for the patients with return of sponta-
neous circulation (ROSC) and for those without ROSC. Statistics
used: Student’s t test, χ2 test, P<0.05 was considered significant.
Results From February 1998 to February 2002 we analyzed 126
patients with cardiac arrest (initial rhythm VF/pulseless VT) and
36 patients with cardiac arrest due to asphyxia (initial rhythm
asystolia or PEA). Patients with cardiac arrest caused by asphyxia
were younger than patients whose cardiac arrest was provoked by
VF (50.7±21.4 vs 64.5±15.4; P<0,05). Time spent from begin-
ning of the arrest to start of CPR was not significantly different
(patients with ROSC: 8.2±5.2 min vs 9.1±4.6 min, P=0,79;
patients without ROSC: 14.1±4.6 min vs 13.6±5.2 min,
P=0.83). The mean value of EtCO2 for all patients (with and
without ROSC) is presented in Table 1. In the group of patients
who presented with arrest due to asphyxia there was no significant
difference in initial values of petCO2, even when compared with
those with and without ROSC (72.4±13.4mmHg vs
67.4±14.6mmHg). However, there was a significant difference in
petCO2 after 1 min of CPR between those patients with ROSC
and those without ROSC (34.5±9.7mmHg vs 18.1±8.3 mmHg).
Conclusions  In cardiac arrest caused by asphyxia, the initial
petCO2 is much higher than in cardiac arrest due to VF and does
not correlate with ROSC.
After 1 min of CPR, petCO2 correlates with ROSC and it is an
important method for noninvasive monitoring of the effectiveness of
CPR.
Table 1
The value of initial, average, final and petCO2 after 1 min of CPR for arrest due to asphyxia and VT/VF cardiac arrest
Initial petCO2 petCO2 after 1 min of CPR Average petCO2 Final petCO2
(mean) (mean) (mean) (mean)
Asphyxial arrest 64.2±15.2 28.4±5.3 43.2±10.2 28.4±10.6
VF/VT cardiac arrest 12.5±5.1 23.6±4.3 16.4±6.3 22.4±8.3
P <0.05 0.71 <0.05 0.65
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Introduction Previous research has shown that increased coronary
perfusion pressure (CPP) during cardiopulmonary resuscitation
(CPR) correlates with increased coronary blood flow and improved
survival from sudden cardiac arrest. The purpose of this clinical
study was to determine whether a novel chest compression device
(AutoPulse; Revivant Corp, Orange County, CA, USA) improves
hemodynamics during CPR when compared with manual chest
compressions. The AutoPulse is an automated, electromechanical
chest compression device that utilizes a load-distributing band to
compress the anterior chest. AutoPulse automatically adjusts to
the size and shape of each patient.
Methods With institutional review board approval, 16 terminally
ill subjects (68±6 years) who suffered inhospital sudden
cardiac arrest were studied. All subjects were endotracheally
intubated. Following a minimum of 10 min of failed advanced life
support, fluid-filled catheters were advanced into the thoracic
aorta and the right atrium, with placement confirmed by pressure
waveforms and chest radiograph. Subjects then received alter-
nating periods of manual and AutoPulse chest compressions for
90s each. Chest compressions were administered at 100/min
for manual, and 60/min for AutoPulse. Subjects received bag-
valve ventilation (12/min) between compressions. Epinephrine
(1mg IV bolus) was given at the request of the attending physi-
cian at 3–5 min intervals. CPP was measured as the difference
between the aortic and right atrial pressures during chest
decompression.
Results Peak aortic pressures were higher with AutoPulse chest
compressions when compared with manual chest compressions
(150±8 vs 122±11mmHg, P<0.05; mean±SEM), as was CPP
(20±3 vs 15±3mmHg, P<0.02). The AutoPulse improved peak
aortic pressure and CPP despite the use of high-quality manual
compressions (47±3kg).
Conclusion Hemodynamics with the AutoPulse were improved
over those of standard manual CPR in this terminally ill patient pop-
ulation. CPP was raised above the level generally associated with
improved survival, and strongly suggests that survival may be
improved with the use of AutoPulse in viable patients.S33
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Purpose Ventricular fibrillation (VF) and ventricular tachycardia
(VT) are the major underlying rhythm during inhospital cardiac
arrest. For a patient in VF/VT the probability of successful defibrilla-
tion and subsequent survival to hospital discharge is directly and
negatively related to the time interval between onset of the arrhyth-
mia and delivery of the first shock. The data about this interval in
clinical practice is heterogeneous and inconclusive, however the
literature estimates it to be about 60s in monitored units. Continu-
ous ECG monitoring allows identification of such arrhythmias and
alert nursing and medical staff. The time delay between the arrhyth-
mic event and human intervention is still a challenge for clinical
practice.
Methods We reported the use of an automated external car-
dioverter defibrillator (AECD) in 45 patients considered to be at
higher risk for malignant arrhythmia for 24–48 hours. The inclusion
criteria was acute coronary syndrome, cardiogenic shock and pre-
vious episode of sudden death or malignant ventricular arrhythmia.
The exclusion criteria was the use of pacemaker or an implantable
cardioverter defibrillator and an R-wave amplitude less than 0.7mV
peak to peak at the monitor.
Results We recorded 17 episodes of VT/VF in three patients. The
median time between the beginning of the arrhythmia and the first
defibrillation was 33.37s (range 21–65s). The sensibility and
specificity were 100%. The success of the defibrillation was
94.11% (16/17) for the first shock and 100% (1/1) for the second
shock. There was no adverse event during the study period and no
episodes of inappropriate therapy delivery (the detection was
accurate in all episodes — sensitivity 100%).
Conclusion AECD was safe and effective. It presents the possibil-
ity of providing consistently rapid identification and response to
ventricular malignant arrhythmia.
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Background Clinical studies have shown the efficacy of the bipha-
sic waveform (BW) in reversion of ventricular fibrillation using lower
energies. However, the effects of the BW in the treatment of other
arrhythmias is unclear. The amount of energy of each shock and the
sequency of shocks are to be determined. The purpose of this study
is to compare the efficacy and side effects of the BW and the
monophasic waveform (MW) in reversion of atrial fibrillation (AF).
Methods In this prospective, randomized and unicenter trial we
submitted 158 patients with AF to transthoracic cardioversion
(CV). They were randomized in two groups. Group I, 80 patients
underwent BW shocks (average age 55.9±12.6 years old); and
Group II, 78 patients underwent MW shocks (average age
59.8±13.0 years old). Group I received sequential shocks of
50, 100, 150, and 175J (half the energy used in Group II). Group II
received sequential shocks of 100, 200, 300 and 360J. We
analyzed the clinical characteristics of both groups before CV
(weight, height, AP thoracic diameter, body surface, oxymetry,
body temperature, noninvasive blood pressure, duration of AF, ven-
tricular response). Blood samples of cardiac and muscle markers
of injury (CK, MB-CK, AST, ALT, DHL) were obtained before,
1 hour and 24 hours after CV.
Results The first-shock efficacy was similar in both groups (56.3%
vs 53.9%, Group I and Group II, respectively) as well the cumula-
tive efficacy of sequential shocks rate (88.0% vs 92.3%,
P=0.415). Baseline characteristics were similar in both groups.
Age and baseline cardiac frequency were independent predictors
of CV success. Patients in Group II had higher elevations on serum
CK (83.0±106.3 vs 178.9±306.9, P=0.0087). There was a
clear relation between CK elevation and cumulated energy used in
CV (P=0.0001). No other injury marker was elevated after CV in
both groups.
Conclusions Biphasic shock with a truncated exponential wave-
form was equally effective as monophasic damped sine waveform,
causing less muscular injury, using only half the energy of the
monophasic defibrillator.
P67 Ventricular fibrillatory frequency and its correlation with transthoracic defibrillation current requirement
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Correlation between ventricular fibrillatory frequency (VFF) in patients
with ventricular fibrillation (VF) and transthoracic defibrillation current
was studied. Strong positive correlation between VFF and optimal
defibrillation current was revealed in patients with primary VF. There
was a significant negative correlation between TTI and defibrillation
current, that ceased secondary VF, and there was no significant cor-
relation between TTI and current in patients with primary VF.
Introduction  The efficacy of external defibrillation depends on
various both cardial and noncardial factors. Heart function status,
waveform shock (monophasic and biphasic) and chest impedance
play important roles among them. The aim of this study was the
research of the correlation between VFF in patients with primary
(1-ry) and secondary (2-ry) VF and the value of defibrillation
current.S34
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Methods Twenty patients with 1-ry VF and 28 patients with 2-ry VF
were studied. VF mostly occurs during the acute phase of myocar-
dial infarction. The efficacy of external defibrillation depends on
various both cardial and noncardial factors. Heart function status,
waveform shock (monophasic and biphasic) and chest impedance
play important roles among them. The duration of VF was from
1 to 8 min (definition: 2-ry VF, fibrillation that occurs in patients with
clinical signs of acute or chronic heart failure; 1-ry VF, in patients
with the absence of these signs). Defibrillation was done with a
biphasic quasi-sinusoidal shock through hand-held electrode
paddles (12/12cm diameter); the peak current (I [A]), delivered
energy (DE [J]) and transchest impedance (TTI [Ohm]) were regis-
tered during the shock. VFF was estimated 5–7s before the suc-
cessful shock from surface ECG lead I or II.
Results  A strong positive correlation between VFF (range
310–435 per min) and the value of the optimal defibrillation current
(range 8–21 A) (r=0.81; P<0.001) was revealed in patients with
1-ry VF. The correlation coefficient between VFF and defibrillation
energy (range 16–85J) was less to some extent (r=0.69;
P<0.01). There was no correlation in patients with 2-ry VF (range
of VFF 200–410 per min; range of I (A) 9–40 A). Meanwhile, there
was a significant negative correlation between TTI (range 22–117
Ohms) and the value of the defibrillation current, that ceased 2-ry
VF (r=–0.69; P<0.01), and there was no significant correlation
between TTI and I (A) in patients with 1-ry VF (r=–0.32, P=0.11).
Conclusions The obtained data suggest that the strong positive
correlation between ventricular fibrillation frequency and defibrilla-
tion current value in patients with 1-ry VF is mainly related to elec-
trophysiologycal heterogeneity of the myocardium. At the same
time the influence of chest impedance on the value of the current
depolarising critical amount of myocardium was, probably, insignifi-
cant. Fibrillation frequency obtained from the surface ECG predicts
current and energy requirements in patients with primary VF under-
going external defibrillation.
P68 Post-resuscitation myocardial dysfunction: correlated clinical factors and prognostic implications
WT Chang, MHM Ma, Ch Hwang, WJ Chen, FY Lin, YT Lee
Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan
Critical Care 2003, 7(Suppl 2):P068 (DOI 10.1186/cc1957)
Purpose To evaluate the clinical course of post-resuscitation LV
dysfunction, clinical factors correlated with its severity, and the
prognostic value in the survival outcome.
Methods Forty-two patients (26 men and 16 women) resuscitated
from out-of-hospital cardiac arrest underwent echocardiographic eval-
uation of the LV systolic and diastolic functions 6 hours, 24 hours,
3 days, and 7 days after return of spontaneous circulation. The serial
LV functions were analyzed in correlation to the event characteristics,
resuscitation factors, and the patients’ survival outcomes.
Results The LV fraction shortening and ejection fraction were
impaired on the first day and improved gradually on serial followup.
Isovolumic relaxation time (IVRT) lengthened gradually. Patients
with cardiac etiologies had worse LV systolic function on the first
and third post-resuscitation days. Defibrillation and use of high
doses of epinephrine during resuscitation were associated with
poorer LV systolic function on day 1, while the effect of amio-
darone persisted up to 3 days. In terms of the prognostic implica-
tions, initial rhythm of VT/VF, lower doses of epinephrine during
resuscitation, and shorter IVRT at the 6th hour were correlated
with better survival outcomes.
Conclusion LV function is impaired early in the post-resuscitation
phase, and would recover gradually within the first 3 days. Several
event and resuscitation factors are associated with this dysfunc-
tion. Once the patient survives the initial stage, the prognostic
value of this transient phenomenon seems limited.
P69 The gamma isoform of enolase (NSE) is predictive of mortality after cardiopulmonary resuscitation (CPR): comparison
with clinical neurologic examination and CT scan of the brain
K Magnusson1, M Stemberg1, T Othman2, NA Cicco1, EG Vester1
1Department of Cardiology and 2Department of Internal Medicine, Evangelisches Krankenhaus, Duesseldorf, Germany
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Introduction NSE (the gamma isoform of enolase) is released into
the cerebrospinal fluid and blood after the occurrence of stroke
and anoxia; and correlates with the extent and duration of ischemia
in animal models of stroke and the outcome in humans, including
neonates, with hypoxic ischemic encephalopathies.
Accordingly, the objective of the current study was: 1) To assess
the prognostic significance of plasma concentrations of NSE for
early prediction of outcome in patients at risk for anoxic
encephalopathy after CPR. 2) To compare the prognostic informa-
tion provided by NSE measurements with that provided by conven-
tional risk indicators (clinical neurological examination and CT scan
of the brain).
Results Ten patients (age 60.5 years [mean]±20.8 [SD]) were
enrolled up to now. In two patients CPR was performed due to
ventricular fibrillation, in one due to low blood pressure during
hemodialysis, in three due to acute myocardial infarction, in three
due to cardiac arrest for unknown reason and in one patient due to
ketoacidotic coma. Clinical neurological examination, computed
tomogram of the brain, and plasma concentration of NSE on the
third day after CPR were compared. The clinical neurological
examination was differentiated in standardized three levels of mid-
brain syndrome (MBS) and three levels of bulbar brain syndrome
(BBS). Four of the patients had a MBS I, one had a MHS II, two
had a MBS III, and three had a BHS III at the third day after CPR. In
three patients neurological examination was not reliable due to
given anticonvulsive therapy because of early onset of myoclonias.
The CT scan of the brain showed only in six patients cerebral
edema; in two patients there was no CT scan available because of
the deleterious hemodynamic situation; and in two patients
ischemic lesions were found, but no edema. The NSE level was
elevated in seven of 10 patients (61.0±65.1ng/ml [range
7.2–194.6]). In three patients the level was normal. Surprisingly
the low NSE level found in this patient was associated with a sig-
nificant swelling due to cerebral edema documented by the neu-S35
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roimaging study. This patient had the highest neurological score
(BBS III). All patients with elevated NSE levels died, one patient of
those with normal NSE level died, and the others with normal levels
survived. The mean survival time after admission was
12.8±5.0 days. CT scan of the brain and neurologic examination,
especially in patients with early onset of myoclonias, were less sen-
sitive than NSE in predicting a poor outcome.
Conclusion In patients who have been resuscitated after cardiac
arrest or other conditions associated with hypotension, increased
plasma levels of NSE predict an increased risk of death. NSE mea-
surements appear to provide prognostic information complemen-
tary to and possibly superior to that obtained from the neurological
examination and CT scan of the brain.
P70 Clinical and electrophysiologic associations with outcome in initially comatose survivors of cardiac arrest
GB Young1, G Doig2, A Ragazzoni3
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Background Prognostic assessment of the comatose survivor of
cardiac arrest with intact brain stem reflexes is still problematic and
requires further study to determine those factors correlate with an
outcome no better than vegetative state (VS).
Methods Inclusion criteria: Comatose survivors of cardiac arrest
with GCS ≤8 on day 1 before sedation; first EEG and SSEP
between 24 and 36 hours from cardiac arrest; survival for at least
4 days. Exclusion criteria: patients with brain death, sedation immedi-
ately after resuscitation, additional cause for coma, preceding periph-
eral neuropathy or cervical myelopathy. Standardized EEG
classification system and SSEPs were applied. Followup at
3 months with phone call to determine the Glasgow Outcome Scale
score (GOS) and whether or not awareness had been recovered.
Results Forty-six men and 29 women with mean age of 74 (range
21–84) years. Fifty-seven (76%) of the arrests were out-of-hospital
and were due to primary cardiac causes in 70 (93%). Significant
differences in clinical features between those who died and those
who survived were oculovestibular and pharyngeal reflexes (no sur-
vivors in those who lost these) and motor response. There were no
survivors with better than VS in those with generalized epileptiform
discharges or suppression of <20µV on EEG and absent N20 on
SSEPs. EEG and EP responses correlating with recovery of
awareness included those with intermittent EEG slowing and those
with preserved N70 responses.
Conclusions In this preliminary study, the only variables that were
consistently associated with an outcome no better than VS were:
absence of oculovestibular and pharyngeal reflexes, generalized
epileptiform discharges or suppression of <20µV on EEG and
absent N20 on SSEPs.
P71 Continuous EEG recording in the intensive care unit: epileptiform activity
GB Young
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Background Digital EEG technology has recently become avail-
able for long-term ICU recordings. Epileptiform activity, as seizures
or spikes, is worthy of detection, as this often indicates structural
brain lesions, and seizures may contribute to further damage.
Methods Adult patients in our general ICU were randomized into
two groups: those who received continuous digital EEG (CEEG)
and those who had standard, 20-min recordings. We excluded
those in coma after cardiac arrest and others for whom the progno-
sis was deemed to be hopeless for significant recovery.
Results Of patients with acute structural brain lesions (ASBLs),
31 had CEEG and 21 had standard care; each group was similar
for age, sex ratio and initial Glasgow Coma Scale scores. Of
these, 10 of the 32 (32%) CEEG patients and only two of the
21 (9.5%) of the standard group had showed epileptiform activity
(P<0.05). In two separate, comparable groups of patients with
metabolic encephalopathies, two of 24 (8%) patients with CEEG
and zero of 13 (0%) with standard care showed epileptiform activ-
ity (P=0.04).
Conclusions CEEG monitoring of patients with ASBLs gives a
considerably higher yield of epileptiform activity than standard EEG
in these patients or CEEG or standard EEG in patients with meta-
bolic disorders. This has implications for further study and resource
utilization.
P72 The role of EEG and brain stem auditory evoked potentials (BAEPS) as predictors of outcome in severe brain injury
A Donati, AM Mauro, G Bini, M Bonifazi, P Carletti, M Ruzzi, E Papadopoulou, P Pelaia
Department of Neurology and Intensive Care Unit, Torrette Regional Hospital, University of Ancona, via Conca 1, 60020 Torrette di Ancona, Italy
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Objective To determine the role of EEG and BAEPs to predict the
outcome and to build a predictive model in patients suffering from
severe head injury (SHJ).
Materials and methods The prospective cohort study includes
102 patients admitted to a university ICU. The first EEG and
BAEPs recordings were obtained within 48 hours of the trauma,
followed by recordings after 2 days and later on the basis of the
clinical evolution. For every patient the first Glasgow Coma Scale
(GCS) and the worst CT scan during the first week were evaluated
following Marshall classification. The patient’s outcome was classi-
fied on the basis of the Glasgow Outcome Scale (GOS): 1) deathS36
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or vegetative state, and 2) recovery (with different degrees of
impairment). The EEG was classified on the basis of reactivity in
three categories: 1) flat, 2) reactivity, and 3) no reactivity [1]. The
BAEPs were classified on the basis of the Greenberg classification
criteria and subsequently for statistical evaluation compacted on
two classes: 1) present, and 2) absent [2]. First, each clinical and
instrumental parameter was tested for discrimination, calculating
the area under the receiving operator curve (ROC). Then, a predic-
tive model was made using Stepwise Logistic Regression (SPSS
10.1). EEG, BAEPs, GCS, CT scan and age were the parameters
tested to enter the model. Calibration was evaluated with the
Goodness-of-Fit Hosmer–Lemeshow test and discrimination with
the ROC curve.
Results The mean age of the patients was 40.5±20.3 and GCS
was 7.4±2.7. Seventy-eight of the 102 patients had a GOS=2
(recovery). Parameters with good discrimination were: EEG (area=
0.888; ES=0.051; P<0.0001); GCS (area=0.828; ES=0.052;
P<0.0001); BAEPs (area=0.765; ES=0.065; P<0.0001). Para-
meters that entered the model were: GCS (βG=–0.404); EEG
(βEl=6.83004;  βE2=–1.426608;  βE3=–5.386608); BAEPs
(βBl=0.827; βB2=–0.827); constant=5.640. This model was well
calibrated (Hosmer–Lemeshow test=8.91; P=0.350) and had a
good discrimination (area under the ROC=0.981; P<0.0001).
Conclusions The different parameters considered have good dis-
crimination ability to predict the outcome of the patients. The EEG
seems to be the best parameter to predict the patient’s outcome,
even if all the patients were sedated. In our case studies, this did
not seem to significantly influence the parameter of reactivity to
sensory stimulus. Age seems not to be a reliable parameter to
predict outcome.
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Introduction Lundberg B waves, characterized as repetitive
changes in intracranial pressure occurring at frequencies of
8–33mHz, have been attributed to cerebral blood flow fluctuations
induced by central nervous system pacemakers and cerebral pres-
sure autoregulation.
Methods Simultaneous measurements of mean arterial pressure
(MAP), intracranial pressure (ICP), mean flow velocity (MFV) of the
middle cerebral artery (transcranial Doppler WAKI™) and left and
right spectral edge frequency (SEFl, SEFr) of continuous EEG
recording (Philips™ technologies) obtained 10±4 days after injury
in six patients with a closed head injury were recorded and digital-
ized at a frequency rate of 50Hz (AcqKnowledge™ software). All
patients were mechanically ventilated and sedated using a combi-
nation of sufentanil and midazolam.
Results Cerebral electric activity (oscillations at a mean frequency
of 26±9mHz) and MFV fluctuations were synchronous and in
phase with the B waves (mean frequency 23±7mHz). Figure 1
illustrates simultaneous recording of (from the top to the bottom)
MAP, MFV, ICP and SEFr on one characteristic patient.
Discussion The change in cerebral electrical activity observed by
the use of continuous EEG recording resulting from cerebral pace-
makers could increase CMRO2, leading to an increase in cerebral
blood flow and secondarily of ICP through a change in cerebral
blood volume.
Figure 1
P74 Hyperventilation-induced reductions in cerebral blood flow velocity outlive the reduction in intracranial pressure in head-
injured patients
LA Steiner1,2, M Balestreri1, AJ Johnston2, M Czosnyka1, JP Coles2, JD Pickard1, DK Menon2
1Academic Neurosurgery and 2Department of Anaesthesia, Addenbrooke’s Hospital, Cambridge, UK
Critical Care 2003, 7(Suppl 2):P074 (DOI 10.1186/cc1963)
Objective In healthy volunteers, cerebral blood flow (CBF) recov-
ers to baseline within a few hours of continued hyperventilation due
to normalization of perivascular pH. The same mechanism is
thought to be responsible for the brevity of intracranial pressure
(ICP) control in head-injured patients. We measured recovery of
middle cerebral artery mean flow velocity (FVm) in head-injured
patients during continued hyperventilation and investigated the
relationship between the time-course of changes in FVm and ICP.
Methods  Twenty-eight head-injured patients were investigated.
After recording baseline data (cerebral perfusion pressure, ICP,
averaged bilateral FVm, PaCO2) for 20 min, the respirator settings
were changed to achieve an acute 20–25% increase in minute
volume. This was followed by a 10-min stabilization period and
50 min of continued hyperventilation at constant arterial CO2 levels.
Results: In 64% of the patients FVm did not recover during hyper-
ventilation. The time-course of ICP changes was significantly differ-
ent from that of FVm, with ICP reaching its lowest value earlier
(23±12 vs 37±20 min; P=0.001) and returning more rapidly
towards baseline than FVm (0.23±0.22 vs –0.04±0.14%/min;
P=0.00001) (Fig.1).S37
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Conclusions The impaired FVm recovery and the discordance
between ICP and FVm recovery patterns suggest that cerebrovas-
cular responses to hyperventilation are altered after head injury.
Reductions in ICP and reductions in FVm may involve different
microvascular compartments. Potentially harmful reductions in CBF
persist beyond the duration of useful ICP reduction.
Figure 1
P75 Decompressive craniectomy in severe traumatic brain injury
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Introduction The management of refractory post-traumatic cere-
bral oedema remains a frustrating endeavour for the neurosurgeon
and the intensivist. Mortality and morbility rates remain high,
despite refinements in medical and pharmacological means of con-
trolling intracranial hypertension.
Materials and methods In this retrospective study we have evalu-
ated the efficacy of therapeutic decompressive craniectomy with
uncontrollable intracranial pressure as a last resort therapy in
16 patients, from March 2000 to October 2002. The patients were
treated according to a local protocol that assigned them to barbitu-
rate coma or decompressive craniectomy. The following parame-
ters were considered: age, GCS after stabilization, intracranial
pressure, GOS at ICU discharge and at 6 months, neuropsycho-
logical evaluation for patients with GOS 4 and 5 after 6 months.
The mean age of the patients was 28±11.5 years and the GCSm
after stabilization varied from 1 to 5.
Results All the 16 patients have been operated on by a FTP
craniectomy when ICP was higher than 30mmHg for more than
15 min. At 6 months three of them were dead (19%), one was in
PSV (6%), one was severely disabled (6%), four were moderately
disabled (25%) and seven had a good recovery (44%). All the
patients with GOS of 5 had normal neuropsychological tests, and
all the patients with GOS of 4 had at least one pathological neuro-
psychological test.
Discussion We evaluated our ability to be accurate to the local
protocol for decompressive craniectomy. We found that when we
did not respect the inclusion criteria according to the patient’s age
(<50 years old) we still had good results, but when we did not
respect the inclusion criteria for GCSm after stabilization (≥3) we
obtained poor outcome. In our opinion patients with STBI, develop-
ing delayed intracranial hypertension caused by diffuse cerebral
oedema, definitely benefit from craniectomy when ICP is out of
control. Nevertheless, of extreme importance is our ability to iden-
tify those patients who could really benefit by this therapy in terms
of GOS. In our experience, age <50 years old could be a too
restrictive criteria, but all the patients with GCSm ≤3 had a poor
outcome irrespective of age.
P76 Sequential organ failure assessment in neurocritical care
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Purpose  To determine the incidence of non-neurological organ
dysfunction in the neurologically injured patient and to determine
its association with outcome.
Methods We calculated daily modified SOFA (mSOFA) scores for
patients with TBI or SAH admitted to the Neuroscience Critical
Care Unit at Addenbrooke’s Hospital. The mSOFA score was
defined as the sum of the five non-neurological component SOFA
scores (range 0–20). Maximum mSOFA was defined as the sum of
the most abnormal non-neurological SOFA component scores
during the patient’s stay. ∆mSOFA was defined as the difference
between the maximum SOFA and the admission mSOFA. An
organ system failure was defined as a SOFA component score ≥3.
Results Thirty-two patients with severe TBI and 23 patients with
SAH were included in the study. Sixty-seven per cent of patients
were male. Mean age was 41±18. The mean APACHE II score
was 13.6±6.8. Hospital mortality was 29%. Median ICU LOS was
11 days. Mean admission, maximum and ∆mSOFA scores were
4.4±2.5, 7.2±2.7, and 2.8±2.1, respectively. Eighty per cent ofS38
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patients developed respiratory failure and 82% of patients devel-
oped cardiovascular failure. No patient developed renal or hepatic
failure. Three patients (5.5%) developed haematological failure.
Those patients with a maximum mSOFA score ≥8 had significantly
longer ICU and hospital LOS. There was no significant difference
between survivors and nonsurvivors with respect to admission
mSOFA (P=0.45), maximum mSOFA (P=0.54), or ∆mSOFA
(P=0.19). Neurological outcome was available for 45 patients
(82%). There was no significant difference between those patients
with good or poor neurological outcome with respect to admission
mSOFA (P=0.24), maximum mSOFA (P=0.84), or ∆mSOFA
(P=0.20). The development of multiple organ dysfunction (≥2
organ dysfunctions) was not associated with mortality or neurologi-
cal outcome.
Conclusions We found no association between non-neurological
organ dysfunction as measured by the modified SOFA score and
mortality or neurological outcome. The use of sequential organ dys-
function scores as surrogate outcomes in this population must be
questioned.
P77 Osmolality changes during mannitol therapy in cerebral oedema
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Introduction Mannitol is still used for reduction of intracranial pres-
sure (ICP) in cerebral oedema. Its therapeutic effect might be
caused by different mechanisms. One of them is an increase in
blood–brain osmotic gradient, which is followed by a reduction of
the brain water.
Method Our investigation was prospectively carried out on 60 ICU
patients. Fifty-eight patients had acute brain disease with Glasgow
Coma Scale (GCS) in the range 11–14 (tumour, 23 patients;
trauma, four patients; subarachnoid hemorrhage, eight patients;
intracerebral haemorrhage, 21 patients; infection, one patient;
epilepsy, one patient) and two patients had spine trauma.
The investigation started at least 24 hours from the beginning of
therapy with 20% mannitol. Serum sodium and osmolality were mea-
sured before and after the mannitol infusion and before the next
dose. Patients were divided into three groups, which differed in
doses of mannitol and intervals between infusions (each infusion
lasted 20 min): I, 40g/day (10g/6 hours); II, 60g/day (10g/4 hours);
III, 80g/day (20g/6 hours).
No other hypertonic agents were used. All samples were taken
from the same vein on an extremity where neither mannitol nor any
other infuse were applied.
Results There were no significant changes in blood sodium con-
centration or osmolality in any of the groups. For parameters, refer-
ence ranges, mean values±standard deviations in samples 1, 2
and 3, see Table 1.
Conclusion This prospective study does not show any evidence
that 20% mannitol significantly altered blood sodium or osmolality
values in CNS diseases, although the osmolality was around the
upper reference range. Therefore, there still remains a question,
whether this significant elevation of serum osmolality is sufficient
for a reduction of the brain volume or whether the reduction is
caused by a different mechanism.
References
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Table 1
Reference 
Parameter range (mmol/l) Mannitol (g) Sample 1 Sample 2 Sample 3
S_Na+ 132–146 40 142 ± 3.52 141 ± 3.35 143 ± 3.73
60 142 ± 3.93 141 ± 3.86 142 ± 4.08
80 143 ± 3.48 141 ± 3.73 143 ± 3.93
S_osm 275–295 40 296 ± 9.86 297 ± 8.76 297 ± 7.31
60 293 ± 7.93 294 ± 7.16 294 ± 7.88
80 298 ± 10.2 298 ± 8.72 299 ± 8.82
S_osmC 275–300 40 298 ± 7.51 297 ± 6.88 299 ± 7.97
60 296 ± 8.20 295 ± 7.90 297 ± 8.32
80 299 ± 7.34 296 ± 7.45 300 ± 8.26
S_osmE 272–290 40 291 ± 7.47 290 ± 6.8 292 ± 7.75
60 290 ± 7.69 289 ± 7.53 291 ± 7.97
80 293 ± 6.83 290 ± 7.22 293 ± 7.77
S_osmC, calculated osmolality; S_osmE, calculated effective osmolality.S39
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Background and goal of study CDP Choline (CDPC, citicoline) is
one of the neuroprotectants used for the clinical and experimental
treatment of stroke [1] and brain injury [2]. In the present study the
authors examined the effect of citicholine treatment on survival and
neurological outcome in patients with brain injury caused by iso-
lated head trauma.
Materials and methods The study was approved by the institution
ethical comity. Twenty-eight patients after head trauma (23 men)
were randomly enrolled to typical treatment + citicholine (1g IV for
14 days) group or typical treatment + placebo group. Glasgow
Coma and Glasgow Outcome Scale (GCS, GOS) were used to
monitor patients up to 30 days.
Results and discussions Our preliminary report of the citicoline-
treated group shows no correlation between GCS in day 7
(GCS 7) and day 14 (GCS 14). This lack of correlation is inter-
preted as a result of treatment, and significant correlation between
GCS 14 and GCS 21 (r=0.82;  P<0.007) is interpreted as an
expanded effect of treatment to 21 days. In the citicoline group,
GCS 21 is significantly correlated with GOS 30 (r=0.68;
P<0.01) showing the protective effect of the used drug.
Conclusions Our preliminary results suggest that CDPC can be
an effective neuroprotective agent in patients with brain injuries fol-
lowing head trauma. Our study has to and will be continued to
confirm our data.
References
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Table 1
Variable n Mean Standard deviation Median Minimum Maximum
GCS 0 14 6.00000 1.10940 6.00000 4.00000 8.00000
GCS 1 13 6.03846 1.19829 6.00000 4.00000 8.00000
GCS 7 11 7.13636 2.12239 6.00000 4.00000 10.00000
GCS 14 10 9.35000 2.62520 9.50000 4.00000 13.00000
GCS 21 9 11.33333 3.67423 13.00000 4.00000 15.00000
GCS 30 8 12.50000 2.77746 13.50000 8.00000 15.00000
GOS 30 14 2.42857 1.55486 2.00000 1.00000 5.00000
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Delayed paraplegia is an unpredictible, albeit devastating compli-
cation of thoracoabdominal aortic aneurysm (TAAA) repair [1]. We
report on a patient who, 24 hours after TAAA repair, developed
paraplegia that was announced by biochemical changes in cere-
brospinal fluid (CSF).
A 57-year-old man was submitted to TAAA repair. A lumbar spinal
drain was placed after induction of anesthesia and left in place in
order to reduce CSF pressure and sample collection. Samples
were collected immediately after catheter placement and at time
intervals during aortic cross-clamping, after cross-clamp release
and postoperatively in the ICU, and stored at –80°C. Excitatory
and inhibitory amino acids (glutamate, aspartate, glycine, GABA),
non-transmitter amino acids (taurine, alanine), energetic metabo-
lism parameters (lactate, adenosine) were analyzed by HPLC alto-
gether 5 days later. The surgical procedure was performed with the
aid of a left-side bypass.
Fifteen minutes after proximal aortic cross-clamping, excitatory,
inhibitory and nontransmitter amino acids in the CSF increasedS40
Critical Care    March 2003 Vol 7 Suppl 2 23rd International Symposium on Intensive Care and Emergency Medicine
several times with respect to baseline and stayed high throughout
reperfusion. Proximal aortic cross-clamping resulted also in an
increase of lactate that stayed high also during reperfusion, while
adenosine, a product of purine metabolism, increased during
cross-clamping and normalized at reperfusion. Four hours after the
end of surgery, while the patient was in the ICU, all parameters
returned to baseline. The following day, a new sample of CSF was
collected. At that time the patient was awake, hemodynamically
stable, CSF pressure was 10mmHg, and his lower extremities
motility was preserved. Three hours later he developed paraplegia.
Emergency CT scan excluded epidural hematoma. The analysis of
the CSF sample collected 3 hours prior to the onset of paraplegia
showed an increase of excitatory, inhibitory and nontransmitter
amino acids, as well of lactate and adenosine.
Altogether our findings indicate that the biochemical changes that
occurred in the CSF of our patient announced the impending
spinal cord ischemia. Bedside, real-time evaluation of the biochem-
ical changes in CSF, which has been recently made possible by
new apparatus, could be useful to evaluate spinal cord perfusion
and, hopefully, to contrast the onset of paraplegia associated with
TAAA repair.
Reference
1. Crawford ES, et al.: J Thorac Cardiovasc Surg 1988, 95:357-
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Introduction Brain natriuretic peptide (BNP) is a member of the
family of natriuretic peptide hormones, which are involved in regula-
tion of sodium and water homeostasis. It has been proven that
natriuretic peptide plays a role in sodium dysbalance in acute brain
diseases, especially in Cerebral Salt Wasting Syndrome (CSWS).
It is also elevated in intracranial hypertension. Now there is a
method available that can assay an N terminal fragment pro brain
natriuretic peptide (NT-proBNP).
Method We retrospectively analysed 77 blood samples for
NT-proBNP from 18 patients hospitalised at our ICU from February
until May 2002. Seventeen patients had acute brain disease (sub-
arachnoid hemorrhage [SAH], eight cases; intracerebral hemor-
rhage, one case; tumor, five cases; and others, five cases) and one
patient had spine disease.
All patients were classified as NYHA I, and their age was between
23 and 73 years (mean age 53 years).
We investigated NT-proBNP, serum osmolality (S_osm) and
sodium (S_Na+) on day 1. S_osm, S_ Na+, daily urinary loss of
sodium (dU_Na+), creatinine clearance (C_krea), diuresis, income
of fluids and sodium in 24 hours on day 2. Moreover, we assessed
NT-proBNP changes in time. Upper reference range for NT-proBNP
is 150pg/l.
Results Parameters±standard deviation (SD) and correlation
coefficients (r) are presented in Table 1.
NT-proBNP was significantly elevated in all the patients
(P=0.007) and the value did not significantly change in time (dif-
ference between two samples in 13 patients; P=0.3), and in tree
samples in eight patients (P=0.28, P=0.37). NT-proBNP had no
correlation with other parameters measured.
Conclusion In our retrospective study we found significant eleva-
tion of NT-proBNP in patients with acute brain disease and without
sodium dysbalance. Values of NT-proBNP did not significantly
change in time and did not correlate with any biochemical parame-
ters measured.
References
1. Berendes E, Walter M, Cullen P: Secretion of brain natriuretic
peptide in patients with aneurysmal subarachnoid haemor-
rhage. Lancet 1997, 349:245-249.
2. Betjes MGH: Hyponatremia in acute brain disease: cerebral
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Table 1
Income Income 
NT-proBNP S_Na+ S_Na+ S_osm S_osm dU_Na+ C_krea  Diuresis  of fluids  of Na+
Parameter (pg/l) (mmol/l) (mmol/l) (mmol/l) (mmol/l) (mmol) (ml/s) (ml) (ml) (mmol)
Day 1 1 2 1 2 2 2 2 2 2
Minimum 31 132 135 278 284 207 1.2 2150 3000 254
Median 227 142 143 290 294 459 1.8 3700 4000 400
Maximum 834 149 151 314 305 735 3.1 7000 7680 590
Mean value ±  321 ±  141 ±  142 ±  292 ±  293 ±  449 ±  2.1 ±  3756 ±  4192 ±  427 ± 
SD 244 5 5 11 6 160 0.6 1302 1095 91
Correlation coefficient 0.13 0.0006 0.34 0.003 0.10 0.12 0.2 0.20 0.17S41
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P81 Transcranial cerebral oximetry (TCCO) monitoring in neurosurgical critically ill patients
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Introduction Near-infrared spectroscopy (NIRS) has been used to
monitor cerebral oxygenation in various clinical fields. However, its
utility has not been demonstrated in more complex situations, such as
neurosurgical critically ill patients. The objective of this study was to
examine the ability of TCCO to detect cerebrovascular events, such
as oligemic hypoxia, relative cerebral hyperemia and vasospasm in
neurosurgical critically ill patients with different outcome.
Methods This study involved a retrospective analysis of regional
cerebral saturation (rSO2) data collected in 64 neurosurgical
patients in critical states using the INVOS 4100 cerebral oximeter as
a part of multimodal neuromonitoring. Patients were divided into
three groups: group I, good outcome/moderate disability (GOS 5–4,
14 male/four female, 38.9 years old); group II, severe disability/vege-
tative state (GOS 3–2, 12 male/four female, 37.6 years old); and
group III, dead (20 male/10 female, 39.2 years old). The outcome
was assessed at discharge of the patients from the hospital.
Results  TCCO monitoring detected a pathological pattern of
regional cerebral oxygenation in 83% of patients. In patients with
vasospasm, early appearance and increasing rSO2 fluctuations
more than 10% were correlated with poor outcome. 74.3% of
patients where we monitored both rSO2 and SjbO2 have had the
same pattern of increased or decreased parameters (Table 1).
Discussion  As a noninvasive, bedside, nonoperator-dependent
tool TCCO is effective in identifying such cerebrovascular events
as oligemic cerebral hypoxia, relative cerebral hyperemia and
vasospasm, which were more pronounced in neurosurgical
patients with unfavorable outcome.
Table 1
Group I (n = 18) Group II (n = 16) Group III (n = 30)
Patients with normal rSO2 pattern (%), mean rSO2 (%) 22%, 71.5 ± 2.8 25%, 69 ± 1.7 10%, 67 ± 2.4*
Patients with decreased rSO2 pattern (%), mean rSO2 (%) 17%, 55.6 ± 3.3 37.5%, 51 ± 2* 40%, 50.4 ± 4.4*
Patients with erradic rSO2 pattern (vasospasm) (%), mean rSO2 (%) 72%, 67 ± 10 25%, 63.8 ± 13.5 40%, 58.1 ± 16.5*
Patients with increased rSO2 pattern (%), mean rSO2 (%) 5.5%, 78.4 ± 1.7 18.7%, 78 ± 3 33%, 83 ± 4
Parameters of NIRS are mean ± SD. * P < 0.05 in comparison with group I.
P82 Transcranial Doppler ultrasonography at the admission of trauma head-injured patients and their neurological outcome at
3 months
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Introduction Early cerebral ischemia after brain trauma is predic-
tive of poor outcome [1]. Since brain hemodynamics can be non-
invasively assessed using transcranial Doppler ultrasonography
(TCD), we prospectively investigated the relation between TCD
measurements at the admission of head-injured patients and their
neurological outcome at 3 months.
Methods  Twenty-nine head-injured patients (35±16 years,
Glasgow Coma Scale [GCS] 10±4, Apache II score 35±15)
were included in the study, in the absence of systemic hypotension
(systolic blood pressure >90mmHg), hypoxemia (SpO2>92%)
and PaCO2 alterations (PaCO2 4–4.5kPa) at the admission. TCD
right and left middle cerebral artery systolic (SV), diastolic (DV) and
mean (MV) flow velocities and pulsatility index (PI) were measured
within the first 6 hours after the brain trauma (Waki 1-TC; ATYS
Medical, Lyon, France). Neurological evaluation was performed at
3 months following the brain trauma, using the Glasgow Outcome
Scale (GOS). A GOS score of 4 and 5 (moderate disability to total
recovery) was considered as a good outcome (group 1), and a
GOS score of 1–3 (death to severe disability) as a bad outcome
(group 2). The Student t test was used to compare the data
(mean±SD), and P<0.05 was considered significant.
Results Nine patients had bad outcome at 3 months (five deaths,
four GOS score of 3), and 20 had good outcome (five GOS score
of 4, 15 GOS score of 5). At admission, there was no significative
difference between the two groups in their age, the systemic blood
Table 1
Group 1 Group 2 P values
Right MCA SV 92 ± 22 85 ± 16 0.46
MV 51 ± 14 36 ± 6 0.006
DV 39 ± 12 23 ± 6 0.01
IP 1.23 ± 0.52 1.88 ± 0.67 0.01
Left MCA SV 97 ± 24 82 ± 15 0.11
MV 53 ± 17 43 ± 18 0.10
DV 41 ± 13 23 ± 10 0.003
IP 1.23 ± 0.53 1.89 ± 0.67 0.01S42
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pressure, the ventilatory parameters, and the GCS. Group 2 exhib-
ited lower DV and higher PI values than did group 1 (Table 1).
Conclusions Noninvasive estimation of brain hemodynamics by
TCD at the admission of head-injured patients could be related to
neurological status at 3 months. Further studies are needed to
determine TCD threshold values of outcome.
Reference
1. Marion DW, Darby J, Yonas H: Acute regional cerebral blood
flow changes caused by severe head injuries. J Neurosurg
1991, 74:407-414.
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Introduction Neurological monitoring is very important to change
the prognosis of a critical neurological patient. The jugular venous
bulb saturation is extremely important to evaluate the consumption
and delivery of oxygen.
Objective To describe complications during insertion and the per-
manence period of a jugular venous bulb catheter.
Materials and methods Prospective, observational study of
21 patients from June 2000 to September 2002 in an intensive
care unit. All patients were monitored with an intracranial pressure
device (ICP — CAMINO). The jugular venous line was cannulated
independent of which side. The catheter flow was sustained by
continuous saline infusion (rate, 3ml/hour). The monitor used was
VIGILANCE (Baxter). Complications were observed during inser-
tion such as arterial puncture, bleeding, and misplacement; during
catheter permanence, obstruction and infection (daily examination);
after decanulation, thrombosis detected through Doppler, which
was performed after 24 hours. All the catheter tips were sent to
bacteriological examination.
Results The meaning time of canulation was 5 days. The thrombo-
sis rate detected by Doppler was 31.6% (without clinical compro-
mise). The catheter obstruction rate was 15.8% and the infection
rate 10.5%.
Conclusion Strict control with Doppler examination is very impor-
tant to warrant optimal flow. The catheter must be changed every
5 days in order to avoid infection.
P84 The incidence of sinusitis and the use of ultrasound in early diagnosis of sinusitis in patients with head injury
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Introduction Sinusitis, complication of the head injury in critically ill
patients, is an important cause of sepsis and may well be difficult
to be diagnosed. In this study, we assayed the sensitivity and
specificity of ultrasonography (USG) by comparing it with the com-
puterized tomography (CT) and we determined the incidence of
maxillary sinusitis with existing fluid in the maxillary sinuses.
Materials and methods In an 8 month period, 41 patients with
head injury that requires CT for diagnosis and control were admit-
ted to the ICU. The paranasal CT was performed along with the
routine cranial control CT in these patients. After paranasal CT
scanning, a B-mode USG was performed blindly. Radiological
maxillary sinusitis (RMS) is defined by an air-fluid level or a com-
plete opacification of the maxillary sinus area in the CT. Absence of
RMS was defined as a normal sinus. Total opacity or air-fluid level,
larger than half of the sinus area, defined important RMS. Air-fluid
levels inferior to the half of the sinus area defined moderate RMS.
In an ultrasonographic procedure, if the acoustic shadow rises
from the front wall, the image is defined normal. Moderate form
was defined as the hyperechogenic visualization of the whole pos-
terior wall. Severe form was defined as the hyperechogenic visual-
ization of both the posterior and internal wall of the sinus as a
border of hypoechogenic sinus cavity. The indication of the punc-
tion includes moderate and/or severe RMS, fever (temperature
≥38°C), leukocytosis (white blood cell >12,000/mm3) and an
increase in CRP values. When the maxillary sinusitis developed we
performed a punction of the maxillary sinus using a sinoject. All
aspirated material was cultured for aerobic and anaerobic agents.
Antibiotics were modified according to the sensitivity of the
cultures.
Results In an 8 month period we performed 100 CT and USG
examinations at the same time. Sensitivity and specificity of USG
compared with CT were, respectively, 92.15% and 81.63%. We
performed a punction in 35 of 47 sinuses, which show medium
and/or severe fluid existence in both CT and USG. Using appropri-
ate microbiological techniques 22 bacterial strains were isolated in
19/35 aspirates (40.42%). The most frequently isolated species
were  Pseudomonas sp. (n=8, 36.36%) and E. coli (n=5,
22.72%).
Conclusions The incidence of sinusitis is indicated high in patients
with head injury. USG may be proposed in first-line diagnosis of
radiological maxillary sinusitis.S43
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Background Ischemic stroke is a disease with high mortality and
morbidity because of the limited advance in therapeutics and lack
of adequate technology for its treatment in some hospitals. The
objective of our study is to demonstrate which factors are related
to higher mortality, so they can be taken into account in selecting
high risk groups at the time of treatment.
Methods A retrospective study was made in patients who were
admitted with diagnosis of ischemic stroke at the Hospital Médico
Quirurgico del ISSS in a period of 18 months, from July 2000 to
December 2001. Twenty-eight variables were analyzed, including
clinical criteria, laboratory and imagining. A total of 106 patients
were studied, excluding 14 patients who did not fulfill inclusion cri-
teria. The statistical analysis was realized by chi-square test and
Student t test and we took P<0.05 to consider a significant differ-
ence. The odds ratio (OR) was determined for each variable.
Results Ninety-two patients were studied, of which 36 (39.1%)
were female with average age of 71 years, and 56 (60.9%) were
male with average age of 69 years. Twenty-four (26.1%) died and
68 (73.9%) were discharged. We found only 10 variables to be
statistically significant: mean arterial pressure (MAP) at admittance,
seizures, temperature >37.5°C, hyperglycemia, sepsis, age,
arrhythmia, cardiovascular complications, computerized tomography
(CT) results at admittance, and leucocytosis (Table 1). The average
MAP in deceased patients was 91mmHg, and pressures below
this value were related to death with an OR=5.92 (range:
1.93–18.59) and P=0.0003. Patients who were given hospital
discharge had an average MAP of 107mmHg, and pres-
sures=107mmHg had an OR=0.24 (range: 0.06–0.85) and
P=0.012, which shows it is beneficial to maintain a relatively high
MAP to ensure adequate cerebral perfusion. Other significant vari-
ables related to death were: temperature >37.5°C at admittance,
with OR=13, and P=0.000038; seizures with OR=17.63, and
P=0.011; hyperglycemia (>200mg/dl) with OR=6.27, and
P=0.00031; leucocytosis (WBC>12,000) with OR=13.11, and
P=0.0000005. In patients with a negative CT at admittance, an
OR=0.04 was found, with P=0.000076. All patients with
ischemic stroke and sepsis died.
Conclusions There are risk factors closely related to mortality in
patients with ischemic stroke, some of which may be modified at
admittance, such as temperature >37.5°C, MAP<91mmHg, and
hyperglycemia. Some require early detection to avoid further com-
plications, such as seizures, arrhythmias and leucocytosis. Certain
factors are related to lower mortality rate: age ≤69 years, negative
CT at admittance and MAP ≥107mmHg.
Table 1
Variable Survivals (n = 68) Deaths (n = 24) OR P
Seizure 1.5% (1) 20.8 % (5) 17.63 0.001
Temperature > 37.5°C 4.4% (3) 37.5% (9) 13.0 0.00038
Arrhythmias 10.3% (7) 54.2% (13) 10.3 0.0000084
MAP ≤91mmHg 19.1% (13) 58.3% (14) 5.92 0.0003
Hyperglycemia (>200mg/dl) 32.3% (22) 75% (18) 6.27 0.00031
Cardiovascular complications 1.5% (1) 12.5% (3) 9.57 0.023
Sepsis 4.4% (3) 79.2% (19) 125.4 0.0000000
CT (–) at admittance 50% (34) 95.8 % (23) 0.04 0.000076
Leucocytosis 13.2% (9) 66.7% (16) 13.11 0.0000005
Age ≤69 years 54.4% (37) 29.2% (7) 0.34 0.034
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Background Critical illness polyneuropathy is a well known com-
plication of critical illness causing prolonged artificial ventilation,
increased ICU and inhospital length of stay and higher mortality in
critically ill patients. Although two studies reported early signs of
polyneuropathy on day 2–5 after ICU admission, the exact time of
onset of this complication is still unknown.
Aim To investigate the electrophysiologic manifestations of critical
illness polyneuropathy in a porcine model of sepsis during the first
24 hours after the septic insult.
Materials and methods Seven anaesthetised, artificially ventilated
and multicatheterized domestic pigs (body weight 29.7±3.9kg)S44
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were randomly subjected to either live E. coli IV infusion to induce
sepsis (n=4) or to a sham procedure (n=3). Animals were fluid
resuscitated with 20ml/kg per hour of Ringer’s lactated solution.
Conduction studies (compound muscle action potential after
supramaximal stimulation, latency and duration of the potential) of a
motoric peripheral nerve (n. peronaeus) and needle electromyogra-
phy (insertion activity, presence of positive sharp waves or fibrilla-
tions) of one of the corresponding muscles (m. tibialis longus) on
the left pelvic extremity were recorded before, and 6, 18
and 24 hours after E. coli infusion. For statistical analysis, ANOVA
for repeated measures and Fisher’s LSD test were used.
Results No differences were present in latency and duration of the
compound action muscle potential between septic and control
animals. No changes in insertion activity and no signs of sponta-
neous muscle activity (presence of positive sharp waves or fibrilla-
tions) were found in either groups. Compound muscle action poten-
tials (CMAP) were significantly reduced compared with baseline in
septic animals starting from 6 hours (P<0.01) after microbial infu-
sion and further decreasing at 18 (P<0.0001) and 24 hours
(P<0.00001). In control animals, there was significant decrease in
CMAP at 24 hours (P<0.05). The time course of CMAPs was sig-
nificantly different between the groups (P<0.04). Positive fluid
balance was significantly higher in the septic group (P<0.00001).
Conclusions We detected a very early and significant decrease of
compound muscle action potential in septic animals. This result
may be caused by the changes in peripheral nerve or in the corre-
spondent skeletal muscle analogic to either critical illness polyneu-
ropathy or myopathy, although changes due to tissue edema can
not be excluded. To our best knowledge, this is the first animal
model of critical illness neuromuscular abnormalities.
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S-100B is a small dimeric calcium-binding protein that is abundant
in astroglial cells within the central nervous system (CNS). It has
been shown to increase in cerebrospinal fluid (CSF) and serum
after various neurological diseases, including minor head injury,
severe head injury, subarachnoid haemorrhage and cerebral infarcts
as well as after cardiopulmonary bypass surgery.
We report on a patient with severe head injury after a traffic acci-
dent who was followed with routine neuromonitoring techniques
(intracranial pressure [ICP], microdialysis, clinical examination and
neuroimaging) with the addition of serial serum S-100B measure-
ments (a total of 41 S-100B measurements during admission of
almost 3 days). Results of S-100B analysis were available within
2 hours of sampling allowing us to increase the sampling rate at
physician discretion. Cerebral herniation, confirmed by cerebral
angiography, occurred 1 day after admission. After brain death was
established we continued to monitor S-100B levels in conjunction
with an organ harvesting procedure for transplantation.
We found that S-100B levels seemed to peak immediately prior to
cerebral herniation and then decreased shortly thereafter. In con-
junction with the organ harvesting procedure S-100B levels
increased, indicating a clear extracerebral source of the protein.
P88 Motor neuron disease caused prolonged mechanical ventilation after high-voltage electrical injury
M Yilmaz, L Dosemeci, E Kaplan, R Yagmur, A Ramazanoglu
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Objective In the literature, 65 cases with diagnoses of ALS/motor
neuron disease after electrical injuries have been reported.
However, in almost all of these cases the onset of the neurological
findings was delayed and the evidence of the damage of spinal
cord could not be shown. We describe a case, requiring pro-
longed mechanical ventilation, with the early onset neurological
injury after high voltage electrical injury and showed evidence of
the damage of the spinal cord on MR.
Case report A 29-year old man was admitted into our ICU as a
result of being exposed to high voltage (31,500V) current and then
falling down from 10 meters. He was unconscious and had second
to third degrees of burned areas on the right side of his face (exit)
and right lower limb (entry). There was no abnormality on his cervi-
cal CT and X-rays. After 1 week of his admission and mechanical
ventilation, when he became conscious and cooperated, we
noticed that there was no motor response on his four limbs with
normal touch and pain sensation. DTR were not taken on the upper
limbs.
Results Needle EMG revealed diffuse, acute denervation poten-
tials on all studied muscles. Cervical magnetic resonance imaging
(MRI) indicated myelomalasic changes (transverse myelitis) on the
C2–5 segments of the spinal cord. The first motor response was
noticed on the 55th day of his admission and he could be liberated
from mechanical ventilation on the 70th day.
Conclusion Electrical shocks commonly cause immediate damage
to the heart and musculoskeletal system. However, a few cases
with neurological complications secondary to electrical injury have
been reported in the literature. In the reported cases, the onset of
motor neuron disorder usually occurred in the limb through which
the shock entered and none of them required prolonged mechani-
cal ventilation due to respiratory muscle weakness. The patho-
genesis of most acquired motor neuron disease is poorly
understood, and treatment is mainly supportive.
We showed in this case the pathologic change of the spinal cord
on MRI, which may lead to the motor weakness.S45
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Introduction Magnetic resonance imaging (MRI) has been widely
used in brain imaging, and diffusion weighted imaging (DWI) with
MR has been used to image early ischaemia in stroke. We have
used early DWI following head injury to map cerebral ischaemia.
Patients and methods We studied six patients with severe head
injury, with a median (range) initial Glasgow Coma Score 3.5
(3–8), and X-ray computed tomography (CT) demonstrated contu-
sions in all subjects. All patients were managed using protocol-
driven therapy including sedation, neuromuscular blockade and
mechanical ventilation, and were imaged at a mean of 63 hours
(range 15–90 hours) post injury. MRI examination included DWI
and fluid attenuation inversion recovery (FLAIR) sequences, the
latter showing vasogenic oedema as high signal intensity on CSF
nulled images.
Results All patients showed substantial but variable perilesional
oedema, best demonstrated on FLAIR images. Perilesional
oedema was well seen as early as 15 hours post injury, suggesting
that some previous estimates of temporal evolution of this process
may have been incorrect [1]. In addition many images show
regions of restricted diffusion in the brain adjacent to the perile-
sional oedema, suggesting evolving pathophysiology with cytotoxic
oedema.
Discussion These results underline the superiority of MRI in
imaging the pathophysiological processes in acute head injury. The
diffusion weighted abnormalities that we observe are intriguing, but
their mechanism remains uncertain. The confounding effects of
microhaemorrhage and high oxygen extraction may need to be
considered in the interpretation of such images.
Reference
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E: The time course of vasogenic oedema after focal human
head injury — evidence from SPECT mapping of blood brain
barrier defects. Acta Neurochir Suppl (Wien) 1990,  51:286-
288.
Figure 1
(a) Diffusion image. (b) FLAIR image.
P90 BrainView: a software designed for quantifying brain volume, weight and density
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Introduction Because radiological densities are linearly correlated
with the physical densities in human tissue, the use of CT gives the
opportunity to measure in vivo the volume, weight and density of
the brain. BrainView is a software specially designed to compute
these parameters.
Methods DICOM images obtained from the cerebral CT (high-
speed advantage CT scan; GE medical system, USA) performed
for headache assessment in 10 patients (43±18 years,
mean±SD) were analyzed. Each exam, acquired as 5-mm-thick-
ness contiguous slices, was considered as normal by the neuro-
radiologist (AZ). As a first step, BrainView automatically excluded
extracranial compartments on each CT section by means of a
mathematical morphology-based algorithm. One single physician
(TL) then delineated on each section the two hemispheres, the
cerebellum, the brainstem and the intraventricular and subarach-
noid cerebrospinal fluid (CSF) according to anatomical landmarks.
The volume of each anatomical compartment was computed as the
number of voxels included in this compartment times the volume of
the voxel. The weight of each voxel was computed as its volume
Table 1
Volume, weight and physical density of each compartment (mean±SD)
Right hemisphere Left hemisphere CSF Cerebellum Brainstem Total intracranial
Volume (ml) 517 ± 64 517 ± 61 130 ± 60 143 ± 19 25 ± 5 1348 ± 150
Weight (g) 534 ± 66 534 ± 64 132 ± 61 149 ± 20 26 ± 6 1392 ± 155
Density (g/ml) 1.0334 ± 0.0012 1.0332 ± 0.0011 1.0209 ± 0.0012 1.0377 ± 0.0014 1.0278 ± 0.0016 1.0325 ± 0.0014
(a)                                                     (b)S46
Critical Care    March 2003 Vol 7 Suppl 2 23rd International Symposium on Intensive Care and Emergency Medicine
times its density knowing that the physical density of a voxel having
a radiological density of 0HU (i.e. water) is 1g/ml. The weight of
each compartment was computed by summing the weights of all
voxels composing it.
Results See Table 1.
Discussion BrainView is a tool providing the measurements in vivo
of volume, weight and density of the human brain. It gives new
opportunities to assess the global and regional effects of anti-
edematous treatment as well as the permeability of the
brain–blood barrier in patients with intracranial hypertension.
P91 Brain temperature changes during selective brain cooling
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Introduction Induced hypothermia is used in patients with brain
injury [1,2]. During selective brain cooling (SBC), only the brain
temperature (TB) is reduced while the core temperature (TC)
remains unchanged [3]. Under normal conditions TB≤TC; however,
in some diseased states TB>TC is found [4]. Since SBC renders
TB<<TC, heat deposition from incoming blood to brain tissue can
occur. The purpose of our animal study was 1) to investigate the
temperature changes that can arise during SBC and 2) relate them
to commonly encountered clinical situations (i.e. seizure activity,
hypercapnia) with respect to brain temperature.
Methods Experiments were conducted in artificially ventilated rats
under sedation with α-chloralose (40mg/kg per hour IP) and
d-tubocurarine (0.05mg/kg per hour). Bicuculline (1mg/kg; Sigma-
Aldrich, St Louis, MO, USA) was infused for generalized seizure
induction. The animal was placed on a heating blanket with its head
in a stereotaxic holder. Through a small burr hole a thermocouple
wire (Oxylite™; Oxford Optronix, Oxford, UK) was inserted to
measure the brain temperature in the cortex (n=18). The head was
covered with cotton balls to minimize heat loss to the environment.
SBC was achieved by a new approach: Tygon™ Ultra-Soft tubing
(R-1000, ID 3.2mm; SGPP Corp, Akron, OH, USA) was perfused
with water at +4°C. A V-shaped part of the tubing with inflow and
outflow was placed into the pharynx of the animal (n=8). The
temperature in the mouth during SBC was measured (n=2). To
raise pCO2 to ca 80mmHg, the ventilatory rate was halved.
Results With SBC TB could be lowered to 33.1±1.23°C
(mean±SD) from 36.9±0.67°C (P<0.001). There was a trend
towards a lower TC during SBC (from 36.90 to 36.44, P=0.22).
The temperature in the pharynx during SBC was 29.1±2.19°C.
From the lowest achieved SBC temperature TB rose during CO2
challenge by 1.22±0.67°C which is significantly higher than the
increase of TB seen without SBC (0.85±0.34°C, P<0.05). The
increase in TB from the lowest SBC level during seizure was
2.08±0.35°C (1.15±0.55°C in non-SBC animals [P=0.001]).
Conclusion Significant cooling of the cortex could be achieved by
SBC from the pharynx in a rat model. Marked changes during
hypercapnia and with seizure activity were seen that partially
reversed the cooling effect of SBC. It therefore seems advisable to
avoid, for example, permissive hypercapnia in patients where SBC
is to be achieved. Whether the proposed approach to cool the
brain from the pharynx can be applied in a clinical setting needs to
be tested in larger animal species because of different anatomical
compositions.
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P92 A comparison of effects of propofol or remifentanil bolus on BIS variations during tracheal suction in mechanically
ventilated critically ill patients
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Background and objective of study The tracheal suction — a part
of routine care in ICU — is a nociceptive stimuli. We evaluated the
impact of remifentanil or propofol bolus on Bispectral index varia-
tions and cardiovascular response to tracheal suction in ICU
sedated patients.
Patients and methods Nineteen ICU sedated (midazolam),
mechanically ventilated patients were enrolled into a prospective
pilot study.
Observation Continuous monitoring BIS, cardiovascular parame-
ters measured before and after administration of drug (propofol
100mg or remifentanil 1µg/kg), and after suctioning. All patients
received propofol, and for next routine suctioning remifentanil.
Results The steady-state BIS value was 52.21±9.9. After admin-
istration of propofol and remifentanil, BIS decreased significantly:
31.5±15.9 vs 37.64±9.1, respectively. During the first minute
after suctioning, a higher increase in BIS level was observed for
remifentanil (72±16.28) than for propofol (63.14±30). The mean
duration of returning the BIS value to baseline was for propofol
23.5±7 min and for remifentanil 14.2±9 min (P<0.05). Systolic
arterial pressure was initially 125±12.97mmHg and decreased
significantly after administration of propofol and remifentanil:
107.35±22.12mmHg vs 107.5±20.53mmHg, respectively. After
suctioning SAP increased more for propofol (120±20.45mmHg)
than for remifentanil (113.21±24.33mmHg). The HR initially was
95.78±14.84bpm, and changed after administration of drugs:
94.85±17.61bpm vs 95.78±20.26bpm for propofol andS47
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remifentanil, respectively, and after suctioning: 100.64±16.45 vs
97.43±20.62bpm, respectively.
Conclusion Propofol and remifentanil altered the BIS variation and
cardiovascular response to tracheal suctioning in similar way.
However, remifentanil seemed to be more effective in providing the
required level of sedation. We found BIS monitoring helpful during
routine care in the ICU.
P93 The COX-2-specific inhibitor parecoxib sodium is opioid-sparing and improves pain relief as part of a multimodal
treatment strategy
F Camu1, TP Malan2, RH Wender3, MC Snabes4, RC Hubbard4
1University of Brussels, Belgium; 2University of Arizona Health Sciences Center, AZ, USA; 3Cedars-Sinai Medical Center, CA, USA;
4Pharmacia Corporation, Skokie, IL, USA
Critical Care 2003, 7(Suppl 2):P093 (DOI 10.1186/cc1982)
Background Opioid analgesics, although effective in managing
acute postoperative pain, are associated with side effects, which
can limit pain control and can delay recovery. Thus, multimodal
(combination) analgesia is often utilized to reduce opioid use and
improve pain relief. The opioid-sparing effects and analgesic effi-
cacy of parecoxib sodium (parecoxib), a novel injectable COX-2-
specific inhibitor, were evaluated in two postsurgical pain
models.
Methods In two multicenter, double-blind, randomized, placebo-
controlled studies, patients who had undergone either hip or knee
replacement received morphine by patient-controlled analgesia
(PCA) plus either parecoxib 20mg IV every 12 hours, parecoxib
40mg IV every 12 hours, or placebo. The total cumulative amount
of morphine used, pain intensity difference, pain relief, and
Patient’s Global Evaluation of Study Medication were assessed.
Results Parecoxib demonstrated significant opioid-sparing effects
in both surgical models. In the first 24 hours following surgery,
patients receiving parecoxib 20mg and 40mg used 16–22% and
28–39% less morphine, respectively, than patients receiving
placebo. The effects of parecoxib on morphine consumption were
dose dependent and statistically significant. Despite this reduction
in morphine use, parecoxib-treated patients experienced signifi-
cantly improved pain relief and significant reductions in pain inten-
sity compared with patients receiving morphine alone. For example,
in the hip replacement model, 85.2% and 81.8% of patients in the
parecoxib 20mg and 40mg treatment groups were categorized as
having ‘a lot’ or ‘complete’ pain relief compared with 61.9% of
patients receiving morphine alone (P<0.05). Consistent with
these findings, in both studies parecoxib-treated patients reported
a significantly better level of satisfaction with their medication than
those receiving morphine plus placebo. Parecoxib also demon-
strated significant reductions in some adverse events (fever and
vomiting) in the hip replacement model.
Conclusions Parecoxib in combination with morphine provides
significant opioid-sparing effects, and improved pain management
and patient satisfaction, in two major surgical pain models, com-
pared with morphine alone.
P94 Efficacy and safety of a single dose of IV parecoxib sodium followed by up to 7 days of oral valdecoxib for pain following
laparoscopic cholecystectomy
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Objectives To assess the efficacy and safety of a single dose of
parecoxib sodium 40mg IV given 30–45 min preoperatively, fol-
lowed by oral valdecoxib 40mg every day for pain given for up to
7 days postsurgery.
Methods This was a multicenter, randomized, double-blind, paral-
lel-group trial. All patients received standard of care (SOC) fen-
tanyl on demand for pain during the immediate postoperative
period and acetaminophen 500mg/hydrocodone 5mg PO every
4–6 hours as required (for pain) following discharge for up to day
7 postsurgery. The active arm received, in addition, parecoxib
sodium 40mg IV administered 30–45 min preoperatively and
valdecoxib 40mg every day initiated 6–12 hours after surgery and
continued up to day 7 postsurgery. The comparator arm received
placebo (SOC) matched for the parecoxib sodium and valdecoxib.
Pain was evaluated daily using the modified Brief Pain Inventory
(mBPI) with ‘Worst Pain’ assessed using a 0–10 numerical rating
scale (NRS) where 10=worst pain imaginable.
Results In the cohort (n=223) during the immediate postoperative
period (4 hours), the parecoxib sodium group (n=119) required
significantly lower amounts of fentanyl (152.8µg vs 192.9µg:
P=0.011) than the comparator group (n=104). Significantly
fewer patients in the valdecoxib group required supplemental anal-
gesia over days 1–5 postsurgery (P<0.02). ‘Worst Pain’ scores
were also statistically significantly improved in the valdecoxib-
treated group compared with placebo (SOC). Percent of patients
reporting worst pain as none or mild (NRS≤4) in the valdecoxib
and placebo (SOC) group on day 1 was 63.1% vs 29.2%
(P<0.001); day 2 69.2% vs 56.0%. The most common adverse
events were nausea, headache, constipation, pain, fatigue and
diarrhea, which were comparable between groups.
Conclusions Preoperative administration of parecoxib sodium
40mg IV resulted in significant opioid sparing immediately follow-
ing laparoscopic cholecystectomy surgery. Valdecoxib 40mg every
day provided significant opioid-sparing effects and reduced ‘Worst
Pain’ levels in these patients following discharge. Both parecoxib
sodium and valdecoxib were well tolerated.S48
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Introduction Adequate sedation of critically ill patients is essential
to ensure maximal quality of care in the high-stress enviroment of
the intensive care unit. The main goals of sedation include augmen-
tation of pain control, management of agitation and psychological
distress, and improvement of patient tolerance and acceptance of
the endotracheal tube and ventilatory support.
Dexemedetomidine (DEX) is a potent α2-adrenoceptor agonist with
an α2: α1 ratio of 1300:1 that produces stable tranquility with rous-
ability. DEX permits haemodynamic stability by effectively blunting
both cathecolamine and haemodynamic responses to endotracheal
intubations, surgical stress, and arousal from anesthesia.
Materials and methods A retrospective analysis of the data of
240 patients admitted to a 27-bed general intensive care unit
(ICU) from 0ctober 2000 to May 2002 was performed
We evaluated duration of DEX usage, posology — average and
maximum doses, length of stay in ICU, and patient average age.
Results Patient age average was 65.3 years and APACHE II score
was 13.4. The average dose used was 0.3µg/kg per hour
(0.2–0.6). Time of usage was 3.24 days (1–19 days). The length of
hospitalization was 8.9 days.
Conclusions  The use of Dexmedetomidine beyond 24 hours
appears to be safe and effective for the sedation of ICU patients.
The need for other sedating/analgesic drugs occurred in less than
one-quarter of the patients and was well tolerated with no extra
pyramidal signs seen with antipsychotic drugs or respiratory
depression with opiates
P96 Effects of intravenous loxapine on systemic and brain hemodynamics
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Introduction Intravenous loxapine is an injectable neuroleptic that
can be used as a sedative drug in intensive care. Its effects in
patients with severe head trauma are still unknown. The effects of
intravenous loxapine on intracranial pressure, cerebral hemody-
namics and EEG were studied 11±5 days after trauma
(mean±SD) in seven severe brain-injured patients sedated with
continuous infusions of sufentanil and midazolam and mechanically
ventilated (age=37±11 years, initial Glasgow coma scale =7±3,
mortality=0%).
Methods Loxapine (10mg) was injected IV at a constant flow
during a period of 10 min; mean arterial pressure (MAP), end tidal
CO2 (ETCO2), intracranial pressure (ICP), heart rate (HR), mean
flow velocity (MFV) and pulsatility index (IP) of the middle cerebral
artery (transcranial Doppler WAKI™), left and right spectral edge
frequency (SEFl, SEFr) of continuous EEG recording (Philips©
technologies) were simultaneously recorded and digitalized at a
frequency rate of 50Hz (AcqKnowledge™ software) before, during
and after loxapine. Statistical analysis was performed by Student
t test. P<0.05 was considered significant.
Results Before loxapine injection: MAP=99±11mmHg,
ICP=14±5mmHg, MFV=53±16cm/s, IP=0.96±0.26 mmHg,
SEFl=3.1±1.4Hz, SEFr=2.5±1.2Hz. Loxapine did not induce
any significant change on these parameters: MAP=98±12mmHg
(P=0.7), ICP=13±4mmHg (P=0.1), MFV=53±16cm/s
(P=0.9), IP=1.00±0.20 (P=0.5), SEFl=2.4±0.9Hz (P=0.06),
SEFr=2.2±0.7Hz (P=0.56). ETCO2 and the dose of vasopres-
sors did not change during the recording.
Discussion Deep sedation is necessary to control ICP but should
not induce a decrease in cerebral perfusion pressure or a direct
vasoconstrictor effect. The use of loxapine is safe in terms of cere-
bral mechanics and hemodynamics and might permit a reduction of
benzodiazepine’s consumption.
Conclusion A 10mg IV injection of loxapine does not induce any
change in intracranial pressure, cerebral blood flow or brain electri-
cal activity in patients with severe head trauma.
P97 Morphine and remifentanil and their effects on dreams, nightmares and hallucinations in critically ill patients
M Lane, A Serrano, S Walters, GR Park
The John Farman Intensive Care Unit, Addenbrooke’s Hospital, Cambridge CB2 5EG, UK
Critical Care 2003, 7(Suppl 2):P097 (DOI 10.1186/cc1986)
Background  Dreaming, nightmares and hallucinations are
common in the critically ill and have many causes. These may lead
to serious adverse psychological sequelae such as post-traumatic
stress disorder. The type of sedation and analgesia used to make
patients comfortable may influence this. Morphine causes dreams
because of its µ-agonist effects. It is unknown if the new highly
lipophilic and potent opioid remifentanil is different.
Method We studied the influence of sedative practice on many
variables over an 8 month period in 2002. During the first period of
12 weeks, ‘conventional’ sedative and analgesic techniques were
used where midazolam and propofol were titrated to make the
patient comfortable and analgesics added. Over the next 2 months
we developed guidelines for the use of remifentanil relieving pain
first and adding hypnotics only if needed. The final 12 weeksS49
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involved using remifentanil as the major sedative agent in the ICU,
as part of an analgesia-based regimen. As part of the followup in
the first 4 days after discharge all patients are asked whether they
had any dreams, nightmares or hallucinations and, if so, were they
distressing?
Results In the first 12 weeks, 47 patients were followed up and
20 (42%) of them experienced dreams or hallucinations, 13 (65%)
did find the experience distressing. These patients all received
morphine in combination with midazolam and propofol. In the final
12 weeks, 57 patients were seen and 28 (49%) of them experi-
enced dreams or hallucinations and 16 patients (57%) found them
unpleasant or distressing. Morphine (12), remifentanil (12), propo-
fol (9) and midazolam (2) were given to 26/28. Two patients
received no sedative or analgesic drugs.
Comment This study shows that the use of potent opioids, such
as remifentanil, does not increase the risk of dreaming. Some
patients have distressing dreams despite having had no hypnotic
or analgesic drugs.
Conflict of interest statement This study was sponsored by Elan
Pharma Ltd and GSK Ltd.
Acknowledgement We thank the medical and nursing staff of the
ICU for their invaluable contribution to this study.
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Background and objective This study evaluated the effects of
varying doses of propofol and midazolam on the vasodilatation due
to low-dose dopamine in an isolated rabbit artery model.
Methods Twenty-four New Zealand rabbits (2–2.5kg) were used
in the study. All of their left renal arteries were extracted. Renal
artery strips 2–3 mm in length were mounted in 20ml organ baths
containing Krebs–Henseleit solution. In order to determine the
maximal concentration for dilating the artery tissue, dopamine was
added in cumulative log concentrations (10–9–10–5M) to the bath
after the tissue had been contracted with the KCl solution. The
concentration that had the maximal relaxation effect was the one
used in the subsequent trials of propofol and midazolam. After con-
traction with KCl solution and then relaxation with low-dose
dopamine, tissue preparations were exposed to either cumulative
log concentrations (10–9–10–5M) of propofol (n=8) or midazolam
(n=10). The force on the transducer was then recorded, and
these measurements were translated into percentages of the initial
contraction force.
Results Dopamine-induced relaxation (3×10–7M) of the renal
artery preparation was increased to a similar extent with the addi-
tion of midazolam at all concentrations (10–9–10–5M). Propofol
caused a concentration-dependent increase in relaxation
(P<0.05). Midazolam concentrations greater than 10–9M
(10–8–10–5M) resulted in a significant increase in relaxation of the
artery tissues (P<0.05). The amount of relaxation in the propofol
and midazolam groups was not significantly different (P>0.05).
Conclusions In this rabbit renal artery dilatation model using
dopamine, the addition of either propofol or midazolam results in a
statistically significant increase in the vasodilatatory effect of
dopamine.
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The opioid agonist fentanyl is widespread used for acute pain man-
agement and sedation in the ICU. The aim of this study was to
investigate the effects of fentanyl on both innative and adapted
immune function in surgical cancer patients recovered in the ICU.
Materials and methods This study was prospectively performed
in 10 cancer patients (mean age 66±5, APACHE II 9±3) who
underwent elective surgery and who recovered in the ICU for
2 days. Fentanyl was administered for analgesia during surgery and
postoperatively as the only analgesic and sedative for a total of
12 hours. The dose of FNT was regulated according to the
demands of the patients in order to obtain optimal analgesia and
sedation. Respiratory burst activity and phagocytosis of both poly-
morphonuclear cells (PMNC) and monocytes (MNC), as well as
NKc percentage and phenotypes of peripheral blood lymphocytes
were determined from blood samples drawn before induction of
anesthesia and at 24 and 48 hours after surgery. Sample testing
was performed utilizing the flow cytometric technique.
Statistical analysis was computed with the paired t test. P<0.05
was considered significant.
Results The cumulative dose of fentanyl was 2.58±1.03mg.
MNCs presented a statistically significant (P<0.05) increase in
their phagocytic function at 48 hours while their respiratory burst
activity increased significantly at 24 hours and returned to baseline
values at 48 hours. Phagocytic function of PMNCs was signifi-
cantly (P<0.05) depressed at 24 hours but recovered at 48 hours
while their respiratory burst activity remained unchanged. The per-
centage of NK cells decreased significantly (P<0.05) at 48 hours.
Overall, T lymphocytes as well as the subsets of T-helper and
T-cytotoxic cells decreased significantly (P<0.05) at 24 hours but
returned to baseline values at 48 hours. There was no effect on
B lymphocytes.
Conclusion Protracted administration of recommended doses of
fentanyl affects both innative and adapted immune function in sur-S50
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gical cancer patients. It exerts a suppressive effect on PMNCs,
NKc and T lymphocytes while it is enhancing in MNCs. This effect
is generally transient, reversing 36 hours after the interruption of
the administration with the exception of NKc and the phagocytic
function of MNCs, the changes of which are significantly persistent
The different response between MNCs and PMNCs might be
attributed to different opioid receptors.
P100 Effect of high dose remifentanil or sufentanil on postoperative pulmonary function in patients undergoing coronary surgery
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Introduction Intraoperative use of high dose opioid anesthesia is
common practice for hemodynamic control in patients undergoing
coronary artery bypass grafting (CABG). It is unclear whether post-
operative pulmonary function is affected by this practice. Remifen-
tanil is an ultra-short acting µ-agonistic opioid [1]. We
hypothesized that remifentanil is associated with improved pul-
monary function, compared with longer acting opioids. Therefore,
we performed a controlled randomized trial to evaluate pulmonary
function in patients undergoing CABG with high dose remifentanil
versus sufentanil.
Methods Fifty patients undergoing CABG were randomized to
receive intraoperative remifentanil or sufentanil via continuous infu-
sion. Demographic data, surgery, and anaesthesia times, ICU and
hospital LOS, Parsonett, and Tumanscore were recorded. Pul-
monary function was evaluated by measuring functional residual
capacity (FRC), CO2-rebreathing method, spirometry, and chest
radiography before surgery, and up to the third postoperative day.
Results Demographic data, risk scores, weaning time, and surgery
characteristics did not differ between groups. Lung volumes
decreased to 21% vs 26% compared with preoperative values,
and reached 48% vs 76% on the third postoperative day. Postop-
erative CO2 sensivity was significantly decreased in both groups.
Partial lung collapse on postoperative chest X-ray was present in
half of the patients. No differences between groups could be
detected for any measurement.
Conclusion Pulmonary function is impaired after CABG. Despite
its short half-life, intraoperative use of high dose remifentanil was
not associated with an improvement of pulmonary function, com-
pared with sufentanil.
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P101 Combination of mild hypothermia and delayed fluid resuscitation improved the survival rate after uncontrolled
hemorrhagic shock in rat
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Objective To evaluate the effect of mild hypothermia combined
with delayed fluid resuscitation on the survival rate in mechanically
ventilated rats.
Methods An initial blood withdrawal of 3ml/100g over 15 min of
time followed by 75% tail amputation of its length and observed
during an additional 45 min to induce phase I. Homeostasis of the
tail wound and maintaining the mean arterial pressure (MAP) of
100mmHg during resuscitation phase II from 60 to 120 min.
Phase III is an observational phase up to 72 hours. Forty-eight male
rats were anaesthetised, mechanically ventilated and were ran-
domised into four groups (12 in each group). Group 1 received
immediate fluid resuscitation and normothermia; group 2 received
immediate fluid resuscitation and mild hypothermia. Both these
groups were allowed to normalize the MAP by giving Ringer’s solu-
tion. Group 3 received limited Ringer’s solutions to maintain a MAP
of 40mmHg and normothermia. In group 4, the rats also received
limited Ringer’s solution to maintain a MAP of 40mmHg but were
subjected to mild hypothermia. During phase II, all rats were
allowed to normalize the MAP by giving shed blood. At the end of
the observational phase III, the rats were killed, and the brain was
fixed and histologically analysed.
Results The blood loss from the tail during phase I was signifi-
cantly higher in groups where immediate fluid resuscitation was
performed (groups 1 and 2). Group 4 required the lowest fluid
resuscitation. The survival rate was 33.3%, 83.3%, 58.3% and
91.7%, respectively, in group 1, group 2, group 3 and group 4. In
all surviving rats no brain histological damage was observed.
Conclusions Mild hypothermia or limited (hypotensive) fluid resus-
citation increases the survival rate. However, when mild hypother-
mia and limited fluid resuscitation were combined during phase I,
the survival rate was the highest.
P102 The effect of resuscitative mild hypothermia and oxygen concentration on the survival time during lethal uncontrolled
hemorrhagic shock in mechanically ventilated rats
X Yang, S Hachimi-Idrissi, M Zizi, L Huyghens
Laarbeeklaan 101, Department of Critical Care Medicine and Cerebral Resuscitation Group, 1090 Brussels, Belgium
Critical Care 2003, 7(Suppl 2):P102 (DOI 10.1186/cc1991)
Objective To test the hypothesis that resuscitative mild hypother-
mia (MH) (34°C) or breathing FiO2 of 1.0 would prolong survival
time during lethal uncontrolled hemorrhagic shock (UHS) in
mechanically ventilated rats.S51
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Methods Forty Wistar rats were anaesthetised with halothane, N2O
and O2 (70/30%), intubated and mechanically ventilated. UHS was
induced by volume-controlled blood withdraw of 3ml/100g over
15 min, followed by 75% tail amputation of its length. The animals
were randomised into four UHS treatment groups (10 rats in each
group): group 1 was maintained on FiO2 of 0.21 and rectal tempera-
ture of 37.5°C. Group 2 was maintained on FiO2 of 0.21 and induced
MH. Group 3 was maintained on FiO2 of 1.0 and 37.5°C. Group 4
was maintained on FiO2 of 1.0 and MH. Rats were observed other-
wise untreated until death (pulseless and mean arterial blood pres-
sure [MAP] less than 10mmHg, and without fluctuation).
Results During the initial blood withdraw, MAP decreased to an
average of 40mmHg, and the heart rate (HR) increased to an
average of 400 beats/min. Induction of MH increased the MAP to
60mmHg, and the survival time moreover, it reduced the HR to
300 beats/min but did not increase bleeding. Ventilation with FiO2
of 1.0 did not influence the MAP, the blood loss or the survival
time, but increased the PaO2. The mean survival time was 62 min,
202 min, 68 min and 209 min in group 1, group 2, group 3 and
group 4, respectively. Blood loss from the tail was 1.0ml, 1.2ml,
0.9ml and 0.7ml, respectively, in group 1, group 2, group 3 and
group 4 (not significant).
Conclusion MH prolonged the survival time during UHS in
mechanically ventilated rats. However, a FiO2 of 1.0 did not influ-
ence the survival time or the blood loss from the tail.
P103 Usefulness of transarterial embolization in patients with blunt splenic injury showing transient response
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Purpose  The usefulness of transarterial embolization (TAE) in
patients with blunt splenic injury has been recently reported.
However, TAE can be performed only in patients who are hemody-
namically stable on admission or who rapidly respond to fluid
resuscitation (rapid response) according to the Advanced Trauma
Life Support. The present study was performed in order to clarify
whether nonsurgical management using TAE could be performed
even in patients who transiently respond to fluid resuscitation (tran-
sient response).
Methods Contrast CT was performed in the patients with blunt
abdominal injuries except those who did not respond to fluid resus-
citation. Angiography was performed in patients who had contrast
extravasation and/or had splenic injury of AAST grade ≥3 on CT.
TAE was performed when angiography showed disruption of the
terminal arteries or arterial extravasation. When the patients had
complicated injuries, TAE of these complicated lesions was simul-
taneously performed.
Results Of 104 patients with splenic injury who were admitted to
our hospital between January 1999 and August 2002, 73 received
contrast CT. Forty of these 73 patients were in shock status on
admission (SBP ≤90mmHg, shock index ≥1). Twenty-two of the
40 patients showed rapid response. Among them, 16 received
TAE and nonsurgical managements were successfully performed
in all these patients. The remaining 18 patients showed transient
response. The one patient went into no response after CT and
received emergent laparotomy. Therefore, 17 patients were sub-
jects of the present study. The subjects were 11 males and six
females at the mean age of 37.1±19.7 years with a mean ISS
score of 34.6±19.7. Two patients had AAST GradeIII,
13 Grade IV, and two Grade V. TAE for splenic injury was per-
formed for all the 17 patients. Seven patients had complicated
injuries that required TAE (one had renal injury of AIS 4 and pelvic
fracture of AIS 4; one hepatic injury of AIS 4 and pelvic fracture of
AIS 4; two pelvic fracture of AIS 4; two hepatic injury of AIS 4; and
one facial injury of AIS 4 and hepatic injury of AIS 4). TAE of spleen
and complicated lesions was successfully performed on all the
patients. Systolic blood pressure before and after TAE was
79.3±16.9 and 128.3±20.5mmHg, respectively (P<0.001).
Shock index before and after TAE was 1.6±0.6 and 0.8±0.2,
respectively (P<0.001). Fluid resuscitation required after TAE
(196.2±194.7ml/hour) significantly decreased compared with
that required before TAE (1169.5±287.4ml/hour) (P<0.01). Two
patients died of cerebral hernia after head injuries.
Conclusion TAE for blunt spleen injury could be successfully per-
formed in patients showing transient response. TAE could be the
first-choice treatment for splenic injury in patients other than those
showing no response.
P104 Recombinant activated coagulation factor VII (rFVIIa) as an adjunctive hemostatic therapy in patients with multiple system
organ failure and acute upper gastrointestinal bleeding
S Milanov, M Milanov, E Gyurov, Z Shterev
Emergency institute ‘Pirogov’, General ICU, Totleben 21, Sofia, Bulgaria
Critical Care 2003, 7(Suppl 2):P104 (DOI 10.1186/cc1993)
Major upper gastrointestinal bleeding leads to increased length of
stay and increased risk of death among critically ill patients [1].
Despite recent developments in prophylaxis, large randomized
trials have not shown a decrease in mortality. Patients with multiple
system organ failure (MSOF) accompanied by coagulopathy are
among those with high risk for clinically important major gastro-
intestinal bleeding. The combination of increased risk of gastro-
intestinal lesions and coagulopathy makes this population of
critically ill extremely vulnerable once the bleeding begins. Recom-
binant activated factor VII (NovoSeven®; Novo Nordisk, Denmark)
has recently been used to reduce bleeding complications and to
control bleeding in hemophilic patients [2], and also in cases of
intractable postsurgical intra-abdominal hemorrhage and traumatic
bleeding. Fifteen surgical and nonsurgical patients with clinically
significant gastrointestinal bleeding and MSOF (Simplified Acute
Physiology Score II between 53 and 69 points) were enrolled in
this study. All patients had different types and degrees of coagula-
tion abnormalities before the bleeding episode as a part of their
MSOF. After the onset of bleeding all patients required fluid resus-
citation, red blood cell transfusion, fresh frozen plasma and platelet
concentrates, and in 73% we used inotropes and pressors to
support the failing circulation. The initial bleeding rate amongS52
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patients was between 14 and 22ml/min. After the bleeding was
considered clinically significant we used a single standard intra-
venous dose of rFVIIa along with other standard accepted thera-
peutic measures, including endoscopy. Bleeding decreased after
this first dose of rFVIIa and ceased within a period of 18–110 min,
with progressive return of coagulation parameters to near pre-
bleeding values. Four patients required a second dose of rFVIIa.
There were no thromboembolic adverse effects and recurrent
episodes of bleeding within the first 5 days after the bleeding
episode. We concluded the successful use of rFVIIa in patients
with MSOF and acute upper gastrointestinal bleeding, when this
hemostatic agent could compensate for MSOF-related coagulation
abnormalities. Further large studies are needed to assess the effi-
cacy of rFVIIa use and its relationship with possible decreased
transfusion requirements in such patients.
References
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Background Recombinant factor VII (rFVIIa) (NovoSeven®; Novo
Nordisk, Denmark) is mainly indicated for treatment of the patients
with haemophilia and inhibitors in the control of perioperative and
spontaneous bleeding. However, no information is available on the
use of rFVIIa in the treatment of severe and recurrent bleeding and
its complications in the obstetrical patients. Treatment difficulties
of hemorrhagic shock arise from coagulopathy coexistence. There-
fore, the use of rFVIIa in patients suffering from uncontrolled haem-
orrhage appears to be rational.
Methods We report 15 cases of obstetrical hypovolaemic shock
(after massive bleeding) in ATLS classification between II and IV
category (class) with coagulopathy coexistence. After the failure of
conventional methods of therapy, they were treated with small
doses of rFVIIa (median, 18µg/kg; range, 16.7–48µg/kg) to
achieve haemostasis.
Results The rapid response after administration of rFVIIa resulted
in cessation of the diffuse bleeding (in 78.6% bleeding was com-
pletely stopped, in the remaining 21.4% it weakened relevantly)
with significant limitation of supplemented blood products; red cell
concentrate from 2100ml to 1236ml (P<0.05); fresh frozen
plasma from 1000ml to 490ml (P<0.05) and good coagulologic
control; shortening of prothrombin time and activated partial throm-
boplastin time from 16.5s (range, 9.3–25.2s) to 11.1s (range,
9.1–20.2s) (P<0.001) and 52.5s (range, 26.1–80.2s) to 32.75s
(range, 25.9–75.8s) (P<0.001), respectively. In four cases of
uterine atony, the hysterectomy was not necessary after rFVIIa
applications. No side effects related to use of rFVIIa were noted.
Conclusion The results of our study suggest that, in obstetrical
hypovolaemic shock after massive bleeding and coagulopathy,
rFVIIa may play a role as an adjunctive haemostatic agent in these
cases where the surgical haemostasis was adequate.
P106 Life-threatening hemorrhage in neonates and children: treatment with activated recombinant factor VII
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According to the small circulating blood volume, acute hemorrhage
in children, especially in preterms and newborns, leads rapidly into
a life-threatening event. The successful use of activated recombi-
nant factor VII (rFVIIa) in life-threatening hemorrhage has been
reported in adult critical care patients. Except for one case report,
the application of rFVIIa in children has not yet been described.
We report on our experience with five preterms and neonates and
two children (mean age 4 weeks, range 2 days–7 years) with acute
hemorrhage, who were treated with rFVIIa (Novo Seven®; Novo
Nordisk, Denmark). Prior to the acute blood loss they had no
hereditary coagulation disorder nor disseminated intravascular
coagulopathy. One preterm showed bleeding from an intecostal
artery, whereas the manifestation in the other cases was of pul-
monal (diffuse pulmonary bleeding) or abdominal origin (isolated
liver bleeding, traumatic mucosal bleeding of the distal esophagus,
gastrointestinal bleeding according to viscerocutaneous heman-
giomatosis). All patients received rFVIIa after other attempts (treat-
ment with fresh frozen plasma, platelet concentrate and packed
red cells; surgical interventions) failed and hemorrhagic shock per-
sisted. Except in one 7-year-old girl, within 15 min after the applica-
tion or rFVIIa bleeding stopped and all patients recovered. No
acute adverse event nor thromboembolic complications over a long
observation period could be observed.
Conclusion Application of rFVIIa in hemostasiologic healthy new-
borns or children with acute hemorrhage seems to be a promising
therapeutical approach after other pharmacological or surgical
attempts have failed.S53
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Background Human albumin (HA) has been the gold standard for
plasma volume replacement in paediatric anaesthesia in the past
while clinical experiences with artificial colloids such as hydrox-
yethyl starch (HES) are limited.
Patients and methods After local EC approval and parents’
signed consent, 2×41 patients (aged <24 months) scheduled for
major abdominal, cranial, thoracic, or urologic surgery were ran-
domised to receive either 6% HES 130/0.4 (Voluven®) or 5% HA
for intra-operative volume replacement. Study parameters were
haemodynamics, coagulation, laboratory parameters, and adverse
events from induction of anaesthesia until day 3 postoperative. The
treatment groups were compared descriptively by ANOVA or
ANCOVA. Subgroup analyses were performed for age and dose of
colloid. Predefined covariates were surgical procedure and dura-
tion, body weight, baseline value, and centre.
Results Treatment groups were well balanced with respect to
demographics, age groups, and surgical procedures. The mean
dose of colloid infused (HES vs HA) until 6 hours postoperative
was 16ml/kg versus 17ml/kg. No major differences were observed
for infused crystalloids (67ml/kg [HES] versus 65ml/kg [HA]),
changes of haemodynamics (blood pressure, heart rate) and also
of laboratory parameters. In both groups, platelets and Quick
decreased and aPTT increased postoperative; however, they were
not clinically relevant. Adverse events were reported in 80% (HES)
and 78% (HA) of patients, respectively. None of the adverse
events were considered as probably drug related to HES or HA.
Conclusion For the first time the novel HES 130/0.4 was clinically
evaluated in newborns and infants. We conclude that HES
130/0.4 was well tolerated and as safe as human albumin in paedi-
atric surgery.
P108 The effect of different chloride concentrations in intravenous fluids on patient outcomes
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Objective A controversial, but poorly studied aspect of fluid resus-
citation is whether the chloride (Cl) concentration of the fluid is
important. We performed a systematic review of the literature to
determine the effect of different Cl concentrations in intravenous
(IV) fluids on the outcome of critically ill patients.
Data sources Studies were identified by MEDLINE search com-
bining the medical subject heading ‘Fluid Therapy’ with the index
terms: saline, lactate, Ringer’s, and Hartmann’s. Bibliographies
were hand-searched for additional references.
Study selection We selected studies based on the following
inclusion criteria: randomized, controlled trials comparing IV fluids
of different Cl concentration in patients requiring volume resuscita-
tion. We classified the fluids as ‘standard Cl’ (154mEq/l) or ‘low
Cl’(<154mEq/l). Studies comparing: fluids of different tonicities;
crystalloids with colloids; or IV with oral therapy were excluded.
Data extraction We extracted quantitative information regarding
the type of crystalloid used, mortality, hemodynamic changes,
acid–base balance, coagulation, and any other studied endpoint.
Results Of 451 articles identified, seven met inclusion criteria (489
patients, 24–230 patients/study). Five compared normal saline (NS)
(Na 154mEq/l, Cl 154mEq/l) with lactated Ringer’s (Na 131mEq/l,
Cl 111mEq/l), one compared NS with Plasmalyte 148 (Na
140mEq/l, Cl 98mEq/l), and one compared Hespan (Na 154mEq/l,
Cl 154mEq/l) with Hextend (Na 143mEq/l, Cl 124mEq/l). In the
four studies that reported mortality, only three deaths occurred. Two
studies evaluated hemodynamics (changes in pulse pressure, pulse
rate, duration of shock) and found no difference between crystal-
loids. All five studies that evaluated metabolic changes found statisti-
cally significant increases in serum Cl, decreases in pH, and larger
base deficits with standard Cl versus low Cl solutions.
Conclusions Limited data from randomized clinical trials consis-
tently suggest that resuscitation with standard concentrations of
chloride results in metabolic acidosis, but there is insufficient evi-
dence to draw conclusions about the effect on mortality.
P109 Blood substitutes consumption and coagulation changes: 200/0.5 vs 130/0.4 hydroxyethyl starch administration
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Introduction The aim of the study was to evaluate blood substi-
tutes consumption and coagulation profile differences in patients
undergoing liver transplantation (LT) receiving volume replacement
with 6% hydroxyethyl starch (HES 200/0.5) or with a low-molecu-
lar weight (LMW) HES (130/0.4) [1].
Methods Thirty-five consecutive patients scheduled for LT were
prospectively randomized to receive either 6% HES (group HES;
n=20) or LMW (group LMW; n=15) for additional volume
replacement. Normal saline at 10ml/kg per hour was continuously
infused in all patients. Conventional global coagulation tests,S54
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hemoglobin, hematocrit and platelet values were monitored at the
start of surgery (T0), during the anhepatic phase (T1), and at the
end of surgery (T2). All data yielded were compared and analyzed
with the paired Student t test: P<0.05 was considered significant
(SPSS, PC plus).
Results  No differences in coagulation profile was observed
between groups. Fluid and blood substitutes consumption are
reported in Table 1.
Conclusion We observed the same coagulation profile and minor
blood components consumption using either HES or LMW, and
they can be both safely used in liver transplant patients.
Reference
1. Bennett-Guerrero E, et al.: Arch Surg 2001, 136:1177-1183.
Table 1
Fluid Group HES (n = 20) Group LMW (n = 15)
Cystalloids (ml/kg per hour) 6804 (2000), 3700–12350 8114 (2696), 3720–12015
HES 6% (ml) 897 (443), 500–2000
LMW Voluven (ml) 750 (250), 500–1000
FFP (U) 9.3 (3.2), 3–15 7.6 (2.1), 3–10
RBC (U) 3.4 (2.9), 1–12 3.8 (2.9), 1–7
HA (U) [1 U = 50 ml] 6.5 (3.1), 0–12 5.7 (3.2), 0–12
PLT (U) – –
Intraop cell saver (ml) 500(179), 130–890 777 (303), 500–1200
Urine output (ml/kg per hour) 6.1 (2.9), 2.0–9.5 5.0 (2.7), 1.6–8.6
Data presented as mean (SD), range.
P110 The prevalence of deep venous thrombosis in Chinese medical ICU patients
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Introduction and aim The incidence of deep venous thrombosis
(DVT) in critically ill medical patients is approximately 30% [1,2].
The proportion of proximal lower limb thrombi (above the knee) is
reported to be approximately 50% [1]. However, several studies in
Chinese patients have shown a markedly lower rate of DVT than
reported in Caucasian populations [3]. The aim of this study was to
determine the frequency of DVT in Chinese medical ICU patients
not receiving prophylaxis.
Methods We studied a prospective cohort of adult Chinese
medical patients admitted to the ICU and expected to stay longer
than 48 hours. Existing policy was to not routinely prescribe DVT
prophylaxis in Chinese patients. Patients with previously diagnosed
DVT, or already receiving anticoagulant therapy, were excluded.
Screening for lower limb DVT was performed twice weekly in the
ICU and repeated 1 week after discharge. DVT was detected by
compression and duplex Doppler ultrasound.
Results Seventy-eight patients were entered. One patient died
within 48 hours and was excluded. Fourteen patients (18%) died in
the ICU after 48 hours and at least one ultrasound examination. Of
the 77 patients evaluated, 14 (18%) demonstrated DVT. On five of
14 occasions (36%), thrombus was present in both limbs. Proximal
(above knee) DVT was present in three of 14 patients (20%).
Discussion and conclusion The prevalence of DVT in Chinese
medical ICU patients is lower, by approximately 50%, than that
reported for Caucasian medical ICU patients. The proportion of
proximal lower limb thrombi is also lower. We believe the preva-
lence is sufficient, however, to justify the use of DVT prophylaxis.
The data support the need further studies to quantify the possible
benefit of DVT prophylaxis in this group.
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Objective To estimate the prevalence, the incidence, and the
baseline and time-dependent risk factors for lower limb deep vein
thrombosis (DVT).
Design Longitudinal cohort study conducted from January 2001 to
January 2002.S55
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Setting Fifteen-bed medical–surgical closed multidisciplinary ICU
in Hamilton, Canada.
Methods We enrolled consecutive consenting patients age
≥18 years if they were expected to be in ICU for ≥72 hours.
Patients were excluded if they had an admitting diagnosis of
trauma, orthopedic surgery, cardiac surgery, pregnancy, or if they
were undergoing withdrawal of life support. All patients underwent
lower limb compression ultrasonography on admission, twice
weekly, and with any clinical suspicion of VTE. Investigations for
upper limb DVT were performed only if signs or symptoms of DVT
were present. We recorded risk factors for DVT on ICU admission
and daily thereafter. All patients received VTE prophylaxis. We
present prevalence and incidence data as proportions and 95%
confidence intervals (CIs). To identify baseline and time-dependent
independent risk factors for lower limb DVT, we used backwards
stepwise elimination Cox regression analysis.
Results Of 261 patients, we identified lower limb DVT in seven
(2.7%, 95% CI=1.1–5.5) patients on admission to the ICU, in 25
(9.6%, 6.3–13.8) patients over the course of the ICU stay, and in
four (1.5%, 0.4–3.9) following ICU discharge. Upper limb DVTs
were found in three patients (1.1%, 0.2–3.3) all related to central
venous catheterization. We found two independent baseline risk
factors for DVT: personal or family history of DVT (hazard ratio
[HR] 3.95 [1.53–10.15]), and dialysis dependent renal failure (HR
3.71, 1.24–11.08). The two time-dependent risk factors were
vasopressor use (HR 2.70, 1.03–7.07) and platelet administration
(HR 3.08, 1.15–8.20).
Conclusions In medical–surgical critically ill patients, the preva-
lence of lower limb DVT at ICU admission was 3%, and the inci-
dence of ICU-acquired DVT was 11%. Patients with an increased
risk of ICU-acquired DVT are those with a personal or family history
of DVT, pre-ICU dialysis dependence, vasopressor use and platelet
administration.
P112 Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular
weight heparin
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Objective To evaluate serial anti-Xa ‘peak’ levels drawn 2 or
4 hours post LMWH prophylaxis in 13 consecutive ICU patients
with a range of renal function.
Setting  Multidisciplinary, closed, university-affiliated 15-bed
medical–surgical ICU.
Method We measured anti-Xa blood levels either 2 or 4 hours post
dalteparin administration each day until death or discharge. We cal-
culated creatinine clearance daily using the Cockroft–Gault formula.
We graphed these peak anti-Xa levels against calculated creatinine
clearance values, and examined their relation to bleeding events.
Results We performed 287 anti-Xa levels on these ICU patients,
and found that peak anti-Xa levels were consistently less than
0.5U/ml. We did not demonstrate a relationship between the
timing of the peak anti-Xa levels, and a) the value of the peak anti-
Xa levels, b) the patients’ calculated creatinine clearance, or c)
bleeding events.
Conclusions Anti-Xa levels drawn 2 or 4 hours post subcutaneous
injection of 5000U dalteparin in this sample of patients were con-
sistently less than 0.5U/ml, but did not vary significantly with renal
function.
P113 Dalteparin reduces ischemia/reperfusion-induced liver injury in rats by increasing the hepatic tissue level of prostacyclin
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Dalteparin, a low molecular weight heparin, is an anticoagulant
that shows less frequency of bleeding than regular heparin.
Ischemia/reperfusion (I/R)-induced organ injury is a pathologic
condition associated with shock or hepatic transplantation. Since
intravascular coagulation is frequently associated with these
pathologic conditions, dalteparin is used to treat such disease
states. However, whether dalteparin reduces the I/R-induced
organ injury is not known. We examined this possibility using a rat
model of I/R-induced liver injury. Male Wistar rats were subjected
to 60-min ischemia and the subsequent reperfusion. Pretreatment
with dalteparin (300 anti-FXa IU/kg) reduced I/R-induced liver
injury. The I/R-induced decrease in the hepatic tissue blood flow
was inhibited by dalteparin. Hepatic tissue levels of tumor necro-
sis factor (TNF)-α and neutrophil accumulation were increased
after I/R. Dalteparin significantly attenuated these increases.
Neither regular heparin nor DX-9065a, a selective inhibitor of FXa,
showed any protective effects. Dalteparin inhibited neither mono-
cytic TNF-α production nor neutrophil activation in vitro. Dal-
teparin increased the hepatic levels of prostacyclin, which
reduces the liver injury by inhibiting neutrophil activation. Pretreat-
ment of animals with indomethacin completely abrogated the pro-
tective effects of dalteparin. However, dalteparin did not increase
the endothelial production of prostacyclin in vitro. The dalteparin-
induced increases in hepatic tissue levels of prostacyclin were not
observed when animals were pretreated with capsazepine, an
inhibitor of vanilloid receptor-1 of the capsaicin-sensitive sensory
neurons (CSSN) that increase the tissue level of prostacyclin
upon being stimulated. Hepatic tissue levels of calcitonin gene-
related peptide (CGRP), which is released from CSSN, were sig-
nificantly increased by dalteparin. The protective effects induced
by dalteparin were not observed in animals pretreated with CGRP
8-37, an antagonist of CGRP, as well as capsazepine. Administra-
tion of CGRP produced effects similar to those of dalteparin.
These results strongly suggest that dalteparin might reduce the
I/R-induced liver injury by increasing the hepatic tissue level of
prostacyclin through the stimulation of CSSN. The dalteparin-
induced effects could not be explained by its anticoagulant
effects.S56
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Introduction Alveolar dead space is increased in PE and can be
evaluated by measuring the PaCO2–EtCO2 gradient during time-
based capnography. The evolution of this gradient during thrombol-
ysis in six spontaneously breathing patients with massive PE
follows.
Methods Six patients with massive PE were assigned to thrombol-
ysis. Diagnosis was comfirmed by V/Q lung scanning and/or CT
angiography. The ‘massive’ feature was attributed to the presence
of acute right ventricular pressure overload or pulmonary hyperten-
sion signs on the twodimensional and Doppler transthoracic
echocardiography: pulmonary hypertension with a trans-tricuspid
gradient (RA/RV gradient) >30mmHg, paradoxic septal wall
motion, right to left ventricle size ratio >0.6 and loss of inspiratory
collapse of the inferior vena cava. The PaCO2–EtCO2 gradient
was monitored during and several hours after the treatment.
Echocardiography was repeated about 12–24 hours after throm-
bolysis to assess the treatment’s efficacy.
Results  Two patients showed a large decrease in the
PaCO2–EtCO2 gradient (mean gradient from 17mmHg before
treatment to 7 and 1.5mmHg, respectively, at 2–4hours and at
12–24hours) and a nearly complete disappearance of right
cardiac signs with, in particular, a normalization of RA/RV gradient
for one patient and a 62% reduction for the other one. Three
patients had no significant change in the PaCO2–EtCO2 gradient
(from 11.5mmHg to 12mmHg at 2–4hours and 12–24hours)
and showed partial improvement of echocardiographic findings
(mean RA/RV gradient from 61 to 44mmHg). One patient had a
stable PaCO2–EtCO2 gradient in contrast with echocardio-
graphic improvement (RA/RV gradient from 56 to 28mmHg) but
the echocardiographic control was performed 10 days after
thrombolysis.
Conclusions  To our knowledge, this small series is the first to
investigate the interest of capnography as monitoring for thrombol-
ysis in spontaneously breathing patients with massive pulmonary
embolism. The decrease of PaCO2–EtCO2 gradient suggests the
efficacy of thrombolysis, and an elevated persistent PaCO2–EtCO2
gradient may question the efficacy of the treatment. Capnography
could be a promising noninvasive and bedside application in the
monitoring of thrombolysis for massive pulmonary embolism.
P115 Usefulness of double luminal drain with continuous high-pressure aspiration for draining mucinous discharge in
abdominal sepsis: prevention of worsening of local inflammation until definitive surgery
M Yoshihiro, M Sugiyama, K Uchida, H Toyoda, H Tomita, K Yoshida, S Yamagishi, K Kanaya, T Kosuge, T Yamamoto, N Suzuki
Critical Care and Emergency Centre, Yokohama City University Medical Centre, Yokohama, Japan
Critical Care 2003, 7(Suppl 2):P115 (DOI 10.1186/cc2004)
Objective In intra-abdominal abscesses and leakage of intestinal
contents, adequate and effective drainage is essential for preven-
tion of MODS and abdominal sepsis. In the management of these
conditions, we have preferred a double luminal drain with continu-
ous high-pressure aspiration method (DLD-CHPA) with good
outcome. The aim of this procedure is rapid and continuous remov-
ing of discharge and pus, maintaining a dry condition of the
abscess and fistula, and stimulating granulation; which leads (a) to
quickening the closure of the abscess and fistula, and (b) to pre-
vention of worsening of the local condition of the localized abscess
and the leaking point of injured intestine until definitive surgery. We
presented the preliminary report concerning the former (a) effect of
this procedure in the 21st International Symposium. The purpose
of this presentation is to clarify both effects of DLD-CHPA by clini-
cal experience.
Materials and methods DLD-CHPA was performed in 25 patients
(with leakage of intestinal juice, duodenal juice, pancreatic juice, or
bile, or with continuous production of pus) from April 1999 to
March 2002. The volume of discharge soaking in gauze, the char-
acter of a wash recovered in intermittent lavage, the grade of local
inflammation of skin surrounding the drain (DLD), the volume of
aspirated material by DLD-CHPA, the volume of discharge from the
wound and drain other than DLD, and the frequency of dressing
changes per day were examined before and after CHPA. The fun-
damental structure of a DLD is same as that of aspiration device
used during surgery, which consists of an outer tube with multiple
pores (or basket) and an inner tube directly connected with a high-
pressure central aspirating system. We use a Duple Drain or
20~26Fr size of Nelaton Catheter as an outer tube. Some addi-
tional side pores are punched out in this outer tube according to
the condition of the abscess cavity or fistula, and the velocity and
character of the discharge. As an inner tube, we prefer an 8~12Fr
size of aspiration catheter, which is fixed in the position of the tip
situated 5mm behind of the tip of the outer tube by sticking-tape
for easy and quick change of the inner tube. The inner tube is fre-
quently changed as soon as it is obstructed due to adhesion of dry
material of the discharge. The inner tube is aspirated with a high
pressure of central vacuum system (valve of the vacuum system is
fully open).
Results 1. Discharge soaking in gauze, a wash recovered in inter-
mittent lavage, local inflammation of the skin surrounding the drain
(DLD): the mean grade of all these factors improved with statistical
difference after DLD-CHPA (P<0.001).
2. Volume of aspirated material by DLD-CHPA, volume of dis-
charge from the wound and drain other than DLD, and the fre-
quency of dressing change: the mean volume of discharge from
the wound and drain other than DLD was depressed from
880±630g/day before DLD-CHPA to 270±330g/day after DLD-
CHPA (P<0.001). The mean volume of aspirated discharge by
DLD-CHPA for 3 days was 440±480g/day. The sum of the
volume of discharge and aspirated material after DLD-CHPA is
smaller than the volume of discharge before DLD-CHPA, with a
statistical difference (P=0.005). The frequency of dressing
change including daily routine procedure was significantly
decreased from 7±3/day to 3±1/day (P<0.001).S57
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3. Prevention of worsening of the local condition of the abscess
and leaking point until definitive surgery: in all cases, we were able
to perform definitive surgery without worsening of local inflamma-
tion, especially inflammation of skin around the drain, even with
continuous leakage of intestinal juice or bile.
4. Complications due to DLD-CHPA: there was no complication
with DLD-CHPA.
Conclusion  DLD-CHPA is thought to be useful for managing
abdominal sepsis by draining mucinous purulent fluid effectively.
This procedure can prevent worsening of the local condition of a
localized abscess and the leaking point of injured intestine until
definitive surgery with continuous leakage of the intestinal juice.
P116 Complications of arterial lines in an intensive care unit
MG Rodrigues, DR Salgado, RAN Paiva, VM Resende, A Chindamo, JCR Verdeal
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Introduction Arterial cannulation is a very useful tool in the man-
agement of patients in mechanical ventilation or hemodynamic
instability. However, local complications are always a concern.
Objective To describe complications of different arterial cannula-
tion sites, correlating them with line obstruction, local and distal
ischemia, infection and thrombosis.
Materials and methods A prospective, observational study of the
arterial cannulations performed in a clinical and surgical intensive care
unit from October 2001 to November 2002. Daily evaluations for
catheter obstruction (dumping of waves, difficulty in draining blood) or
local and distal ischemia (livedo reticularis, pale or cyanotic extremity)
were carried out. Arterial Doppler scans were obtained 24 hours after
catheter removal, searching for partial or total obstructive thrombosis.
Results Five hundred and sixty-five arterial cannulations were analyzed
(Table 1).
Conclusion Despite the lower utilization of the axillary artery, the
number of complications favored this site for monitoring over the
mostly used radial artery.
Table 1
Radial Axillary D. pedis Femoral
n (%) 272 162 89 42
Obstruction 15 (5.51%) 4 (2.46%) 6 (6.74%) 1 (2.38%)
Ischemia 45 (16.54%) 0 7 (7.86%) 0
Pseudo-aneurisma 0 1
Thrombosis 74 (27.2%) 0 16 (17.97%) 0
Dumping wave 19 (6.98%) 10 (6.17%) 14 (15.73%) 2 (4.76%)
Total 153 (56.25%) 14 (8.64%) 43 (48.31%) 4 (9.52%)
Chi square = 20.26, degrees of freedom = 5, P = 0.00111922.
P117 Arterial catheter-related infections in the intensive care unit: prospective study during 1 year
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Introduction Peripheral arterial catheters (PAC) are usually
inserted into the radial or femoral artery and permit continuous
blood pressure monitoring and blood gas measurements. There
are no recommendations concerning change for arterial catheters.
Aim To estimate the incidence of the arterial catheter-related infec-
tions (ACRI) and to identify the associated risk factors.
Materials and methods It is a prospective study, performed
between December 2001 and November 2002. We realize a
culture of the hub of stopcock. After removal, the tip of the catheter
was systematically cultured using a quantitative culture technique
and we realize a simultaneous bloodstream by venipuncture.
Results One hundred successive PAC are studied (77 radial and
23 femoral) in 70 patients with mean age 48±18 years, sex
ratio = 1.5, SAPS II=42±17, APACHE II=20±10, McCabe=
0.95±0.9, OSF=2.7±1. The mean duration of cannulation was
7.3 days. Twelve are contaminated (<103CFU/ml), two colo-
nized (>103CFU/ml). The rate of catheter-related sepsis is three
of 100, and that of catheter-related bacteraemia is two of 100.
Risk factors retained are: duration of catheterization (additional
risk is multiplied by 4.33 in passing from 1–5 days to 6–10
days), length of stay in ICU (>28 days), and positive culture of
the hub of stopcock (sensibility=100%, specificity=82%, posi-
tive predictive value=22% and negative predictive value=
100%).S58
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Discussion Peripheral arterial catheters can be accessed several
times per day for haemodynamic measurement or to obtain samples
for laboratory analysis, increasing the potential for contamination
and subsequent clinical infection. The following three risk factors for
catheter-related infections were identified: duration of catheteri-
zation, length of stay in ICU and manipulation of the stopcock.
Conclusion The ACRI are not frequent. Their arising is bound to
the duration of catheterization with an increase of the risk of colo-
nization after 5 days. A positive culture of stopcock may indicate
the removal or the change of APC.
P118 Femoral central lines and clinical sepsis
V Poulose, J Tan, A Tee
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Objective Femoral central lines are traditionally believed to have a
higher risk of septic complications when compared with neck lines.
Our study looked at the incidence of catheter-related blood stream
infections and local sepsis from femoral central lines placed in the
medical intensive care unit (MICU).
Methods A prospective observational study of central venous
catheters placed in the femoral veins over a 4 month period. The
patients were assessed daily for evidence of local infection (ery-
thema, purulent discharge) or catheter-related blood stream infec-
tions (CRBSI). CRBSI was defined by a) clinical evidence of new
sepsis (fever or leukocytosis) plus b) isolation of the same bacteria
from the culture of the catheter tip and a peripheral blood culture.
Results Sixty catheters were placed in 53 patients with a total of
367 catheter days. The mean duration of catheter placement was
6.1 days. There was one case of CRBSI (1.66% or 2.7 per 1000
catheter days) and no incidence of local infection.
Conclusion Femoral central venous lines, when placed over an
average duration of 1 week, have a low incidence of septic compli-
cations. The rate compares favourably with the data from neck
catheterization.
P119 The efficacy of an antiseptic-impregnated catheter on catheter-related bloodstream infection in the ICU
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Aim Despite improvement in central venous catheter (CVC) design
and insertion techniques, catheter-related bloodstream infection
(CRBI) continues to be a significant problem in the intensive care
unit (ICU) [1]. Recently, CVCs impregnated with chlorhexidine and
silver sulfadiazine (CCS) have been introduced for the prevention
of CRBI [2,3]. The objective of this study is to compare between
the efficacy of CCS-impregnated CVC and a standard catheter
during the CRBI incidences in the ICU.
Method In this prospective study, we observed that 108 patients
who needed a CVC were randomized to receive either a triple-
lumen catheter impregnated with CCS (ARROWgard Blue, PA,
USA;  n= 54) or a standard triple-lumen catheter (Certofix®;
B/Braun, Melsungen, Germany; n= 54). We observed each
patient from catheter insertion to removal, and collected data on
patient-related factors. Catheters were removed when no longer
needed or suspected as a cause of infection. The tip and a 5cm
segment of the intradermal portion of the catheter were cultured
using the semiquantitative technique developed by Maki et al. [4]. If
sepsis was suspected, peripheral venous blood samples, blood
aspirated from the distal lumen and also approximately 20cm2 of
the skin at the insertion site were cultured. Catheter colonization
(CC) was defined as the presence of ≥15CFUs. CRBI was
defined as isolation of the same organism from a catheter segment
semiquantitative culture and from a peripheral blood culture.
Results Data are mean±standard error of mean or the number of
patients (Table 1).
Conclusion These findings suggest that a CVC impregnated with
CCS does not affect the incidence and magnitude of CC and
CRBI in long-term catheterization but it could be beneficial for
short-term catheterization in critically ill patients.
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Table 1
Duration of 
catheterization 
Group APACHE II (days) CC/CRBI (n)
CCS CVC (n = 54) 18.3 ± 0.7 11.8 ± 0.8* 12/4
Standard CVC (n = 54) 19.3 ± 0.7 8.6 ± 0.6 13/1
* P < 0.01.S59
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Introduction Catheter infection, the most frequent complication of
the central venous catheter (CVC), is associated with increased
morbidity, mortality and duration of hospital stay. In this study we
evaluated the relationship between catheter indwelling time and
catheter-related infections. Besides, we searched for the incidence
of mechanical complications due to placement of the CVC, the
microorganisms responsible for catheter infections and risk factors
associated with the catheter infection.
Materials and methods During the study period (January–October
2002), 140 nontunneled CVCs having been replaced in 100
patients in our 25-bed ICU were collected. They were replaced
when there was a suspicion of catheter-related infection or when
there was no more need for a CVC. When a CVC was removed, the
distal and the subsegmental part were cut off aseptically, and sent
to the microbiology laboratory at our hospital where they were cul-
tured by a semiquantitative method and two sets of blood samples
were drawn for culture, with at least one set drawn percutaneously.
Cultures yielding 15 or more colonies were recorded.
Results  Forty-eight mechanical complications occurred in total,
including arterial puncture in 30 procedures (21%), cardiac
arrhythmias in 14 procedures (10%), pneumothorax in three proce-
dures (2%) and catheter malposition in one procedure (0.7%). The
incidence of catheter-related sepsis (CRS), catheter colonization,
secondary bacteremia, catheter-related bacteremia (CRB) and exit
site infection were 8% (n=11), 13% (n=19), 11% (n=16), 4%
(n=5) and 2% (n=2), respectively. In 87 (62%) catheters, no
clues for infection were found. The patients were respectively
assigned to two groups according to the indwelling time of
catheters (group I, less than 12 days; group II, more than 12 days).
In groups I and II, CRS was observed in eight (73%) and in three
(27%) patients, respectively. The mortality rates in the patients with
CRS or bacteremia were 73% and 60%, while the mortality rate
was 31% in patients without infection. S. aureus (18%), Klebsiella
(18%) and C. albicans (18%) were found as the most frequent
microorganism causing CRS. Coagulase-negative staphylococcus
was the first bacteria causing colonization (63%) and bacteremia
(60%).
Conclusion  Although the group with indwelling time more than
12 days was associated with increased mortality and the incidence
of CRS and CRB were higher in group II, these evaluations were
not verified according to the statistics. Even though we have com-
pleted an extensive study on 140 catheters, we believe the study
should be improved with participation of a large series.
P121 Intravascular catheter infection during 10,000 days of risk
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Objective  To analyze central venous and artery catheterization-
related infections in critical care.
Methods It is a prospective study in a 20-bed medical surgical
ICU. We included 500 patients, who had some catheter during
24 hours or more, admitted from 1 May 2000.
Results The study finised on 26 February 2001. Included were
500 patients (58.20%). Mean age was 56.48±17.60 years,
APACHE II was 13.30±5.24. Mortality was 15.80%. Patient dis-
tribution was: 47.4% cardiac surgery, 8% cardiologic, 6% respira-
tory, 4.6% digestive, 12% neurologic, 11% traumathology, 3.4%
intoxication, 7.2% sepsis and 0.4% others. The number of central
venous catheters and the length of stay (days) were: global 882
and 6226, peripheral access 182 and 1186, jugular 382 and
2258, subclavian 237 and 2118, femoral 81 and 664. Central
venous catheter-related infections and bloodstream infections
secondary to central venous catheter per 1000 days of catheteri-
zation were: general 4.81 and 1.44, peripheral access 2.52 and
0.84, jugular 6.20 and 0.88, subclavia 1.88 and 1.41, femoral
13.55 and 4.51. The number of artery catheters and the length of
stay (days) were: global 675 and 3925, radial 578 and 3149,
femoral 69 and 595, pedia 17 and 128, humeral 11 and 53.
Artery catheter-related infections and bloodstream infections sec-
ondary to artery catheter per 1000 days of catheterization were:
general 1.01 and 0.25, radial 0.95 and 0.31, femoral 1.68 and 0,
pedia 0, humeral 0.
Conclusions There were more intravascular catheter infections in
central venous catheters and in femoral localization.
P122 Bacterial colonisation of midline and central venous catheters
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The provision of parenteral nutrition conventionally requires the
insertion of a central venous catheter (CVC) with the attendant
risks of pneumothorax, vascular damage and line sepsis [1]. In
addition, CVC insertion requires appropriately trained medical staff.
It is possible to provide central venous access with peripherally
inserted central catheters (PICC) but these are associated with
malposition, catheter fracture, leakage and occlusion [2]. An alter-
native to these is the use of 20cm single lumen 22 G venous
catheters inserted in the antecubital fossa (midlines). This unit pro-
vides a ‘midline’ service for parental nutrition or long-term venous
access, and this audit describes the experience of this service to
date. All lines were inserted on a general ward by a trained theatre
technician using standard sterile techniques including chlorhexi-
dine or iodine (in 70% methylated spirit) skin preparation and aS60
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semipermeable film dressing (tegaderm™). At removal, midline tips
were sent for microbiological analysis using a Maki roll technique.
There were 160 midlines inserted over an 18 month period, 139
catheters were inserted for parental nutrition and 21 for other
reasons. Catheters remained in situ for median of 6 days with a
range of 1–60 days. Reasons for catheter removal included block-
age (13%), concerns over arm swelling (17.5%) and completion of
therapy (39%). Of the 160 midlines inserted, microbiological data
were available on 120. There was an overall bacterial colonisation
rate of 20.8%. By comparison the colonisation rate for CVC in this
unit is 49%. The colonisation rates for midlines and CVCs become
significantly different by day 7 (P=0.03, χ2) and remain so there-
after. For midlines, the majority of catheters that eventually become
colonised do so by day 8. In contrast, for CVCs the colonisation
rate continues to rise until day 15. The majority of organisms iso-
lated from midline catheters were staphylococcus epidermidis
(19/27). Other organisms included β-haemolytic streptococcus
(two cases), enterobacter aerogenese (two cases), MRSA (one
case), coliform (one case), staphylococcus aureus (one case) and
candida (one case).
Midline catheters represent a simple technique that can be performed
by nonmedical staff. They can be used for long-term intravenous
access with a lower risk of colonisation than central venous catheters.
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Background Primary bloodstream infections resulting from central
venous catheterization are a leading source of nosocomial infection.
The purpose of this study was to investigate whether the implemen-
tation of a prevention program aimed at improving central venous
catheter (CVC) insertion and care, directed towards ICU doctors
and nursing stuff, could decrease the occurrence of catheter-related
infections and the frequency of catheter removal and exchange.
Methods This prospective cohort study was performed in 80
critically ill patients admitted in a 19-bed general intensive care unit
at a tertiary center between August 2002 and October 2002.
Patients were divided into two groups: Group A, 40 patients
(APACHE II 17±4, mean age 49±15 years) were studied in the
preintervention period; Group B, 40 patients (APACHE II 17±5,
mean age 50±18 years) were studied in the postintervention time.
The incidence of catheter-related infections classified as catheter-
related bloodstream infection (CRBSI) (definite or probable), exit-
site catheter-related infection (CRI) and no CRI (colonized,
contaminated, sterile) was measured. The frequency of catheter
removal and exchange was also measured in the two groups.
Statistical analysis was computed by paired t test. P<0.005 was
considered significant. The relative risk (RR) was also determined.
Results The median duration of CVC use was 7.6±1.8 days in
Group A and 8±1.9 days in Group B.
We investigated 314 catheter days in Group A and 323 in Group B.
Twenty CRI occurred in 80 patients (25 CRI/100 admissions). The
incidence rate of CRBSI was 31.8 episodes/1000 catheter days in
Group A and 9.3 episodes/1000 catheter days in Group B (RR 0.3).
Corresponding rates of exit-site infections were 16 episodes/1000
catheter days and 6 episodes/1000 catheter days, respectively (RR
0.4). The incidence density of catheter colonization was
28.6 episodes/1000 catheter days in Group A and 12.3 episodes/
1000 catheter days in Group B, while catheter contamination was
25 episodes/1000 catheter days and 12 episodes/1000 catheter
days, respectively. After the intervention, the incidence density of
exit-site catheter infection decreased by 61% (P<0.005) and that of
bloodstream infection decreased by 71% (P< 0.005)
Fofty-seven catheter exchanges were measured in Group A versus
44 catheter exchanges in Group B, leading to a decrease of 25%
(P<0.005) in the frequency of catheter removal and exchange.
The mean length of catheter stay before a new site replacement
was 6.9±2.6 days in Group A versus 7.9±2 days in Group B.
Discussion Our results demonstrate that a focused and multi-
dimensional invention directed at the ICU physicians and nursing
staff can lead to a dramatic decrease in the incidence of catheter-
related infections.
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Background Pseudomonas aeruginosa infections are associated
with high mortality. Ps. aeruginosa has developed, after many
years, multidrug resistance. We conducted a retrospective study
to identify risks factors associated with acquisition of MDR
Ps. aeruginosa in ICU patients.
Methods  A retrospective study was performed in the 12-bed
medico-surgical ICU from January to December 2000. All charts
corresponding to acquisition of Ps. aeruginosa were reviewed;
among them, we compare patients with or without a MDR strain. The
MDR strains were genotyped by pulsed-field gel electrophoresisS61
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(PFGE) and were defined as resistance to at least three drugs
among ciprofloxacin (CIP), amikacin, ceftazidim and imipenem.
Results Six hundred and ninety-nine patients were admitted to the
ICU during the study period. Fifty-two (7.5%) had a colonization or
an infection with Ps. aeruginosa during their ICU stay. Forty (77%)
had a susceptible strain and 12 (23%) had a MDR strain. Alco-
holism was more frequent in the MDR group (P=0.047). The pre-
vious use of CIP, cefuroxime (CEF) and bitherapy with cefepime
(CEP) plus amikacin were identified as a risk factor associated with
acquisition of a MDR Ps. aeruginosa (for CIP, P=0.0012; for CEF,
P=0.03; and for bitherapy, P=0.026). No clonal strain was identi-
fied by PFGE.
Conclusions The previous use of some broad-spectrum antibiotics
was associated with development of MDR Ps. aeruginosa. Control
prescriptions and optimizing use of broad-spectrum antibiotics is
now established in our hospital to reduce the risk of emergence of
MDR strains.
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Introduction Administration of antibiotics represents a cornerstone
in the treatment of severe bacterial infections. In addition to their
antibacterial effect, antibiotics have been shown to cause other
effects on the inflammatory response. Aminoglycosides have been
considered to neutralise endotoxin and ceftazidime to modulate the
inflammatory response by an antioxidative effect.
The primary aim of this study was to investigate whether endotoxin
given as an infusion in a porcine model could be neutralised by the
addition of tobramycin. The secondary endpoint was to study
whether ceftazidime could affect the inflammatory response by
modifying the cytokine release during the end of the study period.
Methods Fourteen pigs were exposed to an endotoxin infusion of
4µg/kg during 30 min followed by 1µg/kg during the rest of the
6 hour experiment. Five of the animals were randomised to receive
tobramycin 6mg/kg, five were given ceftazidime 40mg/kg, and
four received saline solution.
Results The endotoxin levels remained stable after 1 hour of the
experiment and there was no difference between the treatment
groups, thus indicating that there were no neutralising effects by
any of the antibiotics. The plasma TNF-α levels reached peak
values 1 hour after starting the endotoxin infusion, median value
7265ng/l (2492–10,625ng/l), and there were no significant differ-
ences in peak TNF-α or elimination rate between the treatment
groups. Plasma IL-6 levels peaked after 2–3 hours with a median
maximum IL-6 value of 2509ng/l (1544–7854ng/l). A significantly
greater reduction of IL-6 was seen in the animals treated with cef-
tazidime or tobramycin compared with those receiving saline
(P<0.05). In the ceftazidime group also, absolute values obtained
at 6 hours were significantly lower than the corresponding values
in the saline group (P<0.05).
Conclusion Endotoxin was not neutralised by tobramycin or cef-
tazidime in this porcine model. However, data indicate a slight anti-
inflammatory effect of ceftazidime and perhaps also of tobramycin
as measured by the reduction in IL-6.
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Objectives Carbapenems such as imipenem (IM) provide impor-
tant antimicrobial activities against Pseudomonas aeruginosa (PA)
and Acinetobacter calcoaceticus/baumanii (ACB). Additionally co-
administration with an aminoglycoside provides broad-spectrum
coverage. The current activity of IM, and the activity of IM and gen-
tamicin (GN) or amikacin (AK), considered together, was reviewed
by analysis of cross-susceptibility to this combination, as reported
to physicians, by clinical microbiology laboratories in Germany.
Methods Data were analyzed (January 1999–October 2002) from
The Surveillance Network® (TSN) Database Germany, an elec-
tronic surveillance system that collects routine susceptibility test
results from 169 hospital laboratories distributed throughout the
country. Only data from nonrepeat isolates from patients
>17 years of age, located on ICUs, and derived from antibiotics
concomitantly tested were included in the analysis. NCCLS (2002)
breakpoints were used to interpret the data.
Results For all PA (n=1316) isolated from lower respiratory tract
infection (LRTI) specimens during 1999–2000, 65.3% were
reported susceptible (S) and 20.9% resistant (R) to IM. The follow-
ing susceptibility and resistance frequencies were found for PA
from LRTI, reported by year: 1999 (n=127; 65.4% S; 31.5% R),
2000 (n=346; 66.5% S; 28.9% R), 2001 (n=539; 63.5% S;
15.4% R), and 2002 (n=304; 67.1% S; 17.1% R). Among PA
from blood reported by year: 1999 (n=7; 85.7% S; 14.3% R),
2000 (n=20; 80.0% S; 15.0% R), 2001 (n=31; 74.2% S; 16.1% R),
and 2002 (n=39; 84.6% S; 12.8% R). Considering data of IM
combined with an aminoglycoside, for PA from LRTI isolated
during 2000–2002, 86.3% of isolates were S (n=1634; 5.8% R)
to both IM and gentamicin (GT), and 93.8% of isolates were S
(n=1171; 2.8% R) to IM and AK. PA isolates from blood were
89.1% S (n=64; 3.1% R) to the combination of IM and GT, and
100% S (n=45) to the combination of IM and AK. Overall
(2000–2002) for ACB isolated from LRTI, 98.2% were S (n=225;S62
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0% R) compared with 100% S (n=25) for blood isolates. For
ACB by year, the following IM susceptibility percentages were
detected: 90.5% S in 2000 (n=21; 9.5% R), 99.3% S in 2001
(n=143; 0.7% R), and 97.5% S in 2002 (n=163; 0% R).
Conclusions: In Germany, IM susceptibility has remained consis-
tent for PA since 1999 and ACB since 2000, and no increase in
resistant phenotypes was detected. Combinations of IM with an
aminoglycoside still approach 100% coverage against PA.
P127 Activity of ceftriaxone and comparator agents against bacterial pathogens isolated from central nervous system (CNS)
(meningeal) specimens: TSN Database USA 2000–2002
ME Jones1, DD Draghi2, JA Karlowsky2, C Thornsberry2, DF Sahm2
1Focus Technologies Inc, Hilversum, The Netherlands; 2Focus Technologies Inc, Herndon, VA, USA
Critical Care 2003, 7(Suppl 2):P127 (DOI 10.1186/cc2016)
Objectives Meningeal infections are life-threatening and require
immediate, parenteral treatment, often with β-lactams such as
ceftriaxone (CTX). Using The Surveillance Database (TSN®) USA, we
analyzed the susceptibility of pathogens frequently causing meningitis
isolated from CNS specimens (including cerebral fluids and shunts).
Methods We analyzed data (January 2000–October 2002) from
The Surveillance Network (TSN®) Database USA, an electronic
surveillance system that collects routine susceptibility test results
from 326 hospital laboratories distributed throughout the USA.
Data is the same data reported to physicians. Only data from non-
repeat isolates from patients’ CNS specimen sources were
included in the analysis. NCCLS (2002) breakpoints (BPs) were
used to interpret as susceptible (S) or resistant (R) (included CTX
BPs for meningeal isolates of Streptococcus pneumoniae [SP]).
The number of organism susceptibilities tested by drug varied.
Results A total of 10,436 organisms were isolated and the sus-
ceptibility tested. The relative incidence of key pathogens known to
be frequently involved in meningitis was coagulase-negative
Staphylococci (CoNS) (44.9%, n=4688) (1.5%, n=155 isolated
from shunt infections), Staphylococcus aureus (SA) (10.7%,
n=1114),  SP (5.6%,  n=580),  Escherichia coli (EC) (2.5%,
n=266) (n=11 isolated from shunt infections), S. agalactiae
(SAG) (1.1%, n=114),  Haemophilus influenzae (HF) (0.7%,
n=71), and Neisseria meningitidis (NM) (0.3%, n=26). 72.2%
(n=1046) of SA from all CNS sources and 33.8% (n=145) of
CoNS were involved in shunt infections, and were oxacillin-suscep-
tible. Among oxacillin S SA, 99.4% of isolates tested were S to
CTX (n=179). Against all CNS sources, 85.3% (2.9% R) of SP
and 100% of SAG were S to CTX. SP and SAG were 55.7% S
(17.9% R) and 100% S to penicillin, respectively. All Gram-posi-
tive isolates tested were vancomycin S. Erythromycin R was
detected in all streptococcal species. EC isolated from shunts
were 100% (n=6) S to CTX and 100% (n=7) were S to
imipenem. For HF from all CNS sources, 29.1% (n=55) were
ampicillin R but 100% (n=45) CTX S. No interpretive criteria are
defined for NM, although 39 isolates were identified during this
time period.
Conclusions Although oxacillin-resistant Staphylococci would
require glycopeptide therapy, after 18 years of clinical use CTX
retains very high efficacy against most isolates likely to cause
meningeal infections, including SP and HF.
P128 Continuous infusion versus intermittent bolus of ceftazidime for the treatment of nosocomial pneumonia
L Lorente, C García, MM Martín, R Galvan, J Villegas, ML Mora
Department of Intensive Care, Hospital Universitario de Canarias, Tenerife, Spain
Critical Care 2003, 7(Suppl 2):P128 (DOI 10.1186/cc2017)
Objective Betalactamics antibiotics exhibit concentration-indepen-
dent bactericidal activity. The primary determinant of betalactamics
efficacy is the duration of time that concentrations remain above
the minimum inhibitory concentration (MIC). Several studies have
found that ceftazidime by continuous infusion appears to optimize
the pharmacodynamic profile by constantly providing concentra-
tions in excess of the MIC of susceptible organisms over the
course of therapy. Limit data exist on clinical efficacy by continuous
infusion of ceftazidime. The purpose of this study was to evaluate
the clinical efficacy associated with the administration of continu-
ous infusion of ceftazidime (CI) and intermittent bolus of cef-
tazidime (IB) for the treatment of nosocomial pneumonia (NP) in
critically ill patients.
Methods Prospective and randomized study of patients admitted
in the ICU from 1 July 2002 to 31 October 2002 and who devel-
oped late-onset NP. Pneumonias were diagnosed according to
CDC criteria. NP were treated during 14 days with two antibiotics:
ceftazidime plus another (aminoglycoside or quinolone). Patients
were randomized in two groups: one group received CI of cef-
tazidime (4g/day IV), and another group IB of ceftazidime
(2g/8 hours IV). The statistical analysis was realized by chi-square,
Student t, and values P<0.05.
Results Twenty-seven patients were included. Both groups of
patients (13 with CI and 14 with IB) were similar in age, sex,
APACHE II, failure rate of different system organs (cardiovascular,
respiratory, renal, hematologic, hepatic), number of organ failures,
microorganisms responsible for NP, NP with bacteremia. Clinical
cure in the patient group treated with ceftazidime administration by
CI was higher, but not statistically significant (92% vs 60%,
P=0.08), with one-third of total doses of ceftazidime.
Conclusions These data suggest that continuous infusion cef-
tazidime therapy may have more clinical efficacy and may be
cheaper than intermittent bolus administration for the treatment of
nosocomial pneumonia, but further larger studies are required to
confirm it.S63
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P129 Use of ‘Synercid’™ (Aventis) in 132 polytrauma patients with Gram-positive nosocomial infection
E Gyurov, S Milanov, M Milanov, J Shterev
General ICU, University Hospital ‘N.I. Pirogov’, 21 ‘Totleben’ 1606 Sofia, Bulgaria
Critical Care 2003, 7(Suppl 2):P129 (DOI 10.1186/cc2018)
The purpose of this study was to evaluate the effectiveness of a
new powerful antibiotic ‘Synercid’™ (Aventis) in the treatment of
ICU patients with nosocomial infection. During 2002
(January–September) we prospectively followed 132 patients with
polytrauma (two body cavities and/or pelvic bones and/or extremi-
ties injured) requiring mechanical ventilation for more than
72 hours. These patients suffered Gram-positive nosocomial infec-
tion and were treated with new for Bulgaria antibiotic agent
‘Synercid’™ (Aventis) after microbiological confirmation. Eighty-two
patients (62%) were treated for nosocomial pneumonia, which was
diagnosed clinically (fever, leucosytosis, purulent tracheal secre-
tions and new infiltrate on chest X-ray) and by positive culture
(transtracheal aspirate). Forty-three patients (32.6%) were treated
for bacteriaemias (fever, leucosytosis, positive blood culture). The
rest of the patients were with surgical wound infections (local signs
of infection and systemic inflammatory response syndrome). The
main causative pathogen was methicillin-resistant S. α-haemolyti-
cus (59 patients with pneumonia [72%]; 34 patients with bacteri-
aemias [79%]). In patients with surgical wound infections
(17 patients), the leading role belonged to methicillin-resistant S.
epidermidis (11 patients, or 64.7%) and to MRSA (four patients, or
23.5%). The treatment lasted between 8 and 16 days (mean
11±2 days). The rate of success for pneumonia was 96.3% (79
patients). Three patients developed Gram-negative infection. The
rate of success for bacteriaemias was 100%. The rate of success
for surgical infection was 82% (14 patients) and the reason was
some delayed surgical debridement of the wound. In conclusion,
we appreciate the power of this new, for our country, antibiotic
agent and added it to group 3 (Hospital Antibiotic Management
Policy Protocol) for use only after microbiological confirmation.
P130 Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy
JJ De Waele, S Blot, E Hoste, J Decruyenaere, F Colardyn
Intensive Care Unit, Ghent University Hospital, Ghent, Belgium
Critical Care 2003, 7(Suppl 2):P130 (DOI 10.1186/cc2019)
Introduction Infection of pancreatic necrosis is associated with an
increased mortality rate in patients with severe acute pancreatitis. It
is not clear whether fungal involvement in pancreatic infection
further increases the odds for mortality.
Objective To analyze the incidence of fungal infection in patients
with infected pancreatic necrosis, to identify risk factors for devel-
opment of fungal infection and to assess the use of early flucona-
zole treatment.
Patients and methods We retrospectively (1995–2002) analyzed
46 consecutive patients with infected pancreatic necrosis from a
total of 106 patients that were admitted to the ICU because of
severe acute pancreatitis. We recorded demographic characteris-
tics, incidence of organ failure, data on antimicrobial and antifungal
treatment, and disease severity.
Results  Intra-abdominal fungal infection was found in 17 of
46 patients (37%). Primary infection was present in eight patients,
in nine others fungal infection occurred later in the course of the
disease. Candida albicans was isolated most frequently (15/17);
C. tropicalis and C. Krusei were found in one patient each. Charac-
teristics (age, gender, APACHE II score, Ranson score, the use
and duration of prophylactic antibiotics) of patients with fungal
infections were not different from patients without fungal infection.
Mortality was statistically not significantly different in patients with
fungal infections (35% vs 27% in the other patients, P=0.58).
Antifungal prophylaxis or pre-emptive antifungal therapy was used
in 19 patients, and only three of them developed fungal infection:
there was one breakthrough infection with C. Krusei, and two
patients developed C. albicans infections later in the course of the
disease, after antifungal treatment had been stopped for 3 and
4 weeks, respectively.
Conclusion  The incidence of fungal infections in patients with
infected pancreatic necrosis is high. In this cohort of critically ill
patients, no risk factors for fungal infection could be demon-
strated, and mortality was not different. Early treatment with flu-
conazole seems to prevent fungal infections in these high-risk
patients.
P131 Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients
O Tuil, Y Cohen
Hospital Avicenne, Bobigny, France
Critical Care 2003, 7(Suppl 2):P131 (DOI 10.1186/cc2020)
Aim To investigate the efficacy and safety of the itraconazole intra-
venous (IV) formulation followed by oral solution in the treatment of
candidemia in non-neutropenics versus fluconazole.
Methods This was an international multicenter, randomized, open-
label study, sponsored by Johnson & Johnson Pharmaceutical
Research and Development (Beerse, Belgium). The study involved
patients with candidemia documented by at least one positive blood
culture with isolation of yeast (presumed Candida spp.) within
4 days of study entry, and clinical evidence of infection. Patients
were randomized to receive either itraconazole or fluconazole. Intra-
venous itraconazole 200mg was given twice daily on days 1 and 2,
and then once daily for 5 days (and for a further 7 days if the patient
could not take or tolerate oral medication); subsequently, itracona-
zole oral solution 200mg twice daily was given until 14 days after
resolution of symptoms and signs of fungal infection and cultures.
Intravenous fluconazole 400mg was given once daily for 7 days
(extended for a further 7 days if required); then oral fluconazole
400mg once daily was given until 14 days after resolution of infec-
tion and cultures. The intention-to-treat (ITT) population included allS64
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randomized patients who had candidemia documented by at least
one positive blood culture of Candida spp. The primary efficacy
measure was the investigators’ global assessment of successful
response to treatment at followup week 12.
Results The study was terminated early because of the very slow
enrollment rate after 197 patients had been randomized (n=99
itraconazole and n=98 fluconazole). The ITT population consisted
of 193 patients (n=96 itraconazole and n=97 fluconazole);
however, only 37 patients receiving itraconazole and 44 patients
receiving fluconazole could be evaluated for the primary efficacy
measure. At week 12 of followup, itraconazole had a success rate
of 92% (34 of 37 patients) compared with a 91% success rate for
fluconazole (40 of 44 patients). The overall safety profiles of the
itraconazole and fluconazole groups were similar.
Conclusion Results from this study do not indicate any clinically
meaningful differences in efficacy or safety outcomes in patients
with candidemia treated with itraconazole compared with those
treated with fluconazole.
P132 Treatment of invasive candidiasis with caspofungin in the intensive care unit
MJ DiNubile, RJ Lupinacci, CA Sable, NA Kartsonis
Merck Research Laboratories, West Point, PA, USA
Critical Care 2003, 7(Suppl 2):P132 (DOI 10.1186/cc2021)
Background Invasive candidiasis (IC) is increasingly recognized
as an important complication of intensive care, and yet remains dif-
ficult to diagnose. Standard therapies have included
amphotericin B (AmB), despite concerns about its toxicity, or flu-
conazole, even though some non-albicans Candida species may
be azole-resistant. Caspofungin (CAS) is a novel, generally well-
tolerated antifungal drug with fungicidal activity against both
C. albicans and non-albicans Candida species. We retrospectively
examined the demographics, risk factors, baseline characteristics,
and outcomes of patients initially treated in an intensive care unit
(ICU) enrolled in a randomized study of CAS vs AmB for IC.
Methods Adults with symptoms or signs of IC and positive cul-
tures for Candida from blood and/or another normally sterile site
were eligible for participation in a double-blind, randomized trial
comparing CAS (50mg/day after a 70mg/day loading dose) with
AmB (0.6–1.0mg/kg per day). Antifungal therapy was to be contin-
ued for 14 days after the last positive Candida culture, but could
be completed with oral fluconazole after 10 days of intravenous
(IV) study drug. A favorable outcome required complete resolution
of symptoms and eradication of Candida pathogen(s). We have
retrospectively analyzed results from all patients who received their
first dose of study drug while in the ICU. All treated patients with a
confirmed diagnosis were included in the modified intention-to-
treat (MITT) analysis at the completion of IV study therapy; missing
assessments were counted as unfavorable. Mortality rates include
death due to any cause from the initiation of the study through the
6–8 weeks following completion of IV therapy. Relapse rates repre-
sent documented relapses in the 6–8 weeks after completion of IV
therapy in those patients who achieved a favorable response at the
completion of IV study therapy.
Results Ninety-seven (43%) of the 224 MITT patients received
their first dose of study drug in an ICU, including 40/109 (37%) of
the CAS-treated patients and 57/115 (50%) of the AmB-treated
patients (P=0.06). Medians (range) for age and APACHE II score
were 59 (17–84) and 17 (6–36). Investigator-specified risk
factors present in >20% of patients were: broad-spectrum anti-
biotics (92%), central venous catheters (84%), recent surgery
(70%), hyperalimentation (47%), and underlying cancer (22%).
Eighty-one percent of the ICU patients were candidemic, includ-
ing three who also had pleural or peritoneal candidiasis. Among
the ICU patients, there were no differences between the two
treatment arms with regard to age, APACHE II scores, risk factors,
or site of Candida infection. ICU and non-ICU patients had com-
parable baseline characteristics, except for lower APACHE
scores (13; 0–28) and less frequent surgery (35%) in the non-
ICU group. Favorable response, relapse, and mortality rates were
as presented in Table 1.
Conclusions In this post hoc subgroup analysis, the efficacy of
CAS was similar to AmB for IC in patients whose treatment was
initiated in the ICU. CAS provides another therapeutic option for
seriously ill patients with documented IC.
Table 1
End of IV  Confirmed relapse at  All-cause mortality at 
study therapy 6–8 weeks post-therapy 6–8 weeks post-therapy
ICU patients 59/97 (61%) [51%, 71%] 10/59 (17%) [7%, 27%] 41/97 (42%) [32%, 52%]
CAS 27/40 (68%) [53%, 82%] 5/27 (19%) [4%, 33%] 18/40 (45%) [29%, 61%]
AmB 32/57 (56%) [43%, 69%] 5/32 (16%) [3%, 28%] 23/57 (40%) [28%, 53%]
Non-ICU patients 92/127 (72%) [65%, 80%] 5/92 (5%) [1%, 10%] 30/127 (24%) [16%, 31%]
Data presented as m/n (%) [95% confidence intervals].
P133 Nosocomial infection incidence in patients after hepatic transplantation
MM Martin, C Colmenero, L Lorente, I Molina, A Trujillo, A Chopitea
Department of Intensive Care, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Canary Islands, Spain
Critical Care 2003, 7(Suppl 2):P133 (DOI 10.1186/cc2022)
Objective To determine nosocomial infection incidence of patients
undergoing liver transplantation.
Methods It is a descriptive study in a tertiary hospital. Included
were all patients admitted to the ICU after liver transplant duringS65
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5 years (from 16 April 1996 to 16 April 2001). Infections were
diagnosed according to the criteria of the Centers for Disease
Control and Prevention (CDC). We analyzed the percentage of
patients who developed device-associated infection and the
number who developed device-associated infection per 1000 days
of device-days.
Results Included were 96 patients (68.25% male). Mean age was
50.87±9.86 years. Mean ICU stay was 7.35±7.54 days. ICU
mortality was 13.54%. Etiology of liver failure was: alcoholic cirrho-
sis 44.06%, virus hepatitis 28.81%, autoinmmune disease
12.70%, metabolic 5.92%, cancer 1.69%, cirrhosis crytogenic
4.30%, genetic disease 0.84%, vascular disease 2.54%. Patients
developed further infections: 10 ventilation-associated pneumo-
nias, six central venous catheter-related infections, four abdominal
infections, two urinary tract infections, four surgical wound infec-
tions. The percentage of patients who developed pneumonia,
venous central-related infections and urinary tract infection were,
respectively, 10.41%, 2.08% and 6.25%. The number of ventila-
tion-associated pneumonia, central venous catheter-related infec-
tions and urinary tract infections per 1000 device-days were,
respectively, 28.57, 5.67 and 2.83.
Conclusions The most frequent infection in patients undergoing
liver transplantation was respiratory. Our infection incidence is
similar to other seria.
P134 A decade with Falciparum Malaria in the ICU
A Aaron1, AS Bachwani2, SU Madkaiker1, R Singh3
1Intensive Care Unit, Parsee General Hospital, Cumballa Hill, Mumbai 400026, India; 2BARC Hospital, Mumbai 400094, India; 3Breach
Candy Hospital, Mumbai 400026, India
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Aims and introduction To study and compare the various treat-
ment modalities and the attendant complications of Falciparum
Malaria with or without concomitant Vivax in the intensive care unit.
Method Retrospective study between 1993 and 1995 and
prospective study from 1996 to 2002 of patients having severe
malaria warranting intensive care management.
Table 1
Drug(s) used Year Complication Comments
Mefloquine 1993–1997 Prolonged parasitemia High incidence of drug resistance and side effects
Mefloquine + others 1993–1997 Nausea, vomiting High incidence of gastro side effects
Mefloquine + others + Quinine 1993–1997 Vomiting, intolerance Neither cost nor time effective, unpredictable response
and outcome
Quinine 1993–1999 Mainly GI in PO administration Better results in all types except MOF/shock
Artesunate 2000–2002 Virtually nil Drastic reduction of parasite index
Artemether 2000–2002
Quinine + Artesunate 1999–2002 Virtually nil; noteworthy is no  Best combination to date; reserved for P.I. > 4%, 
prolongation of QT interval failure to reduce P.I. by 25% in 48 hours and shock
Table 2
Year  Total Died % Complications, survivor group Complications, mortality group
1993–1995 39 29 75 30 uncomplicated; given Quinine 86% had ARDS, of which 50% were directly 
admitted to the ICU
1996 09 05 55 8 CNS, ARF, ARDS; excellent  45% of the remainder developed ARDS on the
response to early Quinine 4th day of admission
1997 19 07 36 6 MOF; excellent response to  ARDS was the single most common dreaded 
Quinine + Artesunate complication during the course of 
management
1998 14 07 50 20 treated with multidrug regime 
had delayed recovery and 
unacceptable rates of side effects 
and complications
1999 15 05 33
2000 24 10 55
2001 34 01 2.5
2002 19 02 03S66
Results A total of 173 patients; 107 survived and 66 died (61%
survival, 38% mortality) (Fig.1).
Conclusions  Quinine has given good and consistent results
(10mg/kg up to 600mg, thrice daily for 5–10 days) and can cure
all stages of Falciparum and other plasmodia. The treatment must
be initiated with Quinine only in patients sick enough to need the
ICU.
Parasites may have developed resistance to a multidrug regimen. It
is also very much in evidence in the study that if the Quinine is
given after Mefloquine the results are not really encouraging,
besides having an unacceptable rate of side effects due to its long
half-life.
Artisunate 120mg bolus followed by 60mg daily IV ×5 days given
with Quinine yielded good results. This is perhaps the best that
can presently be offered to patients with shock/MOF.
Artesunate or Arthemether alone although effective are probably
insufficient to treat severely complicated patients.
Cinchonism and hypoglycemia were easily manageable. Most
importantly, prolonged QTc was not encountered in any patient.
Patients who came to the ICU in multiorgan failure did not do well
with whatever interventions. We must do a planned study on these
patients and the blood exchange transfusion therapy must be tried
to salvage these patients.
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P135 No significant excess mortality in ICU patients with nosocomial Escherichia coli bacteremia
S Blot, K Vandewoude, F Colardyn
Intensive Care Unit, Ghent University Hospital, Ghent, Belgium
Critical Care 2003, 7(Suppl 2):P135 (DOI 10.1186/cc2024)
Purpose and methods The objective of this retrospective
matched cohort study was to evaluate the excess mortality in criti-
cally ill patients with E. coli bacteremia after accurate adjustment
for severity of illness. ICU patients with nosocomial E. coli bac-
teremia were matched (1:2 ratio) on the basis of the APACHE II
system: equal APACHE II score (±2 points) and diagnostic cate-
gory. Since expected mortality can be calculated from this severity
of disease scoring system, this matching procedure results in an
equal expected inhospital mortality rate for patients with (cases:
n=64) and without E. coli bacteremia (controls: n=128).
Results The average APACHE II score (±SD) for cases and con-
trols was 25±9.2 (median: 23). This represented an expected
inhospital mortality rate of approximately 47±27.4%
(median 44%) in both groups. ICU patients with E. coli bacteremia
had more hemodynamic instability (75% vs 56%; P=0.009), they
were mechanically ventilated for a more extended period (median
14 days vs 3 days; P=0.001), and had a longer ICU stay (median
17 days vs 5 days; P<0.001). No statistically significant differ-
ences between cases and controls were noted in incidence of
acute respiratory failure (respectively 81% vs 77%; P=0.534),
acute renal replacement therapy (respectively 27% vs 18%;
P=0.167) and age (respectively median 57 years vs 58 years;
P=0.260). Inhospital mortality rates for cases and controls were
not different, respectively 43.8% and 43.0% (P=0.918). Thus, the
excess mortality was 0.8% (95% CI: –14.1 to 15.7%). The
absence of a significant excess mortality in the cases might be due
to the high rate of appropriate antibiotic therapy (93%) and the
overall short delay in the start of treatment (0.6±1.0 days).
Conclusion After careful adjustment for severity of underlying disease
and acute illness, no significant excess mortality was found between
ICU patients with and without E. coli bacteremia. These results must
be seen in the light of fast initiation of appropriate therapy.
P136 Nosocomial bloodstream infection from abdominal origin in a general ICU: microbiological factors influencing outcome
S Blot, J De Waele, F Colardyn
ICU, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium
Critical Care 2003, 7(Suppl 2):P136 (DOI 10.1186/cc2025)
Purpose and methods A retrospective (January 1992–December
2000) cohort study was performed in order to identify microbiolog-
ical factors associated with bad outcome in ICU patients with
nosocomial bloodstream infection (BSI) from abdominal infection
(n=96).
Results During the study period, 1071 episodes of nosocomial BSI
were found in 29,727 patients admitted to the ICU. In 91 patients,
143 BSI were found originating from an abdominal source. In
patients with multiple episodes only the first was considered for the
outcome analysis. Mean (±SD) age of the patients was 54 (±16.1).
Figure 1S67
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APACHE II scores averaged 24 (±9.5). The median length of ICU
stay prior to the BSI was 6 days and the total ICU stay 20 days. The
inhospital mortality was 57.2%. In 25 patients the BSI was poly-
microbial (27.5%). The causative microorganisms and respectively
associated mortality rates were: Gram-negative bacteria (n=64;
59.4%), E. coli (n=20; 60.0%), Enterobacter spp. (n=11; 63.6%),
P. aeruginosa (n=9; 66.7%), Klebsiella spp. (n=9; 44.4%),
Acinetobacter spp. (n=8; 37.5%), other Gram-negatives (n=12;
75.0%), Gram-positives (n=30; 50.0%), coagulase-negative
Staphylococci (n=11; 45.5%), Enterococci and Streptococci
(n=16; 50.0%), S. aureus (n=6; 50.0%), Candida spp. (n=9;
77.8%) and anaerobe bacteria (n=6; 50.0%). No type of micro-
organism was associated with a statistically significant higher mor-
tality (P>0.05). In 39.6% of BSI the microorganism involved was
antibiotic resistant. In Table 1, microbiological factors are compared
for hospital survivors and nonsurvivors. Also in a multivariate analy-
sis no microbiological factor could be recognised as independently
associated with mortality (P>0.05).
Conclusion In our cohort of ICU patients with nosocomial BSI
from abdominal origin, microbiological characteristics of the infec-
tion seem not to affect the outcome.
Table 1
Survivors (n = 39) Nonsurvivors (n = 52) P value
Antibiotic-resistant microorganism 17 (43.6%) 19 (36.5%) 0.523
Colonization prior to onset BSI 23 (59.0%) 24 (46.2%) 0.290
Polymicrobial BSI 9 (23.1%) 16 (30.8%) 0.482
> 1 presumed source of BSI 6 (15.4%) 4 (7.7%) 0.312
P137 Transfer in ICU of febrile neutropenic patients: prospective validation of a prognostic score identifying ‘high-risk’ patients
J Larché1, F Alla2, P Maurer1, O Kunzberger1, A Gérard1
1Service de Réanimation Médicale, CHU Nancy Brabois, 54500 Vandoeuvre les Nancy, France; 2Service d’Epidémiologie et d’Evaluation
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Objective Infectious complications in neutropenic febrile patients
are associated with a high mortality rate. A previous case–control
study in postchemotherapy neutropenic patients identified three
early risk factors for ICU transfer (abnormal chest X-ray, positive
blood cultures, and C-reactive protein ≥120mg/l), and a prognos-
tic score based for ICU transfer on the presence or not of at least
one of these variables was then performed. Our objective was to
validate accuracy, adequacy and reliability of this score with
another cohort of febrile neutropenic patients.
Design A prospective consecutive cohort study over 18 months in
a tertiary care hospital.
Results and measurements Ninety patients have been included;
57.7% were men, and mean age was 50±19 years. The majority
of them were hospitalized for acute myeloblastic leukaemia (AML)
(78 patients), the others for acute lymphoblastic leukaemia (ALL)
(12 patients). Twenty-four (26.7%) patients were referred in the
ICU and nine (37.5%) of them died in the ICU. The following data
were associated with an increased risk of transfer in the ICU during
their stay in the hematology ward: ALL, more than three previous
episodes of febrile neutropenia, microbiological documentation,
clinical pulmonary location, and abnormal chest X-ray. When
applied to this prospective cohort, sensitivity, specificity, negative
and positive predictive values of our prognostic score were,
respectively, 100%, 56.1%, 100% and 45.3%.
Conclusion No prognostic score focused on identification of ‘high-
risk’ neutropenic patients has yet been validated. Moreover, differ-
ent severity-of-illness scores used in the ICU and recently tested in
hematology wards have failed to predict accurately patients at
‘high risk’. These results confirmed the validity of this score for
eliminating patients without risk of transfer in the ICU, but also for
identifying a ‘sensitive’ population at higher risk of complication
and transfer in the ICU. The use in haematology wards of such a
prognostic score, associated with an optimization strategy, should
be prospectively tested on febrile neutropenic patients in a ran-
domized controlled trial, with outcome as the primary objective.
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Objective To determine the incidence, microorganism responsible
and mortality of bacteremias in critically ill patients. To analyze bac-
teremia mortality according to microorganisms responsible and
origin sources in critically ill patients.
Methods It is a prospective study of bacteremias in patients admit-
ted in a medical–surgical ICU, from 1 May 2000 to 31 August
2002. We analyzed mortality bacteremia according to the micro-
organism responsible and bacteremia mortality according to origin
sources. The statistical analysis was realized by chi-square test
and we took values P<0.05 to consider a significant difference.
Results Included were 1389 patients. Diagnosed were 116 bac-
teremias, due to 116 microorganisms, in 106 patients (a total ofS68
7.63% patients developed bacteremia). The mortality of patients
who developed bacteremia was 19.81% (21/106). Bacteremia
mortality for each microorganism responsible was: MRSA 1/9,
MSSA 3/5, CNS 6/44, Streptococcus faecalis 2/13, Streptococ-
cus pneumoniae 1/4, Escherichia coli 3/8, Proteus mirabilis 0/2,
klebsiella 2/4, Morganella morgani 0/2, acinetobacter 0/1, enter-
obacter 1/7, Pseudomonas aeruginosa 1/7, Candida albicans 1/4,
others 0/6. Bacteremia mortality for each origin source was:
primary 9/55, respiratory 6/25, central venous catheter 5/22,
wound surgical 1/4, others 0/10. No significant differences were
found in bacteremia mortality according to the microorganism
responsible and according to origin source of bacteremia.
Conclusions In our series, bacteremia mortality was not different
according to origin source nor according to the microorganism
responsible.
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Objective Severe CAP is a common reason for emergency paedi-
atric intensive care (mortality rate: 40–70%). In this population,
refractory hypoxemia is frequently associated with poor outcome.
Our hypothesis is that the mortality rate in infants with severe CAP
and ARDS correlates not only with respiratory impairment, but also
with associated organ failure. The purpose of this study is to evalu-
ate organ failures quantified with paediatric modified SOFA
(mSOFA) score and to correlate it with mortality.
Design A retrospective observational study. Period of the study:
January 2000–January 2002.
Setting PICU in a national children’s hospital.
Methods Twenty-two infants with severe CAP meeting
ACCP/SCCM criteria for ARDS, age between 6–24 months
admitted in the hospital less than 2 days before. Excluded were
infants with ARDS from RSV, prematurity and bronchodysplasia,
neuromuscular diseases, immunodepression or immunosuppres-
sion, congenital cardiopathy. The ventilatory strategy employed
was permissive hypercapnia (target pO2 ≥60mmHg, pH >7.25)
with limitation of peak inspiratory pressure (Pplat <35cm H2O)
while employng elevated mean airway pressure to ensure maximum
lung volume recruitment (PEEP above the lower inflection point on
PV curve). Sedation and paralysis were performed according to
Table 1
Population on admission
Dead (D) Survivors (S) P (*)
Age (months) 13 ± 6 16 ± 6 NS
Weight (kg) 7.3 ± 6 9.1 ± 1 NS
Prism 17 ± 11 11 ± 6 NS
Lung injury score 3 2 NS
Table 2
Results
D1 D2 D3 D7 D0
DSDSDSDSDS
Lactate (*) 4.0 ±  0.5 ±  2.6 ±  0.5 ±  3.0 ±  0.3 ±  2.8 ±  0.9 ±  5.8 ±  1 ± 
2.4 0.5 1.2 0.9 1.2 0.5 1 0.3 1.2 0.2
P < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
LDH (**) 1693 ±  847±  1575 ±  824 ±  1466 ±  672 ±  2700 ±  760 ±  2700 ±  680 ± 
1124 251 775 211 405 500 2300 168 2000 170
P < 0.05 < 0.05 < 0.05 < 0.01 < 0.01
SOFA TOT (*)  8.0 ±  3.2 ±  8.0 ±  3.1 ±  8.3 ±  3 ±  7.7 ±  2 ±  9.7 ±  1.8 ± 
1.3 1.2 2.9 1 2.4 0.9 2 0.9 1.8 0.2
P < 0.01 < 0.01 < 0.01 < 0.01 < 0.01
SOFA EMO (*) 1.5 ± 0.8 ±  1.7 ± 0.5 ±  1.5 ± 0.2 ±  3.5 ±  0 3.5 ±  0.2 ± 
1.9 1.5 1.8 0.6 1 0.6 0.5 0.5 0.1
P NS NS NS < 0.01 < 0.01
SOFA RES (*) 3.3 ±  3 ±  3.3 ±  2.5 ±  3.4 ±  2.6 ±  4.0 ±  1.4 ±  4 ±  2 ± 
0.5 0.4 0.4 0.3 0.3 0.5 0 0.5 0 0.3
P NS NS NS < 0.05 < 0.01
SOFA PLT (*) 2.2 ±  0.2 ±  2.3 ±  0.1 ±  2.5 ±  0.1 ±  2.3 ±  1.0 ±  2.0 ±  0
1.2 0.4 1.3 0.3 0.8 0.2 0.7 0.3 0.9
P <0.01 < 0.01 < 0.01 < 0.01 < 0.01S69
clinical protocols. At different times, day 1 (D1), day 2 (D2), day 3
(D3), day 7 (D7), day 0 (D0: exitus vs dimission), were collected
the mSOFA score, HR, mean arterial pressure, lactate, pH, BE,
WBC, PCR, LDH. The end point was mortality in PICU, outcome 2
and 6 months after dimission. The data were analysed with
Microsoft Excel 7.0 and Statview McIntosh statistical software:
Student’s t test (P<0.05) (*), Mann–Whitney test (P<0.05) (**),
Fisher’s exact t test (P<0.05) (***).
Results: Enrolled patients were divided into two subgroups:
deaths (n=10 [D]) and survivors (n=12 [S]). Mortality in the PICU
was 45%. Eighty per cent of survivors were still alive 6 months
later.
The following parameters are statistically different in the studied
subgroups: lactate, LDH, mSOFA total, mSOFA coagulation.
Lactate (cutoff 3mmol/l), and mSOFA total (cutoff ≥5) were corre-
lated with mortality on admission and in all observations (P<0.001
Fisher’s exact test). There were no other differences between the
two subgroups.
Conclusion The study suggest that the early evaluation of total
mSOFA, lactates and LDH can be used to identify infants with
severe CAP at elevated risk of death.
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Good glycemic control has been shown to decrease mortality in
critically ill patients [1], the predominant effect being a decrease in
the incidence of serious infection. Glucose is normally absent from
airway surface liquid [2], which may be important to host defenses
against infection. Glucose in endotracheal secretions has been
attributed to the aspiration of enteral feed [3]. Previously we have
found this to be false and that glucose appears in the airway sec-
ondary to hyperglycemia. We hypothesize that glucose in airway
secretions increases the risk of bacterial airway infections. Our
objectives were to observe for relationships between hyper-
glycemia and the presence of glucose and bacteria in airway
secretions.
Methods and results One hundred critically ill, ventilated patients
admitted to a general (medical and surgical) adult intensive care
were recruited. Glucose concentrations were measured simultane-
ously in arterial blood (ABL2000; Radiometer, Copenhagen,
Denmark) and endotracheal (ET) secretions (glucose oxidase
sticks and GM9D Analyzer; Analox, London, UK). Sputum samples
were sent for qualitative microscopy and culture. All patients were
enterally fed, unless clinically contraindicated.
Of 100 patients, 89 had microbiology results returned. Fifty-four of
100 had glucose detected in their ET secretions (>0.5mmol/l).
Patients with ET glucose had a significantly higher blood glucose
(8.82±0.31) than those without (6.69±0.23, P=0.004); this was
unrelated to enteral feeding. Significantly more patients with ET
glucose had Staphylococcus aureus detected in their sputum
(33/49 vs 10/40, P=0.007). Table 1 presents the results for sen-
sitive S. aureus and methicillin-resistant S. aureus (MRSA).
Comment Glucose appears in airway secretions and is associated
with hyperglycemia. It is not related to enteral feeding. Possible
mechanisms include saturation of airway epithelial sodium glucose
cotransporters, or increased epithelial permeability. Glucose in
airway secretions is strongly associated with S. aureus infection
(Table 1). This may be one mechanism by which control of glucose
decreases infectious complications.
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Table 1
Microbiology results
Positive Negative  Significance 
for ET  for ET  P
glucose glucose (χ2 test)
Total number of patients 49 40
Sensitive S. aureus 8 0 0.007
MRSA 25 10 0.017
Total 33 10 < 0.0001S70
Background and goal of study Brain-injured patients are charac-
terized by an increased risk to develop respiratory failure due to
pneumonia, incidence of which is estimated at around 30–50%
[1]. The aim of this study was to analyze in brain-injured patients
during mechanical ventilation: 1) the incidence of pulmonary infec-
tion (P.I.), diagnosed by cultural data of bronchoalveolar lavage
(>104cfu/ml); 2) predisponent factors of P.I.; 3) the prevalence of
sepsis and severe sepsis criteria [2]; 4) the association with mor-
phological alterations of chest X-ray, respiratory failure (PaO2/FiO2
<200mmHg), presence of tracheobronchial secretions; 5) the
association with leucocyte count and core temperature; 6) periph-
eral organ failure, evaluated by SOFA score.
Material and methods In this study we prospectively analyzed
60 brain-injured patients (sex M/F, 40/20; age, 43±20 years; BMI,
24.5±2.7kg/m2; trauma/not trauma, 23/37; GCS, 9±3) during
mechanical ventilation.
Results and discussion Results are specified in Tables 1 and 2.
Conclusions In brain-injured patients, during mechanical ventila-
tion: 1) 48% of patients developed P.I.; 2) GCS at entry seems to
be the principal risk factor of P.I.; 3) 48.4% of patients without P.I.
developed signs of SIRS + cathecolamines need; 4) the chest X-
ray of 96.5% of patients with P.I. was modified, associated with
severe hypoxiemia in the 58% of cases; 5) 40–50% of patients
without P.I. showed alterations of the leukocyte count and of the
secretions; 6) peripheral organ failures (renal, cardiac, hepatic) are
infrequent.
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Table 1
Number of patients GCS at entry SIRS Sepsis Septic shock SIRS+cathecol
BAL+ 29 7.8 ± 3.7 0% 44.8% 55.1% 0%
BAL– 31 10.5 ± 3.8 48.4% 0% 0% 25.8%
P < 0.05 < 0.01 < 0.01 < 0.01 < 0.01
Table 2
Leucocyte count  Temperature 
Altered chest X-ray  PaO2/FiO2 < 200 Secretions > 12,000 or < 4000 > 38°C or < 36°C
BAL+ 96.5% 58.6% 89.6% 79.3% 86.2%
BAL– 3.2% 9.6% 51.6% 54.8% 25.8%
P < 0.01 < 0.01 < 0.01 < 0.05 < 0.01
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Objective To analyze the mortality of ventilator-asociated pneumo-
nia (VAP) produced for a potential multiresistant microorganism
(PMRM) according to antibiotic sensibility of the microorganisms
responsible.
Methods It is a prospective study of patients admitted in the ICU
from 1 May 2000 until 31 August 2002 and who developed VAP
produced for a PMRM (Staphylococcus aureus,  Pseudomonas
aeruginosa, Stenotrophomona maltofilia, Acinetobacter). The sta-
tistical analysis was realized by chi-square test and Student t test,
and we took values P<0.05 to consider a significant difference.
Results  In the study period, 1389 patients were admitted. We
documented 66 VAP for a PMRM. VAP mortality for MSSA versus
MRSA was 27.77% (5/18) and 14.28% (2/14) (P=0.35). VAP
mortality for a Gram-negative bacilli PMRP was analyzed according
to the sensitivity to four antibiotics (piperacillin–tazobactam,
ceftazidime, imipenem and ciprofloxacin). VAP mortality for
P. aeruginosa with 0–1 antibiotic resistances versus 2–4 antibiotic
resistances was 2/22 (9.09%) and 2/4 (50%) (P=0.03). VAP
mortality for S. maltofilia with 0–2 antibiotic resistances versus 3–4
antibiotic resistances was 0/2 (0%) and 2/2 (100%) (P=0.04).
VAP mortality for Acinetobacter with 0 antibiotic resistancesS71
versus 1–4 antibiotic resistances was 0/2 (0%) and 1/2 (50%)
(P=0.24).
Conclusions In our series, the VAP mortality for P. aeruginosa and
S. maltofilia was different according to antibiotic sensibility, but not
when it was due to S. aureus and Acinetobacter.
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Introduction Ventilator-associated pneumonia (VAP) is associated
with significant morbidity and mortality. Several published guide-
lines recommend early and broad-spectrum empiric therapy for
patients with a suspicion of VAP; however, uncertainty exists
regarding the indications for and selection of appropriate agents.
Methods To determine whether evidence exists to support the use
of a particular parenteral regimen in the empiric treatment of VAP, we
conducted a systematic review of the literature for all randomized
controlled trials (RCTs) from 1966 to November 2002. Two authors
(MWA and JNH) independently searched MEDLINE, EMBASE, the
Cochrane Controlled Trials Register library, and the bibliographies of
all reviews, for RCTs. Experts in the field and all authors of trials
included in this review were contacted to identify unpublished trials.
Data were abstracted and trial quality was assessed independently
by the two review groups. Additional information was sought when
necessary from the corresponding authors of the retrieved trials.
Trials comparing similar antibiotic strategies were pooled, and the
risk difference and relative risk were reported for the outcomes of
mortality, clinical response, superinfections and adverse events.
Results In the 33 trials identified, a total of 5049 patients were
enrolled; 73.0% were ventilated, 65.1% had microbiological evi-
dence of infection, 17.7% had P. aeruginosa isolated from one or
more cultures; and the overall mortality rate was 20.5%
(922/4492). No trials with a placebo arm were identified; however,
24 different comparisons were evaluated involving 27 unique
antibiotic regimens (13 monotherapies, 14 combination therapies).
The sample size of trials ranged from 32 to 400 patients. In every
trial the primary objective was to evaluate equivalence as opposed
to superiority, and no trials were sufficiently powered to determine
a difference of 10% or less between groups. The overall quality of
the 33 trials was very low; randomization was concealed in only 10,
followup was complete in only eight, an intention-to-treat (ITT)
analysis was completed in 18, detection of the outcome was
blinded in 10, and a double-blinded strategy was employed in only
three. All-cause mortality did not significantly differ between treat-
ment groups for any individual trials or when data was pooled.
When evaluating clinical response, a significant benefit was
demonstrated with amikacin/ceftazidime versus pefloxacin/cef-
tazidime, risk difference (RD)=20% (95% CI, 4–36%), in a single
low-quality trial. With pooling of trials a significant benefit was also
demonstrated with meropenem versus the combination cef-
tazidime/amikacin, RD=13% (4–22%); and aztreonam versus an
aminoglycoside, RD=25% (4–45%).
Conclusions There is some evidence to suggest that choice of
parenteral empiric antibiotic therapy for VAP may influence
outcome, although study design limitations preclude strong recom-
mendations regarding the optimal choice of therapy. There is no
proven beneficial empiric therapy for which to compare alternate
regimens; and no trials have ever evaluated the utility of empiric
therapy versus a strategy of delayed directed therapy based on
culture results.
P144 Impact of ventilator-associated tracheobronchitis on outcome in patients with chronic obstructive pulmonary disease
S Nseir1, C Di Pompeo2, S Soubrier1, P Pronnier1, T Onimus1, F Saulnier1,2, A Durocher1,2
1ICU, Calmette Hospital, CHRU, bd du Pr Leclercq, 59037 Lille cedex, France; 2Medical Assessment Laboratory, Lille II University, Lille, France
Critical Care 2003, 7(Suppl 2):P144 (DOI 10.1186/cc2033)
Background In the absence of nosocomial pneumonia (NP), venti-
lator-associated tracheobronchitis (VAT) may generate weaning
difficulties in patients with chronic obstructive pulmonary disease
(COPD), resulting in longer duration of mechanical ventilation (MV)
and intensive care unit (ICU) stay. The aim of our study is to test
this hypothesis.
Methods A prospective matched risk-adjusted cohort study, in a
30-bed ICU, over a period of 6.5 years. Immunocompetent medical
COPD patients who were intubated and ventilated for >48 hours
were eligible. All patients with NP were excluded. Tracheobronchi-
tis was defined as follows: fever (>38°C) with no other recogniz-
able cause; new or increased sputum production, and a positive (≥
106cfu/ml) endotracheal aspirate culture, yielding a new bacterial
strain; without radiographic evidence of pneumonia. Only first
episodes of VAT occurring after >48 hours of MV were included.
A matching process was conducted according to the following cri-
teria: MV duration before the occurrence of VAT, primary diagnosis
for admission, indication for MV, SAPS II on admission ±5, age
±5, and date of admission. McNemar’s test and the Wilcoxon log-
rank test were used to compare cases with controls. Univariate and
multivariate analyses were performed in order to determine vari-
ables associated with longer than median MV duration among case
and control patients.
Results A total of 1259 patients were eligible; 128 (10%) of them
were excluded for NP. VAT was diagnosed in 103 (8%) patients;
11 (10.6%) of them were excluded for subsequent NP. Matching
was successful for 88% of the cohort; 81 matched case–control
pairs were studied. Acute exacerbation of COPD was the main
cause for admission (64%). P. aeruginosa was the most common
causing bacteria (27%). Although the mortality rate was similar
(40% vs 34%; P=NS), the median duration of MV (20 days vs
12 days; P=0.015) and ICU stay (25 days vs 18 days; P=0.022)
were higher in cases than in controls. VAT was the only variable
independently associated with longer than median duration of MV
(OR=4.7 [95% CI=2–10.9]; P<0.001). In patients with VAT,
antibiotics were associated with shorter median duration of MV
(15 days vs 23 days; P=0.043), and ICU stay (23 days vs
29 days;  P=0.007) and similar mortality rate (40% vs 41%,S72
P=NS). Appropriate antimicrobial treatment was associated with a
tendency towards a better outcome.
Conclusion VAT is associated with increased duration of MV and
ICU stay in COPD patients. Antibiotics are associated with shorter
length of MV and ICU stay in patients with VAT. Further studies are
required to confirm our results.
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Introduction The best method for diagnosis of ventilator-associ-
ated pneumonia (VAP) in children is much debated. Clinical criteria
alone may not be sufficiently reliable. Bronchoscopic techniques
are not routinely used. Blind (nonbronchoscopic) protected bron-
choalveolar lavage (BAL) has been studied in pediatrics but has
never been validated according to the gold standard (autopsy).
Objective To compare different diagnostic methods of VAP in chil-
dren, using clinical judgment of an adjudicating committee of
experts as the reference standard.
Methods  Setting Prospective study of all consecutive PICU
patients <18 years with suspected VAP.
Diagnostic methods compared 1) clinical data using Centers for
Disease Control (CDC) criteria; 2) blind protected BAL, evaluating
quantitative cultures, bacterial index, Gram stain and presence of
intracellular bacteria; 3) nonquantitative cultures of endotracheal
secretions.
Reference standard Consensus of three independent experts
(Delphi method) who retrospectively established the presence of
VAP based on clinical, microbiological and radiological data.
Analysis Concordance between each diagnostic method and the
reference standard was evaluated by concordance percentage and
kappa score. Validity was evaluated using sensitivity, specificity
and global value.
Results Thirty patients were included in the study. According to
the reference standard, VAP occured in 10/30 patients (33%).
Concordance and validity of the different methods are presented in
Table 1.
Conclusion  Our data show that the most reliable diagnostic
method for VAP is a bacterial index >5. Further studies should
evaluate the validity of all these methods according to the gold
standard (autopsy).
Table 1
Number of  Concordance 
patients with  with reference 
Diagnostic method positive results (n/30) standard (%) Kappa score Sensitivity (%) Specificity (%) Global value (%)
Clinical criteria (CDC) 28 43 0.11 100 15 43
BAL
Culture ≥ 102 CFU/ml 14 67 0.32 70 65 67
Culture ≥ 103 CFU/ml 11 70 0.34 60 75 70
Culture ≥ 104 CFU/ml 9 70 0.31 50 80 70
Culture ≥ 105 CFU/ml 6 67 0.17 30 85 67
Intracellular bacteria 4 73 0.29 30 95 73
Gram stain 9 70 0.31 50 81 73
Bacterial index > 5 9 83 0.61 78 86 90
Endotracheal culture 21 57 0.24 90 40 57
P146 The complications associated with mechanical ventilation
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Objective  Although mechanical ventilation (MV) of critically ill
patients may be life saving, complications associated with MV
occur commonly. In this prospective study, we investigated the
complications of the MV including injuries to the airway due to intu-
bations and/or tracheostomy, self-extubation, nosocomial pneumo-
nia (NP), and barotrauma. Furthermore, we noted the duration of
MV and prognosis of the patients with and without NP.
Materials and methods Fifty-five patients who required MV for
more than 48 hours in our ICU during a 6 month period were
included in the study. Patients who had pneumonic infiltration at
admission and/or underwent ventilatory therapy in other hospitals
were excluded from the study. The patients were daily evaluated in
terms of the complications of MV. Age, Glasgow Coma Scala
(GCS) score, APACHE II score, risk factors, duration of MV andS73
prognosis of the patients were recorded daily. The nurse-to-patient
ratio was 1:4 in our ICU.
Results The average age, GCS score, APACHE II score, and MV
duration were 47.2±20.9 years, 8.2±4.1, 17.8±5.7 and
15.0±11.2 days, respectively. In 23 patients (41.8%) NP was
diagnosed, and the NP/ventilation day ratio was 23/836
(27.5/1000). The mean MV duration in patients with or without NP
was 20.4±12.8 and 11.2±8.1 days, respectively (P<0.05). The
mortality rate was 34.8% in the pneumonia group and 18.8% in
the nonpneumonia group (P>0.05). Barotrauma related to MV
(pneumomediastinum and subcutaneus amphisema) was observed
in two patients, and the other complications including larengeal
edema, cuff leak, self-extubation and right main bronchial intubation
were seen in 13 patients.
Conclusions The incidence of NP and other complications deter-
mined in this study was comparable with previous studies reported
in the literature [1]. The mortality rate of the patients with NP was
found to be higher than the patients without NP, but the difference
was not statistically significant. The duration of MV in the pneumo-
nia group was significantly higher than the nonpneumonia group.
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Summary Stress ulcer is one of the most common complications
in ICU patients. Usually an H2-blocker or sucralfate is used for pro-
phylaxis. In the past decade, some investigators showed a
decreased number of aspiration pneumonia in patients receiving
sucralfate compared with receiving ranitidine or a control group.
Method  During a 7 month course (October 2001–April 2002),
150 patients in the ICU were randomized to two 50 patients
groups receiving sucalfate (1g every 6 hours PO) and ranitidine
(50mg every 8 hours IV) and a control group. All patients were
examined daily and, if needed, laboratory examinations or radi-
ographs were requested for the diagnosis of aspiration pneumonia.
Results Aspiration pneumonia was observed in 13 patients in the
sucralfate group, 15 patients in the ranitidine group and
10 patients in the control group. There was no significant differ-
ence between suralfate and ranitidine (P=0.65), sucralfate and
control (P=0.48) or ranitidine and control (P=0.25).
Also, the difference between three groups was not significant
(P=0.51).
Conclusion In this study no significant difference in the frequency
of aspiration pneumonia was observed between sucralfate, raniti-
dine and control groups.
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Objective To analyze the utility of periodic change of ventilator cir-
cuits (PCVC) to prevent the incidence of ventilator-associated
pneumonia (VAP).
Methods  It is a prospective study. Included were all patients
admitted in the ICU from 1 April 2001 until 30 September 2002
and who required mechanical ventilation for 72 hours or more. At
admission to the ICU patients were randomized in two groups: one
group ventilated with PCVC each 48 hours, and another one
without PCVC. A throat swab on admission and afterwards twice
weekly were taken. Infections were diagnosed according to CDC
criteria and classified bassed on throat flora in endogenous and
exogenous. The statistical analysis was realized by chi-square test
and Student t test, and we took values P<0.05 to consider a sig-
nificant difference.
Results Included were 304 patients (62.82% male). Mean age was
58.86±18.24 years. APACHE II was 16.01±7.26. Mortality was
32.23%. Both groups of patients (143 with PCVC and 161 without
PCVC) were similar in age, sex, mortality and APACHE II. No signifi-
cant differences were found in the percentage of patients who devel-
oped VAP (23.07% vs 22.98%), nor in the number of VAP per 1000
mechanical ventilation-days (20.27 vs 27.81). Neither in the percent-
age of patients who developed VAP and in the number of VAP per
1000 mechanical ventilation-days in each group of mechanical venti-
lation-days. Neither in the percentage of patients who developed
exogenous VAP (2.79% vs 2.48%), neither in the number of exoge-
nous VAP per 1000 mechanical ventilation-days (1.71 vs 1.09).
Conclusions In our series, the periodic change of ventilator circuits
did not reduce the incidence of VAP nor was VAP exogenous.
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Objective To analyze the incidence of ventilator-associated pneu-
monia with a closed endotracheal suction system (CESS) versus
an open system (OESS).
Methods It is a prospective study during 3 months. Included were all
patients who required mechanical ventilation for 12 hours or more. At
admission to the ICU patients were randomized in two groups: oneS74
group was suctioned with CESS, and another group with OESS.
Infections were diagnosed according to CDC criteria. The statistical
analysis was realized by chi-square test and Student t test, and we
took values P<0.05 to consider a significant difference.
Results Included were 121 patients (64% male). Mean age was
57.68±16.90 years, APACHE II was 14.40±6.25. Mortality was
14.85%. Patient distribution was: 50% cardiac surgery, 9% cardi-
ologic, 7% respiratory, 4% digestive, 10% neurologic, 11% trau-
mathology, 3% intoxication, 6% abdominal sepsis. Both groups of
patients (58 with CESS and 63 with OESS) were similar in age,
sex, diagnosis groups, mortality and APACHE II. No significant dif-
ferences were found in the percentage of patients who developed
ventilator-associated pneumonia (13.79% vs 14.28%), nor in the
number of ventilator-associated pneumonia per 1000 mechanical
ventilation-days (15.85 vs 16.12).
Conclusions In our series, a closed endotracheal suction system
did not reduce significantly the ventilator-associated pneumonia
incidence.
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Introduction Percutaneous tracheostomy is a well-established
technique in the ICU setting. The methods described by Ciaglia
et al. and by Griggs et al. are the most popular and have been
advocated by many authors. Translaryngeal tracheostomy (TLT)
according to Fantoni and Ripamonti was initially introduced in
1997. The aim of the present study was to assess the difficulties
and complications of TLT and forceps dilatational tracheostomy
(FDT) in critically ill patients.
Methods Sixty patients were randomized to undergo TLT or FDT.
The techniques as described by Griggs and Fantoni were followed
with the use of commercially available kits. Statistical analysis was
performed using the Student t test. At the end, tracheal injury was
assessed by endoscopy.
Results There were no significant statistical differences regarding
the age, sex, Apache II score or the endotracheal intubation
between the two groups. Table 1 summarizes the perioperative
complications and duration of TLT and FDT.
Conclusion Based on our data we conclude that TLT represents
an equally safe percutaneous technique as FDT and is also an
attractive alternative in long-term airway access in critically ill
patients.
Table 1
TLT FDT P value
Hemorrhage minor 0 1 NS
Difficult cannula insertion 1 0 NS
Cuff damage 0 2 NS
Duration of procedure (min) 17 ± 2.5 6 ± 2 < 0.0001
Posterior tracheal wall injury 0 1 NS
Paramedical tube insertion 0 1 NS
Total 1 5
NS, nonsignificant.
P151 Dilatation tracheostomy under visual control
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Introduction In our ICU we use modified bedside operative tra-
cheostomy. The operation consists of consecutive blunt dilatation
of all tissular structures above the trachea with the aim of
denudating it. After that we execute a small incision of the trachea
between the second and the third annulus, dilatation of trachea
and insertion of a tracheostomy cannula with the possibility of an
adjustment tracheal aperture. There is no need for ligation of the
thyroideal isthmus or resection of the tracheal cartilage.
The aim of this study was to compare our method with surgical tra-
cheostomy (ST) and percutaneous dilation tracheostomy (PDT-
Ciaglia) for early and long-term complications.
Method The group of 205 patients with tracheostomy was
included in our observation (hospitalized 1997–2001 in our ICU)
without exceptions (basic diagnosis, indication of tracheostomy,
anatomical conditions and other risk factors to the results of the
operation). Data of long-term complications were gained from a
questionnaire. Data of ST and PDT were taken from medical litera-
ture. Descriptive statistical methods and the Student t test were
used to analyze the data.
Results  Results in percent of complications are graphically
demonstrated in Figs 1–3.
The total complication rate for our method was found to be 11.7%.
Incidence of bleeding (perioperative and postoperative) was 5.3%.
There was no need for use of transfusions. Infectious complica-
tions were 5.9%. Other complications including pneumothorax,
pneumomediastinum, subcutaneus emphysema and other minor
complications were 0.5%.
The total number of patients who were discharged from our hospi-
tal was 67. Rate of return of the questionnaire was 46%. Long-
term complications were: none of the patients developed
laryngotracheal stenosis, cosmetic difficulties with cicatrice (23%),
voice changes (15%), and dysphagia (8%).S75
Conclusions Our method of tracheostomy can be an accepted
procedure for airway access. The rate of complications is compara-
ble with other methods (PDT, ST). There are also important differ-
ences in costs. The cost of the described method is one-third of
the cost of PDT in Czech conditions. Prospective randomized
studies are necessary to compare the late complications of these
reported techniques.
Available online http://ccforum.com/supplements/7/S2
Figure 1
Comparison of early complications of the visual technique with PDT.
Figure 2
Comparison of early complications of the visual technique with ST.
Figure 3
Comparison of long-term complications of the visual technique with
PDT.
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Since complication rates from clinical trials may not reflect those
obtained in practice we report the prospectively audited complica-
tion rates from the 201 percutaneous tracheostomies performed
on the intensive care unit at the Chelsea and Westminster Hospi-
tal, London between 6 March 1997 and 3 December 2002. All
were performed under anaesthetic consultant supervision, and
bronchoscopic confirmation of tracheostomy position and compli-
cations was utilised.
Of the 201 tracheostomy patients, 28 patients had complica-
tions; an incidence of 13.9%. Comparing the patients who suf-
fered complications with those who did not, their median
admission APACHE was worse (25 vs 21) and more died in
intensive care (40% vs 19%) although length of stay was similar
(26 days vs 25 days). There was a highly significant sex differ-
ence in the incidence of complications; for males the complica-
tion incidence was 6.3% (seven of 111 patients), whereas for
females the complication incidence was 23.3% (21 of 90
patients), P=0.0005.
Serious complications occurred in 15 patients, an incidence of
7.4%. Surgical intervention was required in four patients, two for
major early bleeding and two for major late bleeding. There was
one arrest secondary to respiratory obstruction by blood clot but
no tracheostomy-associated mortality.
Three different insertion methods were used, without randomisa-
tion; Griggs’ forceps (Portex, NH, USA) in 65 patients, Ciaglia
sequential dilators (Cook, IN, USA) in 87 patients, and single
tapered dilators in 49 patients (from Cook in 31 patients and from
Portex in 18 patients). Comparing the different insertion methods,
the incidence of complications was 11 of 65 patients or 17% with
Griggs’ forceps, 14 of 87 patients or 16% with sequential dilators,
and three of 49 patients or 6% with a single tapered dilator,
although differences were not significant.
In summary, we report a serious complication rate of 7.4% in 201
percutaneous tracheostomies performed on the Chelsea and
Westminster intensive care unit, with no mortality. We found a
lower incidence of complications using the single tapered dilator
methods for tracheostomy insertion, as opposed to Griggs’
forceps or sequential dilators, although differences did not reach
statistical significance. We also found a highly significant associa-
tion of complications with female sex.S76
Objective This study investigates the immediate complications and
adverse consequences of endotracheal intubation (ETI) and
bedside percutaneus dilatational tracheostomy (PDT) performed in
ICU patients.
Design Prospective observational study.
Setting  Two 15-bed general ICU units in a 600-bed general
hospital.
Subjects All ETI and PDT that were carried out in our ICUs, over a
period of 6 months, were studied prospectively. The procedures
were performed by skilled ICU attending physicians or by super-
vised residents. Complications and adverse consequences, which
occurred during the procedures, were recorded, as well as seda-
tives, muscle relaxants and any other drug used, according to a
previously approved protocol.
Results One hundred and forty-two ETI and 54 PDT were carried
out successfully. Complications occurred in 41% of ETI and 33%
of PDT cases. Major ETI complications including difficult or
esophageal intubation, aspiration, desaturation of hemoglobin and
severe hypotention, were recorded in 34.5% of cases. Local injury
and transient hypotention occurred in 9% of cases. Severe compli-
cations (bleeding, false passage of tracheostomy tube, desatura-
tion of hemoglobin, severe hypotention) occurred in 15% of PDT
cases. Minor complications that are false or difficult passage of the
guide wire and puncture of the ET tube were noted in 19% of
cases. No difference was recorded in the incidence of complica-
tions regardless of whether the procedure was performed by the
attending physicians or the supervised residents.The only inci-
dence that was statistically higher in the ETI group (P<0.01329,
χ2 test) was desaturation. Also no significant differences were
recorded between the groups treated with different sedatives and
analgesics.
Conclusions 1) Adverse consequences and complications com-
monly happen in the ICU during ETI and PDT. 2) ETI and PDT can
be safely performed by supervised residents.
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Background Guidelines for minimum standards of monitoring in
the anaesthetic room and operating theatres are now part of stan-
dard anaesthetic practice throughout the UK. Manipulation of the
airway, including tracheal intubation and percutaneous tra-
cheostomies, is a common undertaking in the intensive care unit
(ICU). Critically ill patients can pose specific technical difficulties
during tracheal intubation. There is no accepted minimum standard
of monitoring for procedures involving manipulation of the airway in
UK ICUs. We surveyed monitoring practices used for the confirma-
tion of tracheal tube placement during tracheal intubation and per-
cutaneous tracheostomy.
Methods  Anonymous questionnaires were sent to the clinical
directors of randomly selected general adult ICUs across the UK.
Results One hundred and thirty-six replies were received out of
200 questionnaires sent (response rate 68%). The majority (73%)
of tracheal intubations were performed by trainee anaesthetists.
Only 14% of the ICUs always used end-tidal carbon dioxide
(FÉCO2) monitoring during tracheal intubation. Twenty-five per cent
of the ICUs did not have a FÉCO2 monitor. Eighty-nine per cent of
the ICUs routinely performed percutaneous tracheostomy. Sixty-
seven per cent of the ICUs used fibreoptic bronchoscopy to
confirm tracheostomy tube position, 7% used FÉCO2 monitoring
alone. Seventeen per cent of the ICUs used both. Nine per cent of
ICUs relied on clinical signs alone to confirm tracheostomy tube
placement. Nearly one-half of the respondents from ICUs without a
FÉCO2 monitor cited lack of resources as one of the reasons for
not routinely using this monitoring parameter.
Conclusions Most tracheal intubations in ICUs are performed by
trainee anaesthetists, and percutaneous tracheostomy is a widely
accepted practice in the UK. Although 75% of units had a FÉCO2
monitor, only a small proportion of intensivists used it to confirm
correct placement of the tracheal tube after intubation and percuta-
neous tracheostomy.
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Background and goals To evaluate the relationship between
absolute humidity of inspired (AHi) and expired gases (AHe) during
mechanical ventilation using a hot water humidifier
(ConchathermIII®).
Materials and methods We measured the absolute humidity (AHi)
and relative humidity (RHi) of inspired and expired gases in
40 sedated and paralyzed patients (mean age 60.7±16.9 years).
The AHi and AHe was measured using a psycrometer (Yoko-S77
gawa®). The airflow was separated by a flow separator placed
between the Y piece of the ventilator circuit and the catheter
mouth. The psycrometer is made of four thermic probes, two of
them measure the dry temperature and two of them, covered with a
cotton gauze (wet with physiological solution 15 min before every
measurement), measure the wet temperature. Dry and wet temper-
atures were measured on the inspiratory and expiratory lines at the
flows separator. We set the active humidifier at 31, 34, 36 and
38°C, and the measurements were made after 30 min for each
temperature.
Results The relationship between AHi and AHe are shown in
Fig.1.
Conclusions 1) AHi is related to AHe (AHi>38.8mg/l, positive
airway fluid balance; AHi<38.8mg/l, negative airway fluid
balance). 2) We suggest an AHi of 38.8mg/l (RHi 100%) with a
temperature of 34°C during mechanical ventilation to maintain ade-
quate airway conditioning.
Available online http://ccforum.com/supplements/7/S2
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P156 Use of the ProSeal Laryngeal Mask to protect the airway from methylene blue dye
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Introduction In the trauma patient tracheal soiling is usually from
the upper airway [1]. Although the ProSeal Laryngeal Mask Airway
(LMA) gives a better seal pressure than the standard LMA [2] and
is designed to prevent inadvertent gastric insufflation, and thus
should reduce aspiration of gastric contents, its ability to protect
the airway from material already in the mouth has not been formally
assessed.
Method After local ethics committee approval, 13 ASA 1 and 2,
starved patients undergoing elective general anaesthesia gave
informed consent. Only patients with grade 1 or 2 direct laryngo-
scopic views were included. At induction of anaesthesia, an appro-
priately sized ProSeal LMA was placed into the larynx and the cuff
inflated. Ten millilitres of 0.1% methylene blue dye was instilled in
the mouth. Full monitoring was used and adequate ventilation
ensured throughout. At the end of surgery, or after a minimum of
10 min, all dye was suctioned away and the oral cavity dried with
swabs. The ProSeal LMA was removed and the airway examined
by direct laryngoscopy for dye staining. Other adverse events were
also noted.
Results  No dye was detected in the trachea of 10/13 (77%)
patients. Two of 13 (15%) of the patients had significant blue
staining of the vocal cords. One patient developed stridor following
dye removal, prior to the ProSeal LMA removal, and the trachea
was intubated for the remainder of the duration of surgery. There
were no problems at extubation, and the trachea was free from
dye.
Conclusions The ProSeal LMA failed to protect 2/13 (15%) of
patients from aspiration of dye from the oral cavity. In the trauma
setting blood and oral debris may therefore not be prevented from
entering the airways. One of these failures may have occurred after
patient movement; however, patient movement would be expected
in the trauma situation.
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Heliox has been reported to reduce work of breathing and to
improve aerosol deposition in patients with acutely obstructed
airways. We wanted to evaluate the effects of an aerosol delivery
system (Aerogen, Inc, Mountain View, CA, USA) with a prototype
heliox delivery system (Datex-Ohmeda, Inc, Madison, WI, USA)
incorporating an electronic demand valve with an active exhalation
valve, and its impact on aerosol deposition and tidal volume (Vt).
Methods Air and heliox (70% He, 30% O2) were administered
through a 60 inch coaxial circuit to an absolute filter and active
servo test lung (IngMar) set to simulate spontaneous tidal ventila-
tion (rate 20, Vt 500ml). To simulate airway obstruction, fixed
orifice resistors producing resistive pressures of 20cmH2O/l pers
(Rp20) and 50cmH2O/l pers (Rp50) were placed between the
distal end of the coaxial circuit and the filter. Three milliliters of
0.083% albuterol (Dey Labs) was aerosolized in an Aeroneb® Pro-
fessional Nebulizer placed in the inspiratory limb of the circuit, at
the outlet of the prototype heliox delivery device, with both gases
and both resistors (n=3 for each test). Drug was eluted from the
filter and assayed to quantify deposition as a percent of the total
dose. The delivered tidal volume was measured at the test lung.
Results Presented in Table 1.S78
Both aerosol deposition and tidal volume were lower with the
greater resistance of the Rp50 than with the Rp20. Compared with
air, heliox increased tidal volume 30% with both resistors, while
deposition increased 30% and 38% (with Rp20 and Rp50,
respectively). We conclude that heliox administration improved
both tidal volume and aerosol deposition in this in vitro model of
airway obstruction.
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Table 1
Rp 20 Rp 50
Deposition (mean ± SD) (%) Tidal volume (ml)  Deposition (mean ± SD) (%) Tidal volume (ml)
Air  36.8 ± 1.9 410 32.2 ± 1.8 330
Heliox 70:30 47.8 ± 2.5* 535 44.3 ± 1.1* 430
* P < 0.05.
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International Organization of Standardization recommends that
inspiratory gas should possess absolute humidity of more than 33
mg/l. In this study we measured the temperature in the endotra-
cheal tube (ETT) with a hypothesis that actual temperature of inspi-
ratory gas is lower than that set by heated humidifier resulting in an
inadequate humidification.
Methods A lung model (TTL, Michigan Instruments) was ventilated
using a PB840 ventilator (Puritan-Bennett) via an 8mm ETT. A
heated humidifier (MR290, Fisher & Paykel) was set in the inspira-
tory limb of a standard ventilator circuit with a target temperature of
37°C. The ventilator settings were: volume control mode, rate
10/min, PEEP 0cmH2O with various tidal volumes (VT). The tem-
perature of inspiratory gas was measured at 22cm, 27cm and
32cm from the distal end of the ETT using a thin wire thermo-
couple thermometer.
Results Mean inspiratory temperatures (°C) are shown in Table 1.
Conclusion The actual mean inspiratory gas temperature was
lower than the target temperature set by the humidifier, especially
with low VT, which may result in an inadequate humidification.
Table 1
VT (ml) 300 ml 400 ml 500 ml 600 ml 700 ml
22 cm 28.9 ± 0.1 29.9 ± 0.1 31.8 ± 0.1 32.6 ± 0.0 32.5 ± 0.0
27 cm 30.6 ± 0.1 31.2 ± 0.1 31.8 ± 0.1 32.3 ± 0.2 32.2 ± 0.1
32 cm 32.5 ± 0.1 33.2 ± 0.2 33.7 ± 0.1 33.7 ± 0.0 34.2 ± 0.1
VT, tidal volume (ml). Values expressed as mean ± standard deviation calculated from three breaths.
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At present, high-frequency jet ventilation (HFJV) is a common and
well-accepted method of ventilation during laser therapy performed
using a rigid bronchoscope [1]. The ability of jet ventilation to main-
tain an adequate oxygenation and to provide an effective CO2 elim-
ination during operative procedures, allowing the bronchoscopist
satisfactory operating conditions, is well known [2]. Oxygenation of
the patient can be monitored in an easy way by means of a pulse
oximetry (measurement of SpO2); carbon dioxide monitoring is
more difficult to evaluate and requires adequate equipment [3].
The aim of this study was to assess the reduction of transcuta-
neous CO2 partial pressure, as an approximation for PaCO2, mea-
sured by a new noninvasive technique at the ear lobe during
progressive changes of the driving pressure (DP).
Methods After informed consent, 20 adult patients, scheduled for
elective interventional rigid bronchoscopy, were enrolled. Patients
undergoing broncoscopy for bronchial cancers involving the
carena, post-intubation or post-tracheostomy malacia, and tracheo-
bronchial stenoses were treated with laser therapy and/or tracheo-
bronchial stent implantation. Total intravenous anaesthesia (TIVA)
was conducted with propofol and fentanyl for induction and main-
tenance, and with rocuronium for muscle relaxation. HFJV was per-
formed with a jet ventilator (Acutronic Medical Systems, Hiezel,
Switzerland) via the rigid bronchoscope. A respiratory frequency of
120 cycles/min, an inspiratory duration of 40% and a fraction of
inspired oxygen of 50% were set. During the procedure, DP was
set at different levels (1.5, 2, 2.5atm), on the basis of clinical evalu-
ations and of intraoperative CO2 monitoring. In addition to theS79
usual monitoring, all patients had a transcutaneous sensor in the
ear lobe for the noninvasive measurement of arterial oxygen satura-
tion and CO2 partial pressure (TOSCA System; Linde Medical
Instruments, Basel, Switzerland). PtCO2 values were documented
at various DP settings.
Results The results obtained (Fig.1) show how the progressive
increase of jet DP may avoid the rise of PtCO2  during bron-
choscopy. In particular, a DP of 2.5atm (P<0.01) seems to be the
best ventilatory setting to assure an adequate PCO2 elimination
(with a CO2 reduction of 8.3% in comparison with a DP of 2atm).
Conclusion In conclusion, our study confirms that HFJV may
assure an effective CO2 elimination during rigid bronchoscopy and
suggests that the TOSCA system allows a reliable estimation of
ventilation efficiency, with increased sensitivity during PCO2
changes and the benefit of avoiding hypercapnia.
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Figure 1
a, basal; b, 1.5 atm; c, 2 atm; d, 2.5 atm. Wilcoxon test,d significantly
different vs b and c (P < 0.01), d vs a not significantly different.
P160 Inhaled nitric oxide in postpneumonectomy pulmonary edema
MT Keegan1, ML De Ruyter2, C Deschamps1, BA Harrison2
1Mayo Clinic, 200 1st Street SW, Rochester MN 55905, USA; 2Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Critical Care 2003, 7(Suppl 2):P160 (DOI 10.1186/cc2049)
Introduction The one published case series detailing the use of
inhaled nitric oxide (INO) in acute respiratory distress syndrome
after lung resection found a 31% increase in oxygenation associ-
ated with a 70% survival [1]. The total cost of INO therapy if using
commercial INO was approximately $500,000. This abstract
details our experience with the use of INO in postpneumonectomy
pulmonary edema (PPPE).
Methods We retrospectively reviewed the charts of all PPPE
patients between 1994 and 2001 who received INO. Outcomes
and physiological endpoints including P/F ratio, pulmonary artery
pressures and PEEP were analyzed.
Results There were nine right-sided and one left-sided pneu-
monectomy patients. There were five deaths, all directly related to
PPPE. There were no complications from the use of INO. The
approximate total commercial cost of the INO was $108,700.
Figure 1 demonstrates the change in mean PaO2/FiO2 ratio, pul-
monary artery pressure, positive end expiratory pressure and INO
concentration.
Discussion The increased PaO2/FiO2 ratio was similar to the pre-
vious report, with minimal change in mean PEEP. Mean pulmonary
artery pressure did not increase during INO therapy. The mean
INO concentration was 10ppm. Although promising with respect
to physiological endpoints, considering the expense of INO and
equivocal outcome, a randomized control trial of the use of INO in
this condition is needed.
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Background and aim Inhaled nitric oxide therapy is an established
method for management of PPHN — introduced in our unit 3 years
ago. We summarized our experience with iNO treatment in search
for predictors of the outcome.S80
Materials and methods Thirty newborns (range of gestational
age, 25–39 weeks; birth weight range, 700–4500g; CRIB range,
1–14; mean, 9pts) admitted to neonatal intensive care unit with
clinical features of PPHN and treated with inhaled nitric oxide were
analysed. The mean time of NO inhalation was 83 hours (range:
4–192 hours). All infants were ventilated with a Babylog 8000
infant ventilator with NO-Domo adapter. Twenty-two survived, eight
died. Arterial blood gases, hemoglobin saturation (pulsoxymetry),
respiratory parameters and echocardiography were obtained at
least every 12 hours up to 24 hours after discontinuation of the
therapy. High pulmonary resistance was defined by tricuspid regur-
gitation jet Vmax >3m/s, pulmonary artery blood flow AT/ET<0.27
and decreased cardiac output CO <200ml/kg per min.
Results The group of survivors did not differ in respect to gestational
age and Apgar scores from fatal cases. However, survivors had sig-
nificantly higher birth weight (3094±940g vs 2075±1018g,
P<0.05) and lower CRIB (8±3 vs 12±2pts, P<0.001).
The newborns in the survival group had significantly higher hemo-
globin saturation (88±8% vs 74±20%, P=0.03) and blood
hydroxycarbonate levels (21.7±3.3 vs 18.7±2.5mmol/l, P=0.03)
and lower serum lactates values before the initiation of therapy
(4.0±3.7 vs 11.5±2.8mmol/l, P<0.001). In ECHO evaluation all
nonsurvivals presented very severe pulmonary hypertension, while
in the other group nine had severe and 13 had moderately elevated
resistance in pulmonary circulation. A marked decrease in mean
airway pressure (MAP) and oxygenation index (OI) accompanied
with an increase in pO2 was observed since the 6th hour of treat-
ment in the group of survivals. The decline of serum lactates was
observed much later (after 24 hours). Such changes were not
observed in nonsurvivors. Twelve hours after discontinuation of the
therapy, transient increases in MAP and decrease in pO2 were
observed.
Conclusions Based on the results we conclude that initial values
of hemoglobin saturation and blood hydroxycarbonate as well as
quick improvement of OI and pO2 and a decrease in MAP are
important predictors of survival PPHN newborns designated for
iNO therapy. Additionally, high serum lactate concentration at the
beginning of iNO therapy, persistent through the following hours,
very strongly indicates a negative outcome.
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Background  In perioperative and critical patients, inhaled nitric
oxide (NO) decreased pulmonary artery pressure and pulmonary
vascular resistance in several diseases [1]. In the presence of pul-
monary vasoconstriction, the higher pulmonary vascular resistance
then the greater the inhaled NO vasodilator effect. Recently it has
been demonstrated that inhaled NO could attenuate the pulmonary
vasoconstriction caused by active mediators in an experimental
model of massive air pulmonary embolism (PE) [2].
Objective The goal of study is to investigate the effects (hemody-
namics and in gas exchange) of inhaled NO in a massive pul-
monary embolism model in dogs.
Materials and methods We performed a prospective study in four
groups of adult mongrel dogs in two phases. Phase 1 (normoventi-
lated with FiO2 0.21): Group A (control), nine dogs; Group B (NO
inhaled), nine dogs. Phase 2 (normoventilated with an hypoxic
mixture [FiO2 0.16]): Group C (control), five dogs; Group D, six
dogs (NO inhaled). Pulmonary embolism was induced by the modi-
fied Fisher’s method [3]. Inhalation of NO was started 15 min prior
to induction of PE and was kept constant throughout the experi-
ment. Mean pulmonary artery pressure (PAPm), central venous
pressure (CVP) and mean systemic arterial blood pressure
(SAPm), cardiac output, arterial and mixed venous blood samples
were obtained in basal conditions, hypoxic period previous
embolism, after started NO inhalation and 5, 15, 30 and 45 min
after embolism induction. Results as expressed as mean±standard
deviation.  Nonparametric test (Mann–Whitney U test and
Wilcoxon test) were used. Statistical significance was set at
P<0.05.
Results In phase 1 no significant differences in all variables mea-
sured at any time were found. There was an improvement in gas
exchange. In phase 2 NO inhalation both improved gas exchange
and reduced PAPm in the hypoxic ventilation prior to PE. After pul-
monary embolism we observed a reduction in PAPm and improve
arterial oxygenation but no statistical differences were found. No
significant intergroup differences were found with regard to CO,
PVC. A trend to lower cardiac output was observed in the group of
inhaled NO.
Conclusions  Our data suggest that in pulmonary embolism
induced by Fisher’s method, inhaled NO did not modify either pul-
monary haemodynamics or oxygenation. We have shown that
inhaled NO improved the hypoxic induced pulmonary hypertension
without effects in systemic arterial pressure.
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Respiratory drive at rest and during exercise has not been fully
investigated in obstructive sleep patients. The aim of this study is
to enlighten the response of respiratory drive to CPAP treatment in
obstructive sleep apnea patients.S81
Methods Fifteen consecutive patients (14 males/one female, aged
53±6 years) with newly diagnosed disease were enrolled in this
study. Diagnosis was made by all-night polysomnography using stan-
dard criteria. Blood gases, body mass index measurement (BMI) and
spirometry were performed in all patients. P0.1 and the mean inspira-
tory flow (VT/TI) were used as indices of respiratory drive. All parame-
ters of the respiratory cycle were measured during the P0.1
procedure (VT, f, VE, TI, TTOT, TI/TTOT). We measured the parameters
at rest and during two stages of submaximal exercise. We evaluated
all the parameters before and 6 months after CPAP treatment.
Results Our patients seem to have moderate to severe disease as
indicated by polysomnographic data (apnea hypopnea index
34–120). There was no significant difference in BMI, FEV1 and
FVC before and after treatment. PO2 was significantly increased
(76±11mmHg vs 82±9mmHg, P<0.01) and PCO2 was signifi-
cantly reduced (45±6mmHg vs 41±2mmHg, P<0.01). At rest
there was no difference in respiratory drive and respiratory cycle
parameters. At the first stage of submaximal exercise P0.1 was sig-
nificantly reduced (6.7±2.7cmH2O vs 5.0±2.2cmH2O, P<0.05)
and VT/TI was reduced (75±29l/min vs 61±12l/min, P<0.05).
At the second stage of submaximal exercise P0.1 was unchanged,
VT/TI was significantly reduced (99±33l/min vs 85±17l/min,
P<0.05) and TI was significantly increased (0.9±0.3min vs
1.3±0.2min, P<0.05).
Conclusion Respiratory drive indices and respiratory cycle para-
meters at rest did not change in our population, although mild
hypoxemia and hypercapnia significantly improved. Changes in res-
piratory drive during submaximal exercise could possibly explain
changes of ventilatory control after CPAP treatment, which may not
be detected at rest.
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To evaluate, in ARDS/ALI patients ventilated with a low tidal
volume and PEEP, according to the NIH network trial [1], the
effects on the parameters of the pressure/volume (PV) curve of the
respiratory system.
Four ARDS/ALI sedated and paralyzed patients (age
62±24 years, weight 66±10kg, PaO2/FiO2 216±70mmHg,
PEEP 12.7±2.2cmH2O) were studied. P/V curves were per-
formed at the beginning and after 120 min with the supersyringe
technique. A recruitment maneuver was performed at the begin-
ning of the study. Chest wall volume was measured by the opto-
electronic plethysmography technique. Lower and upper inflection
points (Pcl, Pcu), maximal compliance (Cmax) and vital capacity
(VC) on the inflation limb were computed according to Venegas’
analysis [2]. Compliance at 100ml (C0.1), inflation compliance
(Cinf), percentage hysteresis (Hyst%) and unrecovered volume
(UV) were calculated using standard formulas [3]. In Table 1, the
results are expressed as mean±SD.
These data suggest that after 2 hour ventilation with a low tidal
volume strategy there are no major modifications in the P/V curve
parameters.
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Table 1
Time 0 Time 120 min
Pcl (cmH2O) 7.4 ± 3.4 4.9 ± 2.2
Pcu (cmH2O) 33.1 ± 5.1 33.2 ± 6.6
Cmax (ml/cmH2O) 46.2 ± 19.3 41.0 ± 16.6
VC (l) 1.1 ± 0.4 1.1 ± 0.4
C0,1 (ml/cmH2O) 14.5 ± 2.9 13.1 ± ±2.7
Cinf (ml/cmH2O) 40.0 ± 14.7 33.9 ± 12.1
Hyst% 15.7 ± 5.3 15.6 ± 4.0
UV (ml) 142.5 ± 43.5 185.0 ± 78.5
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Introduction and purpose Acute lung injury (ALI) resulted from
acid aspiration is an important problem for anaesthesia and inten-
sive care. In our study, we aimed to compare the histopathological
effects of lidocain and methylprednisolone used in the treatment of
ALI developed by acid aspiration.
Materials and methods With the approval of the faculty ethic
board, we formed three groups randomly from 30 rabbits as a
0.9% NaCl control group (Group C, n=10), a lidocain group
(Group L,  n=10), and a methylprednisolone group (Group M,
n=10). The subjects were applied tracheotomy under anaesthesia.
Anaesthesia induction and maintenance, 2% isoflurane, 50%
oxygen, 50% N2O were used. Later all the subjects were given
3ml/kg of 0.1N HCl (pH 2) as drops intratracheally. Following this,
the subjects in group C were administered 2ml/kg per hour contin-
ious 0.9% NaCl infusion and 2ml/kg intravenous bolus, those in
Group L 2ml/kg per hour continuous infusion and 2mg/kg intra-
venous bolus lidocain, and those in Group M 30mg/kg intravenous
bolus single dose methylprednisolone. ALI development was deter-
mined by PaO2/FiO2. After 6 hour mechanical ventilation, the sub-
jects were sacrificed. ALI was scored histopathologically as to
alveolar congestion, hemorrhage, neutrophil infiltration or aggrega-
tion, and alveolar wall thickness–Hyalin membrane occurrence.
Each item was graded as 0=least injury, 1=slight injury, 2=mod-S82
erate injury, 3=severe injury, 4=maximum injury. The groups were
statistically evaluated with Kruskal–Wallis variance analysis.
Results Average total ALI scores of the groups were 8.80±1.54
for group C, 4.06±1.07 for group L and 2.80±1.03 for group M.
ALI was found to be higher in group C than in groups L and M
(P<0.01). Likewise, ALI was higher in group L than in group M
(P<0.01) (Fig.1).
Conclusion We have the conclusion that lidocain and methylpred-
nisolone are the drugs to be used for reducing histophatological
effects of ALI, and methylprednisolone is more effective than lido-
cain. However, we are of the conclusion that our findings should
be supported with clinical studies.
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Figure 1
Comparison of ALI in groups (* P < 0.01).
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The purpose of our research was to evaluate the effects of the per-
fluorocarbon emulsion in patients with ARDS by the results of bio-
chemical testing of expired air condensates.
We have examined expired air condensates (EAC) in patients
with various stages of ARDS using spectrophotometry to study
NO metabolites and fluorescence to study H2O2. Perfluorocar-
bon emulsion, perftoran, was administrated 5ml/kg two to three
times on the day. Our investigation showed the increase of NO
metabolite level in EAC patients with the first and second stages
of ARDS and its significant reduction in EAC patients with the
third and fourth stages. The level of H2O2 in EAC elevated with
the progression of ARDS. In the present study, it was estab-
lished that the NO metabolite level and H2O2 level in the EAC
patients with perfluorocarbon administration was not so
increased as the level in the EAC patients without it. It was more
expressed in the patients with the first and second stages of
ARDS. All these patients had positive disease dynamics. Admin-
istration of perftoran to the patients with the third and fourth
stages was not noted as a clear dynamic of inflammatory marker
level.
We conclude that infusions of oxygen-carrying blood substituted
by the oxidative stress, which takes place in the last ARDS stages,
may increase lung injury due to the increase of the H2O2 level.
Applications of perfluorocarbon emulsion to the ARDS patients are
effective and pathogenic expedient methods in the early stages
(first and second) of ARDS.
P167 Improvement of cardiac output with BiLevel ventilation in patients with high airway pressures
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Hypothesis Studies have shown that airway pressure release ven-
tilation increases cardiac output when compared with synchro-
nized intermittent mandatory ventilation (SIMV). This occurs by
allowing more spontaneous ventilation, which increases venous
return. BiLevel ventilation is a form of augmented pressure ventila-
tion that allows for spontaneous breathing at any moment of the
ventilatory cycle. The purpose of this study is to determine whether
BiLevel increases cardiac output when compared with SIMV.
Method Patients on a ventilator with high peak airway pressures in
an intensive care unit from December 2000 to November 2002
were studied. Patients with respiratory failure were initially managed
with SIMV. If the peak airway pressure persistently remained greater
than 40cmH2O, patients were changed to BiLevel using a Puritan-
Bennett 840 ventilator. Cardiac output measurements were made
while on SIMV and after being converted to BiLevel. Results were
compared using a paired Student t test.
Results Thirty-six patients met criteria for the study. Thirteen
patients developed respiratory failure from sepsis, 11 from trauma,
seven from pneumonia, two from congestive heart failure, one from
variceal bleeding, one with renal cell cancer and one after a lung
lobectomy. Twenty-five patients (69%) increased their cardiac
output after being changed to BiLevel. In 11 patients with a PaO2S83
A–a gradient >500, five (45%) increased their cardiac output.
Overall results are as presented in Table 1. There was no signifi-
cant difference in the systemic vascular resistance and wedge
pressure.
Conclusion: BiLevel can increase cardiac output in most patients
at lower airway pressures when compared with SIMV. It is less
likely to increase cardiac output in patients with severe lung injury.
Further studies are needed to determine whether this improvement
in cardiac output will affect outcome.
Available online http://ccforum.com/supplements/7/S2
Table 1
Stroke volume  Peak airway 
Cardiac output (l/min) (ml/beat) pressure (cmH2O) PaO2/FiO2 PO2 A–a gradient
SIMV 6.8 ± 2.6 63 ± 26 40.2 ± 3.8 160 ± 81 351 ± 166
BiLevel 7.3 ± 2.8 67 ± 28 32.9 ± 4.1 176 ± 93 336 ± 157
P value 0.01 0.05 0.01 NS NS
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Introduction The aim of the study was to evaluate the effects of
PEEP on intrathoracic blood volumes and cardiac function mea-
sured by the COLD system in ARDS patients.
Methods We studied eight sedated and paralyzed ARDS patients
(age 58±13.8 years, PaO2/FiO2 146±84mmHg), ventilated in
CPPV. All patients had a Swan–Ganz catheter and a 4F thermis-
tore-tipped, fiberoptic catheter inserted through a femoral artery,
both connected to the COLD system. All patients randomly
received, for at least 30 min, three levels of PEEP (5, 10 and
15cmH2O). We measured: cardiac (CI) and stroke volume (SVi)
indexes; heart rate (HR), central venous pressure (CVP); wedge
pressure (WP); intrathoracic (ITBVi), global-end diastolic (GEDVi),
right heart end-diastolic (RHEDVi), left heart end-diastolic
(LHEDVi), and pulmonary (PBVi) blood volume, all indexed for body
surface area. PEEP effects were assessed by one-way analysis of
variance for repeated measurements and linear trend analysis. Mul-
tiple regression analysis by a stepwise procedure was used to find
major determinants of stroke volume index (SVI) and cardiac index
(CI) changes induced by PEEP.
Results Increased PEEP levels resulted in a significant reduction
of CI, RHEDVi, PBVi and an increase in CVP. GEDVi, ITBVi,
LHEDVi, HR and WP did not change significantly with PEEP. HR
changes correlated with pH and PaCO2 changes. SVi changes
were explained by changes of RHEDVi and LHEDVi (∆SVi=
0.0365×∆LHEDVi+0.122×∆RHEDVi,  r2=0.823,  P<0.01). CI
changes were positively correlated with GEDVi, ITBVi, RHEDVi,
and PaCO2 changes, and were negatively correlated with pH
changes. CI changes were explainable by changes of RHEDVi
and PaCO2 (∆CI=0.007×∆RHEDVi+0.113×∆PaCO2, r2=0.78,
P<0.001).
Conclusions In ARDS patients, PEEP affected significantly the
RHEDVi and PBVi. RHEDVi and LHEDVi changes accounted for
82% of SVi changes induced by PEEP. Changes in PaCO2 and
RHEDVi were the main determinant of CI changes.
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Post-traumatic acute respiratory distress syndrome (ARDS) is a
stereotyped response caused by a variety of pulmonary and extra-
pulmonary insults following major trauma. Increased intrapulmonary
oxygen consumption (VO2ipulm) was described in different condi-
tions with impairment of lung function, including septic patients
with ARDS [1] and patients with pneumonia [2]. In this study we
measured intrapulmonary oxygen consumption and oxygenation
index (OI=Paw×FiO2×100/PaO2) in order to describe and
compare the time course of these variables on the 1st, 3rd, 7th,
10th and 14th day after the ARDS onset. The study was performed
in our level 1 trauma center ICU. We prospectively measured all
hemodynamic and oxygen transport variables, including VO2ipulm
and OI in 37 adult ventilated trauma patients, who fulfil the ARDS
criteria according to the North American Concensus Conference.
All patient were post-traumatic, ventilated with volume-controlled
mode, and were included in the study if they met the above criteria
at any time during their ICU stay. We excluded those patients with
history of Chronic Obstructive Lung Disease and those ventilated
with FiO2 >0.80. VO2ipulm was estimated by subtracting calcu-
lated VO2 using the reverse Fick method from whole body VO2
using indirect calorimetry (Datex Ohmeda M-COVX metabolic
monitor). All measurements and calculations were performed simul-
taneously during steady-state conditions four times daily and the
mean values were taken. The overall mortality in this setting was
57%. We found substantial increases in VO2ipulm as a component
of whole body VO2 in all patients with post-traumatic ARDSS84
(median 31.3%; interquartile range 27.2–34.1%) and good posi-
tive correlation between VO2ipulm and OI on the 3rd, 7th, 10th
and 14th day, but not on the first day after the onset of ARDS. Our
data suggest that VO2ipulm can be used as an additional pul-
monary injury severity parameter but large observational studies
are needed to link this variable with mortality in post-traumatic
ARDS patients.
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In a randomized trial the effect of a predefined strategy of prone
positioning on the duration of mechanical ventilation was evaluated
in multiple trauma patients with acute lung injury or acute respira-
tory distress syndrome. Patients in the prone group (n=21) were
continuously kept prone for at least 8 hours and a maximum of
24 hours per day. Prone positioning was continued until a
PaO2:FiO2 ratio of more than 300 was present in the prone as well
as the supine position over a period of 48 hours. Patients in the
supine group (n=19) were positioned according to standard care
guidelines. The duration of ventilatory support did not differ signifi-
cantly between the two groups (20±17 days in the prone group
and 33±23 days in the supine group). The mean duration of venti-
latory support in prone position was 11±5 hours a day. A mean of
7±4 posture changes was applied per patient. One patient in the
prone group and three patients in the supine group died due to
multiorgan failure (P=0.33). The PaO2:FiO2 ratio increased signifi-
cantly more in the prone group than in the supine group in the first
4 days (P=0.03). Thereafter no significant difference in the
PaO2:FiO2 ratio was evident between the two groups. The number
of adverse effects was not different between the groups. There-
fore, despite an improvement of gas exchange, no clinical outcome
benefit was detected.
P171 Kinetic therapy in Germany: results of a randomized cross-sectional survey
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Introduction  Prone positioning developed to the most hopeful
therapeutical approach in the treatment of severe respiratory
failure. Different types of kinetic therapy are practiced, but so far no
data are available about the real number of institutions that practice
kinetic therapy in the treatment of respiratory failure and which sort
of therapy is practiced. For the first time we present representative
data of the number of clinics that practice kinetic therapy in
Germany. Eighty-six per cent of all answering clinics practice prone
positioning. The mean time for positioning was 17 min, the mean
duration was 4.8 hours. Mostly a usual ICU bed was used. No
severe unexpected events were reported. The estimation of this
sort of treatment was mostly good (62%) and very good (32%).
Methods In order to evaluate the incidence of kinetic therapy in the
treatment of respiratory failure in Germany we initiated a random-
ized survey, including all 1589 German ICUs. Following a regional
randomization, to achieve a representative distribution of the hospi-
tals we divided into four groups of ICUs: surgical=SICU (52),
anaethesiological=AICU (15), medical=MICU (52) and multidisci-
plinary=MdICU (124). According to statistical analysis we sent a
standardized questionnaire to 201 hospitals, enough to receive
representative results. For statistical analysis the Chi-Quadrat test,
the exact Fischer test, and the Wilcoxon test/Kruskal–Wallis test,
following the NPAR1WAY procedure, were used. We asked what
sort of bed was used, how often and how long prone positioning
was performed, how many nurses were involved and the time it
took for positioning and the duration of prone therapy. Additionally
we asked for the indications and main complications of
prone/kinetic therapy. Finally we asked for the general estimations
of kinetic therapy.
Results Most of the ICUs were MdICU (124), followed by SICU
(52), AICU (15) and MICU (nine). One hundred and seventy-three
(86%) ICUs practice kinetic therapy, only 28 ICUs (14%) did not;
79% (136ICUs) used a normal bed for kinetic therapy, just 6%
(11ICUs) used special beds for prone positioning. Rotorest® beds
(side-to-side) were used by only 2% (three ICUs). In 23%
(15ICUs), special beds like water beds, rotational beds or similar
were used. Usually three persons were needed to turn a patient
into prone positioning, with a mean time of 17 min (SD 9.28),
Prone positioning lasted 4.8 hours (SD 2.82), with a maximum of
10.27 hours. ARDS/ALI (58%) were main indications for kinetic
therapy. In 18% it was used on prophylactic purposes. Main com-
plications were welling (35%), skin lesions (32%) and short-time
hemodynamic instability (13%). The estimation of kinetic therapy
and its value in the treatment of respiratory failure was good (62%)
and very good (32%).
Conclusion For the first time we present representative data of the
number of clinics that practice kinetic therapy in Germany. Eighty-
six percent of all answering clinics practice prone positioning. The
mean time for positioning was 17 min, and the mean duration was
4.8 hours. Mostly a usual ICU bed was used. No severe unex-
pected events were reported.S85
Introduction In acute respiratory failure, classified as acute lung
injury (ALI) or the more severe acute respiratory distress syndrome
(ARDS), prone position ventilation (PPV) can improve oxygenation
by recruiting alveoli situated in dorsal-dependent regions of the
lung and by alteration of the ventilation/perfusion ratio. The aim of
our study is to analyze the prognostic value of the change of oxy-
genation after starting prone position ventilation in ARF.
Methods We studied 110 consecutive patients with an ARF,
n=18 with ALI and n=92 with ARDS, at a mean age of 66±13
(SE) years in a clinical followup design at a surgical ICU in a uni-
versity hospital, who met the criteria of the American European
consensus definition. All patients were ventilated intermittent in the
SP and in the PP (135° left/right-side-position) for at least 6 hours
per day for supportive treatment of ARF. Data collection included,
apart from baseline characteristics, the individual oxygenation
index. We compared the individual oxygenation index (PaO2/FiO2)
before and after the start of prone position with the SPSS®
Mann–Whitney test and the data set of each patient with outcome.
Results PPV was well tolerated in all n=110 patients and showed
a significant increase of PaO2/FiO2 ratio in n=106 within the first
6 hours of PPV (SP 149±0.52 vs PP 230±0.73mmHg
[mean±SEM]). In the remaining four cases there was a positive
effect within the first 24 hours. The surviving patients (n=43) and
the patients who survived 28 days, but died in further course,
showed a median increase of oxygenation index of +50.00 and
+65.67mmHg, respectively, after 24 hours of ventilation in the
prone position. The patients who died within the first 7 days in ICU
showed a median deterioration of –11.46mmHg. Patients who
died after 8–28 days after starting PPV showed a median improve-
ment of +29.92mmHg after the first 24 hours of ventilation in the
prone position.
Conclusion Our results show that in patients with an acute respi-
ratory failure who are ventilated in the prone position the extent of
functional recruitment as a result of the body position change is of
prognostic value. Patients with an improvement of the oxygenation
index of 50mmHg and more within the first 24 hours after starting
prone position ventilation have a better prognosis than patients
with a slight increase or even a deterioration. A less improvement
of oxygenation index seems to increase the risk to die in the course
of acute respiratory failure. Thus, patients with a high risk of
change for the worse can be identified in good time and lead to
more interventional approaches for treatment of acute respiratory
failure.
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Introduction Adaptive support ventilation (ASV) is a microproces-
sor-controlled ventilatory mode allowing automated weaning.
Under controlled ventilation a preset minimum minute ventilation is
guaranteed and, based on a breath-to-breath-analysis, ventilatory
support is withdrawn gradually with recovering spontaneous
breathing. The self-controlled weaning process includes both
reduction of mandatory breaths and reduction of pressure support.
Respiratory rate and tidal volume are calculated using Otis’ formula
for optimal breathing pattern [1].
We asked whether there are differences between weaning proto-
cols based on ASV or on common ventilatory modes after cardiac
surgery regarding clinical and economical aspects.
Methods  After IRB approval and informed consent we studied
2×28 patients for hemodynamic and 2×10 patients for ventilatory
parameters admitted to the ICU after aortocoronary bypass
surgery. They were randomly assigned to the ASV group
(GALILEO®; Hamilton Medical, Rhäzüns, Switzerland) or to the
standard group (EVITA 4®; Dräger Medical, Lübeck, Germany).
ICU staff was not involved in the study except in the instruction to
use ASV in the ASV group until extubation, and no interventions
were planned. The standard group was ventilated in the routine
way using CPPV, SIMV and PS. Switches in the ventilatory mode
(standard group) and ventilator adjustments according to blood
gas analyses (both groups) were carried out by the nursing staff in
consultation with the physician. All patients were sedated with
propofol during the rewarming phase until the rectal temperature
reached 36°C. Extubation was possible at normothermia, hemody-
namic stability, sufficient spontaneous ventilation and without signs
of imminent organ failure or major complications. We documented
ventilatory and hemodynamic parameters every 60 min from admis-
sion to the ICU until transfer to the peripheral ward. For statistical
analyses we built up matched pairs by age, gender and pre-
existing diseases. Patient groups were equal regarding anaesthe-
sia, postoperative sedation, kind and duration of operation and
body temperature.
Results There were no significant differences between both
groups, neither in hemodynamic parameters nor in breathing para-
meters or blood gas analyses. Length of ICU stay was
1.7±2.5 days (standard group) and 1.5±1.4 days (ASV group),
and time until extubation totalled 7.2±3.4h (standard group) and
7.8±4.5h (ASV group). Reintubation was not necessary in both
groups. No patient failed ASV, so there was no need to change the
ventilatory mode in this group. Using the ASV ventilator, adjust-
ments were necessary 0.5 times at median (range 0–3), adapting
the guaranteed minimal ventilation (‘%MinVol’) to blood gas analy-
ses. In the standard group, the ventilatory mode was switched
once at median (range 1–3), plus adaption of respiratory frequencyS86
or pressure support until extubation. The procedures to reduce
FiO2 were equal in both groups and PEEP remained constant.
Conclusion In this study no differences in clinical parameters
could be found between closed loop control and standard weaning
protocol using the fast track concept after cardiac surgery. Consid-
ering economical aspects, adaptive support ventilation was supe-
rior to standard weaning since the nursing staff spent significantly
less workload on ventilatory adjustments.
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Introduction The aim of this study was to compare the effects of
different weaning modes (pressure support ventilation [PSV], con-
tinuous positive airway pressure [CPAP], T-piece) on stress
response in humans.
Methods  The study was performed on 60 patients, which were
mechanically ventilated for 2 days or more and had inclusion
weaning criteria in ICU. After taking the initial blood samples for
cortisol, insulin and glucose values and urine samples for vanilman-
delic acid (VMA) value measurement, patients were randomly
divided into three groups (n=20). In group 1, the patients venti-
lated with PSV, with FiO2 <0.4, level of support <10cmH2O,
PEEP <5cmH2O, parameters for 2 hours. In group 2, the patients
received 5cmH2O CPAP via endotracheal tube for 2 hours. In
group 3, the patients received 4l/min oxygen via T-piece for
2 hours. At the end of the 2 hours and after 48 hours of extubation,
blood and urine samples were taken for aforementioned measure-
ments. Weaning was considered successful if reintubation was not
required within 48 hours of extubation.
Results  Insulin, cortisol and urine VMA values of group 3 were
higher than of groups 1 and 2, after 48 hours of the extubation
(P<0.01, P<0.05, P<0.05, respectively). Blood glucose values
of group 3 were lower than those of groups 2 and 1 after 48 hours
of extubation (P<0.01, P<0.01, respectively).
Conclusion The T-piece device had a higher stress response than
PSV and CPAP modes after weaning off mechanical ventilation.
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The goal of this study was to find out whether daily exercise with
the upper limb trainer (ULT) has an influence on lung volumes and,
by consequence, on the diaphragm. By doing so we hope to
improve the process of weaning from mechanical ventilation in
order to prevent weaning failure.
We tested four adult patients at our university hospital intensive care
unit in Belgium. They were ventilated for at least 1 week and fell
within the scope of the following weaning criteria: PaO2/FiO2>200,
PEEP≤5cmH2O, HF<120bpm and RR≤35breaths/min.
The patients were asked to perform 10 min of cycling with the ULT.
This was done daily, up to the moment that the patients were extu-
bated or until they no longer fell within the scope of the criteria.
One patient was tested 2 days, the others only 1 day.
Respiratory rate, tidal volume and minute volume were measured
before, during and after cycling. Heart rate and blood pressure were
monitored continuously. Before and after the testing, arterial blood
was taken and PaO2, PaCO2, pH and lactate were measured. We
found a decrease in pH, but an increase in PaCO2. This seems to
indicate that this exercise was too demanding for our patients. The
fact that the respiratory rate increased during cycling while the tidal
volume stabilized proved that there was no shallow breathing.
More investigations to confirm these findings have to be per-
formed. Moreover, a parameter immediately indicating the load of
the exercise needs to be found. Our findings suggest that arm
exercise with the ULT could have a positive influence on the
diaphragm and, hence, can be useful for patients who fail to wean.
Acknowledgement This work was performed in association with
the ‘Arteveldehogeschool’, Department of Health Care, Ghent.
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Introduction Weaning from mechanical ventilation in critical care
patients is responsible for alterations in cardiorespiratory function.
However, it is not clear whether different methods of weaning are
associated with different cardiorespiratory responses. The goal
from this study was to compare cardiorespiratory measurements
during pressure support ventilation (PS) and during T-piece.S87
Materials and methods Twenty patients in the weaning process
(57±15 years) were studied in this crossover randomized clinical
trial comparing PS and T-piece. Variables recorded at 0, 15 and
30 min in each method included: mean arterial pressure (MAP),
heart (HR) and respiratory (RR) rates, arterial oxygen saturation
(SaO2), end-tidal CO2 (PetCO2), tidal volume (VT), minute ventila-
tion (VE), total work of breathing (WOB), mean airway pressure
(Pmean), changes in ST segment in the electrocardiogram and pres-
ence of arrhythmias. The t test, ANOVA and χ2 tests were used in
the statistical analysis. The level of significance was P<0.05.
Results The comparison between PS and T-piece showed that: no
significant difference was observed in MAP and HR; values of
SaO2, PetCO2, VT,  VE, total WOB and Pmean were significantly
higher with PS at 0, 15 and 30 min (P<0.05); values of RR were
lower with PS, at least at 0 and 15 min (P<0.05), and they
increased from 0 to 30 min (P<0.05); alterations in ST segment
(nine patients in each method) as well as the occurrence of
arrhythmias (four in each method) and of sinus tachycardia (five in
each method) were similar.
Conclusion Comparing PS with T-piece, no differences were
observed concerning cardiovascular measurements or electrocar-
diographic evaluation, but a better response was observed in the
respiratory pattern and oxygenation.
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Introduction The need for reintubation within 24–72 hours of
planned extubation is an event occurring in 2–25% of extubated
patients [1]. Developing predictive tools and optimizing extubation
decisions require knowledge of the risk factors and clinical fea-
tures of patients with extubation failure (EF).
Methods We studied all patients who were intubated and mechan-
ically ventilated in a polyvalent intensive care unit (ICU) during a
12-month period. The following data were collected: age, sex,
SAPS II on admission, Glasgow Coma Score (GCS) on day of
extubation, length of mechanical ventilation (MV), length of ICU
stay (LOS), ICU and hospital mortality. Patients who need reintuba-
tion after successful trial of weaning and planned extubation were
identified (EF). We considered two parameters that assess airway
patency and protection like predictors of EF: cough strength and
suctioning frequency. Parameters were analysed using Student’s
t test (P<0.05).
Results Six hundred and sixty-five patients were admitted to the
ICU during the study period; 511 of them (76.8%) underwent intu-
bation and MV. Twenty-three patients (4.5%) (17 men and six
women) needed reintubation. EF occurred in seven elective
surgery, seven emergency surgery, eight medical and one trauma
patient. Causes of EF were: inability to manage respiratory secre-
tions (9/23, 39.1%), surgical complications (9/23, 39.1%), severe
alteration in consciousness (3/23, 13.2%), pulmonary embolism
(1/23, 4.3%) and septic shock (1/23, 4.3%). Significant differ-
ences regarding age (72.2±10.8 vs 65±16, P<0.05) and
SAPS II (45±12.7 vs 34±13.1, P<0.05) were found between EF
patients and the others with extubation successful. The value of
GCS was similar (14±2.5 vs 13.8±3.1, NS). EF patients have a
longer period of MV (11±15.8 vs 4±8.9, P<0.05) and LOS
(23±24.3 vs 6.6±11, P<0.05); they even have greater ICU and
hospital mortality (39.1% vs 9.9% and 47.8% vs 16%). Seven EF
patients (30%) needed at least one suctioning every 2 hours after
extubation; moreover almost one-half of the patients (10/23,
43.3%) had a weak cough.
Conclusion Clinical features associated with EF include age, severity
of illness and being a medical patient. EF increases the length of VM
and LOS and is associated with a higher mortality. Most of EF is
unable to protect the airway, a cause of weak cough and abundant
secretions; moreover, during the trial of extubation, it is also important
to consider the ability to cough and to clear respiratory secretions.
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High-frequency oscillatory ventilation (HFOV) has been described
as an effective therapy of RDS in prematurities and neonates.
However, there are only few reports about using this technique in
adults. The main goals of our study were establishing, during adult
ventilation, the optimal parameters for monitoring HFOV, relative
risk of hemodynamic disturbances connected with HFOV, and con-
traindications for HFOV. Until the present time six patients were
enrolled to the study. The indications were: unsuccessful classical
ventilation (CMV+PEEP+Plateau for at least 6 hours), or unsuc-
cessful weaning (routine procedure for at least 7 days). After quali-
fication all patients were ventilated using the SensorMedics 3100B
oscillator. The following parameters were continuously measured:
cardiac output using the Doppler technique (Abbott monitor), heart
rate, blood pressures (systolic, diastolic, mean), EKG, SaO2, and
ETCO2. Every hour CVP, arterial gases and diuresis were mea-
sured. In all patients a rapid increase in PaO2 was observed, which
enabled progressive decrease in FiO2 (20–40%). After several
hours of HFOV the condition of two patients deteriorated and it
was necessary to immediately resume classical ventilation. One of
these patients was morbidly obese (BMI=43.2), whereas the other
had critically low ejection fraction (14.3%) and low cardiac output
(2.7–3.4l/min). The first symptom of disturbances was a decrease
of signal and amplitude of the plethysmographic curve. At that
moment PaCO2 was 34.2 and 47.0mmHg, respectively, andS88
cardiac output was a little higher than initially. Another symptom
was the disappearance of pleth signal. The next symptom was
bradycardia and a sudden decrease of cardiac output (30–50%),
while the stroke volume value remained unchanged. After resuming
classical ventilation (CMV mode) and hemodynamic stabilization, a
temporary increase of PaCO2 was observed (60.1 and
65.3mmHg). We concluded that: 1) The documented scenario of
the deterioration was different from that typically observed during
classical ventilation; 2) The SaO2 and pleth curve monitoring
during HFOV is essential for safety reasons; 3) The first symptom
of deterioration during HFOV may be the decrease of amplitude
and signal of the pleth curve; 4) The disappearance of the pleth
signal is a sign of an imminent deterioration during HFOV; 5) The
arterial gas analysis may not give sufficient information about the
patient’s condition; 6) Significant obesity and left ventricular insuffi-
ciency may be contraindications for HFOV in adults.
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Introduction Intra-abdominal pressure (IAP) is an important para-
meter and prognostic indicator of the patient’s underlying physio-
logic status [1]. Measurement of IAP via the bladder has been
forwarded as the gold standard. The abdomen is considered pri-
marily fluid in character and therefore it follows the law of Pascal. If
this is true IAP should be the same regardless of the body position
since fluid is not compressible. Putting the patient in the upright
position is a common practice in patients with acute respiratory
failure (e.g. lung oedema). This study will look at the effects of dif-
ferent body positions on IAP and dynamic compliance (Cdyn) in
mechanically ventilated patients.
Methods In total, 79 paired IAP and Cdyn measurements were
performed at each body position in 10 mechanically ventilated ICU
patients. The four positions studied were: supine, anti-trendelen-
burg, trendelenburg and the upright position. The IAP was calcu-
lated using the gold standard via an indwelling bladder catheter
with a pressure transducer [1]. The Cdyn was calculated by divid-
ing tidal volume (ml) by plateau pressure minus PEEP (cmH2O).
The male/female ratio was 3/2, BMI 26.3±5.4, age
64.5±15.7 years, APACHE II score 30.3±10.5, SAPS II score
59.5±11.1, MODS score 8.3±3.8, and SOFA score 10.7±3.6.
The number of measurements in each patient was 7.9±4. Statisti-
cal analysis was performed with SPSS 10™ software, and values
are expressed as mean±SD.
Results Table 1 presents the mean values for IAP and Cdyn in the
different positions. The IAP was significantly higher in the anti-
trendelenburg and upright positions versus the supine, and signifi-
cantly lower in the trendelenburg position versus the supine
(P<0.0001, one-way ANOVA). The Cdyn was lowest in the
upright position (P=NS). There was only in the upright position a
poor but slightly significant correlation between IAP and Cdyn
(P=0.047). In five patients with a BMI>25 (mean BMI 30.8±3.2)
the effect on IAP of the upright position versus the supine was sig-
nificantly greater compared with patients with a BMI<25 (mean
BMI 21.8±1.6): 10.1±4.4 versus 6.8±3.3 (P=0.001), but the
effect on Cdyn was the opposite: 6.8±12.3 versus 21.1±35.6
(P=0.02).
Conclusions Putting a patient in different body positions has sig-
nificant effects on IAP. This is in contradiction with the hypothesis
that the abdominal compartment is primarily fluid in character,
since IAP would then remain constant regardless of body position.
Assessment of IAP should therefore always be done in the com-
plete supine position. The upright position significantly increases
IAP, and lowers Cdyn although not significantly. The effects on IAP
are more pronounced in obese patients, and the effects on Cdyn
more in the nonobese. Putting a patient with acute respiratory
failure in the upright position may further deteriorate respiratory
function, caused by the acute increase in IAP.
References
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Table 1
P value 
Supine Anti-trendelenburg Trendelenburg Upright Total (ANOVA)
IAP (mmHg) 8.8 ± 3.9 13.3 ± 4.8 4.3 ± 3.8 17.1 ± 6.1 10.9 0 ± 6.8 < 0.0001
Cdyn (ml/cmH2O) 40.2 ± 18.8 39.7 ± 18 38.6 ± 19.9 36.8 ± 18.6 38.8 ± 18.8 NS
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Purpose To investigate the relationship of pressure in the inferior
vena cava (Pivc) with a) pressure in the superior vena cava (Psvc),
and b) intra-abdominal pressure as measured in the urinary bladder
(Pcyst).
Materials  and results A prospective study of 38 mechanically
ventilated patients. Simultaneous measurements of Psvc, Pivc and
Pcyst (151 sets of measurements) were performed. Measure-
ments were divided in: Group A (Pcyst <10mmHg), group BS89
(10mmHg ≤Pcyst <15mmHg), group C (Pcyst ≥15mmHg). Sta-
tistical analysis was performed with the paired t test, Pearson cor-
relation. Results are expressed as mean±SEM (Table 1).
There was significant correlation of Psvc and Pivc in groups A
and B (group A r=0.93, group B r=0.87). In Group C, Pivc corre-
lated (P<0.01) with both Pcyst (r=0.78) and Psvc (r=0.7).
When Pcyst>Psvc, Pivc was higher than Psvc (P<0.01). Further-
more: a) with Pcyst <15mmHg, no significant difference was
found between Pcyst and Pivc (P= 0.068) and they were corre-
lated (r=0.766, P<0.05). Pressures in the superior and inferior
vena cava were also correlated (r=0.764, P<0.05). b) With Pcyst
≥15mmHg, Pivc was lower than Pcyst (P<0.01). It highly corre-
lated with Pcyst (r=0.85, P<0.01) and less strongly correlated
with Psvc (r=0.701, P<0.01).
When Pcyst≤Psvc, no difference between Pivc and Psvc was
observed. Furthermore: a) with Pcyst <15mmHg, Pivc was higher
than Pcyst (P<0.01) and highly correlated with Psvc (r=0.932,
P<0.01). Pivc also correlated with Pcyst (r=0.69, P<0.01). b)
With Pcyst ≥15mmHg, Pivc was higher than Pcyst (P<0.01) and
correlated with Psvc (r=0.74,  P<0.01) and Pcyst (r=0.789,
P<0.01).
Conclusions Although Psvc and Pivc are interchangeable in the
absence of an increased Pcyst, when Pcyst is high measurements
of Pivc are misleading. A Pcyst >Psvc results to a ‘waterfall’ effect,
and Pivc does not accurately reflect Psvc any more.
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Table 1
Psvc (mmHg) Pivc (mmHg) Pcyst (mmHg)
Group A (n = 62) 10.8 ± 0.5 10.93 ± 0.49 6.35 ± 0.26*
Group B (n = 45) 14.44 ± 0.71 14.67 ± 0.58 11.44 ± 0.22*
Group C (n = 43) 16.39 ± 0.72* 18.88 ± 0.69 19.18 ± 0.63
* Difference from Pivc statistically significant (t test, P < 0.05).
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We set out to investigate whether continuous negative abdominal
pressure (CNAP) might be used to decrease abdominal pressure.
We investigated the effects of CNAP on both intra-abdominal
pressure (IAP) and central venous pressure (CVP) on 30 consecu-
tive patients admitted to our ICU (age 62±14 years, BMI 26.3±4,
SAPS II 40.4±18). Patients with severe hemodynamic instability
and/or with recent laparotomy were not studied. Measurements
included bladder pressure as an index of IAP, CVP, invasive mean
arterial pressure (APm) and heart rate (HR). Following baseline
measurements (Basal), CNAP (Life Care – Nev 100, Respironics)
was applied on the abdomen at three levels: CNAP=, CNAP–5
and CNAP–10, corresponding to negative pressure equal to base-
line IAP, 5 or 10cmH2O lower than CNAP=, respectively. Results
are as presented in Table 1.
CVP was correlated with IAP (R2=0.790,  P<0.001, multiple
linear regression).
Given these results, we conclude that CNAP decreases IAP and
CVP; the higher the negative pressure applied, the greater the
changes. CVP decreases possibly because of a blood shift from
the intrathoracic compartment.
Table 1
Basal CNAP = CNAP –5 CNAP –10 RM ANOVA
IAP (cmH2O) 11.9 ± 5.8 8.2 ± 5.7* 5.9 ± 4.3*† 5.2 ± 4.9*† < 0.001
CVP (mmHg) 9.2 ± 3.4 8.4 ± 3.4* 7.5 ± 3.5*† 7.5 ± 3.8*† < 0.001
APm (mmHg) 88 ± 13 86 ± 14 86 ± 14 87 ± 15 NS
HR (bpm) 87 ± 16 89 ± 18 88 ± 17 91 ± 19* 0.03
* P < 0.05 vs basal, † P < 0.05 vs CNAP =. Multiple comparisons (Student–Newman–Keuls).
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We set out to investigate whether continuous negative abdominal
pressure (CNAP) may produce blood shift from the intrathoracic
compartment, and whether this effect would be influenced by
abdominal pressure. We investigated eight sedated, paralysed and
mechanically ventilated pigs (19.4±4kg). Blood shift was assessed
by measuring intrathoracic blood volume (ITBV; PiCCO Pulsion),
and central venous pressure (CVP). Measurements were taken
before (Pre), a few seconds and 15 min after CNAP (–20cmH2O;
Life Care – Nev 100, Respironics) was applied on the abdomen
(CNAP 1 and CNAP 2, respectively), and after CNAP was relieved
(Post). The sequence of measurements was taken with and without
abdominal hypertension. This was induced by means of helium (He)
insufflation targeted to a value of 25mmHg (24.7±5.5 direct peri-
toneal measurement), corresponding to a bladder pressure ofS90
29±4cmH2O. Basal and He measurements were randomised with
respect to time. Results are shown in Table 1.
CVP was correlated with ITBVI (R2=0.818,  P<0.001, multiple
linear regression).
We conclude that CNAP induces a blood shift from the intratho-
racic compartment. Blood shift is greater without abdominal hyper-
tension.
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Table 1
Pre CNAP 1 CNAP 2 Post RM ANOVA
ITBV Basal 293.2 ± 41.6 256.6 ± 43.6* 254.0 ± 37.9* 291.4 ± 31.1 < 0.001
He 333.5 ± 44.9  331.3 ± 47.3 318.9 ± 33.9 337.1 ± 44.5
CVP Basal 6.36 ± 1.63 4.02 ± 1.75* 4.61 ± 1.71*† 7.03 ± 1.64 < 0.001
He 6.67 ± 2.11‡ 6.84 ± 2.06 6.81 ± 2.09 6.77 ± 2.13
* P < 0.05 vs Pre, † P < 0.05 vs CNAP 1, ‡ P < 0.05 vs basal. Multiple comparisons (Student–Newman–Keuls).
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Introduction Intra-abdominal pressure (IAP) is an important para-
meter and prognostic indicator of the patient’s underlying physio-
logic status [1]. Correct IAP measurement therefore is crucial.
Most of the direct and indirect techniques are not free of risks and
require some time and skills. This study will look at the possibility of
using the abdominal perimeter (AP) as a quick estimation for IAP.
Methods In total, 132 paired measurements were performed in
12 ICU patients. The IAP was calculated using the gold standard
via an indwelling bladder catheter using a pressure transducer [1].
The AP was calculated by measuring the abdominal circumference
at its largest point using body marks as reference for consecutive
measurements. The male/female ratio was 7/5, age
68.5±17.2 years, APACHE II score 27.8±6.5, SAPS II score
58.9±12.5. The number of measurements in each patient was
11±4.2. Calculation of correlation was done with the Prism
GraphPad™ software (version 2.00, 31 October 1995), values are
mean±SD.
Results  The values for IAP (mmHg) were 13.2±12.6 versus
106.7±15.2 for AP. There was a poor but slightly significant cor-
relation between IAP and AP (Fig.1): AP=1.0357×IAP+94.107
(R2=0.12, P=0.042), but the bias was considerable. The correla-
tion was better between ∆IAP (the difference between two con-
secutive IAP measurements) and ∆AP (the difference between two
consecutive AP measurements) in 119 paired measurements
(Fig.2): ∆AP=0.4598×∆IAP+0.158 (R2=0.22, P<0.0001, two-
tailed Pearson correlation). The analysis according to Bland and
Altman showed that ∆IAP was almost identical to ∆AP with a mean
difference or bias of 0.05±3.54(SD)mmHg (95% CI –0.6 to 0.7);
the limits of agreement (LA) were –7.04 to 7.13mmHg (95% CI
–8.16 to –5.92 for the LLA and 6.01 to 8.25 for the ULA), these
intervals are large and thus reflect poor agreement.
Conclusions In view of the poor correlation between IAP and AP,
the latter cannot be used as a clinical estimate for IAP. The evolu-
tion of AP (∆AP) can be used as an indicator for the evolution of
IAP over time (∆IAP); however, for making a definite diagnosis of
IAH or ACS, the exact value of IAP needs to be measured.
Reference
1. Malbrain MLNG: Intra-abdominal pressure in the intensive
care unit: clinical tool or toy? In Yearbook of Intensive Care and
Emergency Medicine. Edited by Vincent JL. Berlin: Springer-
Verlag; 2001:547-585.
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Introduction Intra-abdominal pressure (IAP) is an important para-
meter and prognostic indicator of the patient’s underlying physio-
logic status [1]. Correct IAP measurement therefore is crucial.
Because measurement of IAP by an indwelling catheter in the
urinary bladder is simple, minimally invasive, and reproducible, it
has been forwarded as the gold standard. It was thought that the
highly compliant wall of the bladder acts as a passive diaphragm,
and intrinsic bladder pressure did not rise when its volume is
between 50 and 100ml. However, considerable variability in the
measurement technique has been noted, not only interindividual
and intraindividual but also intercentre and intracentre. Variations in
IAP from –6 to +30mmHg have been noted. The measurement
technique itself is also not uniform, some authors recommend
injecting 50 ml saline, others up to 200ml. The aim of the present
study is to determine the optimal bladder volume for correct IAP
transmission but without the risk of ‘over inflation’ of the bladder
and raising intrinsic intrabladder pressure (IBP).
Methods In six sedated and mechanically ventilated patients sterile
saline was injected via a Foley catheter with 25ml increments up to
300ml. In total 13 ‘insufflation’ and ‘deflation’ pressure–volume
(PV) curves were constructed in these patients. The male/female
ratio was 5/1, age 63.8±14, MODScore 8.6±4, SOFA score
10±4.5, APACHE II score 31±11.4, SAPS II score 59.2±13.2.
The number of measurements in each patient was 2.3±0.5. Con-
struction of PV curves was done with the SPSS 10™ software,
values are mean±SD.
Results The values for IBP with regard to bladder volume are sum-
marized in Table 1. Figure 1 plots the ‘insufflation’ and ‘deflation’
PV curve as a curve fit of the means of the 13 measurements. A
lower inflection point (LIP) can be seen at a bladder volume of
100ml and an upper inflection point (UIP) at a bladder volume of
250ml. The difference in bladder pressure was 2.7±3.3mmHg
between 0 and 50ml volume, 1.7±1.2mmHg between 50 and
100ml, 7.7±5.7mmHg between 50 and 200ml, and
16.8±13.4mmHg between 50 and 300ml.
Conclusions  If IBP is used as an estimate for IAP the volume
instilled in the bladder should be between 50 and 100ml;
however, in some patients with a low bladder compliance, intrinsic
bladder pressure can be raised at low bladder volumes. Ideally a
bladder PV curve should be constructed for each individual patient
before using IBP as an estimation for IAP.
Reference
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Verlag; 2001:547-585.
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Table 1
Bladder volume (ml) 0 50 100 150 200 250 300
IBP (mmHg) 4.2 ± 3.2 6.9 ± 5 8.7 ± 5.2 11.8 ± 6.8 14.6 ± 8.9 18.2 ± 12.3 23.7 ± 16.1
Figure 1
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Objectives Noninvasive bioelectrical impedance analysis (BIA)
measures resistance, reactance and the derived phase angle (phi,
degrees). A low phase angle has been associated with an altered
cellular membrane function [1]. In septic shock patients, a phase
angle of less than 4° has been reported to be associated with
increased mortality [2]. Furthermore a low phase angle was highly
correlated with mortality in patients with AIDS [3] and burns [4]. In
our study we examined the prognostic value of the phase angle
using BIA in patients with systemic inflammatory response syn-
drome (SIRS).
Design Prospective clinical observational study.S92
Measurements Thirty consecutive patients (11 female, 19 male,
median age of 67 [16.5] years) were included after admission to
the intensive care unit, all of whom met two or more SIRS criteria.
SIRS was defined using the criteria suggested by ACCP/SCCM
guidelines. Severity of illness was characterised according to the
Acute Physiology and Chronic Health Evaluation (APACHE) II.
Noninvasive impedance analysis was performed using a tetra polar
hand-to-foot BIA measuring device (BIA 2000, Data input) as resis-
tance (Ohms) and reactance (Ohms). The derived phase angle
was calculated as arc tan(reactance/resistance). Two diagnostic
electrodes were attached to the hand and two diagnostic elec-
trodes were attached to the ipsilateral foot. All measurements were
performed in supine position of the patient with special care taken
that arms and legs did not touch the rest of the body or any
grounding object. The joints were semiflexed. Data are presented
as median and interquartile range (IQR). Fisher’s exact test was
performed to compare a phase angle of more than 4° at inclusion
day with the 28 day mortality and APACHE II scores between sur-
vivors and nonsurvivors. P<0.05 was considered significant.
Results After 28 days, out of the 30 patients investigated 10 had
died and 20 were survivors. The APACHE II score on inclusion day
of the survivors was 11 (7.0) compared with 16 (6.8) in nonsur-
vivors (P=0.87). In seven out of the 20 survivors a phase angle of
more than 4° was measured on the first study day, whereas in all
patients who died the phase angle was smaller than 4° (P=0.038).
Conclusion These results demonstrate that, in patients developing
SIRS, an initial phase angle of more than 4° may be significantly
correlated with survival.
References
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Introduction Estimation of extravascular lung water (EVLW) by the
single indicator dilution technique (SDT) implemented in the
PICCO monitoring system relies on a relationship between
intrathoracic blood volume (ITBV) and global end diastolic volume
(GEDV), which has been derived from a large population of mixed
critically ill patients using the double indicator dilution technique
(thermal and indocyanine green dyes, DDT): ITBVsdt=
1.25×GEDV [1]. Since the difference between ITBV and GEDV
corresponds to pulmonary blood volume (PBV), we can write:
PBVsdt=0.25×GEDV. Any factor influencing this relationship can
affect SDT accuracy. The aims of our study were: 1) to compare
SDT versus DDT for EVLW measurements in ARDS patients; and
2) to explore factors influencing the PBV and GEDV relationship,
and affecting SDT accuracy.
Methods We studied 21 ARDS patients (PaO2/FiO2=165±65),
monitored with a Swan–Ganz catheter, and a 4F thermistore-
tipped, fiberoptic catheter inserted through a femoral artery, both
connected to a COLD monitoring system. SDT measurements
were obtained by mean transit time and down slope time of thermal
indicator using standard formula. Statistical analysis was per-
formed by single and multiple linear regression analysis; accuracy
was assessed according to Bland and Altman method.
Results Agreement between EVLWddt and EVLWsdt showed a
bias of 15.3±135.8, and a 95% confidence interval of –256 and
287; the correlation coefficient was r=0.92 (P<0.001). Correla-
tions of GEDV and PBVsdt with PBVddt, although significant, were
poor (r=0.394,  P<0.01). EVLWddt indexed to body weight
(EVLWi) and cardiac index (CI) explained 64% of PBV indexed to
body surface area (PBVi) variance (P<0.001). EVLWi, CI, central
venous pressure (CVP), and PaCO2 explained 82% of PBVi to
GEDVi ratio variance (P<0.001). EVLWddt to EVLWsdt differences
were highly correlated with PBVddt (r=0.88, P<0.001). EVLWi, CI
and PaCO2 explained 65% of the differences between EVLWddt
and EVLWsdt variance (EVLWddt – EVLWsdt=–263 + 18.64×
EVLWi – 50.9×CI + 5.3×PaCO2, r2=0.65, P<0.001).
Conclusions The SDT gives acceptable estimates of EVLW in
ARDS patients. EVLWi, CI and PaCO2 may influence the relation-
ship between PBV and GEDV, and may affect accuracy of EVLW
measured by SDT.
Reference
1. Sakka SG, et al.: Assessment of cardiac preload and extravas-
cular lung water by single transpulmonary thermodilution.
Intensive Care Med 2000, 26:180-187.
P187 Is there a role of extravascular lung water (EVLW) in the development of atelectasis in ARDS?
T Szakmány, Z Molnár, P Heigl
Department of Intensive Care, University of Pécs, Ifjuság 13, 7643 Pécs, Hungary
Critical Care 2003, 7(Suppl 2):P187 (DOI 10.1186/cc2076)
Objectives To evaluate the relationship between PaO2/FiO2 ratio
and EVLW in septic shock induced ARDS in a prospective obser-
vational clinical trial.
Materials and methods Twenty-three patients suffering from
sepsis-induced ARDS were recruited. All patients were ventilated
in pressure control/support mode. Haemodynamic parameters
were determined by arterial thermodilution (PiCCO) 8 hourly for
72 hours. At the same time blood gas analyses were done and res-
piratory parameters were also recorded. Data are presented as
mean±SD. For statistical analysis, Pearson’s correlation test, and
analysis of variance (ANOVA) was used, respectively.
Results Significant negative correlation was found between EVLW
and PaO2/FiO2 (r=–0.355,  P<0.001), and significant positive
correlation was shown between EVLW and PEEP (r=0.557,S93
P<0.001). A post-hoc analysis was also performed when ‘low’
PEEP (<10cmH2O) and ’high’ PEEP (≥10cmH2O) were applied
(Table 1).
Discussion Several animal trials reported contradicting results on
the effect of PEEP on EVLW [1]. We found significant correlation
between EVLW and PaO2/FiO2 and PEEP. Furthermore, patients
with increase EVLW required higher PEEP, while none of the other
parameters differed significantly when ‘high’ or ‘low’ PEEP were
applied. Based on the current results we assume that it is the
EVLW that indirectly determines the required PEEP by playing a
part in the development of alveolar atelectasis. Further studies are
required to evaluate the clinical significance of this finding, for
example in the fine-tuning of PEEP in ARDS.
Reference
1. Ruiz-Bailen M, Fernandez-Mondejar E, Hurtado-Ruiz B, et al.: Crit
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Table 1
‘Low’ PEEP  ‘High’ PEEP 
(n = 49) (n = 140) P
PaO2/FiO2 (mmHg) 175 ± 56 170 ± 73 0.730
PaCO2 (mmHg) 44 ± 8 46 ± 11 0.155
∆P(PIP – PEEP) (cmH2O) 20 ± 4 20 ± 6 0.960
EVLWI (ml/kg) 9 ± 2 13 ± 5 0.001
P188 Intrathoracic blood volume is not a sensitive indicator for hypervolaemia in healthy, mechanically ventilated pigs
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Objectives Intrathoracic blood volume (ITBV) measured by the
transpulmonary technique has been suggested as an alternative
parameter predicting cardiac preload in critically ill patients [1]. So
far, it has never been shown that by measuring ITBV it is possible
to detect hypervolaemia.
Design Prospective animal laboratory study.
Setting University animal laboratory.
Measurements Healthy, anaesthetized, and mechanically venti-
lated pigs (n=4) with a median weight of 24.5kg (23.3–26.5kg)
were investigated. A pulmonary artery catheter (831HF75, 7.5F
Edwards Lifesciences Ltd) inserted via the right jugular vein and an
arterial catheter for transpulmonary thermodilution (4F PV
2014L16, Pulsion Medical Systems) was inserted into the right
carotid artery. Measurements of haemodynamic parameters
included heart rate (HR), mean arterial pressure (MAP), cardiac
output (CO), pulmonary arterial occlusion pressure (PAOP),
central venous pressure (CVP), extravascular lung water (EVLW)
and ITBV. After baseline measurement, hypervolaemia was
induced by stepwise (10% per step) cumulative administration of
50% of the estimated blood volume of the animals (80ml/kg) using
6% hydroxyethylstarch 200/0.5. The interval between each of the
five steps was 10 min. Haemodynamic parameters, EVLW and
ITBV before and after hypervolaemia were compared by Fried-
man’s test. Data are presented as the median and interquartile
range. P<0.05 was considered significant.
Results After establishment of hypervolaemia the following
parameters increased significantly: HR from 85 beats/min
(68–103) to 130 beats/min (124–134), MAP from 98mmHg
(96–101) to 116mmHg (107–128), CO from 120ml/min per kg
(100–138) to 190ml/min per kg (156–233), EVLW from 3.9ml/kg
(3.5–8.5) to 19.0ml/kg (14.8–24.2), CVP from 9mmHg (8–9) to
27mmHg (25–30), and PAOP from 10mmHg (10–11) to
27mmHg (25–27), whereas ITBV did not change significantly from
21.9ml/kg (19.0–24.7) to 23.1ml/kg (20.8–26.3).
Conclusion Intrathoracic blood volume is not a sensitive indicator
for hypervolaemia in healthy, mechanically ventilated pigs in the
presence of severely increased EVLW.
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1. Sakka SG, Bredle DL, Reinhart K, et al.: J Crit Care 1999, 14:78-
83.
P189 Ultrasound diagnosis of an acute dyspnea
D Lichtenstein, G Mezière
Hôpital Ambroise Paré, Department of Intensive Care, F-92100 Boulogne (Paris), France
Critical Care 2003, 7(Suppl 2):P189 (DOI 10.1186/cc2078)
Introduction Acute dyspnea is a typical emergency situation. The
usual tools (physical examination, radiography) can sometimes be
insufficient. Although 1) ultrasound is rarely performed in emer-
gency by the physician, and 2) lung is considered out of reach of
the ultrasound field, we have studied its potential to provide an
adequate diagnosis, at the bedside.
Patients This prospective study initially included 74 consecutive
patients seen for acute dyspnea and referred to the intensivist by a
senior (ER, prehospital setting). Fourteen patients where no defi-
nite diagnosis was made were subsequently excluded. Sixty
patients were thus enrolled (27 women and 33 men, mean age
73 years, range 22–91 years). The patients had cardiogenic pul-
monary edema (n=16), acute pneumonia (n=16), exacerbation of
chronic obstructive pulmonary disease (n=11), severe asthma
(n=7), pulmonary embolism (n=6), pneumothorax (n=2) and sub-
stantial pleural effusion (n=2).
Methods  The ‘initial diagnosis’ was the diagnosis made by the
senior using clinical examination and basic tools like bedside radi-
ograph, before admission of the patient to the ICU. The ‘ultrasound
diagnosis’ was a diagnosis made after studying six items and
establishing an ‘ultrasound profile’. Lung sliding, comet-tail arte-
facts of the type ‘lung rockets’ (i.e. interstitial syndrome), alveolarS94
consolidation, pleural effusion (with quantitative approach), left
ventricle and venous status were included. ‘Initial diagnosis’ and
‘ultrasound diagnosis’ were compared together. The gold standard
was the diagnosis concluding the hospitalisation report. The
patients were analysed with a small ultrasound unit Hitachi-405
equipped with a 5MHz probe without Doppler, by an intensivist
trained to emergency general ultrasound. The whole examination
took less than 5 min. This study did not consider the ability of
decreasing delay for adequate treatment.
Results Ultrasound was possible in all patients (i.e. a feasibility of
100%). All in all, the initial diagnosis was correct in 31 cases (i.e.
51% of cases). The ultrasound diagnosis was correct (allowing
appropriate management) in 51 cases (i.e. 85% of cases).
The number of cases in which ultrasound gave the correct diagno-
sis in a patient with a wrong initial diagnosis was 24. The number
of cases in which ultrasound led to a wrong diagnosis in patients
whose initial diagnosis was correct was four. In 32 cases, ultra-
sound was not contributive (27 cases whose initial diagnosis was
correct, and five cases in whom both initial diagnosis and ultra-
sound diagnosis were in failure).
Conclusions Taking into account ultrasound items using simple
methods provided an accurate diagnosis of acute dyspnea in 85%
of cases, versus 51% with the traditional methods. The ultrasound
approach checked lungs, heart and veins like a stethoscope. Obvi-
ously, the physician’s accuracy will be enhanced by integrating
clinical and paraclinical data. In conclusion, this method should
contribute to quicker diagnosis, resulting in decreased costs, and
above all quicker relief of dyspneic patients.
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Introduction Unavailability of online continuous data, invasiveness,
and expensiveness are the major drawbacks of the most commonly
employed techniques to measure cardiac output. Cardiac output
(CO) is often monitored after cardiac operations with a pulmonary
artery catheter. A new method has been introduced that measures
cardiac output by arterial pressure (pressure recording analytical
method [PRAM]) without calibration by thermodilution (ThD). This
study assessed the reliability of cardiac output determinations by
PRAM before, during and after cardiac surgery.
Materials and methods In 12 patients undergoing aortocoronary
bypass surgery, between September and November 2002 at the
Department of Cardiothoracic Surgery of the University of Siena,
CO was measured after induction of anesthesia, after closure of
the sternum, and upon returning to the ICU (30 min and 3 hours)
by thermodilution and PRAM. PRAM is a new method based on
the objective mathematical analysis of changes of arterial pressure
profile with time. PRAM allows real time beat-by-beat CO assess-
ment from the pressure signals recorded in radial artery without
calibration by ThD. Cardiac output (l/min) was measured continu-
ously throughout the duration of the study.
Statistical analysis CO values obtained at the same time of the
ThD dilution curve (240 paired data) were used for the comparison
by linear correlation and Bland–Altman analyses. ThD, the estab-
lished clinical method to measure CO, was taken as the indepen-
dent variable.
Results The correlation between PRAM and ThD CO values was
0.83 (R2=0.69; P<0.01) with a bias of 0.05 (95% CI –0.71 to
0.81). The correlation at 3 hours from arrival at ICU (the moment of
steady-state clinical condition) showed a better agreement
(R2=0.82; P<0.001) with a bias of 0.02 (95% CI –0.78 to 0.86).
Conclusions In this small series of cardiac surgery patients, PRAM
reflects ThD values and permits one to monitor continuously CO
with reduced invasiveness and at a much lower cost with respect
to ThD. In conclusion, PRAM provides reliable estimates of cardiac
output in hemodynamically stable and unstable cardiac patients.
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191 Early detection of cardiovascular instability by monitoring oxygen uptake and carbon dioxide production
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The oxygen uptake and carbon dioxide production were measured
in 21 patients in sepsis during conventional hemodynamic resusci-
tation. We assumed that in the state of low oxygen delivery, carbon
dioxide is increasingly eliminated from the body. We hypothesized
that this condition can be recognized from the VCO2/VO2
relationship.
VO2 and VCO2 were measured by analysis of expired gas by meta-
bolic monitor; hemodynamics was monitored by pulmonary artery
catheter. Cardiac output was determined by thermodilution, oxygen
transport variables were gauged according to standard formulas
using samples from peripheral arterial and mixed venous blood
from pulmonary artery.S95
The patients were monitored for 6 hours. Lower values of VO2
were followed with higher values of VCO2. There was a high coeffi-
cient of negative correlation between cardiac index and respiratory
quotient (r=–0.85;  P=0.002). The similar correlation, as
expected, was found between oxygen delivery and respiratory quo-
tient (r=–0.75; P=0.01). The positive correlation was detected
between respiratory quotient and venous–arterial CO2 difference
(v–aDCO2) (r=0.79; P=0.016).
Our preliminary conclusion was that cardiovascular instability in
patients with sepsis can be recognized from variations in VO2 and
respiratory quotient.
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Introduction The aim of the study was to compare ITBVI and
EVLWI measured by the double indicator (ITBVITD, EVLWITD) [1]
with those estimated by the single indicator technique (ITBVIST,
EVLWIST) [2].
Methods Thirty-five patients (24 male, 11 female), mean age 49
(10) years, body surface area 1.8 (0.2)m2, undergoing liver trans-
plantation (Ltx) were studied. Each patient received a pulmonary
artery catheter placed via the right internal jugular vein and a 4Fr
thermistor-tipped fiberoptic catheter for thermal dye dilution
inserted into the descending aorta connected to the COLD-Z021
(Pulsion Medical System, Munich, Germany). For the double indi-
cator method, a bolus injection was made with cooled (0–4°C)
indocyanine green dissolved in glucose 5% in a concentration of
2mg/ml, and for the single indicator technique 15ml cooled
normal saline was used. Bland and Altman analysis was used for
statistical evaluation.
Results  The mean bias between ITBVITD and ITBVIST was
8.6ml/m2 with a standard deviation of 61.8ml/m2, and the mean
bias between EVLWITD and EVLWIST was –0.2ml/kg with a stan-
dard deviation of 2.2ml/kg.
Conclusions The single transpulmonary thermodilution technique
is as accurate as the double indicator method for ITBVI and EVLWI
estimation.
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Objective The recognition of hemodynamic disturbances during an
apparently uneventful surgery is important. Therefore, we applied
esophageal Doppler monitoring (EDM) to examine cardiovascular
events caused by insufflation during laparoscopy.
Methods Twenty-three patients undergoing laparoscopic chole-
cystectomy were studied. EDM readings were taken, starting
10 min after induction of anesthesia, every 3 min throughout pneu-
moperitoneum, and 10 min after exsufflation.
Results During pneumoperitoneum, the cardiac output was signifi-
cantly lower and the systemic vascular resistance significantly
higher than either before or after insufflation. The semi-continuous
EDM revealed that, despite the sharp decrease in cardiac output
upon insufflation, during pneumoperitoneum it recovered gradually
in many patients. The increase ranged from 4% to 84%. In about
two-thirds of the patients the final values of cardiac output during
pneumoperitoneum were within ±10% of the post-exsufflation
values. In three patients (13%), however, there was a substantialS96
decline of cardiac output during pneumoperitoneum. Obese indi-
viduals exhibited a larger proportional recovery of the cardiac
output during pneumoperitoneum (P=0.009). No gender or age
dependence was noted, and the duration of surgery or ASA grade
was not correlated with the recovery, nor was the absolute drop in
cardiac output upon insufflation.
Conclusions The findings suggest that, after the initial decreases
of venous and portal return, a compensating mechanism, responsi-
ble for the subsequent relief of cardiac output depression,
becomes effective. The findings demonstrate the utility of EDM for
continuous monitoring during laparoscopy, especially in high-risk
patients.
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Background We have recently shown that the renal excretion of
urodilatin (UUROV) can be modified by renal perfusion pressure
in vitro [1]. It is not clear whether an interaction between arterial
blood pressure and UUROV may also be observed in vivo.
Methods Anesthetized male Sprague–Dawley rats were studied
for 180 min. Measurements were performed every 30 min. We
determined mean arterial pressure (MAP), urine flow (UV),
glomerular filtration rate (GFR), the renal excretion of sodium
(UNaV), and of urodilatin (UUROV; determined by RIA). Rats were
randomly assigned to a control group (CON: n=10) and a
hypotension group (HYP: n=10). After 60 min stabilization (base-
line [BL]), in the HYP group, blood pressure was decreased
30mmHg below individual BL levels for 60 min by a continuous
infusion of sodium nitroprusside (intervention [IV]). Thereafter, rats
were allowed to recover for another 60 min (recovery [RC]). Data
were averaged for the respective study periods; renal function
parameters and UUROV are given as relative values in comparison
with the BL period.
Results In the HYP group, the decrease in MAP during the IV
period was accompanied by decreased UV (CON: 216.8±36.9%;
HYP: 89.3±11.1%; P=0.04). UNaV (CON: 267.2±74.9%; HYP:
70.9±12.6%;  P=0.018), and UUROV (CON: 178.4±40.5%;
HYP: 70.9±12.6%; P=0.01). GFR during the IV period was not
different between both groups.
Conclusions These data further support a role of arterial blood
pressure in the regulation of the renal excretion of urodilatin.
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A new monitor, the Dermal Blood Flow (DBF) meter, which non-
invasively (skin probe) assesses capillary flow, has recently been
developed and used in a variety of medical settings, including the
assessment of wound perfusion during surgery and peripheral per-
fusion in patients with vascular conditions. We tested the monitor
in the ICU setting, where early and objective evidence of altered
skin perfusion may provide important information regarding
impending impairment of organ function, and compared it with the
mean arterial blood pressure (MAP).
Methods Ten critically ill patients were included in the study, which
involved the continuous recording of minute-by-minute measure-
ment of DBF and MAP (Datex- Ohmeda). The effect of specific
interventions on both the measures, such as the giving of fluid
boluses or vasopressors, was noted. We determined efficacy in
terms of correlation between DBF and MAP (overall impression
between the series graphs, and graded from rarely change
together to nearly always change together), reliability (evaluated by
a precision test of two randomly selected segments for each
patient where the coefficient of variation is defined as the percent-
age of measurement error to mean results) and sensitivity analysis
(any response to a specific intervention such as fluid bolus or use
of vasopressor).
Results The MAP and DBF changed together mostly or nearly always
throughout the recording for seven of the 10 patients. The DBF
showed superior precision (1.5%, 95% CI 1.1–2.0%) when com-
pared with MAP (2.2%, CI 1.7–3.0%). Response to 16 interventions
in all the patients was detected by a change in DBF in 13 observa-
tions and by a change in MAP in only 11 observations. The response
to vasopressors was always detected while the response to fluid
administration was less well detected by both measures.
Conclusions This preliminary study has shown that the noninva-
sive DBF monitor was sensitive to therapeutic interventions in criti-
cally ill patients and was more reliable than MAP. Further studies
comparing DBF with other modalities of peripheral perfusion are
presently being performed.S97
Background Visceral ischemia and macrophage activation are
early signs in the development of shock and multiorgan failure.
Activated macrophages produce proinflammatory cytokines (like
TNF-α) that generate an inflammatory reaction. If the inhibition of
this reaction (mainly by IL-10) is not strong enough, cascade
systems will be activated; shock and multiorgan failure will be the
result. The aim of this study was to investigate the reliability and
safety of intraperitoneal microdialysis and to find out whether early
visceral ischemia can be detected.
Methods  Nineteen patients were operated, 14 elective patients
and five patients as emergencies. These 19 patients were followed
during 45 postoperative hours with IPM. A CMA 65 catheter was
placed intraperitoneally before closure of the abdomen. Analysis
was performed every second hour of glucose, pyruvate, lactate and
glycerol, the ratio between lactate and pyruvate was calculated as
a factor of peritoneal ischemia. Samples of peritoneal fluid were
collected from an 18Fr peritoneal drainage every sixth hour and
TNF-α and IL-10 were analysed.
Sixteen of the patients had a normal postoperative course during
the study, the lactate/pyruvate ratio started at the level of
20 immediately postoperatively, decreasing to 15 and, after
27 hours there was a short peak to 22, rapidly decreasing to a
steady state around 12. This pattern was also seen regarding
peritoneal TNF-α, it decreased immediately postoperatively and
had a short peak after 27 hours. Peritoneal lactate/pyruvate ratio
and peritoneal TNF-α correlated (Spearman nonparametric test
0.303, P=0.001).
Three of the patients had abnormalities in the microdialysis results.
• Patient 1 was operated due to rectal cancer. After 24 hours, his
lactate/pyruvate ratio started to increase and he developed low
saturation. He was treated with oxygen and the lactate/pyruvate
ratio was normalized. Peritoneal TNF-α and IL-10 had high and
short peaks during this time.
• Patient 2 was operated due to esophageal cancer. After
23 hours, his lactate/pyruvate ratio increased and he developed
abdominal pain despite epidural anesthesia. Peritoneal TNF-α
and IL-10 increased to a second peak after 80 hours.
• Patient 3 was operated due to an acute perforated gastric ulcer.
Postoperatively there was a high lactate/pyruvate ratio, which
increased to 60 after 15 hours; clinically the patient was in
shock with decreasing blood pressure and oliguria. He devel-
oped acute renal failure and died 42 hours postoperatively. His
peritoneal TNF immediately postoperatively was increased
30 times related to the patients with normal postoperative
course. During the last 15 hours, his peritoneal TNF increased,
while his IL-10 decreased.
Conclusions A normal postoperative course results in decreasing
the lactate/pyruvate ratio, peritoneal TNF-α and IL-10. In our study
we present three patients with abnormalities in IPM; these patients
also had clinical and peritoneal cytokine abnormalities that support
the theory that visceral ischemia is a preceeding factor in shock and
multiorgan failure. IPM seems to be a safe method for the patient and
we have not seen any complication due to the catheters in these
19 patients nor in the 65 patients we have studied with postopera-
tive IPM. We believe IPM can act as an early marker of visceral
ischemia even in clinical practice, but further studies to confirm this
are mandatory. Our aim is to continue this investigation in ICU
patients at risk of developing septicemia and multiorgan failure.
Available online http://ccforum.com/supplements/7/S2
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Objective The goal of this study was to evaluate the correlation of
homocystein (HCY) with a severity score and other hematological
and biochemical parameters in critically ill patients treated in a mul-
tidisciplinary ICU.
Materials and methods After ethical committee approval, 31 ICU
patients were enrolled in this prospective study. They had mean age
56.33±15.8 and APACHE score 28.5±3.11 at the time of admis-
sion in the ICU. The 13/31 patients were admitted after surgical pro-
cedures while the others 18/31 on account of medical reasons. The
following parameters were recorded: HCY, folic acid, WBC, PT, PTT,
PLTs, fibrinogen, temperature and CRP. They were all documented in
all patients at admission time and every 2 days for 2 weeks. The statis-
tical analysis was performed with Pearson’s correlation test. The level
of correlating significance was assumed if r<0.05.
Results At admission time, we observed a significant correlation
between HCY and APACHE II score (r<0.01). At the same time,
the parameters temperature, WBC, CRP, folic acid, and PTT were
significantly correlated to HCY (r<0.01, r<0.01, r<0.01, r<0.01,
r<0.05, respectively). The next 4 days after admission the correla-
tion between the parameters mentioned above remains strong but
the correlating level of the significance was lower (r<0.05, for all
parameters). After the 6th day until the end of the study, the corre-
lation was changed and remained steady for folic acid, WBC and
CRP (r<0.05 for each of them). The mean duration of ICU stay
was 17.13±3.14 days.
Conclusions Hcy is an amino acid, which seems to be correlated
with disease severity (APACHE score) and also strongly correlated
with infections factor as temperature, WBC, CRP. This lets us
accept HCY as an evaluation factor of inflammatory conditions in
ICU patients.
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Introduction There is much evidence to suggest that increased,
early induction of PCT following varying incidents is suggestive of
subsequent potential complications. This applies to the postopera-
tive period and multiple trauma, as well as other diseases.
Aim of the study In our study, the purpose was to examine the
PCT fluctuation in relation to the early signs of infection, to find out
whether PCT indicates a significant predictive value of infection.
Materials and methods Between 1 January 2001 and 31 Decem-
ber 2001, 248 patients were studied (among the 347 patients who
were admitted in our general ICU). Finally, 125 patients were strati-
fied in our study. The rest of the patients were excluded because
the length stay in ICU was limited (<5 days). All patients were
divided into four groups according to the reason for admission.
Group A: 56 multiple trauma (43 men, 13 women, mean age 49.2
years, mean ICU stay 13.4 days, APACHE II score 17–22).
Group B: 19 postoperative (10 men, nine women, mean age 49.5
years, mean ICU stay 11.7 days, APACHE II score 20–24).
Group C: 19 pathologic (12 men, seven women, mean age 50.7
years, mean ICU stay 14.8 days, APACHE II score 22–25).
Group D: 31 cerebral stroke (18 men, 13 women, mean age 49.5
years, mean ICU stay 14.2 days, APACHE II score 18–23). Each
group was divided in two subgroups: (I) patients possessing early
(days 0–2) signs of infection (elevated WBC, CRP,
temperature/reduced platelets, fibrinogen/positive cultures);
(II) patients free of early signs of infection.
Results In group A, 32 patients had positive signs of infection, but
PCT had no parallel fluctuation with the other markers of inflamma-
tion, whereas mortality (30%) was related to high PCT levels
(>2ng/ dl). In group B, seven patients had positive signs of infec-
tion, mortality was 31% and similar results with group A were
noted. In group C, nine patients had positive signs of infection and
mortality was 47%, while PCT levels indicated promptly the fatal
outcome. Finally, in group D, only 14 patients had positive signs of
infection, mortality was 32% and PCT levels were slightly higher in
those who did not survive.
Conclusion Numerous triggers can induce PCT and it has no sig-
nificant predictive value as the only marker of inflammation. In our
study, mortality was directly related to high PCT levels (>2ng/dl),
while values more than 30ng/dl were absolutely related to fatal
outcome.
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Introduction Endotoxin has a central role in sepsis and organ dys-
function after surgery. Levels of one of our natural defences
against endotoxin, antibodies to endotoxin core (EndoCAb), are
independent predictors of postoperative outcome [1]. There is a
heterogeneity in EndoCAb levels between European and North
American healthy donor populations that remains unexplained [2].
Methods Blood samples from healthy blood donors were collected
in London, UK and compared with levels of baseline EndoCAb in
previous studies. An ELISA assay of serum EndoCAb IgG
(n=165) and IgM (n=65*) levels was performed and expressed
as median units per ml (MU/ml) [3].
Results The median serum EndoCAb IgG and IgM levels in this
population were 189.7 (41.8–1023) MU/ml and 222.5
(42.3–913.9) MU/ml, respectively (Fig.1).
Conclusion EndoCAb levels are higher in London healthy donors
than in the Scottish population. US cardiac patients show higher
IgG levels than UK cardiac patients and Scottish healthy donors,
but are similar to London healthy donors. US surgery patients show
higher IgM levels than all groups but are similar to London healthy
donors. Differences may be due to prior exposure to endotoxin, dif-
ferent disease process, differences in sampling and patient man-
agement, or genetic variation between countries. We are collecting
further healthy donor samples to assess a larger cohort of
EndoCAb levels in London.
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Introduction Preoperative optimization of ‘high-risk’ elective surgi-
cal patients has been demonstrated to result in improved out-
comes. However, it has been argued that the mortality in the
control groups was higher than expected, given the inclusion crite-
ria. There have been no previous systematic studies of the
outcome of patients who meet ‘high-risk’ criteria.
Method A retrospective cohort study involving case reviews of all
adult (>18 years) patients undergoing elective major general or
vascular surgery in a tertiary referral university teaching hospital
during the year 2001. No patients were admitted to the ICU for
preoperative optimization. Hospital mortality, age, duration of
surgery and the presence or absence of the following risk factors
was recorded: extensive ablative abdominal surgery for cancer,
congestive cardiac failure, ischaemic heart disease, cardiac
arrhythmia, hypertension, chronic obstructive pulmonary disease,
pulmonary embolus, chronic renal insufficiency, diabetes mellitus
with end-organ damage, long-term steroid therapy, chronic liver
disease, cerebrovascular accident and peripheral vascular disease.
Results Data was available from 727 of 874 patients undergoing
major general or vascular surgery. Of these, 450 underwent an
operation lasting 2 hours or more. Only data from these 450
patients was analysed. The average age was 61 years and 48% of
the patients were male. Overall hospital mortality was 3.8%. Hospi-
tal mortality in patients with one or more risk factors was 5.4%. The
mortality associated with the presence of one or more risk factors
is presented in Table 1.
Conclusions The hospital mortality of ‘high-risk’ surgical patients
undergoing elective surgery may not be as high as the control
group mortality (17–50%) of previous randomized controlled trials
[1,2]. As a result, the reduction in mortality demonstrated in these
studies may be an overestimate of the reduction that will be
achieved if preoptimization is provided for all ‘high-risk’ surgical
patients undergoing elective surgery.
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Table 1
Patients aged 
Number of                All patients 60 years or more
risk
factors n Mortality (95% CI) n Mortality (95% CI)
0 172 1.2 (0.3–5.7) 91 2.2 (0.6–7.7)
1 155 4.5 (2.2–9.0) 103 6.8 (3.3–13.4)
2 81 6.2 (2.6–13.6) 46 10.9 (4.7–23.0)
3 or more 42 7.1 (2.5–19.0) 39 7.7 (2.7–20.3)
P201 Perioperative myocardial infarction can be predicted by preoperative electrocardiography
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Preoperative identification of the predictors of perioperative
myocardial infarction following noncardiac surgery (PMI) may help
decrease its high mortality rate. In previous studies, atrial and ven-
tricular rhythm abnormalities in the preoperative ECG have been
identified to be risk factors for PMI. We performed this prospective
study to determine whether or not other ECG findings may also
predict PMI. Adults with significant comorbid conditions admitted
to the SICU following high-risk noncardiac operations and who
underwent workup to rule out PMI were studied. PMI workup con-
sisted of a 12-lead ECG, CK-MB, and later troponin determination
at 6–8 hour intervals for 24 hours. Data collection included patient
demographics, comorbid conditions, preoperative work up includ-
ing 12-lead ECG, surgical diagnoses, type and duration of anes-
thesia and operations, preoperative, intraoperative, and
postoperative vital signs and clinical events, results of PMI workup,
incidence of PMI and final outcome. The data was analyzed using
SPSS statistical software.
There were 356 patients; 168 males and 188 females with the
mean age of 62.9 years. The preoperative ECG was normal in 85
(23.9%) and abnormal in 271 (76.1%) patients. Normal sinus
rhythm was present in 254/356 (71.3%), premature atrial com-
plexes in 11/356 (3.1%), atrial fibrillation in 14/356 (3.9%), prema-
ture ventricular complexes (PVC) in 26/356 (7.3%), left ventricular
hypertrophy (LVH) in 72/356 (20.2%), T-wave abnormality in
156/356 (46.3%), ST segment abnormality in 97/356 (27.2%),
and a Q wave in 53/356 (14.9%). PMI developed in 31/356
(8.7%) patients, and three (9.7%) died as a result.
Comparison of the preoperative ECG findings of patients without
and with PMI showed sinus tachycardia in 45/325 (13.8%)
without PMI and in 7/31 (22.6%) with PMI, atrial fibrillation in
13/325 (4%) without PMI and in 1/31 (3.2%) with PMI, PVCs in
22/325 (6.8%) without PMI and in 4/31 (12.9%) with PMI, LVH in
61/325 (18.8%) without PMI and in 11/31 (35.5%) with PMI, and
ST segment abnormality in 83/325 (25.5%) without PMI and in
14/31 (45.2%) with PMI. Logistic regression analysis showed
LVH and ST segment abnormality to be significant predictors of
PMI.
Conclusion LVH or ST segment abnormality on the preoperative
ECG are predictors of PMI.S100
Introduction The importance of perioperative optimisation using
fluid or inotropic agents has been underestimated, although it is
recognised that preoperative optimisation may improve postopera-
tive mortality after major surgery. Both abdominal aortic aneurysm
(AAA) and major thoracic surgery have among the highest postop-
erative mortality rates. In our institute, all AAA (elective or emer-
gency) patients receive perioperative optimisation in the ICU while
all major thoracotomy (oesophagectomy or pneumonectomy)
patients are cared for by the surgical team on the HDU or ward
until ICU treatments are required. The aim of this study was to
compare ICU overall outcomes between AAA and major thoraco-
tomy groups.
Methods The data were collected from the ICNARC of 429 patients
who underwent AAA (n=211) and major thoracotomy (n=218)
between February 1996 and August 2001. The Mann–Whitney U
test and chi-square test were used for statistical analysis.
Results AAA group had significant lower APACHE II score, length
of ICU stay and ICU mortality despite of greater age, ASA grades
and number of emergency cases compared with the major thoraco-
tomy group.
Conclusion  Perioperative optimisation may be associated with
better ICU outcomes in the AAA group compared with the major
thoracotomy group.
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Table 1
Outcome of AAA and major thoratomy
AAA (n = 211) Major thoracotomy (n = 218)
Age (years) 73 (67–78)* 69 (59–74)
ASA II–III 149/211 (71%)* 212/218 (97%)
ASA IV–V 62/211 (29%)* 6/218 (3%)
Elective/emergency 62/211 (29%)* 6/218 (3%)
APACHE II 13 910–17)* 18 (12–25)
ICU stay (days) 1 (0.8–2.9)* 3 (1.3–7)
ICU mortality (elective/emergency) 11.4 (2.7/31)%* 34 (34/16)%
Data presented as median (interquartile range). * P < 0.05 compared with thoratomy.
Table 2
Outcome of survivals and nonsurvivals in AAA and thorocotomy
Survival AAA (n = 187) Nonsurvival AAA (n = 24) Survival T (n = 144) Nonsurvival T (n = 74)
Age (years) 73 (66–77)*‡ 77 (74–83) 69 (59–74) 66 (61–74)
APACHE II 13 (10–17)*‡ 20 (18–22) 15 (11–19)† 25 (19–36)
ICU stay (days) 1 (0.8–2.3)‡ 1 (0.3–8.5) 2 (1.4–6) 4 (1.2–8.4)
Data presented as median (interquartile range). P < 0.05 compared with * nonsurvival AAA or † nonsurvival T or ‡ survival T.
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Background We have recently shown that the plasma levels of
urotensin II (U-II), a highly potent vasoactive peptide, are increased
in patients with reduced left ventricular function during coronary
artery bypass grafting (CABG) surgery [1]. The present study was
thus designed to confirm whether the plasma levels of this peptide
are indeed related to the severity of coronary artery disease and
accompanying variations in left ventricular filling pressures.
Material and methods Twenty-six consecutive patients (age:
58±11 years) were examined during routine right heart catheriza-S101
tion. Patients were grouped according to the angiographic coro-
nary status at hospital admission into a one-vessel CAD group
(CAD-1; n=13) and a three-vessel CAD group (CAD-3; n=13).
Patients were examined after 30 min supine rest. Mixed venous
plasma levels of U-II were determined by EIA. Data are presented
as mean±SD; statistical analyses were performed by ANOVA.
Results Both groups were comparable regarding risk factors for
CAD and a history of previous myocardial infarction. No group dif-
ferences were observed in cardiac output, mean arterial blood
pressure, heart rate, and central venous pressure. U-II plasma
levels and pulmonary artery pressures are presented in Table 1.
Conclusions Extending previous observations in patients during
CABG surgery, these findings suggest that the plasma levels of U-
II in humans with CAD are related to left ventricular filling pressures
and, hence, left ventricular diastolic dysfunction, further supporting
a role of urotensin II in heart failure.
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Table 1
CAD-1 (n = 13) CAD-3(n = 13) P
PAOP (mmHg) 6.77±2.95 14.39±7.9 0.003
PAPS (mmHg) 21.54±6.62 34.15±14.62 0.009
PAPD (mmHg) 8.92±3.9 14.23±6.66 0.021
PAPm (mmHg) 14.31±4.48 22.93±8.87 0.005
U-II (pg/ml) 1526.1±581.22 3641±3108 0.024
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Introduction After adult cardiac surgery, the inhospital prognostic
value of cTnI, measured at 20 hours after the end of surgery, has
been demonstrated [1]. Various cardiac troponin I (cTnI) assays
are available but the lack of standardization renders difficult any
comparative study [2]. The aim of this study was therefore to deter-
mine cTnI concentration after cardiac surgery using two different
assays, and to evaluate their correlation and their respective prog-
nostic values.
Materials and methods After approval by the local ethic commit-
tee and informed consent, 167 consecutive patients undergoing
either coronary artery bypass grafting (n=80) or valve surgery
(n=87) were prospectively studied. The cTnI was measured by an
immunoenzymatic method at 10 and 20 hours after the end of
surgery (H10 and H20) on two analyzers: RXL® (Dade Behring)
and AxSym® (Abbott). For each patient, the occurrence of a
cardiac event (CE+) was defined as: prolonged low cardiac output
(more than 4 hours), Q-wave perioperative myocardial infarction,
cardiac death.
Results A good correlation was found between assay at H10
(r2=0.81;  P<0.0001) and at H20 (r2=0.80;  P<0.0001).
However, the slopes of the regression equation were different at
H10 (3.8) and at H20 (5.6). In the CE+ group, cTnI concentrations
were significantly higher at H10 and H20 for both assays (at H20;
Dade, 16.3 [28]* vs 3.3 [3.6] cTnI in ng/ml; Abbott, 50.0 [117.9]*
vs 9.6 [14.1] cTnI in ng/ml; median [interquartile range],
*P<0.0001, Mann–Whitney test, CE+ vs CE–). Using ROC curve
analysis, no difference was found in area under the curve (AUC) at
both H10 and H20 between assays, even if at H10 the AUC found
with the Dade assay tended to be higher than that of the Abbott
assay (0.91 vs 0.80, P=0.06).
Conclusion Both assays were found to be well correlated, but the
correlation differed with time. cTnI was associated with CE in both
assays, with a similar predictive value at H20.
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B-type natriuretic peptide (BNP) is a cardiac neurohormone specif-
ically secreted from the ventricles in response to volume expansion
and pressure overload. Plasma levels of BNP have been shown to
be elevated in patients with left ventricular dysfunction and corre-
late with prognosis. The purpose of the present study was to deter-
mine the variations of BNP levels in cardiac surgery patients and to
look for a possible association between BNP levels and periopera-
tive cardiac complications.
Methods After ethics committee approval and patient informed
consent, we studied 94 consecutive patients undergoing elective
coronary artery (36) or valve surgery (58). BNP was measured
using a fluorescence immunoassay Test (Triage, Biosite Inc) before
surgery (day 0), and at days 1 and 5 after surgery. Anesthesia and
cardiopulmonary bypass management was standardized for all
patients. Postoperative cardiac complication (CC) was defined as
hemodynamic instability requiring inotropic support >4 hours, con-
gestive heart failure in ward and cardiac death.
Results At day 0, the levels of BNP were significantly associated
with the NYHA class (P=0.003) and LVEF (P=0.002), but neither
with the type of cardiac disease nor with preoperative pulmonary
artery catheter measurements. BNP concentrations increased in all
patients at day 1 and remained elevated in plateau at day 5. AtS102
day 1, BNP concentrations were associated with the occurrence of
cardiac complications (Fig.1) and length of stay in intensive care
unit. Using ROC curve analysis, the best predictive value (for
cardiac complications) of BNP at day 1 was 450pg/ml.
Conclusion Plasma BNP levels increased in all patients after
cardiac surgery and remained elevated until day 5. High BNP
levels at day 1 were significantly associated with postoperative
cardiac complications.
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Introduction Investigation of the relationship among Lac acid, pHi
and O2ER with cardiac index (CI) and determination of the early
indicator of hemodynamic compromise in patients undergoing
aortic surgery during the first 24 hours of their stay in a multidisci-
plinary ICU.
Methods Our prospective study included 17 patients after aortic
aneurysm surgery. They were all men of mean age 70.5±5.56 with
admission mean APACHE II score 16.2±3.96. In all cases the
duration of cross-clamping was 2–3 hours. The following parame-
ters were recorded: CI, PCWP, Hb, DO2, VO2, SaO2, SvO2,
O2ER, Lac acid and sigmoid pHi. The pHi was monitored continu-
ously with the TONOCAP–™ monitor for regional tonometry. All the
other parameters were recorded at the admission in the ICU and
every 4 hours for 24 hours. Regression analysis and curve estima-
tion were performed among CI and pHi, Lac and estimated O2ER
every 4 hours. Level of significance was P<0.05.
Results At admission in ICU there was correlation between CI and
Lac (r2=0.6, P<0.05). At the first 8 hours there was a statistically
significant inverse correlation between CI and levels of Lac
(r2=0.68, P<0.008). After the 8 hours until the end, pHi was then
statistically correlated to CI (r2=0.65, P<0.01). It is noticeable
that O2ER was strongly inversely correlated to CI (r2=0.91,
P<0.008) during the whole study at any phase of the study.
Conclusions According to our data until now, it seems that the
levels of Lac during the first 8 hours reflect early hemodynamic
instability while the sigmoid pHi, indicating local microcirculation
and reperfusion phenomena, is correlated with CI at later stages
during the cardiovascular and metabolic stabilisation. Finally, O2ER
is the most powerful indicator of the hemodynamic status.
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Background and goals Intestinal failure can be accompanied by
intra-abdominal hypertension (IAH) [1]. Gastrointestinal ischaemia
occurs particularly because of IAH [2]. The index of gut luminal
PCO2 referenced to arterial PCO2 (PgCO2–PaCO2) reflects an
adequacy of splanchnic tissue perfusion and is a predictor of any
later complications [3].
Materials and methods We studied 24 patients with diagnosis of
intestinal obstruction. The survey patients were nearly homoge-
neous on age (average age 46±4 years) and preoperative condi-
tion (APACHE II score 18±1.8). One-half of patients were males.
The same technique of anesthesia was carried out in all the
patients. IAP and PgCO2–PaCO2 (kPa) were measured by TRIP
NGS catheter and Tonocap monitor preoperatively. Cluster analy-
sis was performed on the base of preoperative differences
between IAP and PgCO2–PaCO2.
Results On the results of cluster analysis, the patients were allo-
cated into two groups. In 14 patients (group 1) the mean of pre-
operative IAP was 1.82±0.14kPa. IAP was 0.41±0.06kPa in
10 patients of the second group (P<0.05). Patients with higher
IAP had 2.24±0.42 PgCO2–PaCO2 vs 1.49±0.32 in group 2
(P<0.05). Study of outcomes revealed that six patients of the
group 1 had different serious complications and seven died. Eight
patients from group 2 recovered without complications.
Conclusion A higher level of PgCO2–PaCO2 because of
increased IAP in patients with intestinal obstruction may have a
prognostic value.
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Introduction Recent studies have demonstrated that the outcome
of critically ill patients is better in females than in males. Although
estrogen has been shown to be critically involved in regulation of
immune responses, the detailed mechanism(s) underlying such
gender differences has yet to be fully understood. Since proinflam-
mation plays a critical role in the development of the organ dys-
function seen in such critically ill patients, estrogen might show any
anti-inflammatory effects to attenuate such inflammatory
responses. We previously reported that capsaicin-sensitive
sensory neurons (CSSN), nociceptive neurons, play an important
role in attenuating inflammatory responses by releasing calcitonin
gene-related peptide (CGRP), which promotes the endothelial pro-
duction of prostacyclin, one of the anti-inflammatory prostaglandins
[1]. Since estrogen increases the synthesis of nerve growth factor,
which increases the CGRP production, estrogen might attenuate
inflammatory responses by promoting CGRP release from CSSN.
We examined this possibility in the present study.
Methods and results Gastric accumulation of neutrophils as well
as gastric mucosal injury were significantly less in female rats than
in male rats subjected to water-immersion restraint stress (WIRS).
Gastric levels of CGRP and 6-keto-PGF1α, a stable metabolite of
PGI2, were significantly higher in female rats than those in male
rats subjected to WIRS. Administration of capsazepine, a vanilloid
receptor-1 antagonist, markedly reduced the gastric levels of
CGRP and 6-keto-PGF1α in female rats subjected to WIRS. Both
gastric accumulation of neutrophils and gastric mucosal injury in
female rats pretreated with capsazepine were comparable with
those seen in male rats.
Conclusions These results suggest that CGRP release from
CSSN is more marked in female rats than male rats, contributing to
differences in the gastric tissue levels of PGI2 in rats subjected to
WIRS. This difference in the regulatory function for inflammatory
responses might at least partly explain the gender difference in the
development of stress-induced gastric mucosal injury in rats.
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Objective To evaluate the paracetamol absorption test in comparison
with the clinical test of gastric residual volume, as indicators of gastric
motility, in order to initiate peros feeding in critically ill patients.
Design A prospective self-controlled study, evaluating a clinical
and a laboratory test.
Setting An adult medical–surgical university ICU.
Patients and methods All patients were studied in three steps.
Step I. The gastric residual volume was measured 1 hour (by aspi-
ration of the gastric content) after the delivery of 200ml D5W
(gastric residual volume test [GRVT]) via a nasogastric tube in
18 mechanically ventilated critically ill trauma patients (mean
age±SEM 51.31±4.92 years). Step II. One gram of paracetamol
was delivered via the nasogastric tube, and blood samples were
drawn at time (t) 0 and 30, 60 and 90 min post paracetamol
administration. The paracetamol was administered immediately
after step I. Step III. A try (commercial liquid food) of peros feed
was given in all studied patients right after the 90 min blood
sample was drawn.
All patients were divided in two groups. Group A (n=10): patients
tolerated the peros feeding and were successfully fed peros there-
after. Group B (n=8): patients not tolerated the peros feeding. The
peros feeding was not achieved the day of the study.
Results The mean (±standard error) GRV and paracetamol serum
levels were as presented in Table 1. In all Group A patients the
residual gastric volume was ≤100ml (mean±standard error
=58.0±9.5), whereas in all Group B patients it always was
>100ml (mean±standard error =208.0±18.7). All Group A
patients were successfully fed whereas no one of the Group B was
successfully fed the day of the study.
No statistically significant differences (Mann–Whitney U test) were
observed in blood paracetamol levels between groups at baseline,
30 and 60 min. A statistically significant difference was observed
at 90 min, reflecting the higher blood paracetamol levels of
Group A, which was the successfully peros-fed group.
Conclusions The GRVT is a fast (within 1 hour) clinical tool for
decision making to peros feed a critically ill patient. A gastric resid-
Table 1
GRV (ml) 0 min 30 min 60 min 90 min
Group A 58.0 ± 9.5 0.11 ± 0.08 2.79 ± 0.83 3.69 ± 0.89 4.17 ± 0.88
Group B 208.0 ± 18.7 0.67 ± 0.26 3.01 ± 1.8 2.91 ± 1.36 2.35 ± 0.96
P value* < 0.0001 > 0.05 > 0.05 > 0.05 < 0.05
GRV, gastric residual volume. * Between Groups A and B, Mann–Whitney U test.S104
ual volume <100ml is indicative of a successful peros feeding in
our critically ill patients. The higher paracetamol blood levels at
90 min post paracetamol administration does not seem to be a
useful tool in the peros feeding decision-making process. It
happens because on one hand it is a time-consuming and work-
consuming process and on the other hand there is not a cutoff
paracetamol serum level, which separates the peros food-tolerating
patients.
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Background and goal of study IL-18 is mainly produced by
macrophages, especially by the Kupffer cells of the liver. When
anti-IL-18 antibodies were administered before challenge with LPS
1 week after the injection of P. acnes, the development of liver
tissue necrosis and the associated increase in serum GOT and
GPT levels were prevented. We therefore studied the correlation
between the serum IL-18 levels, severity of the disease, and the
development of liver dysfunction in cases of acute pancreatitis.
Materials and methods Seventeen patients with acute pancreati-
tis treated at our center from the early stage of the disease, were
enrolled in this study. The disease state was mild in four patients,
moderate in five, and severe in eight patients. The IL-18 and TNF-α
levels in the serum were determined by ELISA. The correlations
between the maximum serum IL-18 level and the corresponding
serum TNF-α, IL-6, and IL-8 levels were studied.
Results The levels of IL-18 were 4.3±5.3pg/ml in the mild group,
18.7±67.1pg/ml in the moderate group, and 269.6±2482.1pg/ml
in the severe group. The IL-18 levels increased significantly corre-
sponding to the severity of the disease. The group in which the
complication of MODS developed showed significantly higher IL-18
levels than that in which this complication did not develop. The
IL-18 levels in the survivor group were 132.0±130.7pg/ml, and
those in the nonsurvivor group were 3028.6±2480.8pg/ml, the
levels being significantly higher in the nonsurvivor group. Significant
correlations were observed between the total bilirubin and IL-18
levels (r=0.617, P=0.0003).
Conclusion In this study, the severity of acute pancreatitis was sig-
nificantly correlated with the serum IL-18 levels; conversely,
increased serum IL-18 levels reflected the severity of the disease.
Since significant correlations between the serum IL-18 levels and
APACHE II scores were also observed in cases of sepsis, such a
correlation may not be specific to only acute pancreatitis.
P211 Incidence of organ failure in patients with severe acute pancreatitis
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Introduction The clinical course of severe acute pancreatitis
(SAP) may be complicated by a variety of organ failures, an
ominous evolution associated with high mortality rates. We aimed
to describe a population of patients with SAP and to quantify the
type and frequency of organ failures in these patients.
Methods Retrospective analysis of all medical records of patients
admitted to the MICU between January 1995 and January 2001
due to SAP. SAP was defined as acute pancreatitis associated
with at least one organ failure. Organ failure was defined as a
score of 3 or 4 according to the SOFA score.
Results Seventy-two patients (44 male, 61%) met the criteria of
SAP. The mean age was 54 (range 24–90) years. The average
length of stay in the MICU was 21 days (range 3–133). Average
SAPS II score at admission was 42 (range 19–83), and SOFA
score was 8 (range 1–22). Thirty-six per cent were referred from
other ICUs in other hospitals. The most frequent causes of SAP
were gallstones (32%), alcohol (24%), idiopathic (13%), hyperlipi-
demia (10%), and post-ERCP pancreatitis (8%). Forty patients
(56%) developed respiratory failure with need for mechanical ven-
tilation; nine out of these patients developed ARDS. Thirty-one
patients (43%) developed renal failure, 24 of these patients
required renal replacement therapies. Fifty-one per cent of
patients developed cardiovascular failure with need for vasopres-
sors. Thrombocytopenia <50,000/ml occurred in 14 patients
(19%), and hepatic failure in 15 patients (21%). Eight patients
(11%) developed two organ failures, 16 patients (22%) devel-
oped three organ failures and 15 patients (21%) developed four
or more.
Bacteremia was detected in 32 patients (44%), and in 13 patients
the positive blood cultures were interpreted as contaminants.
According to computertomographic criteria, 54 patients (75%)
were diagnosed with pancreatic necrosis. Pancreatic cultures were
obtained in 30 patients. Microbes were cultured from necrotic
areas in 17 of these patients. Seventeen patients (24%) under-
went surgery (on average, two interventions, range 1–6) because
of infected necrosis or progressive organ failure. Mortality in
patients requiring surgery was 53%; that in those not requiring
surgery 20%. Overall mortality was 28%.
Conclusions In an unselected population of patients with SAP, of
which 75% also had acute necrotising pancreatitis, organ failure is
common. Respiratory failure is most common (56%), followed by
cardiovascular failure (51%), renal failure (43%), hepatic failure
(21%) and coagulopathy in 19% of patients. At 28%, mortality in
these patients remains high.S105
Background The clinical course of acute pancreatitis is deter-
mined by acute lung injury, systemic inflammatory response syn-
drome and septic complications. Microcirculatory dysfunction in
both the intestinal and the pulmonary vessels might be partly
responsible for this process.
Methods Fourteen male Sprague–Dawley rats were randomly
assigned to two groups: acute pancreatitis (AP) was induced by IV
infusion of 10µg/kg cerulein; control rats (CON) received saline
infusion. Four hours later, intravital microscopy of the distal ileum
mucosa was performed. In six villi, the intercapillary area of all capil-
laries (ICA total) and of continuously perfused capillaries only (ICA
cont) was measured. Terminal arteriolar flow was calculated from
arteriolar diameter and plasma flow velocity. In a second set of
experiments, pulmonary endothelial function was assessed in iso-
lated perfused lungs (IPL) in 10 rats using the same study design
and treatment. After 4 hours of treatment, IPL was established
(flow 16ml/min, hematocrit 10%). After stabilization, endothelium-
independent (hypoxic pulmonary vasoconstriction, 3% O2 [HPV])
as well as endothelial-dependent (bradykinin 6µg [BK]) responses
were determined as differences in pulmonary arterial pressure. Sta-
tistical analysis included ANOVA and the Student–Newman–Keuls
test.
Results Acute pancreatitis significantly increased the ICA total,
thereby indicating a loss in capillary perfusion. HPV after AP was
not different from control. In contrast, BK induced pulmonary vaso-
constriction after AP compared with control (* P<0.05 vs control).
Conclusion During AP, the mucosal microcirculation showed
increased arteriolar blood flow and decreased capillary perfusion,
indicating increased intramucosal shunt. This may lead to critical
mucosal hypoxia. Furthermore, pulmonary vascular reactivity was
altered in AP. Mechanisms of AP-induced extrapancreatic microvas-
cular injury need to be further investigated to develop treatment
options in the prevention of severe AP-related complications.
Available online http://ccforum.com/supplements/7/S2
P212 Extrapancreatic microcirculatory injury in acute experimental pancreatitis in the rat
H Freise, LG Fischer, V Hlouschek, MM Lerch, H Van Aken, A Sielenkaemper
Department of Anaestheseiology and Intensive Care, University Hospital of Muenster, Albert Schweitzer Strasse 33, 48149 Muenster, Germany
Critical Care 2003, 7(Suppl 2):P212 (DOI 10.1186/cc2101)
Table 1
ICA total  ICA cont  Diameter  Velocity  Flow  ∆PAP HPV  ∆PAP BK 
(µm2)( µm2)( µm) (µm/s) (nl/s) (mmHg) (mmHg)
AP 874 ± 79 1355 ± 148* 7.0 ± 1.4 729 ± 64* 3.58 ± 0.31* 7.17 ± 1.89 1.5 ± 0.43*
CON 773 ± 45 932 ± 46 7.6 ± 1.1 541 ± 50 2.61 ± 0.31 9.63 ± 1.91 0.57 ± 0.3
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Background With a retrospective study previously published by
our team, we found that acute renal failure in patients with pancre-
atitis had a high mortality rate. The objective was to make a
prospective study in which we could demonstrate whether renal
failure was either associated with a deficit in cardiac preload or
with hypotension.
Methods A prospective study was conducted in all patients with
diagnosis of acute pancreatitis that were admitted to the intensive
care unit during the time of the study, and the following variables
were evaluated at the moment of admittance: RANSON SCORE,
APACHE II, SOFA, age, MAP, CVP, diuresis/hour, creatinin and
BUN. The statistical analysis was realized by Student t test, values
of P<0.05 were considered significant.
Results  During the period of investigation 2449 patients were
admitted to our intensive care unit, of which 46 were diagnosed
with acute pancreatitits (1.8%) with a mortality of 30.4% (n=14).
In the group of deceased patients, the variables age, MAP, SOFA
score and APACHE II score were not statistically significant, and
therefore no difference was found between this group and those
who stayed alive. On the contrary, we observed that the deceased
patients presented lower diuresis and higher BUN retention. The
mean arterial pressure (MAP) showed no difference between both
group, and its values were found to be in normal ranges, which dis-
cards the possibility that the presence of hypotension causes
Table 1
Variable Alive Dead P
Age 56.04 48.37 NS
MAP 88.57 86.78 NS
RANSON 2.72 3.93 < 0.01
SOFA 3.4 4.9 NS
APACHE II 6.4 8.5 NS
CVP 9.84 13.07 < 0.02
Diuresis/hour 42.63 78.79 < 0.006
Creatinin 1.06 1.7 < 0.05
BUN 15.2 40.2 < 0.03S106
acute renal failure. No decrease of preload volume was found,
which suggests that the acute renal failure is caused by an intrinsic
renal dysfunction, which should be studied in later investigations.
Conclusions In patients with acute pancreatitis in our study, the
acute renal failure seems to be a factor associated with mortality,
and it does not seem to be conditioned by a diminished preload or
hypotension, which suggest the possibility that an intrinsic renal
damage is associated with acute pancreatitis.
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The place and role of continuous renal replacement therapy (CRRT)
has recently been evaluated in comparison with intermittent
hemodialysis (IHD) in patients with multiple organ failure (MOF).
The emphasis is on removal of a number of inflammatory cytokines,
not only correction of azotemia which can be achieved with dialysis.
Patients and methods The randomized prospective study on 104
patients with MOF investigated circulatory stability, survival after
28 days, and total survival. Intermittent hemodialysis was per-
formed every day, during 3–4 hours with blood flow rate
200–250ml/min and dialysate flow rate 500ml/min, using a bio-
compatible polysulfone membrane with surface area 1.4–1.6m2,
most frequently without heparin utilization. CVVH was procedure of
continuous venovenous hemofiltration, where in the first
33 patients 18ml/kg per hour were replaced (low volume hemofil-
tration) and, subsequently, 35ml/kg per hour (high volume hemofil-
tration). The membrane used for CVVH was of polysulfone. MOF
was defined as a severe deterioration of at least two organ
systems. Circulatory instability was defined by blood pressure fall
up to 10mmHg or over 10mmHg.
The etiology of MOF was sepsis (52 patients), septic shock
(28 patients) renopulmonary syndrome (five patients), hemorrhagic
fever (seven patients), rhabdomyolysis (five patients), and ishemic
cardiomyopathy (seven patients).
Results Comparison of scoring systems of both patient groups
showed no statistically significant difference: (HD:HF arithmetic
means±SD) APACHE II0 (20.3±8.4 vs 21.9±8.8, P=NS), MAR-
SHALL II0 (8.3±4.0 vs 9.6±3.5, P=NS), SOFA0 (9.2±4.6 vs
10.6±3.8,  P=NS), APACHE II3 (16.4±7.5 vs 18.3±8.2,
P=NS), MARSHALL3 (7.1±3.8 vs 8.1±3.7, P=NS), SOFA3
(7.7±4.6 vs 9.3±4.2, P=NS), APACHE II7 (15.5±8.2 vs
18.2±8.5, P=NS), MARSHALL7 (6.1±3.9 vs 7.3±4.1, P=NS),
SOFA7 (6.6±4.3 vs 8.5±4.6, P=NS). No statistically significant
difference in 28-day survival between IHD and CRRT was seen
(23/52 vs 17/52, P=NS). No statistically significant difference in
total survival between IHD and CRRT was seen (21/52 vs 15/52,
P=NS). Survival of patients on low versus high volume hemofiltra-
tion was studied (9/31 vs 6/21, P=NS). The number of hypoten-
sive attacks, defined by blood pressure fall up to and over
10mmHg in the group of patients on continuous procedures, was
not significantly smaller (Rank Sum 2664.5 vs 2795.5, P=NS)
Conclusion In this randomized prospective study, survival of
patients with MOF after 28 days, total survival, and circulatory
instability were not significantly related to the type of procedure. In
our patients no difference in survival was reached with regard to
the use of low volume versus high volume hemofiltration.
P215 Very high volume haemofiltration (VHVHF) (8.75l/hour) sustained during a 4 hour period of time can remove by filtration
significantly higher amounts of cytokine compared with low volume haemofiltration (LVHF) (1l/hour) and is accompanied
by a significant drop in cytokines only in haemodynamical responders and survivors during early severe septic shock
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Background and objectives It has been speculated that the bene-
ficial effects of VHVHF in refractory septic shock [1] could be
explained or not by cytokine removal. We compared the cytokine
removal in 16 patients with early severe septic shock: eight were
held with VHVHF and were compared with a historical cohort
treated with LVHF.
Setting General intensive care unit, regional centre.
Design Comparative study: 16 patients in early septic shock. Eight
patients were put on VHVHF (8.75ml/hour) and were compared in
term of cytokine filtration with a historical cohort of eight patients
who were treated with low volume haemofiltration (1l/hour).
Results VHVHF was able to remove a significantly higher amount
of IL-6 when compared with LVHF. The total amount removed in
1 hour by VHVHF was 40µg/hour, significantly higher than the
amount removed by LVHF, which was about 1µg/hour (P<0.01).
The extremely important removal was accompanied in patients
treated by VHVHF by a significant drop in serum IL-6 only in
responders and survivors (two out of eight). No decrease was
observed in nonresponders and nonsurvivors (six out of eight) and
was very minimal in the group of LVHF.
During VHVHF, serum IL-10 never dropped, whatever the outcome
of the patient. These results were in agreement with two recent
studies [2,3] where the IL-6 clearance in LVHG was between 15
and 30µg/day.
Conclusion The beneficial effect of VHVHF in refractory septic
shock can be explained at least in part by a significantly higherS107
removal of proinflammatory cytokines compared with LVHF. In
responders and survivors, this was accompanied by a significant
decrease in serum proinflammatory cytokines levels, whereas IL-10
levels did not change at all.
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Objectives To remove humoral mediators in sepsis patients, con-
tinuous hemodiafiltration (CHDF) was performed and its effect on
vascular endothelial cell function was examined.
Subjects and methods The study subjects were 10 patients with
sepsis who received CHDF for more than 3 days at our facility. A
PMMA membrane was used as a hemofilter, and nafamostat mesy-
late was administered as an anticoagulant. Measurements were
performed before CHDF and 30 min and 24, 48 and 72 hours after
CHDF, of granulocytic elastase, PAI-I, IL-6, IL-1ra, ELAM-1,
endothelin-1, and NOx. The survival group (six cases) and nonsur-
vival group (four cases) were separated according to the outcome
at 2 weeks after CHDF and were separately analyzed.
Results Before CHDF treatment, granulocytic elastase, PAI-I and
NOx were significantly higher in the survival group than in the non-
survival group. Starting 48 hours after CHDF, granulocytic elastase
decreased significantly in the survival group and increased signifi-
cantly in the nonsurvival group. PAI-I was significantly lower 24 and
more hours after CHDF in the survivors, whereas it rather
increased in the nonsurvivors. In both groups, IL-6, IL-1ra and NOx
were significantly decreased by CHDF. ELAM-1 and endothelin-1
appeared to decrease in both groups, although there was no sta-
tistical significance. There was no significant difference in BNP
between the groups.
Discussion PAI-I, which is associated with activation of vascular
endothelial cells, and granulocytic elastase, which is associated
with neutrophil activation, were significantly higher in the survival
group before CHDF. After CHDF, they significantly decreased in
the survival group and rather increased in the nonsurvival group.
These data suggest that vascular endothelial cell damage was sup-
pressed by CHDF in the survival group. In the nonsurvival group,
cytokines decreased while granulocytic elastase and PAI-I did not
decrease, suggesting that it is more important to control vascular
endothelial damage in sepsis patients. The NO metabolite NOx, a
vascular endothelial relaxation factor, endothelin-1, a contraction
factor, and ELAM-1, an adhesion factor, decreased during CHDF,
but showed no difference between the two groups of patients.
Conclusion The results suggest the possibility that CHDF sup-
presses vascular endothelial cell damage in sepsis patients.
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Polymyxin B immobilized fiber (PMX-R; Toray industries, Inc) has
been developed in Japan for direct removal of endotoxin (PMX-
DHP). PMX-DHP is used for treatment of patients with sepsis and
septic shock primarily caused by Gram-negative infections, and its
effectiveness of hemodynamic changes has been evaluated. In 119
cases (62±16 years old, 82 men and 37 women) treated with
PMX-DHP, changes in pulmonary oxygenation before and after
PMX-DHP were examined, using PaO2/FiO2 as an oxygenation indi-
cator, separately according to the outcome (80 survivors and 39
who died). Improvement of PaO2/FiO2 was identified in 64% of all
cases. In the survival group, there appeared to be a trend for
PaO2/FiO2 improvement as blood pressure increased. In the non-
survival group, however, no improvement of PaO2/FiO2 was
obtained, regardless of an increase of blood pressure. There was
no significant correlation between PaO2/FiO2 and the rate of
change in endotoxin levels, TNF-α, and IL-6. Granulocyte elastase
increased significantly after PMX-DHP treatment in both groups. In
the survival group, PaO2/FiO2 appeared to increase as macrophage
inflammatory protein (MIP-1) 1-α decreased, suggesting the possi-
bility that changes in MIP-1-α influenced PaO2/FiO2. As the mecha-
nism for the improvement of pulmonary oxygenation by PMX-DHP
has been shown clearly, it remains to be examined further.
P218 Plasmafiltration in septic shock: a review of 15 cases
P Campos, A Maia-Goncalves, A Paiva, C Granja, J Pina
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Introduction  Plasmafiltration is a nonselective method with the
potential of removing harmful mediators, and is being used as
salvage therapy and suggested to play an important role in severe
infection. This study aims to evaluate efficacy and safety of plas-
mafiltration used as salvage therapy in septic shock in our ICU.
Methods  This study enrolled 15 adult patients admitted from
January 1998 to December 2000 to our eight-bed mixed-case ICU
of a tertiary care hospital, with septic shock refractory to conven-
tional therapy. A plasmafiltration session with albumin-electrolyte
replacement solution was initiated for each patient. DemographicS108
and clinical data were collected from clinical registries. Variables
such as systolic pressure, inotropes, oxygen saturation, oxygen
inspiration fraction, PEEP, platelets, and coagulation were col-
lected before plasmafiltration and 6 and 24 hours after. SPSS for
Windows was used for data analysis.
Results From the 15 patients enrolled, 47% were male and mean
age was 53 years; mean APACHE II was 25. Pneumonia was the
primary infection in 40% of patients; peritonitis in 20%. All patients
were under adrenaline or noradrenaline infusion. Twenty-seven per
cent experienced minor hemorrhagic complications during plas-
mafiltration; no fatal complications were attributed to plasmafiltra-
tion. A trend towards lowering inotrope dose was noticed, without
statistic significance. Thirty-three per cent of patients recovered
and were discharged alive from the ICU.
Conclusions Plasmafiltration seems to have an important role in
septic shock, delaying the process of organ dysfunction and allow-
ing treatment of the underlying cause. Moreover, it is a safe proce-
dure. Further investigation is still needed on this subject.
References
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Introduction Continuous venovenous haemofiltration (CVVHF) is
commonly instituted in patients with renal dysfunction in acute liver
failure (ALF), the latter carrying a high mortality rate unless patients
undergo liver transplantation. In this cohort, the prognostic signifi-
cance varying doses of CVVHF has not been established. A retro-
spective analysis of 73 patients admitted to a specialist Liver
Intensive Care Unit.
Methods All patients admitted with acute liver failure and receiving
continuous haemofiltration were studied. We analysed data that
had been acquired between January 1999 to November 2002 util-
ising the Riyadh ICU programme. The variables analysed were
bilirubin, lactate, creatinine, APACHE II score, noradrenaline, and
mechanical ventilation. Patients were divided into three groups.
Group 1, low volume (LV) CVVHF (<2l exchange); Group 2, high
volume (HV) CVVHF (>2l exchange); and Group 3, combination of
HV and LV CVVHF. These three groups were subdivided as to
whether they were receiving noradrenaline, mechanical ventilation
or a combination of both.
Results The survival rate of patients receiving LV or HV CVVHF or
a combination was 50%. The subgroup survival is presented in
Table 1.
Patients receiving LV CVVHF, on noradrenaline, had significantly
higher APACHE II (P<0.03) and creatinine (P<0.003) levels
when compared with those not on noradrenaline. Ventilated
patients, on LV CVVHF, had a significantly higher APACHE II score
than those not ventilated (P<0.001). Twenty-eight per cent of
patients with ALF underwent transplantation.
Conclusion This study shows a more favourable outcome when
compared with similar patients in a general ICU setting. As
expected, patients on HV CVVHF had higher mortality, which is
attributable to their underlying physiology. These patients were
selected for HV CVVHF at the physician’s discretion. The timing of
initiation of HV CVVHF did not affect the outcome of these
patients. This may be related to the fact that standard CVVHF was
initiated early in the time course of the disease.
Table 1
ICU survival (%)/number of patients
Noradrenaline Ventilation
Yes No Yes No
Low volume 72 (8/11) 83 (10/12) 50 (5/10) 100 (13/13)
High volume 10 (1/10) 0 (0/1) 9 (1/11) 0
Combination 42 (13/31) 50 (4/8) 40 (14/35) 75 (3/4)
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Introduction Renal dysfunction is common in critically ill patients
with chronic liver disease (CLD). The outcome of patients with
CLD requiring ITU care with associated renal failure is poorly
defined, as is their response to dose of renal replacement
(CVVHF). We performed a retrospective study of 80 patients with
CLD admitted to a specialist Liver Intensive Care Unit.
Methods All patients admitted with chronic liver disease and
receiving continuous haemofiltration were studied. We analysed
data that had been acquired between January 1999 and November
2002 utilising the Riyadh ICU programme. The variables analysed
were bilirubin, lactate, creatinine, APACHE II score, noradrenaline,
and mechanical ventilation. Patients were divided into threeS109
groups. Group 1, low volume (LV) CVVHF (<2l exchange);
Group 2, high volume (HV) CVVHF (>2l exchange); and Group 3,
combination of HV and LV CVVHF. These three groups were sub-
divided as to whether they were receiving noradrenaline, mechani-
cal ventilation or a combination of both.
Results The survival rate in patients receiving LV and HV CVVHF
or a combination of both was 9%. The subgroup survival is pre-
sented in Table 1.
Patients receiving HV CVVHF, on noradrenaline, had a statistically
significant higher lactate (P<0.003) and APACHE II (P<0.005)
score when compared with those not on noradrenaline. Ventilated
patients, on combination CVVHF, had significantly higher lactate
(P<0.02) and creatinine (P<0.001) than nonventilated patients.
There was no difference between early or late initiation of HV
CVVHF. No patient with a lactate of greater than 3mmol/l survived.
Conclusions The outcome in our cohort of patients with chronic
liver disease and receiving haemofiltration is extremely poor (9%
survival). Our data shows the subgroup of patients on HV haemofil-
tration had 100% mortality rate. We have also shown that patients
who require noradrenaline and ventilation in addition to RRT have a
worse outcome. In addition, the timing of initiation of HV CVVHF
does influence survival.
Available online http://ccforum.com/supplements/7/S2
Table 1
ICU survival (%)/number of patients
Noradrenaline Ventilation
Yes No Yes No
Low volume  31 (5/16) 22 (2/9) 25 (5/20) 40 (1/5)
High volume 0 (0/8) 0 (0/3) 0 (0/10) 0 (0/0)
Combination 4 (1/24) 15 (3/20) 5 (2/40) 50 (2/4)
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Normalized creatinine production (creatinine index [CI]) has been
shown to reflect protein nutritional status and outcome in chroni-
cally hemodialysis patients, but such has not yet been established
in acute renal failure (ARF). We therefore investigated CI as an
indicative parameter of protein denutrition and outcome in ARF
requiring extrarenal replacement therapy (ERRT).
Methods Twenty-four patients (APACHE II score 29.6±5.7) with
ARF treated by intermittent hemodialysis or continuous venove-
nous hemofiltration (CVVHF) have been studied along 7 days from
the first ERRT session (D1–D7). Weight, diuresis, BUN, creatine-
mia, urinary urea nitrogen and creatinine were collected daily,
before and after each ERRT. During CVVHF, fractional ultrafiltrant
urea nitrogen and creatinine collections were also collected. Nor-
malized protein catabolism rate (nPCR) and nitrogen supply were
estimated daily and an average of 7 days (D1–D7) was calculated.
CI was calculated at D1 and D7 according to the formula CI (mg/kg
per 24 hours) = {[(CbT2 – CbT1)×weight×0.6] / T + (Cu × Vu) / T
+ (Cuf × Vuf) / T}×0.113×1440 / weight + [(CbT1 + CbT2) /
2]×0.0429, where C = creatinine in blood (b), in urine (u) and in
ultrafiltrant (uf), V = volume of urine (u) and ultrafiltrant (uf), and
T=time in minutes from T1 to T2. The CI changing rate from D1 to
D7 was calculated according to cCI = (D7CI – D1CI)×100 / D1CI.
From ICU survival, two groups were individualized and compared.
Results The mean CI was 28.3±9.6 at D1 and 22.2±9.4mg/kg per
day at D7 (P<0.05); the mean cCI was –21.5±26.6%. The average
nPCR was 1.87±0.77g/kg per day, whereas the average nitrogen
supply was 0.14±0.06g/kg per day. ICU survival rate was 50%.
No correlation was found between nPCR and CI, nor between
nPCR and nitrogen supply.
Conclusion We conclude that CI before and 7 days after initiation of
ERRT is a predictive factor of outcome in ARF, and that a dramatic
decrease of CI after the first week of ERRT worsens significantly the
outcome. These results would also suggest that, in ARF patients, CI
and CI changes are better indicative of protein denutrition than nPCR.
Table 1
Deceased (12 patients) Survived (12 patients) P
CI D1(mg/kg per 24 hours) 24.0 ± 9.6 32.7 ± 7.9 0.02
CI D7 (mg/kg per 24 hours) 16.8 ± 6.6 27.5 ± 8.8 0.006
cCI (%) –29.7 ± 11.8 –13.3 ± 27.9 0.02
nPCR (g/kg per 24 hours) 2.0 ± 0.9 1.7 ± 0.6 NS
Nitrogen supply (g/kg per 24 hours) 0.16 ± 0.06 0.13 ± 0.07 NS
Correction (10 March 2003)
The original published version of the abstract (as shown above) included incorrect data in the 5th sentence of the Methods section. 
The sentence should read as follows:
CI was calculated at D1 and D7 according to the formula CI (mg/kg per 24 hours) = {[(CbT2 – CbT1) × weight × 0.6] / T + (Cu × Vu) / 
T + (Cuf × Vuf) / T} × 0.113 × 1440 / weight + [(CbT1 + CbT2) / 2] × 0.00429, where C= creatinine in blood (b), in urine (u) and in 
ultrafiltrant (uf), V = volume of urine (u) and ultrafiltrant (uf), and T = time in minutes from T1 to T2.S110
Purpose To study the immediate effects of a bolus of furosemide
on hemodynamics, in critically ill patients, before the appearance of
a significant increase in diuresis.
Methods A double-blind, placebo-controlled study in 34 critically ill
patients; 28 of them with sepsis. All patients participating in the
study had adequate diuresis (at least 0.5ml/min) and none had
received a diuretic in the past 8 hours. All patients randomly received
either a bolus of 40mg furosemide or 4ml N/S (placebo). Eight
hours later there was crossing over to the other branch of the study.
The physician recording the changes in physiologic parameters was
blinded as to the substance infused. We recorded CVP, systolic and
diastolic blood pressure and diuresis per minute at t0 (the time of
infusion), t1 (5 min from infusion) and t2 (15 min from infusion).
Results In the intervention group, CVP at t0 was
11.35±4.80mmHg (mean±SD) and there was no significant dif-
ference in CVP from t0 to t2 (paired t test). No significant differ-
ence was also observed in systolic and diastolic blood pressure
and in heart rate. Although there was an increase in diuresis at t2
compared with t0, it did not reach statistical significance. Addition-
ally, the observed changes at t1 and t2 in CVP, blood pressure and
diuresis in the intervention group did not differ from changes
observed in the placebo group.
Conclusion Before an obvious effect on diuresis has become
obvious, a bolus of furosemide has no immediate effect in CVP or
blood pressure in critically ill patients. Furosemide has no immedi-
ate hemodynamic effects independent of its diuretic action.
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Objective To compare the efficacy of continuous versus bolus
furosemide administration on urinary output, sodium and
furosemide excretion following paediatric cardiac surgery.
Design Prospective, double-blinded, randomised crossover study.
Patients Fifteen infants with postoperative oliguria (urine volume
<1ml/kg per hour) unresponsive to 10ml/kg 0.9% saline bolus
were enrolled in the study. Time of enrolment was between 16 and
24 hours post-PICU admission, which is the period of least ADH-
mediated antidiuresis. Diagnostic groups included Tetralogy of
Fallots (n=7), Norwood Stage 1 (n=2), VSD and arch repair
(n=2), and other (n=4).
Interventions Patients were randomly assigned to receive an
equivalent dose of furosemide either as a single bolus dose
(1mg/kg) with a placebo saline infusion or a continuous
furosemide infusion (0.2mg/kg bolus followed by 0.125mg/kg per
hour) and studied over a 6 hour period. After a 2 hour ‘washout’
period, the patients were crossed over and the study repeated with
the alternative administration method. Urine was collected every
2 hours for electrolytes and urinary furosemide concentration (mea-
sured by high-performance liquid chromatography) [1].
Measurements and results The median age (IQ) was 4.1 months
(0.1–7.6), weight 6.3kg (3.5–7.1) and duration of cardiopulmonary
bypass (n=13) was 99 min (74–112).
Figure 1
Cumulative urine output over time. Bolus therapy (closed circles), and
continuous infusion (open circles). Mean/SEM.
Figure 2
Cumulative furosemide excretion over time. Bolus therapy (closed
circles), and continuous infusion (open circles). Mean/SEM.S111
Cumulative urine output (Fig.1) and Na excretion were similar
between both groups (ANOVA, P=0.3) over the 6 hour study
period. However, cumulative tubular furosemide excretion (Fig.2)
was significantly greater following furosemide bolus (ANOVA
group effect, P<0.02). Additionally, cumulative K excretion was
similar between both treatment methods (ANOVA, P=0.3). No dif-
ferences were observed between treatment groups for the follow-
ing haemodynamic parameters; heart rate (ANOVA, P=0.9), mean
BP (ANOVA, P=0.9) or CVP (ANOVA, P=0.8).
Conclusion Furosemide administration by continuous infusion is
effective as bolus therapy in its diuretic and natriuretic effects in
oliguric infants following cardiac surgery. The continuous
furosemide infusion produces a greater diuresis per urinary tubular
furosemide concentration.
Reference
1. Mills J, et al.:  Quantification of furosemide from serum and
tissues using HPLC. J Chromatogr B 1997,701:65-70.
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Introduction Magnesium has been used since ancient times as a
purgative and uterine relaxant. We obtained excellent results in a
selected group of hypokalemic patients with impaired renal func-
tion by constantly monitoring serum levels of magnesium and cre-
atinine. The results were unexpectedly encouraging and
prompted us to use magnesium on these types of patients more
often.
Selection criteria Severe hypokalemia (K<3); baseline urine
output 5ml/kg per hour and more; serum creatinine 2–5. Anuric
and chronic renal failure patients were excluded from this study.
Methods Five grams of magnesium is administered in D5W over
8 hours for a period spanning up to five consecutive days monitor-
ing parameters such as urine output, creatinine, serum magne-
sium/potassium, deep tendon reflexes and patient outcome.
Results Total patients, n=55 (Fig. 1 and Table 1).
Conclusions Magnesium was given to treat hypokalemia refractory
and otherwise; patients responded very well.
Urine output increased substantially, through indirect diuretic
action of magnesium. Substantial decrease in the creatinine in
selected patients; an event quite unexplainable and contrary to
conventional wisdom, probably another salutary action of magne-
sium, more work is needed on this aspect. Reduction in creatinine
could not be achieved in septic/septic shock patients.
Table 1
Urine output  Urine output 
Serum K  Serum K  Creatinine  Creatinine  before Mg  after Mg 
Conditions n before Mg after Mg before Mg after Mg (ml/kg per hour) (ml/kg per hour)
Dehydration 25 1.5–3 4.5–5 1.4–5 0.8–1.4–1.6 0.5–1 1–3
CHF/LVF 16 2.5–3 3.6–4.5 2–7 1–1.5 0.5–1 1–2
Refractory hypokalemia K 14 2–3 4–4.5 0.8–1.2 0.8–1.2 1 1–3
Figure 1S112
Acute renal failure is a common complication of critical illness.
Renal replacement therapy with continuous venovenous haemofil-
tration (CVVH) is now a routine element of the organ support pro-
vided to these patients. The decision to initiate therapy is made on
the basis of fluid balance, electrolytes, the degree of accumulation
of urea and creatinine and, importantly, on the likely benefit to the
patient.
In order to help inform this decision we conducted a retrospective
audit of the outcome in terms of hospital mortality of patients
receiving CVVH in our district hospital general intensive care unit.
Records were reviewed covering a period of 7 years; September
1995–November 2002. Over this period of time there was a total
of 3848 admissions, with a mean APACHE II score of 16.2; these
patients had a mean hospital mortality of 26%. Over the same
period of time, 276 patients received CVVH. These patients had a
mean APACHE II score of 24.8 and a mean hospital mortality of
53.3%. Examination of the data by age group showed that, up to
the age of 75 years, the mortality rate was around the average.
From 75 years onwards, however, mortality increased rapidly, with
those aged 75–80 years having a mortality rate of 73%, and those
older than 80 years having 100% mortality.
Intensivists require a performance audit of this kind if they are to
establish reasonable limits to the extent of organ support. We
contend that this provides valuable information for clinicians at the
bedside and in discussions with patients and their relatives.
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Figure 1
P226 Time course of organ dysfunction comparing survivors and nonsurvivors: results of the multicentric study ‘Sepsis
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Introduction Multiple organ dysfunction syndrome (MODS) is the
main reason for death in septic patients. Most scoring systems are
aimed to calculate a sum parameter for estimating the individual
risk of the patient. This analysis describes the time course of organ
dysfunction comparing survivors and nonsurvivors.
Figure 1S113
Methods A total of 3147 patients (198 centers from 24 countries)
were included. The time period preceding the day of fatal outcome
(nonsurvivors) or ICU discharge (survivors) was analyzed and
plotted versus the severity of organ dysfunction (SOFA) and the
number of patients (3D histogram). In addition, the SOFA points of
each organ system were calculated over time, considering repro-
ducible time patterns of survivors versus nonsurvivors.
Results The ICU mortality rate was 18.5%. The overall time course
of organ dysfunction was as shown in Fig.1.
Analysis of single organ scores revealed that a cardiac failure was
preceding in the majority of nonsurvivors, whereas other early
organ dysfunctions were only rarely found. In contrast, the severity
of organ dysfunction decreased towards discharge in surviving
patients.
Conclusion This analysis demonstrates that 1) most survivors had
only minor organ dysfunction (one or two organ failures), and 2)
early cardiac failure is typical in nonsurvivors.
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MMODS is a simple modification of the Multiple Organ Dysfunc-
tion Score (MODS). MMODS is calculated by summing up MODS
with the Organ Support Score (OSS). OSS is a dichotomous
score of one or none, given to each organ support the patient
received, namely: ventilation, inotropes and renal replacement
therapy (CVVH). The maximum score a patient could receive
was 3. The above modification was made as MODS variables do
not account for the above therapeutic interventions, but can be
affected by them. This could result in an apparent false improve-
ment in the organ dysfunction parameters, which can affect quan-
tification of organ dysfunction and thus fail to describe organ
dysfunction precisely.
Objective To compare the sensitivity of MMODS with Sequential
Organ Failure Assessment (SOFA).
Design A prospective trial in a tertiary referral multidisciplinary
intensive care setting.
Patients and methods All critically ill patients admitted to the ICU
were studied. All necessary data to calculate daily MMODS and
SOFA were collected and entered into a dedicated database. ICU
outcomes of all patients were also recorded. The sensitivity of both
MMODS and SOFA were compared and the statistical signifi-
cance established using appropriate statistical tests.
Results Ninety-two patients were studied with a male to female
ratio of 2:1 and a mean length of stay of 8.72±8.0 days. The mean
age was 47.62±22.1. The mean MMODS for all patients was
6.41±3.74 and the mean SOFA was 6.66±3.72. The mean
MMODS for survivors was 5.23±2.70 and that of nonsurvivors
was 9.02±4.34 (P≤0.00). The mean SOFA for survivors was
5.61±2.86 and that for nonsurvivors was 8.97±4.32 (P≤0.00).
The contribution to ICU outcome (alive/dead) by both SOFA and
MMODS was evaluated by determining their coefficients in a logis-
tic regression model as shown in Table 1.
The performance of the logistic model was determined by the area
under the Receiver Operating Characteristic (ROC) curve.
MMODS demonstrated a significant effect on the ICU outcome
with an area under the ROC curve of 0.766 in comparison with
that of SOFA (0.726) (P≤0.002).
Conclusion The sensitivity of MMODS was significantly better
than SOFA. Increased sensitivity can augment the efficacy of a
scoring system and thus the evaluation of novel ICU therapies.
Further addition of the simple dichotomous OSS did not compro-
mise the simplicity of the original MODS.
Table 1
Variable β coefficient Wald Significance Exponential β
MMODS 0.304 34.994 0.000 1.355
SOFA 0.004 0.007 0.935 1.004
Constant –2.891 183.401 0.000 0.056
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Introduction  The Standardized Mortality Ratio (SMR) has been
designed as a measurement of the clinical performance in the
intensive care units (ICUs), because it compares the actual mortal-
ity rate with the predicted mortality for each group of patients in the
ICU. However, due to the existence of many scoring systems, an
approach that allows one to settle which scoring system better
shows the real performance of the ICU when it is used in the SMR
does not exist. Therefore, we defined as our objective to establish
a comparison between the results of the SMR using three different
scoring systems (APACHE II, APACHE III, SAPS II).
Methods We determined the severity of disease or injury of the
patients admitted to the ICU, using APACHE II, APACHE III, and
SAPS II. We also determined the crude mortality for each interval
of patients. Then we calculated the real mortality of each interval
and we obtained the SMR using the risk of mortality assessed by
APACHE II, APACHE III and SAPS II, divided by the crude mortal-
ity. Finally, we elaborated the curves of risk of death using the
results of each scoring system.S114
Results  In a prospective study, we collected data from 161
patients admitted in the ICU during 4 months (1 May
2002–30 August 2002). We included in our study 157 patients,
with an average age of 55 years. Seventy-two per cent (n=113) of
the patients included in our study were men, and 28% (n=44)
were women. Most of the patients came from the Emergency
Room: 51% from Maximum Urgency, and 20.4% from the Emer-
gency Operation Room. We obtained a crude mortality of 28%.
The averages of the scores were: APACHE II, 15; APACHE III,
44.7; SAPS II, 35.6. The tendencies of SMR using APACHE II,
APACHE III and SAPS II were compared. The tendencies obtained
from SMR using APACHE II and APACHE III showed a bigger dis-
persion of the results, especially in the intervals of more severity
when they were compared with the tendency of SMR using
SAPS II. From the three scoring systems used, APACHE II showed
higher values of SMR than those from APACHE III and SAPS II,
which demonstrate the inconsistency of the SMR when we use dif-
ferent scoring systems to determine it.
Conclusion Inconsistency exists in the SMR when we use the dif-
ferent scoring systems, especially when we analyze the higher
scores. We should carry out larger studies to define which scoring
system is the one that provides better information about the clinical
performance of ICU, when it is used in the SMR.
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Table 1
APACHE II 1–7 8–14 15–21 22–28 29–35
Risk of mortality 4.82 12.92 27.43 46.54 68.25
Crude mortality 0 12.7 42.5 60.7 50
SMR 0 0.982972 1.549398 1.304254 0.73260
Table 2
APACHE III 1–15 16–30 31–45 46–60 61–75 76–90 91 and more
Risk of mortality 1.7 3.21 7.12 13.94 26 45.13 70.3
Crude mortality 0 12 12.5 20 67.7 53.3 100
SMR 0 3.738318 1.755618 1.43472 2.603846 1.181033 1.422475
Table 3
SAPS II 1–10 11–20 21–30 32–40 41–50 51–60 61 and more
Risk of mortality 0.9 3.06 7.47 18.06 36.6 57.9 80.3
Crude mortality 0 3.03 17.9 20 37.03 70 88.9
SMR 0 0.990196 2.396252 1.10742 1.011749 1.208981 1.107098
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Introduction Although patients developing severe sepsis (SS)
incur high mortality and costs, the extent to which these events are
attributable to SS is unclear, especially in surgical patients. We
conducted a retrospective analysis of the US Medicare hospital
discharge database to estimate the resource use and mortality
attributable to SS in patients >65 years old.
Methods We selected all major surgical prospective payment
system (PPS) discharges from the FY 2000 Medicare hospital dis-
charge database. Costs were calculated by multiplying charges by
institution-specific cost to charge ratios. We defined SS as docu-
mented infection plus acute organ dysfunction using ICD-9-CM-
based criteria. We calculated hospital mortality, length of stay
(LOS), ICU LOS, and total cost for those with and without SS
within each surgical DRG. Attributable outcomes were defined as
differences in absolute outcomes between those with and without
SS within DRG.
Results There were 2.88 million major surgery PPS discharges, of
whom 99.903 (3.4%) developed SS. There were 834,722 dis-
charges that incurred ICU care, of whom 66,222 (7.9%) devel-
oped SS. In the entire SS cohort, the actual mortality was 26.4%,
the expected mortality was 4.8%, and the potential attributable
mortality was 21.6% (n=21,628). In the ICU SS cohort, the actual
mortality was 31.1%, the expected mortality was 8.4%, and the
potential attributable mortality was 22.6% (n=15,057). The addi-
tional SS deaths represented 23.7% of all surgical deaths and
25.3% of all surgical ICU deaths. SS was also responsible for
825,870 hospital days (4.2% of all), 443,113 ICU days (12.6% of
all), and US$1,812,415,000 hospital costs (4.7% of all costs).
This represents an additional 4.4 ICU days, 3.9 floor days, and
US$18,142 per patient.
Discussion The attributable mortality of severe sepsis in elderly
surgical patients appears to be as much as 22%. The only factorsS115
reducing this rate would be concomitant conditions that covaried
with SS and were not captured in our case-mix adjustment. Impor-
tantly, the attributable rate was so high that SS, although occurring
in only a small number of patients, resulted in one-quarter of all sur-
gical deaths. The attributable costs and resource use were also
very high.
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Introduction Sepsis is among the most lethal diseases in Hungary.
While there were 2659 septic events treated in intensive care units
(ICU) in Hungary in 2001, 42.7% of the treated patients died owing
to sepsis. Obviously, this figure calls attention to the need of mea-
suring the effectiveness and efficiency of sepsis treatment. There is
a considerable amount of information related to the effectiveness of
different treatment alternatives. In our study we aimed to assess the
cost-effectiveness of sepsis treatment in Hungary for the year 2001.
Methods To calculate the average efficiency of treatment of a
septic patient in an ICU in Hungary, we constructed a model. This
model was made up of three parts. In the first part we defined a
septic patient cohort based on the age and gender distribution of
all the septic cases treated in ICUs in Hungary in 2001. This
patient cohort entered into the second part of the model, where we
developed a time-dependent Markov model to describe and
analyse the route of Hungarian septic cases through a 28-day-long
period. We defined three Markovian states: survival in the ICU,
leaving the ICU or the hospital alive, and death in or out of the ICU.
Transfer probabilities were defined for each of the 28 days on the
basis of data collected for all septic events treated in ICUs in
Hungary in 2001 (data were provided by Hungarian governmental
health care information suppliers ‘GYOGYINFOK’). In the third
phase, patients’ life-long survival was modelled based on the
average age-specific life expectancy of the Hungarian population
(data source: Hungarian Central Statistical Office). Survival of the
septic patients was corrected by a factor of 0.51 taken from the
international literature. Cost data of treatment of septic patients
was collected in a nonrandom sample of six Hungarian ICUs.
Microcosts of the ICU treatment of 70 septic patients were col-
lected in 2002. Collection and analysis of cost data were
described in a detailed manner in another report. Cost per years of
survival was selected as a cost-effectiveness measure. During the
calculation of efficiency, we used a societal and a Health Insurance
Fund viewpoint.
Results The average survival of a septic patient was 8.6 years in
Hungary. The average cost of treatment was 1,036,474 HUF from a
societal and 462,765 HUF from a Health Insurance Fund (HIF) view-
point. Average cost-effectiveness of sepsis treatment was 120,458
HUF per life years saved from a societal view. The corresponding
figure was 53,765 HUF per life years saved from a HIF viewpoint.
Conclusion Considering all the factors, we found that our model
can assess the efficiency of sepsis treatment in Hungary in a valid
and reliable way.
P231 Outcome and cost of sepsis in intensive care units in Hungary
A Csomós1, G Hoffer2, L Kardos3
1Intensive Care Unit and 3Contract Medical Statistician, Markhot Teaching Hospital, 3300 Eger, Széchenyi út 27, Hungary; 2Contract
Health Economist, School of Public Health, Kassai út 26, 4029 Debrecen, Hungary
Critical Care 2003, 7(Suppl 2):P231 (DOI 10.1186/cc2120)
Introduction Septic patients do not just have higher than average
mortality, but the cost implications of their treatment are significant
as well. In this study we report the incidence of sepsis among
patients treated in intensive care units (ICU) in Hungary in 2001.
We also describe and analyse the outcome and cost of ICU treat-
ment of sepsis in Hungary.
Methods Our study consisted of two parts. In Part 1, we collected
data on nationwide incidence and mortality of sepsis cases treated in
ICUs in Hungary in 2001. We used secondary data provided by the
National Health System database (‘GYOGYINFOK’). All patients
were selected who complied with the following two criteria: the
patient was treated in an ICU and at least one septic ICD-10 code
was included in the diagnostic code list. In Part 2, we conducted
cost data collection and analysis based on the Cost Block Method
[1]. We selected a nonrandom sample of six intensive care units
where cost data of 10 severe sepsis patients were collected consec-
utively from 15 August 2002 backwards. Inclusion criteria were as
described in a sepsis definition paper [2]. In order to validate these
data, the participating units performed a prospective observational
data collection between 15 August and 14 September 2002.
Resource consumption of clinical support services, consumables
and cost of medical and nursing staff were collected on a daily basis.
Results We identified 2659 admissions with a septicaemia diag-
nosis code to ICUs in 2001. Mortality was 42.7%; the average
length of stay was 14.46 days (SD 17.44 days; median value 9)
among patients diagnosed with sepsis. After the intensive treat-
ment, patients remained treated in other inpatient units for a further
18.14 days on average (SD 18.05; median 12). Cost question-
naires based on 70 patients were returned, 60 with retrospective
and 10 with prospective cost evaluation of severe sepsis. The
average daily cost of sepsis was 101,737 HUF (412€), higher on
days 1–3 than later. The main cost drivers were consumables
(42%), clinical support services (19%) and staff cost (18%).
Conclusion The incidence and outcome of severe sepsis in
Hungary is similar to international data. Compared with our previ-
ous study [3], the cost per patient-day of severe sepsis is over
three times more (112€ vs 412€) than that of average intensive
care patients. In proportion to total cost, we spend much more on
drugs and less on personnel.
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Introduction Early goal-directed therapy (EGDT) for severe sepsis
and septic shock has been shown to significantly decrease 60 day
mortality and survivor hospital length of stay [1]. However, concern
exists over the additional resources and personnel required for this
labor-intensive therapy.
Methods We conducted a cost-effectiveness analysis of EGDT
from the US societal perspective, based on the results of a recent
randomized trial [1]. In constructing the reference case, estimates
of short-term effectiveness were based on 60 day survival. Short-
term costs were estimated from mechanical ventilation duration,
hospital length of stay, and the additional requirements for blood,
personnel and capital costs of EGDT. We estimated long-term sur-
vival from prior observational data in sepsis patients and long-term
costs using age-specific annual health care costs from the National
Center of Health Statistics’ Medical Expenditure Survey and pub-
lished costs of nursing homes.
Results The incremental cost-effectiveness ratio (ICER) of EGDT
over standard care was $25,600/QALY (quality-adjusted life-
year) (95% CI: $20,500–78,600/QALY). In multiway sensitivity
analyses, 94% of simulations had an ICER below
$50,000/QALY. EGDT was cost-effective (<$50,000/QALY) as
long as patient volume exceeded 16/year. Cost-effectiveness
increased with greater annual patient volume, decreased long-
term survival, decreased annual health care costs, and decreased
capital costs. EGDT remained cost-effective even if its 60 day
mortality effectiveness was only 20% of that reported by Rivers
et al. [1] (Fig.1).
Discussion EGDT is cost-effective for severe sepsis and septic
shock over a wide range of assumptions.
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Introduction The effect on health of socioeconomic deprivation
has been demonstrated in many areas such as risk for myocardial
infarction [1]. There is little data on its effect on intensive care mor-
tality. The Scottish Intensive Care Society Audit is a computer-
based audit system that all 26 adult general ICUs in Scotland
contribute to. Consequently there is a database for the whole
country. In Scotland, the socioeconomic deprivation category
(DepCat) can be designated by postcode using the Carstairs
score [2]. This is based on housing density, car ownership, male
unemployment and the head of the household’s social class, and
ranges from 1 (most affluent) to 7 (most deprived).
Methods Between 1 January 1995 and 31 December 2000, audit
data were collected prospectively on 44,000 consecutive admis-
sions to all adult general ICUs in Scotland. The Information and
Statistics Division of NHS Scotland undertook the linkage of the
ICU data to hospital activity episodes (Scottish Morbidity Records)
and Registrar General death records. All data were standardised
for age and sex. The Standardised Mortality Rate (SMR) by
DepCat was calculated by comparing the expected and observed
mortality for each DepCat. This enabled us to assess the impact of
socioeconomic deprivation on outcome of ICU admissions.
Results A total of 33,337 case records were able to be allocated a
DepCat score. The SMR for these patients ranged from 0.97 for
DepCat 1 to 1.32 for the most deprived in DepCat 7 (see Table 1).
Conclusions Socioeconomic deprivation appears to affect ICU
mortality with a worsening mortality with worsening deprivation.
The exact causes for this are unclear but may be due to a multitude
of small chronic comorbidities such as smoking, obesity, poor nutri-
tion, alcohol abuse, drug misuse rather than severe chronic ill
health. More work is, however, required to further evaluate this.
Table 1 Standardised ICU mortality by deprivation category
DepCat group 1 2 3 4 5 6 7
SMR 0.97 0.93 0.88 0.99 1.0 1.1 1.32S117
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The Modified Early Warning System (MEWS) was introduced in
1998 to aid in the detection of critical illness within the ward
setting. Strong links were forged between outreach, physiotherapy
and surgery from 1998, as the critical care physiotherapist covered
both areas. Formalisation of multidisciplinary outreach was
achieved in June 2001, with the appointment of an outreach phys-
iotherapist whose role includes not only critical care patients, but
also hospital-wide, ward-based, outreach. Retrospective audit data
on frequency of callout by speciality was collected over 4 month
snapshot periods (April, May, June, and July) for the years
1999–2002 in order to analyse outreach physiotherapy impact on
emergency physiotherapy callouts.
The hospital has a total of 575 beds, of these 424 are inpatient
with 60 acute surgical and 114 acute medicine. The majority of
callouts were to the acute surgical wards (142) in contrast to
acute medicine (42). Evening callouts to acute surgery showed a
consistent decline, as did the frequency of weekend daytime on
call requests. This finding is not surprising, as multidisciplinary out-
reach intervention has been embraced primarily within surgery.
Figure 1 demonstrates the reduction in callouts over the past
4 years. Further audit over the winter period is necessary.
Monitoring the number of out-of-hours physiotherapy callouts is
one way of assessing the impact of specific physiotherapist roles
within outreach.
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Introduction It is very important to maintain the balance between
the clinical and the economical vectors in the situation of strictly
limited resources in the real clinical practice in Russia. The system
of clinical governance must be called into play for this purpose.
The most important sector in the use of clinical governance is the
intensive care units.
Materials and methods Using a computer, the analysis of the
quality of drug-prescribing in the intensive care units of the
Sverdlovsk Area in Russia was carried out by the experts in clini-
cal pharmacology. The methodology of constructing the models of
drug help standards for the intensive care units by computer was
based on the hierarchical principle of structured organization of
the ‘elementary syndromes’ and the corresponding ‘elementary
standard drug protocols’. Databases were set up containing (a) a
list of all drugs and their current market prices, and (b) protocols
for the list of drugs allowed for a given diagnosis on a patient in
intensive care. It became mandatory to use only those drugs in the
list.
Results It was established that 20% of drugs used in the intensive
care units had no proven effectiveness and were therefore not
included in the standards of drug help in the Government Pro-
gramme. In 10% of clinical cases, when antibiotics were used, the
choice of antibiotics was not optimal and rational. In order to regu-
late the quality and rationality of fulfilling the drug help standards
within the framework of the Area Government Programme, stricter
guidelines were laid down. These resulted in a 20–25% reduction
in costs of the drugs used in intensive care. The strict protocol for
using antibiotics has reduced the length of stay for patients in the
ITU. Errors in prescribing have been prevented. This new system
was welcomed by the clinicians.S118
Intensivists are reluctant to take the step into paperless documen-
tation in the ICU mainly due to uncertainty concerning the time
investment, the impact of a radical change in documentation
method on the staff as well as reliability of the software and hard-
ware involved. We describe the implementation of a computerized
data collection and management system — ‘Metavision’ (IMD-
Soft®) — in a 10-bed general ICU (admission rate 750
patients/year) of a 1200-bed tertiary care medical center.
Methods Metavision, which is Windows™ (Microsoft®) based, is a
program charting patient clinical data, including monitoring para-
meters, medical and nursing treatment orders, treatment reports,
diagnoses, followup documentation and laboratory results, which
are inserted either automatically or manually. The system data col-
lection is based on a central server for data storage connected via
the intranet with bedside terminals and other user stations in the
ward. Most of the medical and nursing staff were computer users
with basic knowledge of Windows™, while 20% had no computer
experience at all.
Implementation was divided into three phases, Phase 1 (3 weeks),
project manager and superusers were trained, and the database
was customized to local ICU needs. Phase 2 (4 weeks), configura-
tion and programming of interphases as well as staff training
(12 doctors, 51 nurses, a pharmacist, a physiotherapist, a social
worker and a respiratory technician underwent 45 min of individual
teaching and 45 min of exercise training). The project manager
invested 240 hours in training and customization. Phase 3 Go-live
(105 days after start day), documentation was switched to com-
puterized charting with no double charting. No major difficulties
were registered. Since then all data collection is automated and
the documentation is paperless.
Conclusion: A paperless documentation data collection program
in a 10-bed ICU can be implemented in a relatively short period
with no major difficulties.
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Introduction The Early Warning Score (EWS) [1] has been deliv-
ered within the trust for 2 years. In our institution, the EWS proto-
col has been modified to allow a nurse intervention when EWS=3
(Appendix 1). The aim of the study was to look at the efficacy of
nursing interventions in medical and surgical patient groups.
Method Data were prospectively collected within the surgical and
medical wards over a period of 10 weeks. We recorded informa-
tion for any patient who triggered EWS≥3. The person performing
the first intervention and the prevention of further triggers was
noted.
Table 1
Patients on medical ward Patients on surgical ward Fisher’s exact test, P
Total triggering 500 398
Nurse therapy as first intervention 301 (60%) 42 (16%) < 0.0001
EWS successfully reduced by nurse therapy 188 (62%) 42 (61%) NS
Patients who retrigger following nurse therapy 110  18  NS
Appendix 1
Early Warning Score used in Central Manchester and Manchester Children’s University NHS Trust
32 1 012 3
HR ≤ 40 40–50 51–100 101–110 111–129 ≥ 130
SBP ≤ 70 71–80 81–100 101–199 ≥ 200
RR ≤ 8 9–14 15–20 21–29 ≥ 30
Temperature (°C) ≤ 35.0 35.1–36.0 36.1–37.9 ≥ 38–38.9 ≥ 39
CNS Alert Voice Pain Unconscious
Alert, patient is alert and orientated; Voice, patient responds to voice; Pain, patient responds to painful stimuli; Unconscious, patient is
unconscious.S119
Results Nurses caring for acutely unwell medical patients were
able to intervene in 60% of initial triggers without having to call for
a doctor (Table 1). These interventions successfully reduced the
score in 60% of cases. By contrast, in the surgical group, 16% of
triggers were initially dealt with by the nursing staff, and these
interventions were successful in 60% of cases.
Conclusion A number of factors could explain these differences:
the intensive education package that accompanied the introduction
of the score into medicine, differences within the patient groups,
and the use of medical ward nurses assisting in the implementation
of the score into their areas. Nursing intervention appears effective
as first-line treatment for a trigger in many medical patients and we
believe it is a useful part of the EWS protocol.
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Aim Clinical knowledge and its application underpins delivery of
adult care in our hospitals. Such deficits are well recognised [1,2].
The Greater Manchester Network assessed clinical knowledge and
its application within the trusts in our area.
Method Eleven hospitals were involved in the design and applica-
tion of a questionnaire that asked specific questions in relation to
applied physiology and care of acutely ill patients.
The questionnaire was distributed to coordinators in 11 hospitals
across the network. There were 240 replies (72% response) and
they were completed by: nurses n=134; medical staff n=42;
physiotherapists n=48; and 24 other/unrecorded. The specialities
of those questioned varied with the majority from medical and sur-
gical areas; n=79 and n=72, respectively. The questionnaire con-
tained questions relevant to basic and applied physiology (25); and
qualitative questions pertinent to their perception of their ability to
deal with ill patients
Results Respiratory system; 16% recognised all the signs of respi-
ratory distress; 22% did not know how much oxygen was in room
air; 27% correctly identified factors relevant to the measurement of
oxygen saturation. Forty-eight per cent recognised what respiratory
rate reflects; 50% failed to recognise the role of supplementary
oxygen in an acute asthmatic attack. Forty-two per cent knew when
to take a manual pulse. Eighty-seven per cent knew the normal
range for potassium; 31% recognised the implications of
hypokalaemia and 54% knew what caused hyperkalaemia. Interest-
ingly, even though the questionnaire had areas that required inten-
sive teaching, 71% of the participants said they felt confident in
looking after acutely ill patients.
Conclusion To address this deficit, education and training had
commenced in all the trusts surveyed. A central training centre has
opened within the network and a shared programme of education
has been instituted. The schools of nursing have been approached
to look at preregistration training to try to address these issues
earlier, and the same is to occur with the other training institutions.
Acknowledgement  With thanks to the Greater Manchester
Network Outreach Forum.
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Introduction  Our Trust recently established a critical care out-
reach service. The objectives of the team are to enhance the
quality and continuity of care for critically ill patients and to share
critical care skills with ward staff. Historically, critical care areas
within the Trust have experienced a reluctance from ward nursing
staff to accept patients back into the ward area who still require a
high level of nursing intervention. It became apparent that skill
deficits existed among the ward staff and highlighted the need for
more skills training. The aim of this study was to conduct a training
needs analysis to ensure that future skills training was based on
the ward staff’s perceived needs as opposed to those perceived
by the outreach team.
Table 1
Central lines  CVP  Tracheostomy  CPAP  ECG  Airway  O2
(%) monitoring (%) (%) (%) monitoring (%) suction (%) therapy (%)
Frequency > monthly 41 28 11 15 66 49 0
Frequency < monthly 59 72 89 85 34 51 100
Confidence (high/very high) 38 36 18 12 41 83 59S120
Method A questionnaire was distributed to a random sample of
139 nursing staff of all grades across the Trust. It asked respon-
dents to report knowledge, competence and confidence in the fol-
lowing areas of care: tracheostomy, central lines, CVP monitoring,
CPAP, ECG monitoring, airway suction and oxygen therapy.
Respondents were also asked to report on the frequency with
which they used these skills.
Results Responses were received from 71 staff (51%). The fre-
quency with which skills were used by ward staff and their self-
reported confidence are displayed in Table 1.
Discussion  Apart from ECG monitoring and airway suction,
respondents performed the remaining interventions infrequently.
Lack of knowledge, confidence and competence in performing a
skill may lead to a reluctance to perform that skill. Similarly, infre-
quent opportunities to practice a skill can lead to low levels of con-
fidence. A self-sustaining vicious circle of low utilisation and poor
confidence can then be generated. Following the results of the
initial questionnaire, the Outreach Team implemented a variety of
educational activities including a Critical Care Skills Day and the
multidisciplinary ALERT course in order to address the low levels
of confidence among ward staff. Access to work-based education
and training is essential for ward nurses in ensuring they are com-
petent to assess and manage acutely ill patients who are at risk of
deterioration. Further work to evaluate the impact of this educa-
tional package is now required.
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Introduction Diagnostic blood sampling is an indispensable and
effective tool for assessing critically ill patients. However, the
amount of blood drawn daily can be substantial and deleterious to
patient care [1]. A recent survey [2] on arterial blood sampling
practices in the ICU in England and Wales concluded that blood
conservation is underused. There is commercially available equip-
ment to assist in this by ensuring that the amount of blood dis-
posed during sampling could be kept to a minimum. This
equipment significantly increases the cost of most critically ill
patients. We therefore designed, taught and assessed a sampling
technique that could be performed without modification of the
standard transducer connection, in which any blood returned was
always contained within the closed sterile environment of the trans-
ducer tubing.
Method Blood was initially drawn form the distal three-way tap
through the 120cm extension tubing. As soon as blood reached
this three-way tap, a total of 2.8ml had been withdrawn and a
further 0.2ml was withdrawn from the proximal tap, followed by the
sample in the usual way. The blood still within the tubing could be
flushed back to the patient. In this way we were able to reduce
blood wastage from 3ml to 0.2ml per sample. We trained all staff
for a 2 month period and then proceeded to audit the use of this
technique, allowing us to estimate the amount of blood wastage
that was saved over a 2 month period.
Results During the study period, 949 separate sampling episodes
occurred in 63 patients. All staff confirmed that they had followed
the new technique during this period, and daily observation by the
authors failed to identify any episode when this was not the case.
During the study period, the technique reduced blood wastage
during sampling by 2657ml.
Conclusions This technique is a simple cost-effective approach
that minimises blood wastage which could be successfully taught
and is feasible for everyday use in the critical care environment.
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Introduction Diagnostic blood sampling is an indispensable and
effective tool for assessing critically ill patients. It has been demon-
strated that a substantial blood volume is drawn daily from these
patients [1]. A recent review of UK practice suggested a number of
measures to reduce this [2]. Furthermore the recent introduction of
an integrated electronic record-keeping system in our unit ensured
that maximum information could be derived from each sample. In
order to assess whether it is possible to optimise the amount of
blood sampled, we performed a prospective cohort controlled
study to compare blood volumes used for sampling before and
after a 2 month education period.
Method Sample frequency for both laboratory investigations and
near-patient testing (NPT) was derived from the electronic record
for all patients treated in our ICU during two periods of 2 months.
Education included information on unit guidelines on sample
requirements, demonstration of the benefit of end-tidal measure-
ments and oximetry, the accuracy of near-patient equipment, as
well as education of a new technique designed to minimise blood
wastage. Cost per sample was provided by the laboratory manage-
ment. All sample data were evaluated on a per patient-day basis.
Results There was a significant reduction in total volume, blood
wastage, the frequency of laboratory and near-patient tests per-
formed and overall cost following education (Table 1). Demographics
were not significantly different in the two groups.
Conclusions Education can significantly reduce the volume of
blood used for sampling by ensuring that full use is made of all
information. Our data suggest that this volume is clinically impor-
tant and, furthermore, that this approach can also produce sub-
stantial cost saving.S121
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Table 1
Before education (n = 43) After education (n = 63)
Patient-days (total) 263.1 221.5
APACHE II 21 (6–36) 19 (3–36)
Volume sampled (ml/day) 93.5 (76.4–110.5) 46.0 (36.9–55.1)**
NPT (n/day) 7.1 (6.1–7.9) 5.1 (4.2–6.0)*
Laboratory tests (n/day) 8.7 (6.2–11.3) 5.2 (4.3–6.1)*
Blood discarded (ml/day) 20.9 (18.2–23.6) 1.0 (0.8–1.2)**
Costs (€/day) 94.36 (71.81–116.91) 59.24 (50.13–68.35)*
Data presented as mean (95% confidence intervals), except APACHE as median (range). * P < 0.01, ** P < 0.001.
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Background After the chemical weapon terrorism with SARIN
(methyphosphonofluoridic acid 1-methyl-ethyl ester), a nerve agent
used in Tokyo, Japan in 1995, the Ministry of Health and Welfare
set up the chemical material’s analyzers for countermeasure imme-
diately at 73 emergency centers in Japan. On the other hand, there
are no rare intoxication patients who are transferred to the emer-
gency center and admitted in the ICU because of unconscious-
ness and critical cases. It is important to judge chemical materials
for intoxication cases immediately and also to discriminate what
cause to unconsciousness by intoxication or other diseases. The
purpose of this study is to assess the efficacy of HPLC in the
emergency room and ICU for the unconscious and critical patients
caused by intoxication compared with Triage® (Biosite Diagnos-
tics, San Diego, CA, USA), which is the usual method.
Materials and Methods The clinical records of 120 intoxication
patients who underwent treatment in our emergency room and ICU
between 1999 and 2002 were reviewed retrospectively. These
patients included 40 men and 80 women ranging in age from 17 to
84 years (mean 33±2.1 years).
To evaluate the usefulness and efficacy of HPLC for the critical
cases, we surveyed the detective ability, the duration of examina-
tion, the expense per sample and the technical skill of HPLC com-
pared with Triage®.
Results The drugs and poisons that patients took are presented in
Table 1. Table 2 shows characteristics of HPLC and Triage®.
44.8% of drugs and poisons were detected only by Triage® and
they are some benzosiazepines, hemp and stimulants. Also, HPLC
was not useful for them. 25.4% of materials were positive by HPLC
but negative by Triage®. These chemicals were carbamazepine,
levomepromazine, bromovalerylurea and agricultural chemicals.
9.7% were detected with both of HPLC and Triage®, but 20.1%
were not detected with either HPLC or Triage®. These chemicals
were nicotine, magic mushrooms, bleach, lithium carbonate, and
insecticide (Table 3).
Discussion HPLC is superior to specify the chemicals compared
with Triage®, which can detect only the metabolized products.
Moreover, since HPLC has begun use in our institution, the per-
centages of detection of chemical materials has elevated more
than 25%. However, HPLC takes a long time to get the results, at
much expense and requires more technical skills. Therefore, to
improve the diagnosis for intoxication patients in critical cases, we
should examine with both HPLC and Triage®. But first, Triage®
should be done and, if its result is negative, afterwards HPLC
should be carried out. Furthermore, it was not able to detect
around 20% using both HPLC and Triage®. This result suggests
we have to take into consideration HPLC is not enough equipment
for all chemical materials and we should consider the countermea-
sure for negative materials.
Table 1
Chemical Number of cases
Medicine 100
Amphetamine 6
Agricultural chemicals 5
Nicotine 2
Cocaine 2
Magic mushroom 1
Hemp 1
Bleach 1
Kmarine 1
Adhesive agent 1S122
References
1. West A, Frost M, et al.: Int J Legal Med 1997, 110:251-253.
2. Schwartz JG, Hurd IL, et al.: Am J Emerg Med 1994, 12:513-516.
Critical Care    March 2003 Vol 7 Suppl 2 23rd International Symposium on Intensive Care and Emergency Medicine
Table 2
HPLC Triage®
Kinds of samples Urine, blood, gastric juice Only urine
Duration (min) 120–180 15
Cost ($/sample) 165 37
Technical skill Difficult Easy
Table 3
HPLC-positive (%) HPLC-negative (%)
Triage®-positive 9.7 44.8
Triage®-negative 25.4 20.1
P243 Admission to an adult intensive care unit for poisoning: a review of 230 cases
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Background Poisoning remains a serious public health problem
despite regulatory interventions and medical advances.
Objective To evaluate epidemiological features of poisoning in our
adult ICU (AICU).
Patients and methods We reviewed all patients treated for poi-
sonings in the AICU of University Hospital in Ezurum, Turkey,
between May 1997 and October 2002. A retrospective study was
conducted.
Results Reasons for admission to the AICU were the need for ven-
tilator treatment or invasive monitoring of vital functions. Two
hundred and thirty patients (126 men [57%], 104 women [43%],
mean age 34 years) were treated for poisoning in the AICU. Spe-
cific poisons have been presented in Table 1.
Seventy-three per cent of the patients (n=168) had attempted
suicide, most of them using drugs (n=123). Eleven patients
(6.5%) died. Twenty-seven per cent of the patients (n=62) were
admitted because of accidental poisoning, most of them expected
to be CO intoxications (n=30). Eleven patients (17.7%) died. The
most common cause of death was methyl alcohol poisoning (death
rate 42.8%).
Conclusions In adults, self-poisoning is usually deliberate (suicide
or parasuicide) [1]. Although advanced life support and antidotal
treatments were available, mortality was high. Concrete preventive
measures are mandatory to prevent loss of life and health care
resources.
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Table 1
Agent Total 
Number Died death death 
Causes of poisoning Recovered rate (%) rate (%)
Drugs 123 114 9 7.3 4
Organophosphate 46 44 2 4.4 0.87
Carbon monoxide 30 28 2 6.66 0.87
Methyl alcohol 14 8 6 42.8 2.6
Botulism 8 6 2 25 0.87
Mushrooms 6 5 1 16.6 0.34
Sulphur 2 2 – – –
Lithium 1 1 – – –
Total 230 208 22 – 9.55
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Introduction Organophosphate pesticides are widely used agricul-
tural products that act as acetycholinesterase inhibitors. This study
aimed to describe the presentation and management of
organophosphate poisoning (OPP) in the intensive care unit (ICU).
Method  Retrospective examination of medical records from
25 patients with OPP, who were admitted to the ICU and remained
for  ≥24 hours. Diagnosis was performed from the history taken
either from the patients or from the patient’s relatives. Demo-
graphic, survival data and day 1 APACHE II, APACHE III and
Glasgow Coma Scale (GCS) scores were recorded.
Results There were 20 female and five male patients. Twenty-two
of 25 patients (88%) attempting suicide were admitted to the ICU,
with a mean stay of 11.9 days (range 1–61 days). The
organophosphates were parathion, fenthion, malathion, and diazi-
non. Gastric lavage was performed, and activated charcoal was
administered to all patients. Atropine sulphate was administeredS123
intravenously in repeated doses or infusion to all patients with
bradycardia, diarrhea, salivation, and miosis. Pralidoxime was used
for 24 patients. Mechanical ventilation was required by 68% of
patients because of bronchial secretions, altered conscious level
and paralysis. The mean APACHE II and APACHE III scores were
9.4±5.9 and 34.5±17.5, respectively. Intermediate syndrome
was observed in two patients. Four patients died from ARDS, and
three died from septic shock. Serum cholinesterase level at admis-
sion was well correlated with APACHE II, APACHE III and GCS
scores.
Discussion Ingestion of organophosphate compounds in an
attempt at suicide is a major problem, especially in developing
countries because of the wide availability of pesticides as result of
extensive use in agriculture, and uncontrolled sale of these agents
all over the country. OPP is a serious condition that needs rapid
diagnosis and treatment. Delay in discovery of poisoning and in
seeking medical assistance, inadequate airway management and
severity of OPP may contribute to mortality in these patients.
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Introduction In Scotland, 3% of intensive care admissions relate
to drug overdoses. In Greater Glasgow, £12 million are annually
spent on drug misuse services. UK studies have related a thera-
peutic intervention scoring system (TISS) to expenditure [1]. We
investigated the costs of overdose admissions in a teaching hospi-
tal intensive care unit (ICU) from 1 January 1997 to 31 December
2000.
Method Data were collected prospectively for all overdose admis-
sions to the intensive care unit using Ward Watcher software (Crit-
ical Care Audit Ltd, Yorkshire, UK).
Result A total of 3.8% (n=70) of all ICU admissions (n=1846)
were due to overdoses. During the same period, the Accident &
Emergency Department admitted 4097 patients with the same
diagnosis. Comparing overdose patients with the whole ICU popu-
lation, the mean age was 36.6 years versus 56.5 years; mean stay
was 1 day (median 0.8) versus 4.02 days (median 1.8); TISS score
was 41.8±30.3 versus 144.7±171.7; and available APACHE
scores were 15±6.5 versus 18.84±7.48. Overdose mortality was
3%. Overall ICU mortality was 23%.
Over the 4 years, the whole ICU population accumulated a TISS
score of 266,360. On a basis of £25–31 per TISS point, this
relates to an expenditure of £6.7–8.3 million. The overdose group
collected a score of 2926, giving an overall cost of £0.07–0.09
million.
Conclusion Drug overdoses accounted for 3.8% of ICU admis-
sions but only for 1.1% of the overall treatment costs. Only 1.7% of
overdose hospital admissions required ICU admission. Neverthe-
less, drug overdose admissions are a significant component of the
workload and costs of our ICU.
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Table 1
Cost
Cost
Mortality  Stay in days  APACHE score  TISS score 
(%) (mean [median]) (mean [SD]) (mean [SD]) £ million € million
All ICU admissions (n = 1846) 23 4.0 (1.8) 18.84(7.48) 144.7 (171.7) 6.7–8.3 10.4–12.9
Overdose admissions (n = 70) 3 1.0 (0.8) 15.0 (6.5) 41.8 (30.3) 0.07–0.09 0.11–0.14
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Introduction Successful risk management requires a robust
system for adverse incident (AI) reporting and analysis. Although
many ICU studies have focused on AI categorisation and examina-
tion of factors immediately preceding the AI, few have investigated
the potential contribution from latent or hidden factors (e.g. poor
staff supervision). This phenomenon is well known in other
complex, nonmedical systems such as the aviation and nuclear
industries.
Aim To establish latent risk factors for AI occurrence in a tertiary
PICU.
Methods Data were collected prospectively from 730 consecutive,
12-hour nursing shifts over a 12-month period (816 patient
episodes, standardised mortality ratio 0.77). Incidents were
reported and categorised using a standardised format. Factors
potentially contributing to the occurrence of an AI were classifiedS124
according to temporal aspects (time of day, weekend, etc.), bed
occupancy, patient dependency, patient flux, nursing and medical
skill-mix, junior medical staff supervision, nursing agency (locum)
use and a weighted, composite score quantifying several factors
that may compromise the clinical supervisory role of the nurse in
charge (e.g. patient death on a shift, logistical issues with support
staff such as porters, coverage of meal breaks, etc.). Two logistic
regression models were constructed: one examining the relation-
ship between these variables and the type of AI; the second exam-
ined potential interaction effects between clinically related
variables (e.g. ‘patient workload’ combines bed occupancy with
patient dependency).
Results Two hundred and eighty-four AI occurred during 30%
(220/730) of shifts, of which 181 were patient related and 103
unit or staff related. Patient-related AI were categorised as: drug
errors (55), intravenous/arterial line problems (37), equipment
issues (32), patient injury (26), standard of care (21) and self-extu-
bation (10). One hundred and thirty-four (74%) of the patient-
related CIs resulted in actual harm to the patient, of which 49
(27%) were deemed serious.
Both unit-related and patient-related AI were more common during
the day shift (the period of greatest ICU activity). Unit-related AI
were also associated with factors compromising the senior nurses’
supervising role, OR 1.31 (95% CI 1.03–1.68), while patient-
related AI were less common with increased junior doctor supervi-
sion, OR 0.61 (95% CI 0.40–0.91). Factors associated with the
various categories of patient AI (drug errors, self-extubation, etc.)
included: patient dependency, bed occupancy, number of admis-
sions/discharges per shift, increased nursing agency use, and
absence of a senior sister on the shift. The second regression
model, examining interaction effects, demonstrated an interaction
between nursing supervision factors for unit-related AI, and patient
workload factors for patient-related AI. Both models demonstrated
excellent goodness of fit (Hosmer Lemeshow P>0.10).
Conclusion AI are common and are associated with many latent
factors including time of day, nursing and medical supervision, and
patient workload. This model may provide a focus for strategies
aimed at reduction in AI.
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Introduction Iatrogenic complications (IC) are defined as an
adverse event that occurs independently of the underlying disease.
In fact, in the USA, IC are noted in 4% of hospitalised patients
leading to death in 14% of cases.
Aim To evaluate the incidence and types of IC in the ICU, their
repercussions on morbidity and mortality rates and to identify the
associated factors of risk.
Materials and methods A prospective study, performed between
February 2002 and November 2002. All episodes of IC are
recorded. The type, the cause and the repercussions are noted. IC
were divided, according to their consequences, into three cate-
gories: major, moderate and minor.
Results One hundred and thirty-two patients were hospitalised
during the period of study with mean age 45±19 years, sex ratio =
1.6, SAPS II = 37±18, APACHE II = 18±10, MacCabe =
0.95±0.89, LOD = 6.5±3.75. Fifty-four per cent needed mechan-
ical ventilation. One hundred and thirty-nine episodes of IC
occurred in 59 patients. Incidence 44.7%, prevalence 42.5% and
density of incidence of 101/1000 day stay in the ICU. Cardiovas-
cular complications are the most frequent ones, including mainly
hypotension and arrhythmia (54%). The incidence was judged
major in 26 cases, leading to death in four cases, moderate in 60
cases and minor in 53 cases. Risk factors retained are: prognosis
indices (SAPS II, APACHE II), a high or excessive nursing work-
load expressed by the OMEGA score, duration of mechanical ven-
tilation and length of stay in the ICU.
Discussion IC are frequent, they are induced by the development
of invasive techniques of investigation and monitoring, human errors
and a high or excessive nursing workload. Their pathogenesis is
related to the acute disease and the characteristics of the ICU.
Conclusion To decrease IC incidence, human and material
resources must be optimised and the indications of invasive inves-
tigations and monitoring must be more rigorous.
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Introduction The aim of this study was to determine the level of
‘near-miss maternal mortality’, due to severe obstetrical complica-
tions or maternal disease, in the largest public hospital of Greece.
The objective was also to identify risk factors and outcome of preg-
nant women who required intensive care.
Methods During the period 1990–2001 (12 years), all pregnant
patients who were transferred from the Department of Obstetrics
to the ICU of ‘Hippokration’ General Hospital of Thessaloniki, were
retrospectively included into the study. A ‘near-miss’ describes a
patient with an acute organ system dysfunction that, if not treated
appropriately, could result in death. The cases fitting this definition
and all maternal deaths were analysed. Several factors were
looked for and noted: a) the demographic characteristics of the
patients, b) the diagnosis at admission in the obstetric unit, c) the
indications for admission in the ICU, d) the type of surgery, e) the
consultation of other specialities in the management of the critically
ill, f) the time of hospitalization, and g) the outcome.S125
Results Over 12 years there were 43,754 deliveries in a general
hospital with four university obstetric clinics, which covers the area
of North Greece with a population of nearly 3 million habitants.
One hundred and twenty-two women required transfer for critical
care in the ICU (0.28%); of these, 21% had no medical insurance
and were immigrants. Mean age was 29.1 years. The main causes
of admission in ICU were respiratory insufficiency (32.8%), hypov-
olemic shock due to hemorrhage (27.1%), hypertension (26.3%),
and sepsis (7.4%). Mean time of hospitalization in the ICU was 4.9
days. Several complications, such as DIC, ARDS, acute renal
failure, cerebral hemorrhage, and cardiac dysfunction, needed the
contribution of other specialities. The majority required ventilatory
support, vasoactive drugs and blood transfusions. There were
12 deaths (mortality rate 9.8%).
Conclusions The term ‘near-miss mortality’ implicates the poten-
tially mortal complications of pregnancy that needed admission in
the ICU. In our study it is 0.28%, and it shows the risks of preg-
nancy nowadays and indicates the quality of the obstetric care in
our country.
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Introduction This pilot study aims to find stress (S) and other per-
sonality traits (physical symptoms [PS], anger [A]) among the ICU
staff, and any existing correlation between them and length of
working time (LWT) in the ICU and with educational level (EDL).
Materials and methods The staff (university degree doctors
[UDD], university degree nurses [UDN], technician nurses [TN]
and lower degree staff) of the General ICU (GICU), n=32, and the
respective of the Medical ICU (MICU), n=15, answered the SCL-
90-R questionnaire (a short type of the Minnesota Personality
Inventory) in association with LWT in the ICU, with EDL and demo-
graphic data. We evaluated mean values of scoring points for
stress (S), physical symptoms (PS) and anger (A), between the
two ICU’s staff and LWT and EDL.
Results MICU pathologic scoring: 2/15, 13.3%. PSa: 11.6 points,
PSb: 26 points, Sa: 8.2 points, Sb: 9 points, Aa: 5.25 points, Ab:
9 points. EDL MICU: 2/2 LDS. LWT mean in years: 9. GICU patho-
logic scoring: 3/32, 9%. PSa: 10.5, PSb: 14.25, PSc: 10.5, Sa:
6.5, Sb: 7.5, Sc: 7.5, Aa: 4.6, Ab: 3.5, Ac: 3. EDL GICU: UDD 1/3,
UDN 1/3, TN 1/3. LWT GICU mean: 11 years.
Conclusion Between individuals of the two ICUs, it seems that
MICU staff with a lower degree of education experienced more
stress, anger and physical symptoms than GICU staff.
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Introduction This pilot study aims to define the occurrence of
depression in ICU staff in relation with length of working time
(LWT) in the ICU and with educational level (EDL) (university
degree doctor [UDD], university degree nurse [UDN], technician
nurse [TN], lower degree staff [LDS]).
Materials and methods The staff of the General ICU (GICU:
n=32) and the staff of the Medical ICU (MICU: n=15) answered
the BDI-II questionnaire, which measures depression, in correlation
with EDL, LWT and demographic data. Depression score: 10–17
points = mild, 18–30 points = moderate, >30 points = major.
Results Total depression in GICU 37.5% (12/32) and in MICU
26.6% (4/15). Mild: GICU (n, %): 6/12, 50%; MICU (n, %): 2/4,
50%. Moderate: GICU (n, %): 4/12, 33%; MICU (n, %): 0.25,
25%. Major: GICU (n, %): 2/12, 16%; MICU (n, %): 1/4, 25%.
Individuals in depression A: EDL GICU: 4/12 UDD, 3/12 UDN,
4/12 TN, 1/12 LDS; EDL MICU: 1/4 TN, 3/4 LDS; LWT mean
value in GICU: UDD 14 years, UDN–TN 2 years LDS 3 years. B:
LWT mean value in MICU: UDN–TN 8 years, LDS 2 years.
Conclusion Results showed a higher rate of depression occur-
rence in GICU and especially to individuals bearing a university
degree and having more than 10 years LWT in the ICU.
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Introduction Withdrawal of active treatment (WoT) is increasingly
important as the mode of dying for patients treated in intensive
care units (ICUs). The objective of this study was to ascertain
whether ICU nurses feel adequately prepared to meet the chal-
lenges this presents.
Method The study was performed in the 30-bed general adult ICU
of an academic medical centre, using a self-administered, cross-
sectional survey, comprising mainly closed questions and Likert
scale responses to set statements, allowing numeric values to be
assigned and an overall ‘confidence score’ to be calculated.
Content and face validity of the tool were appraised through a pilot
study. The following key factors were addressed: nurses’ previous
education regarding WoT, how beneficial they believed this to
have been, their previous experiences of WoT, their confidence in
their ability to communicate within the multidisciplinary team (MDT)S126
and with relatives, their knowledge of the legal issues raised during
WoT, and their priorities for strategies to improve the WoT
process.
Results One hundred and twenty-seven nurses were surveyed and
94 (74%) responded, of whom 91 (97%) had experienced with-
drawal of treatment (WoT). The mean overall confidence score was
2.78±0.5, but this was significantly higher (i.e. more confident) by
nursing grade, previous experience and previous education
(P<0.0005 for all). Sixty-two per cent of nurses felt able to repre-
sent their own views and 81% the patient and/or family’s views
within the MDT, while 64% felt confident communicating with the
family. Forty-three per cent of nurses had received some form of
education addressing WoT, but only 55% felt it had benefited their
practice. Fifty per cent were unsure of the legal issues surrounding
WoT, and 72% felt unclear of the correct process for WoT. The
three strategies felt most likely to improve WoT were written guide-
lines (74%), full supervision of first experience of WoT (79%) and
a rostered study day (86%).
Conclusion  This survey shows that ICU nurses are uncertain
about their own abilities and the process when addressing WoT. It
confirms that both experience and education increase confidence
and perceived knowledge, but suggests that education should be
more effective. A more structured approach to WoT may also be of
benefit.
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Objective To examine the incidence and predictors of clinician dis-
comfort about daily advanced life support plans for ICU patients.
Design Prospective international cohort study.
Setting Thirteen university-affiliated ICUs in Canada, the United
States, Australia and Sweden.
Patients Six hundred and thirty-three mechanically ventilated
adults with an expected ICU length of stay of 72 hours or more.
Measurements We documented the daily plan for advanced life
support and asked the bedside nurse, ICU resident and physician
how comfortable they were with this plan. If they were uncomfort-
able, they stated whether the plan was too technologically intense
or not intense enough, and why. We used hierarchical logistic
regression to examine predictors of discomfort.
Results Of 15,800 observations, 1294 (8.2%) indicated discom-
fort with the life support plan. At least one clinician was uncom-
fortable on at least one occasion for 295 (46.6%) patients.
Discomfort occurred more often when the plan was too intense
than when the plan was not intense enough (94.7% vs 5.3%,
P<0.001). We found the following factors independently pre-
dicted discomfort because the plan was too intense: patient age
(odds ratio [OR] 1.19, 95% CI 1.07–1.33 for 10 year intervals),
APACHE II score (OR 1.23, 1.09–1.38 for five-point intervals),
medical admission (OR 2.66, 1.65–4.29), poor prior functional
status (OR 3.52, 1.98–6.26 compared with good functional
status), daily organ dysfunction (OR 1.60, 1.25–2.04 for each
five-point interval), dialysis in the ICU (OR 3.09, 2.05–4.66), plan
to withhold dialysis (OR 2.03, 1.52–2.70), plan to withhold
mechanical ventilation (OR 0.20, 0.06–0.65), first week in the ICU
(OR 1.76, 1.40–2.22), clinician (OR 1.92, 1.75–2.10 for nurse
versus resident and OR 1.57, 1.43–2.1 for attending physician
versus resident), and city.
Conclusions Clinicians often experience discomfort about life
support plans for mechanically ventilated patients. Discomfort occurs
more often among nurses and is more likely for older, more severely
ill medical patients developing acute renal failure, and for extubated
patients for whom there are no plans to withhold ventilation.
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Objective To determine attitudes and practices of the Turkish
anesthesiologists about Do-Not-Resuscitate (DNR) orders and to
recommend educational programs to improve the understanding of
the role of the anesthesiologist in end-of-life care.
Design An anonymous questionnaire consisting of 18 questions
was mailed to 439 members of the Turkish Society of Anesthesiol-
ogy and Reanimation, and 369 returned responses were evaluated.
Results Three hundred and sixty-nine questionnaires were returned
(84% response). Of the respondents, 56% were male 44% female.
Over 90% of the respondents indicated that they were Muslim.
One-half of respondents work in hospitals with more than 800
beds; 49.1% of respondents had an intensive care unit facility of
seven to 12 beds. We found that 66% of respondents had initiated
written or oral (94.2%) DNR orders most frequently after discussing
with colleagues (82.7%). Clinical scenarios provided specific exam-
ples of the decision-making challenges facing the anesthesiologist.
In these examples, support was most often continued even whenS127
the patient had no chance of meaningful recovery no matter
whether the patient had family or not. In this situation, male physi-
cians and physicians having intensive care unit experiences of less
than 5 years showed significantly high rates of maintaining full life
support (62.1% and 61.0%, respectively), even when the family
desired that support be withdrawn. Experience also influenced deci-
sion-making independence. Physicians with less experience indi-
cated that decisions should be made by concensus more often than
did those with over 5 years of experience in intensive care medicine.
Younger physicians also indicated a greater concern about the
potential to be punished for decisions to withhold or withdraw care
than did those with more years of experience.
Conclusions This study defined the attitudes of Turkish anesthesi-
ologists about end-of-life care and DNR orders. While a number of
similarities were found between Turkish physicians and those from
other countries, some specific differences could be identified, par-
ticularly related to concensus decision making and to sharing infor-
mation with other providers and the value of ethics committees in
the decision-making process, even when the family and physicians
concur on the plans for further care.
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Introduction Advance directives (AD) in the form of cardiopul-
monary resuscitation orders are a specific set of interventions in
response to a cardiopulmonary arrest. A priori documentation and
subsequent availability of ADs at the point of care increases the
probability that diagnostic, therapeutic and palliative interventions
will be administered to patients within the framework of these
preferences.
Objectives We conducted a systematic review of educational
advance care planning interventions for adults without terminal
illness to determine their influence on the completion rate of
advance directives for cardiopulmonary resuscitation.
Methods We searched MEDLINE, the Cochrane Library, all
retrieved trials and pertinent reviews for trials published between
1981 and September 2002. We included randomized trials
enrolling patients ≥18 years of age, evaluating an educational inter-
vention comprised of at least one of: written, audio, or video materi-
als, or direct counseling, and whether an outcome included the
completion rate of an advance directive. We appraised the quality
of each trial in terms of methodology and reporting transparency
(quality score range 0–10).
Results We included nine randomized trials enrolling 3206
patients. A variety of interventions were evaluated, primarily among
Caucasian patients, including direct individual counseling,
brochures, both direct counseling and brochures, and direct coun-
seling plus brochures with a video presentation. Some trials
included reminders as part of the intervention. Overall, the method-
ologic quality and reporting transparency were poor, reflected in a
median composite quality score of 5 (interquartile range 4.5–6.0).
The odds ratios for the completion rate of an advance directive
ranged from 0.41 to 106.0 across the trials (test of heterogeneity
P<0.001). The summary odds ratio for these educational interven-
tions was 3.71 (95% CI 1.46, 9.40). Trials with greater method-
ologic rigor and reporting transparency were associated with a
more conservative estimate of the effect, 2.42 [0.96, 6.10], com-
pared with 28.69 [5.08, 162.06] for less rigorous and poorly
reported trials (P=0.013 for the difference).
Conclusions Busy clinicians may use simple educational interven-
tions to increase the completion rate of advance directives docu-
menting patient preferences for cardiopulmonary resuscitation.
Understanding the influence of these interventions on other clini-
cally important outcomes is worthy of further research.
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Background Many patients have an unrealistic gloomy perception of
their prognosis despite realistic appraisals, together with an under-
standable explanation of the pertinent clinical features of the disease.
It has been established that the incidence of psychological complica-
tions and postoperative psychosis is higher in cardiac surgery.
Long-term cognitive changes post CABG has received less atten-
tion and, as up to 42% patients perform below baseline level, it is
understandable that doubt and uncertainty becomes part of their
lives. Patient-perceived quality of life after CABG proved about
one-quarter of the interviewed expressed dissatisfaction concern-
ing their present quality of life. The aim is to determine whether an
effective lifestyle adaptation program post CABG could enhance
the quality of life of the CABG patient.
Methods A qualitative study in which the experiences, as lived, of
the patient and his/her family postoperatively was described in
naïve sketches. The approach was phenomenological This was
completed in a period 2 weeks–2 years post CABG. In the naïve
sketch, the patients were asked to summarize their anxieties,
uncertainties and new demands after the CABG.
Results Among the patients studied, the context being a cardio-
thoracic unit where the patients received assistance in the recuper-
ative phase, 57% summarized anxieties, 37% summarized
uncertainties and 60% summarized new demands post CABG.
Conclusion  The major surgical intervention, the coronary artery
bypass surgery, the operation procedure itself, engrosses theS128
patients’ psyche in such a manner that limitation of space is left for
the thought of lifestyle adaptation thereafter. If intensive care is
truly to develop as a speciality it has to understand the complete
path of the illness process. The critical care nurses are the lifelines
in these criteria. More time should be spent and more support
should be provided in the recuperative phase post CABG. A reha-
bilitation program is warranted.
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Introduction Post-traumatic lung injuries with consecutive ALI and
ARDS are frequent injuries in trauma populations. There is only a
small body of literature dealing with late sequaela of ALI and
ARDS. To evaluate the long-term disability and disorders of lung
function in these patients, we initiated a prospective, nonran-
domised study.
Patients and methods The study population was recruited from a
group of 111 patients from a former study dealing with position
therapy for the treatment of acute lung injuries. Patients were
included if they survived the initial injuries and were avaliable for
pulmonary function testing and had a minimal followup of 1 year. In
all included patients the pulmonary function were tested in the lab-
oratory with a bodyplethysmograph from Jaeger (Wuerzburg,
Germany). The bellows function included vital capacity (VC [l]) and
forced expiratory volume in 1s (FEV1 [l]). In addition, blood
samples for the calculation of capillary blood oxygenation were col-
lected. The pO2/FiO2 rational was calculated. The respiratory data
were compared with a control group from historical literature-
based data including 49 patients. n=19 patients were avaliable for
physical evaluation.
Statistics The initial ISS of the population was 40 (15–59), age
40.5 years (19–71), the initial paO2/FiO2 was 286 (95–466). Time
on the respirator was 14.3 days (3–31).
Results The results of the laboratory examination are presented in
Table 1.
Discussion: The presented study demonstrates a moderate reduc-
tion in respiratory function (VC, FEV1) 1 year after severe chest
injury. Our pulmonary outcome data could not demonstrate a sig-
nificant difference to the historical control group. Blood gas analy-
sis and cardiopulmonary function were normal with the exception
of one case. In conclusion, we postulate that severe injury to the
chest leads to a moderate decrease of pulmonary function in poly-
trauma patients with ALI and ARDS.
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Table 1
Statistical 
Laboratory data G1a G2 [1] G3 [2] significance
VC (l) 89.0 87.0 81.0 NS
FEV1 (l) 79.3 88.0 81.0 NS
a Author study group. NS, not significant.
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Introduction Few studies have analyzed health-related quality of
life (HRQOL) in survivors of acute respiratory distress syndrome
(ARDS) taking prehospitalization baseline data into account.
Patients and methods From June 1997 to May 1999, all admis-
sions (≥18 years) to our medical intensive care unit (ICU), an acad-
emic referral center, who developed ARDS according to the
American–European Consensus Conference definition were eligi-
ble. Baseline HRQOL measures were collected by interview during
the first 24 hours of the ICU stay and 6 months after admission
using a HRQOL questionnaire specifically designed for critically ill
patients [1]. A clinically relevant change score was determined by
survivors ratings of global health change since ICU admission.
Results The 265 enrolled patients had a mean age of 59±16
(±SD) years, median 62 years; 58% were male. The mean ICU
length of stay was 19±23 days, median 11 days; the mean
APACHE II score after 24 hours was 27±9, mean time requiring
mechanical ventilation was 17±22 days, median 9 days. The
most prevalent predisposing conditions for ARDS were pneumo-
nia and severe sepsis. Cumulative mortality rates were 51% in the
ICU, 59% in the hospital, and 65% at 6 months followup. At fol-
lowup, HRQOL data could be obtained in 87 ARDS survivors; six
patients were lost to followup. A change score of –15% was con-
sidered as a relevant deterioration using survivors ratings of health
transition. Compared with baseline data, a relevant deterioration
of HRQOL was reported by 18 (21%) patients in the domain
basic physiologic activities, by 31 (35%) patients in the domain
activities of daily life, and by 29 (33%) patients in the mental
health domain. The majority of the survivors (84%) were living at
home and 76% of those previously in employment had returned to
their former work. Eighty-one survivors (93%) reported that theyS129
would be willing to undergo intensive care again if medically nec-
essary in the future.
Conclusion Compared with prehospitalization HRQOL, about
one-third of our ARDS survivors reported a relevant deterioration in
various HRQOL domains. Satisfaction with care and the return-to-
work rate was high in our sample of medical ARDS survivors.
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